<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Interventions for increasing immunosuppressant medication adherence in solid organ transplant recipients - Mellon, L - 2022 | Cochrane Library</title> <meta content="Interventions for increasing immunosuppressant medication adherence in solid organ transplant recipients - Mellon, L - 2022 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012854.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Interventions for increasing immunosuppressant medication adherence in solid organ transplant recipients - Mellon, L - 2022 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012854.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD012854.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Interventions for increasing immunosuppressant medication adherence in solid organ transplant recipients" name="citation_title"/> <meta content="Lisa Mellon" name="citation_author"/> <meta content="RCSI University of Medicine and Health Sciences" name="citation_author_institution"/> <meta content="lisamellon@rcsi.ie" name="citation_author_email"/> <meta content="Frank Doyle" name="citation_author"/> <meta content="RCSI University of Medicine and Health Sciences" name="citation_author_institution"/> <meta content="Anne Hickey" name="citation_author"/> <meta content="RCSI University of Medicine and Health Sciences" name="citation_author_institution"/> <meta content="Kenneth D Ward" name="citation_author"/> <meta content="University of Memphis" name="citation_author_institution"/> <meta content="Declan G de Freitas" name="citation_author"/> <meta content="Beaumont Hospital" name="citation_author_institution"/> <meta content="P Aiden McCormick" name="citation_author"/> <meta content="St Vincent's University Hospital" name="citation_author_institution"/> <meta content="Oisin O'Connell" name="citation_author"/> <meta content="Mater Misericordiae University" name="citation_author_institution"/> <meta content="Peter Conlon" name="citation_author"/> <meta content="Beaumont Hospital" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="9" name="citation_issue"/> <meta content="10.1002/14651858.CD012854.pub2" name="citation_doi"/> <meta content="2022" name="citation_date"/> <meta content="2022/09/12" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012854.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012854.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012854.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Graft Rejection [drug therapy, prevention &amp; control]; *Immunosuppressive Agents [adverse effects]; Medication Adherence; *Organ Transplantation; Transplant Recipients" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012854.pub2&amp;doi=10.1002/14651858.CD012854.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012854.pub2&amp;doi=10.1002/14651858.CD012854.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012854.pub2&amp;doi=10.1002/14651858.CD012854.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012854.pub2&amp;doi=10.1002/14651858.CD012854.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012854.pub2&amp;doi=10.1002/14651858.CD012854.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012854.pub2&amp;doi=10.1002/14651858.CD012854.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012854.pub2&amp;doi=10.1002/14651858.CD012854.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012854.pub2&amp;doi=10.1002/14651858.CD012854.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012854.pub2&amp;doi=10.1002/14651858.CD012854.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012854.pub2&amp;doi=10.1002/14651858.CD012854.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012854.pub2&amp;doi=10.1002/14651858.CD012854.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012854.pub2&amp;doi=10.1002/14651858.CD012854.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012854.pub2&amp;doi=10.1002/14651858.CD012854.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012854.pub2&amp;doi=10.1002/14651858.CD012854.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012854.pub2&amp;doi=10.1002/14651858.CD012854.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012854.pub2&amp;doi=10.1002/14651858.CD012854.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012854.pub2&amp;doi=10.1002/14651858.CD012854.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012854.pub2&amp;doi=10.1002/14651858.CD012854.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012854.pub2&amp;doi=10.1002/14651858.CD012854.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012854.pub2&amp;doi=10.1002/14651858.CD012854.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012854.pub2&amp;doi=10.1002/14651858.CD012854.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012854.pub2&amp;doi=10.1002/14651858.CD012854.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012854.pub2&amp;doi=10.1002/14651858.CD012854.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="zCmos3jT";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD012854\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD012854\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012854\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012854\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","zh_HANS","zh_HANT","pt","ms","ja","fa","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD012854.pub2",title:"Interventions for increasing immunosuppressant medication adherence in solid organ transplant recipients",firstPublishedDate:"Sep 12, 2022 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Kidney and Transplant Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=zCmos3jT&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012854.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012854.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD012854.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD012854.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012854.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD012854.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD012854.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD012854.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD012854.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD012854.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>3703 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD012854.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012854.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012854.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012854.pub2/full#CD012854-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012854.pub2/full#CD012854-sec-0081"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012854.pub2/full#CD012854-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012854.pub2/full#CD012854-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012854.pub2/full#CD012854-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012854.pub2/full#CD012854-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012854.pub2/full#CD012854-sec-0041"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012854.pub2/full#CD012854-sec-0075"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012854.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012854.pub2/appendices#CD012854-sec-0086"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012854.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012854.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/supinfo/CD012854StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/supinfo/CD012854StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012854.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012854.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012854.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012854.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012854.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD012854.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2022 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Interventions for increasing immunosuppressant medication adherence in solid organ transplant recipients </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012854.pub2/information#CD012854-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Lisa Mellon</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012854.pub2/information#CD012854-cr-0005">Frank Doyle</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012854.pub2/information#CD012854-cr-0006">Anne Hickey</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012854.pub2/information#CD012854-cr-0007">Kenneth D Ward</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012854.pub2/information#CD012854-cr-0008">Declan G de Freitas</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012854.pub2/information#CD012854-cr-0009">P Aiden McCormick</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012854.pub2/information#CD012854-cr-0010">Oisin O'Connell</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012854.pub2/information#CD012854-cr-0011">Peter Conlon</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/information/en#CD012854-sec-0091">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 12 September 2022 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD012854.pub2">https://doi.org/10.1002/14651858.CD012854.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD012854-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012854-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD012854-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD012854-abs-0016">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012854-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012854-abs-0014">Français</a> </li> <li class="section-language"> <a class="" href="full/pt#CD012854-abs-0008">Português</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012854-abs-0005">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD012854-abs-0001" lang="en"> <section id="CD012854-sec-0001"> <h3 class="title" id="CD012854-sec-0001">Background</h3> <p>Non‐adherence to immunosuppressant therapy is a significant concern following a solid organ transplant, given its association with graft failure. Adherence to immunosuppressant therapy is a modifiable patient behaviour, and different approaches to increasing adherence have emerged, including multi‐component interventions. There has been limited exploration of the effectiveness of interventions to increase adherence to immunosuppressant therapy. </p> </section> <section id="CD012854-sec-0002"> <h3 class="title" id="CD012854-sec-0002">Objectives</h3> <p>This review aimed to look at the benefits and harms of using interventions for increasing adherence to immunosuppressant therapies in solid organ transplant recipients, including adults and children with a heart, lung, kidney, liver and pancreas transplant. </p> </section> <section id="CD012854-sec-0003"> <h3 class="title" id="CD012854-sec-0003">Search methods</h3> <p>We searched the Cochrane Kidney and Transplant Register of Studies up to 14 October 2021 through contact with the Information Specialist using search terms relevant to this review. Studies in the Register were identified through searches of CENTRAL, MEDLINE, and EMBASE, conference proceedings, the International Clinical Trials Register (ICTRP) Search Portal and ClinicalTrials.gov. </p> </section> <section id="CD012854-sec-0004"> <h3 class="title" id="CD012854-sec-0004">Selection criteria</h3> <p>All randomised controlled trials (RCTs), quasi‐RCTs, and cluster RCTs examining interventions to increase immunosuppressant adherence following a solid organ transplant (heart, lung, kidney, liver, pancreas) were included. There were no restrictions on language or publication type. </p> </section> <section id="CD012854-sec-0005"> <h3 class="title" id="CD012854-sec-0005">Data collection and analysis</h3> <p>Two authors independently screened titles and abstracts of identified records, evaluated study quality and assessed the quality of the evidence using the GRADE approach. The risk of bias was assessed using the Cochrane tool. The ABC taxonomy for measuring medication adherence provided the analysis framework, and the primary outcomes were immunosuppressant medication initiation, implementation (taking adherence, dosing adherence, timing adherence, drug holidays) and persistence. Secondary outcomes were surrogate markers of adherence, including self‐reported adherence, trough concentration levels of immunosuppressant medication, acute graft rejection, graft loss, death, hospital readmission and health‐related quality of life (HRQoL). Meta‐analysis was conducted where possible, and narrative synthesis was carried out for the remainder of the results. </p> </section> <section id="CD012854-sec-0006"> <h3 class="title" id="CD012854-sec-0006">Main results</h3> <p>Forty studies involving 3896 randomised participants (3718 adults and 178 adolescents) were included. Studies were heterogeneous in terms of the type of intervention and outcomes assessed. The majority of studies (80%) were conducted in kidney transplant recipients. Two studies examined paediatric solid organ transplant recipients. The risk of bias was generally high or unclear, leading to lower certainty in the results. Initiation of immunosuppression was not measured by the included studies. </p> <p>There is uncertain evidence of an association between immunosuppressant medication adherence interventions and the proportion of participants classified as adherent to taking immunosuppressant medication (4 studies, 445 participants: RR 1.09, 95% CI 0.95 to 1.20; I² = 78%). There was very marked heterogeneity in treatment effects between the four studies evaluating taking adherence, which may have been due to the different types of interventions used. There was evidence of increasing dosing adherence in the intervention group (8 studies, 713 participants: RR 1.14, 95% CI 1.03 to 1.26, I² = 61%).  There was very marked heterogeneity in treatment effects between the eight studies evaluating dosing adherence, which may have been due to the different types of interventions used. It was uncertain if an intervention to increase immunosuppressant adherence had an effect on timing adherence or drug holidays. There was limited evidence that an intervention to increase immunosuppressant adherence had an effect on persistence. </p> <p>There was limited evidence that an intervention to increase immunosuppressant adherence had an effect on secondary outcomes. For self‐reported adherence, it is uncertain whether an intervention to increase adherence to immunosuppressant medication increases the proportion of participants classified as medically adherent to immunosuppressant therapy (9 studies, 755 participants: RR 1.21, 95% CI 0.99 to 1.49; I² = 74%; very low certainty evidence). Similarly, it is uncertain whether an intervention to increase adherence to immunosuppressant medication increases the mean adherence score on self‐reported adherence measures (5 studies, 471 participants: SMD 0.65, 95% CI ‐0.31 to 1.60; I² = 96%; very low certainty evidence). For immunosuppressant trough concentration levels, it is uncertain whether an intervention to increase adherence to immunosuppressant medication increases the proportion of participants who reach target immunosuppressant trough concentration levels (4 studies, 348 participants: RR 0.98, 95% CI 0.68 to 1.40; I² = 40%; very low certainty evidence). It is uncertain whether an intervention to increase adherence to immunosuppressant medication may reduce hospitalisations (5 studies, 460 participants: RR 0.67, 95% CI 0.44 to 1.02; I² = 64%; low certainty evidence). There were limited, low certainty effects on patient‐reported health outcomes such as HRQoL. There was no clear evidence to determine the effect of interventions on secondary outcomes, including acute graft rejection, graft loss and death. No harms from intervention participation were reported. </p> </section> <section id="CD012854-sec-0007"> <h3 class="title" id="CD012854-sec-0007">Authors' conclusions</h3> <p>Interventions to increase taking and dosing adherence to immunosuppressant therapy may be effective; however, our findings suggest that current evidence in support of interventions to increase adherence to immunosuppressant therapy is overall of low methodological quality, attributable to small sample sizes, and heterogeneity identified for the types of interventions. Twenty‐four studies are currently ongoing or awaiting assessment (3248 proposed participants); therefore, it is possible that findings may change with the inclusion of these large ongoing studies in future updates. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD012854-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012854-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD012854-abs-0004">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD012854-abs-0017">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012854-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012854-abs-0015">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD012854-abs-0011">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD012854-abs-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pt#CD012854-abs-0009">Português</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012854-abs-0006">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD012854-abs-0007">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD012854-abs-0002" lang="en"> <h3>Interventions to increase immunosuppressant medication adherence after a solid organ transplant </h3> <p><b><i>What is the issue?</i> </b> </p> <p>Solid organ transplantation refers to the transplantation of the heart, lungs, kidney, pancreas or liver. After a solid organ transplant, immunosuppressant medication works to suppress the immune system and ensure the short and long‐term survival of the organ transplant. Taking the immunosuppressant medication at the correct time and at the correct dose is a critical part of post‐transplant care. However, non‐adherence to immunosuppressant medication is frequent and can be a common reason for transplant failure. Clear evidence is required to identify effective interventions that increase immunosuppressant medication adherence following a solid organ transplant. </p> <p><b><i>What did we do?</i> </b> </p> <p>We searched the literature to find studies that described an intervention to increase immunosuppressant medication adherence after a heart, lung, kidney, pancreas or liver transplant. We collected information from the studies and combined this to identify if an intervention was helpful. We examined the quality of these interventions to judge how certain we could be that the effects we observed were reliable. </p> <p><b><i>What did we find?</i> </b> </p> <p>We found 40 studies that involved 3718 adults and 178 adolescents. The majority of studies included participants with a kidney transplant. We found that the types of interventions varied across the studies, and 27 studies included more than one approach to increase immunosuppressant medication adherence. We found some evidence to support the effectiveness of interventions to increase taking the correct dosage of medication. It was unclear whether using an intervention increased adherence to immunosuppressant medication following a solid organ transplant. It was also unclear if interventions affected concentrations of immunosuppressant medication in the blood, rates of transplant rejection, death, the need for hospital admission and health‐related quality of life. There was low confidence in the information about the effects of interventions as some studies were small, the types of interventions varied, and studies defined and measured medication adherence in different ways. We didn't find enough information to assess whether certain types of interventions were more effective than other types. </p> <p><b><i>Conclusions</i> </b> </p> <p>Our findings suggest that the current research evidence examining interventions to increase adherence to immunosuppressant therapy is of low quality, attributable to variability in the type of intervention delivered, the overall low number of participants receiving the intervention, and significant variation in how medication adherence is defined and measured. Existing data provided information that indicated the possible benefits of the interventions for increasing adherence in terms of taking medication and taking the correct dose. No harms related to intervention participation were identified. There are 24 studies either yet to be completed or final results published that weren't included in this review, so a future update of this review may show more certainty in whether an intervention can increase adherence to immunosuppressant medication following a solid organ transplant. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD012854-sec-0081" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD012854-sec-0081"></div> <h3 class="title" id="CD012854-sec-0082">Implications for practice</h3> <section id="CD012854-sec-0082"> <p>Overall, we conclude that the current low certainty evidence may suggest a potential benefit of interventions to increase adherence to immunosuppressant medication in increasing dosing adherence in the solid organ transplant population. However, the quality of the evidence is at present insufficient to provide direction to practitioners working with post‐transplant patients. Specific strategies to maintain clinically advised levels of adherence to immunosuppressants haven't been identified, and such strategies remain absent from treatment guidelines to date. It is important to note that this review identified 22 ongoing studies and two studies awaiting assessment (3248 proposed participants), which reinforces that immunosuppressant medication adherence interventions remain an important priority in post‐transplant settings. A future update of this review may have different results and lead to a better understanding of the effectiveness of interventions to increase immunosuppressant medication adherence. </p> </section> <h3 class="title" id="CD012854-sec-0083">Implications for research</h3> <section id="CD012854-sec-0083"> <p>Electronic Monitoring (EM) is considered the gold standard in the measurement of medication adherence as it allows for intensive recording of each phase of medication‐taking behaviour on a day‐to‐day basis, which reflects adherence over time (<a href="./references#CD012854-bbs2-0088" title="FineRN , BeckerY , De GeestS , EisenH , EttengerR , EvansR , et al. Nonadherence consensus conference summary report. American Journal of Transplantation2009;9(1):35-41. [MEDLINE: 19133930]">Fine 2009</a>). However, there are limitations to EM as a form of measurement. For example, removing medication from an EM device is not proof of medication ingestion; device failure can occur, or there may be an inability to engage with technology, in addition to the personal or health system expense of EM devices (<a href="./references#CD012854-bbs2-0117" title="VrijensB , DimaAL , Van GanseE , vanBovenJF , EakinMN , FosterJM , et al. What we mean when we talk about adherence in respiratory mMedicine. Journal of Allergy &amp; Clinical Immunology in Practice2016;4(5):802-12. [MEDLINE: 27587314]">Vrijens 2016</a>). When considering surrogate objective markers of adherence, 15 studies reported the immunosuppressant trough concentration levels; however, there was considerable heterogeneity in the clinically relevant cut‐offs applied to define non‐adherence. Furthermore, it has been highlighted previously that changes in blood levels may not be a useful surrogate marker of adherence, given that a range of factors other than patient non‐adherence can affect intra‐individual variability of dose‐corrected immunosuppressant trough concentration levels, including the specific analytical assay, diarrhoea, drug‐drug interactions, generic medication substitutions, diet and genetic polymorphisms (<a href="./references#CD012854-bbs2-0002" title="BessaA , MedinaJ , TedescoH , FelipeC . A prospective, randomised, controlled study to assess the effect of pharmaceutical intervention on compliance and knowledge of immunosuppression in kidney transplant recipients [abstract no: DI-090]. European Journal of Hospital Pharmacy2015;22(Suppl 1):A109-10. [EMBASE: 614322295]BessaAB , FelipeCR , HannunP , SayuriP , FelixMJ , RuppelP , et al. Prospective randomized trial investigating the influence of pharmaceutical care on the intra-individual variability of tacrolimus concentrations early after kidney transplant. Therapeutic Drug Monitoring2016;38(4):447-55. [MEDLINE: 27414973]">Bessa 2016</a>). The consequences of non‐adherence may not be immediately clinically evident; therefore, the impact of non‐adherence on clinical outcomes is difficult to assess in studies of small sample sizes and short follow‐up duration. Multi‐measurement approaches are found to have the highest sensitivity (72%) and specificity (42%), particularly self‐report, assay and clinician reports, when compared to EM (<a href="./references#CD012854-bbs2-0088" title="FineRN , BeckerY , De GeestS , EisenH , EttengerR , EvansR , et al. Nonadherence consensus conference summary report. American Journal of Transplantation2009;9(1):35-41. [MEDLINE: 19133930]">Fine 2009</a>). It is recommended that the most appropriate adherence assessment should include multiple methods, including indirect surrogate markers of adherence. In this multi‐method approach, clear operationalisation of adherence measurement is critical for transparency in interpreting research findings. In addition, classifying patients as ‘adherent’ versus ‘non‐adherent’ serves to increase heterogeneity in comparing evidence on different intervention types; therefore, it is recommended to avoid categorisation of adherence in the absence of a strong rationale for this form of adherence operationalisation. </p> <p>Sixty‐eight per cent of interventions in this review were multi‐component interventions, which included two or more behaviour change techniques. It is difficult to untangle the ‘black box’ of multi‐component interventions to identify the effective components, and it is recommended that future studies describe intervention components using the Behaviour Change Technique taxonomy (<a href="./references#CD012854-bbs2-0101" title="MichieS , RichardsonM , JohnstonM , AbrahamC , FrancisJ , HardemanW , et al. The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behavior change interventions. Annals of Behavioral Medicine2013;46(1):81-95. [MEDLINE: 23512568]">Michie 2013</a>) to provide clarity in intervention description and identification of active components when studying intervention effectiveness. Lastly, there is a need to integrate economic evaluations into trial methodology in order to identify unnecessary healthcare expenditure through ineffective interventions to reduce non‐adherence to immunosuppressant medication. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD012854-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD012854-sec-0008"></div> <div class="table" id="CD012854-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Interventions for increasing immunosuppressant medication adherence versus standard care in solid organ transplant recipients</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Interventions for increasing immunosuppressant medication adherence versus standard care in solid organ transplant recipients</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> solid organ transplant recipients<br/><b>Setting:</b> transplant units and outpatient clinics </p> <p><b>Intervention:</b> interventions for increasing immunosuppressant medication adherence<br/><b>Comparison:</b> standard care </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b> </b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with standard care</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with interventions</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Taking adherence</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p> 819 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>893 per 1000</p> <p>(778 to 1000)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> RR 1.09<br/>(0.95 to 1.27) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> 445 (4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2 3 4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interventions were heterogeneous single and multi‐component interventions. Outcome was measured by electronic monitoring devices </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dosing adherence</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>778 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>887 per 1000</p> <p>(801 to 980)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 1.14<br/>(1.03 to 1.26) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>713 (8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/>LOW <sup>1 2 3 4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interventions were heterogeneous single and multi‐component interventions. Outcome was measured via electronic monitoring devices and pharmacy reconciliation </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Timing adherence</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>805 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>885 per 1000</p> <p>(789 to 990)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 1.10<br/>(0.98 to 1.23) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>632 (6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/>LOW <sup>1 2 3 4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interventions were heterogeneous single and multi‐component interventions. Outcome was measured by electronic monitoring devices </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drug holidays</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>676 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>757 per 1000</p> <p>(520 to 1000)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 1.12<br/>(0.77 to 1.62) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>445 (4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/>LOW <sup>1 2 3 4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interventions were heterogeneous single and multi‐component interventions. Outcome was measured by electronic monitoring devices </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Self‐reported adherence (proportion)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>586 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>709 per 1000</p> <p>(580 to 873)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.21<br/>(0.99 to 1.49) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>755 (9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2 3 4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions were heterogeneous single and multi‐component interventions.</p> <p>Self‐report measures included:</p> <p>Basel Assessment of Adherence to Immunosuppressant Medication Scale</p> <p>Immunosuppressant Therapy Adherence Scale</p> <p>MMAS</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Self‐reported adherence (mean)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p> ‐‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SMD was 0.65 higher with the intervention compared to the control<br/>(0.31 lower to 1.60 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>471 (5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2 3 4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions were heterogeneous single and multi‐component interventions.</p> <p>Self‐report measures were heterogenous, and tools included:</p> <p> <ul id="CD012854-list-0001"> <li> <p>Immunosuppressant Therapy Adherence Scale</p> </li> <li> <p>Transplant Effects Questionnaire, Adherence Subscale</p> </li> <li> <p>MMAS</p> </li> <li> <p>Medical Adherence Measure Medication Module</p> </li> </ul> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of immunosuppressant trough concentration levels at target</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>367 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>360 per 1000</p> <p>(249 to 514)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.98<br/>(0.68 to 1.40) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>348 (4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2 3 4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions were heterogeneous single and multi‐component interventions.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>SMD:</b> standardised mean difference </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded one level for inconsistency in intervention type </p> <p><sup>2</sup> Downgraded for inconsistency in outcome measurement </p> <p><sup>3</sup> Downgraded one level for uncertain or high risk of bias </p> <p><sup>4</sup> Downgraded one level for imprecision (small sample size or small number of events, confidence intervals overlap) </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD012854-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD012854-sec-0009"></div> <section id="CD012854-sec-0010"> <h3 class="title" id="CD012854-sec-0010">Description of the condition</h3> <p>Solid organ transplantation refers to the transplantation of the heart, lungs, kidney, liver or pancreas from a deceased or living donor (<a href="./references#CD012854-bbs2-0096" title="LindenPK . History of solid organ transplantation and organ donation. Critical Care Clinics2009;25(1):165-84. [MEDLINE: 19268801]">Linden 2009</a>). Solid organ transplantation is regarded as a highly successful form of intervention following irreversible organ failure, with transplant success rates varying across organ types and the age of the recipient. Median graft survival for an adult kidney transplant recipient is estimated to be 11.7 years for a deceased donor and 19.2 years for a living donor. In paediatric (0 to 18 years) kidney transplant recipients, graft survival is estimated as 91.5% for deceased donors and 96.4% for living donors (<a href="./references#CD012854-bbs2-0087" title="ERA-EDTA Registry. ERA-EDTA Registry Annual Report 2015. Academic Medical Center, Department of Medical Informatics, Amsterdam, the Netherlands, 2015. www.era-edta-reg.org/files/annualreports/AnnRep2015.pdf (accessed 31 March 2022).">ERA‐EDTA 2015</a>). For heart transplantation, one‐year graft survival is estimated at 13 years (<a href="./references#CD012854-bbs2-0098" title="LundLH , EdwardsLB , DipchandAI , GoldfarbS , KucheryavayaAY , LevveyBJ , et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-third Adult Heart Transplantation Report-2016; Focus Theme: Primary Diagnostic Indications for Transplant. Journal of Heart &amp; Lung Transplantation2016;10(35):1158-69. [MEDLINE: 27772668]">Lund 2016</a>) and 15.7 to 21.5 years for paediatric recipients (<a href="./references#CD012854-bbs2-0108" title="RossanoJW , DipchandAI , EdwardsLB , GoldfarbS , KucheryavayaAY , Levvey RnBJ , et al. The Registry of the International Society for Heart and Lung Transplantation: Nineteenth Pediatric Heart Transplantation Report-2016; Focus Theme: Primary Diagnostic Indications for Transplant. Journal of Heart &amp; Lung Transplantation2016;35(10):1185-95. [MEDLINE: 27772670]">Rossano 2016</a>). For lung transplantation, median graft survival is estimated as 8 years for adults (<a href="./references#CD012854-bbs2-0119" title="YusenRD , EdwardsLB , DipchandAI , GoldfarbSB , KucheryavayaAY , LevveyBJ , et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-third Adult Lung and Heart-Lung Transplant Report-2016; Focus Theme: Primary Diagnostic Indications for Transplant. Journal of Heart &amp; Lung Transplantation2016;35(10):1170-84. [MEDLINE: 27772669]">Yusen 2016</a>) and 5.4 years for paediatric recipients (<a href="./references#CD012854-bbs2-0090" title="GoldfarbSB , LevveyBJ , EdwardsLB , DipchandAI , KucheryavayaAY , LundLH , et al. The Registry of the International Society for Heart and Lung Transplantation: Nineteenth Pediatric Lung and Heart-Lung Transplantation Report-2016; Focus Theme: Primary Diagnostic Indications for Transplant. Journal of Heart &amp; Lung Transplantation2016;35(10):1196-205. [MEDLINE: 27772671]">Goldfarb 2016</a>). For liver, one‐year graft survival is estimated as 79% for adults and 84% for children &gt; 2 years of age (<a href="./references#CD012854-bbs2-0073" title="AdamR , McMasterP , O'GradyJG , CastaingD , KlempnauerJL , JamiesonN , et al. Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry. Liver Transplantation2003;9(12):1231-43. [MEDLINE: 14625822]">Adam 2003</a>). Five‐year graft survival for a pancreas transplant is estimated at &gt; 88% (<a href="./references#CD012854-bbs2-0093" title="GruessnerRW , GruessnerAC . The current state of pancreas transplantation. Nature Reviews Endocrinology2013;9(9):555-62. [MEDLINE: 23897173]">Gruessner 2013</a>), with long‐term graft survival estimated as 9.6 years for paediatric recipients (<a href="./references#CD012854-bbs2-0114" title="SpaggiariM , BissingM , CamparaM , YehCC , TzvetanovI , JeonH , et al. Pancreas transplantation from pediatric donors: a United Network for Organ Sharing Registry analysis. Transplantation2017;101(10):2484-91. [MEDLINE: 28319566]">Spaggiari 2017</a>). </p> <p>Adequate suppression of the immune system is required for short‐ and long‐term survival of the organ transplant; thus, adherence to immunosuppressive therapy forms the central part of the prevention of organ rejection, graft loss and death following an organ transplant. Immunosuppressive strategies and pharmacological agents are consistent across all solid organ transplants and most commonly involve lifelong oral administration of a calcineurin inhibitor (CNI) and an antimetabolite, with or without corticosteroids, in order to sustain a graft free from rejection and minimise the potential for acute or chronic graft loss, or death following transplantation (<a href="./references#CD012854-bbs2-0076" title="ButlerJA , RoderickP , MulleeM , MasonJC , PevelerRC . Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review. Transplantation2004;77(5):769-76. [MEDLINE: 15021846]">Butler 2004</a>; <a href="./references#CD012854-bbs2-0107" title="Posadas SalasMA , SrinivasTR . Update on the clinical utility of once-daily tacrolimus in the management of transplantation. Drug Design, Development &amp; Therapy2014;8:1183-94. [MEDLINE: 25210441]">Posadas Salas 2014</a>). </p> <p>There remains a significant imbalance between organ availability and numbers listed for transplantation, with a shortage of organs for transplantation reported worldwide (<a href="./references#CD012854-bbs2-0109" title="RudgeC , MatesanzR , DelmonicoFL , ChapmanJ . International practices of organ donation. British Journal of Anaesthesia2012;108 Suppl 1:i48-55. [MEDLINE: 22194431]">Rudge 2012</a>). The cost benefits of optimised post‐transplant graft survival are substantial when considering the healthcare cost savings through long‐term successful transplantation (<a href="./references#CD012854-bbs2-0074" title="AnyanwuAC , McGuireA , RogersCA , MurdayAJ . An economic evaluation of lung transplantation. Journal of Thoracic &amp; Cardiovascular Surgery2002;123(4):411-8. [MEDLINE: 11882810]">Anyanwu 2002</a>; <a href="./references#CD012854-bbs2-0110" title="SagmeisterM , MullhauptB , KadryZ , Kullak-UblickGA , ClavienPA , RennerEL . Cost-effectiveness of cadaveric and living-donor liver transplantation. Transplantation2002;73(4):616-22. [MEDLINE: 11889442]">Sagmeister 2002</a>; <a href="./references#CD012854-bbs2-0118" title="WhitingJF , KiberdB , KaloZ , KeownP , RoelsL , KjerulfM . Cost-effectiveness of organ donation: evaluating investment into donor action and other donor initiatives. American Journal of Transplantation2004;4(4):569-73. [MEDLINE: 15023149]">Whiting 2004</a>), as graft failure incurs significant hospitalisation costs, in addition to anti‐rejection treatment and life‐sustaining therapies. The importance of adhering to immunosuppressive therapy cannot be overemphasised, with the odds of organ failure increasing seven‐fold for non‐adherent recipients versus adherent recipients (<a href="./references#CD012854-bbs2-0076" title="ButlerJA , RoderickP , MulleeM , MasonJC , PevelerRC . Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review. Transplantation2004;77(5):769-76. [MEDLINE: 15021846]">Butler 2004</a>). This suggests that near‐perfect adherence is essential for reduced patient morbidity and overall reduced healthcare costs (<a href="./references#CD012854-bbs2-0097" title="LowJK , WilliamsA , ManiasE , CrawfordK . Interventions to improve medication adherence in adult kidney transplant recipients: a systematic review. Nephrology Dialysis Transplantation2014;30(5):752-61. [MEDLINE: 24950938]">Low 2015</a>). Medication adherence is defined as a dynamic process where patients take medications as prescribed by the healthcare provider. Medication adherence contains three distinct but interrelated stages – initiation, implementation, and persistence (<a href="./references#CD012854-bbs2-0081" title="De GeestS , ZulligLL , Dunbar-JacobJ , HelmyR , HughesDA , WilsonIB , et al. ESPACOMP Medication Adherence Reporting Guideline (EMERGE). Annals of Internal Medicine2018;169(1):30-5. [MEDLINE: 29946690]">De Geest 2018</a>; <a href="./references#CD012854-bbs2-0116" title="VrijensB , De GeestS , HughesDA , PrzemyslawK , DemonceauJ , RupparT , et al. A new taxonomy for describing and defining adherence to medications. British Journal of Clinical Pharmacology2012;73(5):691-705. [MEDLINE: 22486599]">Vrijens 2012</a>). Initiation involves starting a medication regimen. Implementation requires taking medications as prescribed, including correct dosage and timing, and avoiding drug holidays. Persistence is a continuation of correct medication taking for the prescribed duration. Measurement of adherence differs across each phase, raising challenges in defining and analysing non‐adherence in each stage. Adequate adherence is achieved when the gap between the individual’s actual medication‐taking behaviour and the prescribed regimen has no negative effect on the therapeutic outcome (<a href="./references#CD012854-bbs2-0116" title="VrijensB , De GeestS , HughesDA , PrzemyslawK , DemonceauJ , RupparT , et al. A new taxonomy for describing and defining adherence to medications. British Journal of Clinical Pharmacology2012;73(5):691-705. [MEDLINE: 22486599]">Vrijens 2012</a>; <a href="./references#CD012854-bbs2-0088" title="FineRN , BeckerY , De GeestS , EisenH , EttengerR , EvansR , et al. Nonadherence consensus conference summary report. American Journal of Transplantation2009;9(1):35-41. [MEDLINE: 19133930]">Fine 2009</a>). </p> <p>Accurate estimates of non‐adherence are difficult to obtain, given the variability in the type of adherence assessment and study quality (<a href="./references#CD012854-bbs2-0104" title="NieuwlaatR , WilczynskiN , NavarroT , HobsonN , JefferyR , KeepanasserilA , et al. Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews2014, Issue 11. Art. No: CD000011. [DOI: 10.1002/14651858.CD000011.pub4]">Nieuwlaat 2014</a>). Objective, direct measures of adherence to medication regimens post‐transplant, such as direct observation, are difficult to capture in clinical trial settings. Indirect proxy measures of medication adherence, including self‐report assessments, yield superior rates of medication adherence; however, are open to considerable reporting biases (<a href="./references#CD012854-bbs2-0102" title="MoranC , DoyleF , SulaimanI , BennettK , GreeneG , MolloyGJ , et al. The INCATM (Inhaler Compliance AssessmentTM): a comparison with established measures of adherence. Psychology &amp; Health2017;32(10):1266-87. [MEDLINE: 28276739]">Moran 2017</a>). In transplantation research, objective, indirect surrogate measures of immunosuppressant medication adherence using clinical parameters, such as pharmacy refill data, electronic measurement of pillbox use (<a href="./references#CD012854-bbs2-0082" title="DenhaerynckK , DobbelsF , CleemputI , DesmyttereA , Schafer-KellerP , SchaubS , et al. Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: a literature review. Transplant International2005;18(10):1211-33. [MEDLINE: 16162098]">Denhaerynck 2005</a>), assay of medication or fluctuation in medication trough levels (<a href="./references#CD012854-bbs2-0105" title="O'ReganJA , CanneyM , ConnaughtonDM , O'KellyP , WilliamsY , CollierG , et al. Tacrolimus trough-level variability predicts long-term allograft survival following kidney transplantation. Journal of Nephrology2016;29(2):269-76. [MEDLINE: 26374111]">O'Regan 2016</a>), and/or clinical outcomes such as rejection or organ failure are reported to yield the highest immunosuppressant non‐adherence rates (<a href="./references#CD012854-bbs2-0082" title="DenhaerynckK , DobbelsF , CleemputI , DesmyttereA , Schafer-KellerP , SchaubS , et al. Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: a literature review. Transplant International2005;18(10):1211-33. [MEDLINE: 16162098]">Denhaerynck 2005</a>; <a href="./references#CD012854-bbs2-0080" title="De BleserL , MattesonM , DobbelsF , RussellC , De GeestS . Interventions to improve medication adherence after transplantation: a systematic review. Transplant International2009;22(8):780-97. [MEDLINE: 19386076]">De Bleser 2009</a>). There is also a paucity of evidence on non‐adherence to other prescribed medications in the post‐transplant medication regimen. </p> <p>Meta‐analyses of all solid organ transplant types reported a 22.6% non‐adherence rate to immunosuppressant therapy. Rates of non‐adherence varied by type of transplant, with the highest rates observed for kidney transplants (36%) and the lowest for liver transplants (6%) (<a href="./references#CD012854-bbs2-0084" title="DewMA , DiMartiniAL , De Vito DabbsA , MyaskovskyL , SteelL , UnruhM , et al. Rates and Risk factors for nonadherence to the medical regimen after adult solid organ transplantation. Transplantation2007;83(7):858-73. [MEDLINE: 17460556]">Dew 2007</a>). The rate of non‐adherence may also vary by age of the transplant recipient, with a rate of non‐adherence to immunosuppressants in paediatric recipients estimated as 6 cases per 100 person‐years (<a href="./references#CD012854-bbs2-0085" title="DewMA , DabbsAD , MyaskovskyL , ShyuS , ShellmerDA , DiMartiniAF , et al. Meta-analysis of medical regimen adherence outcomes in pediatric solid organ transplantation. Transplantation2009;88(5):736-46. [MEDLINE: 19741474]">Dew 2009</a>). </p> </section> <section id="CD012854-sec-0011"> <h3 class="title" id="CD012854-sec-0011">Description of the intervention</h3> <p>Post‐transplant immunosuppressant therapy involves a complex programme of medication adherence, including daily dosing schedules, monitoring and management (<a href="./references#CD012854-bbs2-0107" title="Posadas SalasMA , SrinivasTR . Update on the clinical utility of once-daily tacrolimus in the management of transplantation. Drug Design, Development &amp; Therapy2014;8:1183-94. [MEDLINE: 25210441]">Posadas Salas 2014</a>). Specific strategies to maintain clinically advised levels of adherence to immunosuppressants haven't been identified, and such strategies remain absent from treatment guidelines to date. Previous work in 2009, similar to this review, focused on adherence to immunosuppressant therapies for kidney, heart and liver transplants and identified that interventions focusing on increasing treatment adherence largely applied a combination of approaches to increase adherence, namely incorporating educational/cognitive, counselling/behavioural, or psychological/affective domains (<a href="./references#CD012854-bbs2-0080" title="De BleserL , MattesonM , DobbelsF , RussellC , De GeestS . Interventions to improve medication adherence after transplantation: a systematic review. Transplant International2009;22(8):780-97. [MEDLINE: 19386076]">De Bleser 2009</a>). Method of intervention delivery varied widely across studies, including pharmacy, nursing and patient‐led interventions. Authors concluded that limited improvements in adherence to immunosuppressants were evident however, no single type of intervention emerged as the most effective in increasing adherence, and poor methodological quality was evident in 58% of studies identified. Such findings have been reported for other chronic and acute disease populations (<a href="./references#CD012854-bbs2-0075" title="BangaloreS , KamalakkannanG , ParkarS , MesserliFH . Fixed-dose combinations improve medication compliance: a meta-analysis. American Journal of Medicine2007;120(8):713-9. [MEDLINE: 17679131]">Bangalore 2007</a>; <a href="./references#CD012854-bbs2-0104" title="NieuwlaatR , WilczynskiN , NavarroT , HobsonN , JefferyR , KeepanasserilA , et al. Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews2014, Issue 11. Art. No: CD000011. [DOI: 10.1002/14651858.CD000011.pub4]">Nieuwlaat 2014</a>). </p> <p>It is becoming increasingly recognised that reliance on technology is an emerging strategy in healthcare for supporting patient‐oriented self‐management, and different interventional platforms and innovative technologies are being developed to increase adherence in chronic health conditions (<a href="./references#CD012854-bbs2-0104" title="NieuwlaatR , WilczynskiN , NavarroT , HobsonN , JefferyR , KeepanasserilA , et al. Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews2014, Issue 11. Art. No: CD000011. [DOI: 10.1002/14651858.CD000011.pub4]">Nieuwlaat 2014</a>). Individually tailored medical mobile apps, in particular, show potential as an inexpensive and accessible method of intervention delivery to increase adherence to complex medication regimens (<a href="./references#CD012854-bbs2-0079" title="DayerL , HeldenbrandS , AndersonP , GubbinsPO , MartinBC . Smartphone medication adherence apps: potential benefits to patients and providers. Journal of the American Pharmacists Association: JAPhA2013;53(2):172-81. [MEDLINE: 23571625]">Dayer 2013</a>). This review provides an opportunity to identify and examine the efficacy of new innovative intervention platforms for increasing adherence, in addition to more commonly identified intervention delivery platforms, such as tailoring educational materials, reinforcement, feedback, and behavioural skills training (<a href="./references#CD012854-bbs2-0103" title="MullenPD , MainsDA , VelezR . A meta-analysis of controlled trials of cardiac patient education. Patient Education &amp; Counseling1992;19(2):143-62. [MEDLINE: 1299819]">Mullen 1992</a>). </p> </section> <section id="CD012854-sec-0012"> <h3 class="title" id="CD012854-sec-0012">How the intervention might work</h3> <p>It is often assumed that the transplant recipient should be motivated by the potential benefits of successful transplantation to follow the prescribed immunosuppressant regimen; however, estimated non‐adherence rates question this assumption. In order to increase medication adherence, it is vital first to accurately assess the behaviour and to understand what is driving non‐adherence. Reasons for general non‐adherence to prescribed medications are multi‐dimensional and can be attributed as ‘intentional’ or ‘non‐intentional’. Intentional non‐adherence involves conscious decision‐making to alter or abstain from the prescribed regimen, whilst non‐intentional non‐adherence arises from forgetting, misunderstanding medication instructions or administering incorrect doses (<a href="./references#CD012854-bbs2-0086" title="DiMatteoMR , Haskard-ZolnierekKB , MartinLR . Improving patient adherence: a three-factor model to guide practice. Health Psychology Review2012;6(1):74-91. [DOI: 10.1080/17437199.2010.537592]">DiMatteo 2012</a>). Limited evidence is available for examination of reasons for non‐adherence post‐transplant; however, factors such as psychosocial barriers were associated with poorer immunosuppressant medication adherence post‐transplant in adult recipients. For children and adolescents, the drivers of non‐adherence differ from the adult population and can be influenced by the wider family network, with lower family cohesion, parental distress and child distress for paediatric recipients associated with poorer immunosuppressant medication adherence post‐transplant (<a href="./references#CD012854-bbs2-0084" title="DewMA , DiMartiniAL , De Vito DabbsA , MyaskovskyL , SteelL , UnruhM , et al. Rates and Risk factors for nonadherence to the medical regimen after adult solid organ transplantation. Transplantation2007;83(7):858-73. [MEDLINE: 17460556]">Dew 2007</a>; <a href="./references#CD012854-bbs2-0085" title="DewMA , DabbsAD , MyaskovskyL , ShyuS , ShellmerDA , DiMartiniAF , et al. Meta-analysis of medical regimen adherence outcomes in pediatric solid organ transplantation. Transplantation2009;88(5):736-46. [MEDLINE: 19741474]">Dew 2009</a>). Given the complexity of barriers to adherence, strategies to increase adherence must be capable of addressing the multi‐dimensionality of medication adherence. Interventions which identify the reasons for the target behaviour (e.g. intentional versus non‐intentional behaviour) and systematically develop intervention components to address these behavioural drivers are likely to be more effective than interventions whereby a systematic, theory‐driven approach is not applied (<a href="./references#CD012854-bbs2-0077" title="DaviesP , WalkerAE , GrimshawJM . A systematic review of the use of theory in the design of guideline dissemination and implementation strategies and interpretation of the results of rigorous evaluations. Implementation Science2010;5:14. [MEDLINE: 20181130]">Davies 2010</a>; <a href="./references#CD012854-bbs2-0078" title="DavisR , CampbellR , HildonZ , HobbsL , MichieS . Theories of behaviour and behaviour change across the social and behavioural sciences: a scoping review. Health Psychology Review2015;9(3):323-44. [MEDLINE: 25104107]">Davis 2015</a>: <a href="./references#CD012854-bbs2-0100" title="MichieS , vanStralenMM , WestR . The behaviour change wheel: A new method for characterising and designing behaviour change interventions. Implementation Science2011;6:42. [MEDLINE: 21513547]">Michie 2011</a>). Additionally, most intervention studies focus on modifiable factors at the patient level for increasing adherence to immunosuppressant medication, e.g. lack of knowledge, treatment‐related factors and psychosocial factors; however, some factors are outside of the control of the patient. For example, service level factors, including the organisation and delivery of adequate post‐transplant care (<a href="./references#CD012854-bbs2-0111" title="Sanders-PinheiroH , ColugnatiFA , DenhaerynckK , MarsicanoEO , MedinaJO , De GeestS , et al. Multilevel correlates of immunosuppressive nonadherence in kidney transplant patients: the multicenter ADHERE BRAZIL study. Transplantation2021;105(1):255-66. [MEDLINE: 32150041]">Sanders‐Pinheiro 2021</a>) and policy level factors, such as the cost of immunosuppressant medication for patients (<a href="./references#CD012854-bbs2-0083" title="DenhaerynckK , BerbenL , DobbelsF , RussellCL , Crespo-LeiroMG , PonceletAJ , et al. Multilevel factors are associated with immunosuppressant nonadherence in heart transplant recipients: The international BRIGHT study. American Journal of Transplantation2018;18(6):1447-60. [MEDLINE: 29205855]">Denhaerynck 2018</a>), have been associated with poorer immunosuppressant medication adherence. </p> </section> <section id="CD012854-sec-0013"> <h3 class="title" id="CD012854-sec-0013">Why it is important to do this review</h3> <p>Adherence is the single most important modifiable factor that affects treatment outcomes in chronic disease management. Consequently, the identification of successful modes of intervention to increase adherence to immunosuppressant therapy is outlined as a research priority in kidney disease (<a href="./references#CD012854-bbs2-0115" title="TongA , ChandoS , CroweS , MannsB , WinkelmayerWC , HemmelgarnB , et al. Research priority setting in kidney disease: a systematic review. American Journal of Kidney Diseases2015;65(5):674-83. [MEDLINE: 25582284]">Tong 2015</a>). Given the reported high non‐adherence rates, coupled with the critical importance of adherence to the immunosuppressant regimen to maximise and maintain successful transplantation, clear evidence is required to identify effective interventions which increase adherence after a solid organ transplant. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD012854-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD012854-sec-0014"></div> <p>We aimed to look at the benefits and harms of using interventions for increasing adherence to immunosuppressant therapies in solid organ transplant recipients, including paediatric and adult heart, lung, kidney, liver and pancreas transplant recipients. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD012854-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD012854-sec-0015"></div> <section id="CD012854-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD012854-sec-0017"> <h4 class="title">Types of studies</h4> <p>All randomised controlled trials (RCTs), quasi‐RCTs (RCTs where allocation to treatment was obtained by alternation, use of alternate medical records, date of birth or other predictable methods), and cluster RCTs examining interventions to increase adherence following a solid organ transplant (heart, lung, kidney, liver, pancreas). </p> </section> <section id="CD012854-sec-0018"> <h4 class="title">Types of participants</h4> <p>All solid organ transplant recipients, including adults and children.</p> <section id="CD012854-sec-0019"> <h5 class="title">Inclusion criteria</h5> <p>All solid organ transplant recipients, including first or subsequent transplants and multi‐organ transplants. </p> </section> <section id="CD012854-sec-0020"> <h5 class="title">Exclusion criteria</h5> <p>Studies including populations without a solid organ transplant were included only if the data for the solid organ transplant recipients could be analysed separately. </p> </section> </section> <section id="CD012854-sec-0021"> <h4 class="title">Types of interventions</h4> <p>We included studies addressing interventions to increase adherence to immunosuppressant medication in comparison to a control arm. Comparisons of interventions to usual routine care were also included. Given the wide variation in types of interventions to address adherence and methods of adherence measurement, interventions of any sort intended to affect adherence with prescribed, self‐administered immunosuppressant medications were included, but not restricted to: </p> <p> <ul id="CD012854-list-0002"> <li> <p>Patient educational interventions (e.g. books, leaflets, posters, videos, interactive modules) </p> </li> <li> <p>Pre‐planned telephone contacts with nurses/medical team</p> </li> <li> <p>Electronic medication management interventions</p> </li> <li> <p>Pharmacy interventions</p> </li> <li> <p>Medical mobile apps</p> </li> <li> <p>Cognitive behavioural therapy/counselling/behavioural interventions</p> </li> <li> <p>Motivational interviewing</p> </li> <li> <p>Coaching/self‐efficacy training</p> </li> <li> <p>Behavioural contracting</p> </li> <li> <p>Service‐level interventions</p> </li> <li> <p>A combination intervention including one or more of the above‐outlined strategies.</p> </li> </ul> </p> </section> <section id="CD012854-sec-0022"> <h4 class="title">Types of outcome measures</h4> <section id="CD012854-sec-0023"> <h5 class="title">Primary outcomes</h5> <p>The ABC taxonomy for medication adherence has been identified as the gold‐standard approach for measurement of medication adherence (<a href="./references#CD012854-bbs2-0116" title="VrijensB , De GeestS , HughesDA , PrzemyslawK , DemonceauJ , RupparT , et al. A new taxonomy for describing and defining adherence to medications. British Journal of Clinical Pharmacology2012;73(5):691-705. [MEDLINE: 22486599]">Vrijens 2012</a>) and guided outcome selection. The three phases of medication adherence within the ABC taxonomic approach were identified as primary outcomes. The phases of the ABC taxonomy were categorized as follows: </p> <p> <ol id="CD012854-list-0003"> <li> <p>Initiation of immunosuppressant medication regimen</p> </li> <li> <p>Implementation of immunosuppressant medication regimen. This phase of adherence included:</p> <ul id="CD012854-list-0004"> <li> <p>Taking adherence: the proportion of prescribed immunosuppressant medications taken</p> </li> <li> <p>Dosing adherence: the proportion of days with the correct dosage taken, as per the prescribed immunosuppressant medication regimen </p> </li> <li> <p>Timing adherence: the proportion of doses taken on time, as per the prescribed immunosuppressant medication regimen </p> </li> <li> <p>Drug holidays: the proportion of drug holidays taken within the prescribed immunosuppressant medication regimen </p> </li> </ul> </li> <li> <p>Persistence with immunosuppressant medication regimen. Non‐persistence was defined as discontinuation of the prescribed immunosuppressant medication regimen. </p> </li> </ol> </p> <p>The above phases of immunosuppressant medication adherence were measured objectively via electronic monitoring (EM) devices and pharmacy reconciliation data, where possible. </p> </section> <section id="CD012854-sec-0024"> <h5 class="title">Secondary outcomes</h5> <p>We included both subjective and objective surrogate measures of adherence as a measure of the indirect effect of immunosuppressant medication adherence on clinical outcomes. Potential measures of adherence included, but were not restricted to: </p> <p>1. Patient behaviours</p> <p> <ul id="CD012854-list-0005"> <li> <p>Self‐reported adherence</p> </li> </ul> </p> <p>2. Clinical parameters</p> <p> <ul id="CD012854-list-0006"> <li> <p>CNI levels</p> </li> <li> <p>CNI level variability</p> </li> <li> <p>Absolute lymphocyte count</p> </li> <li> <p>Clinically assessed organ rejection</p> </li> <li> <p>Biopsy‐proven organ rejection</p> </li> <li> <p>Death (any cause)</p> </li> <li> <p>Non‐fatal events (e.g. any adverse experience related to the study participation)</p> </li> <li> <p>Health service usage (e.g. clinical attendance, hospitalisations)</p> </li> <li> <p>Health‐related quality of life (HRQoL).</p> </li> </ul> </p> </section> </section> </section> <section id="CD012854-sec-0025"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD012854-sec-0026"> <h4 class="title">Electronic searches</h4> <p>We searched the <a href="http://kidneyandtransplant.cochrane.org/cochrane-kidney-and-transplant-specialised-register" target="_blank">Cochrane Kidney and Transplant Specialised Register</a> up to 14 October 2021 through contact with the Information Specialist using search terms relevant to this review. The Cochrane Kidney and Transplant Specialised Register contains studies identified from several sources. </p> <p> <ol id="CD012854-list-0007"> <li> <p>Monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL)</p> </li> <li> <p>Weekly searches of MEDLINE OVID SP</p> </li> <li> <p>Searches of kidney and transplant journals, and the proceedings and abstracts from major kidney and transplant conferences </p> </li> <li> <p>Searching the current year of EMBASE OVID SP</p> </li> <li> <p>Weekly current awareness alerts for selected kidney and transplant journals</p> </li> <li> <p>Searches of the International Clinical Trials Register (ICTRP) Search Portal and ClinicalTrials.gov.</p> </li> </ol> </p> <p>Studies contained in the Register were identified through searches of CENTRAL, MEDLINE, and EMBASE based on the scope of Cochrane Kidney and Transplant. Details of search strategies, as well as a list of handsearched journals, conference proceedings and current awareness alerts, are available on the <a href="https://kidneyandtransplant.cochrane.org/cochrane-kidney-and-transplant-specialised-register" target="_blank">Cochrane Kidney and Transplant website</a>. </p> <p>See <a href="./appendices#CD012854-sec-0087">Appendix 1</a> for search terms used in strategies for this review. </p> </section> <section id="CD012854-sec-0027"> <h4 class="title">Searching other resources</h4> <p> <ol id="CD012854-list-0008"> <li> <p>Reference lists of review articles, relevant studies and clinical practice guidelines.</p> </li> <li> <p>Letters seeking information about unpublished or incomplete studies to investigators known to be involved in previous studies. </p> </li> </ol> </p> </section> </section> <section id="CD012854-sec-0028"> <h3 class="title" id="CD012854-sec-0028">Data collection and analysis</h3> <section id="CD012854-sec-0029"> <h4 class="title">Selection of studies</h4> <p>The search strategy described was used to obtain titles and abstracts of studies that may be relevant to the review. The titles and abstracts were screened independently by two authors, who discarded studies that were not applicable; however, studies and reviews that might include relevant data or information on studies were retained initially. Two authors independently assessed the retrieved full text of included abstracts to determine which studies satisfied the inclusion criteria. Disagreements between authors in the screening process were resolved by the inclusion of a third author. </p> </section> <section id="CD012854-sec-0030"> <h4 class="title">Data extraction and management</h4> <p>Data extraction was carried out independently by two authors using standard data extraction forms. Studies reported in non‐English language journals were translated before assessment. Translation was completed by a native speaker from the lead institution, RCSI University of Medicine and Health Sciences. Where more than one publication of one study existed, reports were grouped together, and the publications that included data relating to relevant outcomes were used in the analyses. Where relevant outcomes were only published in earlier versions, these data were used. Differences between authors were reconciled by discussion with a third author. </p> </section> <section id="CD012854-sec-0031"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>The following items were independently assessed by two authors using the risk of bias assessment tool (<a href="./references#CD012854-bbs2-0095" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). Cochrane, 2020. Available from www.training.cochrane.org/handbook.">Higgins 2020</a>) (see <a href="./appendices#CD012854-sec-0088">Appendix 2</a>). </p> <p> <ul id="CD012854-list-0009"> <li> <p>Was there adequate sequence generation (selection bias)?</p> </li> <li> <p>Was allocation adequately concealed (selection bias)?</p> </li> <li> <p>Was knowledge of the allocated interventions adequately prevented during the study?</p> <ul id="CD012854-list-0010"> <li> <p>Participants and personnel (performance bias)</p> </li> <li> <p>Outcome assessors (detection bias)</p> </li> </ul> </li> <li> <p>Were incomplete outcome data adequately addressed (attrition bias)?</p> </li> <li> <p>Are reports of the study free of suggestion of selective outcome reporting (reporting bias)? </p> </li> <li> <p>Was the study apparently free of other problems that could put it at risk of bias?</p> </li> </ul> </p> </section> <section id="CD012854-sec-0032"> <h4 class="title">Measures of treatment effect</h4> <p>For dichotomous outcomes (e.g. proportion adherent, organ rejection, death), results were expressed as risk ratio (RR) with 95% confidence intervals (CI). Where continuous scales of measurement were used to assess the effects of treatment (e.g. biochemical indices of adherence to immunosuppressants, HRQoL measures), the mean difference (MD) was used, or the standardised mean difference (SMD) if different scales were used (<a href="./references#CD012854-bbs2-0095" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). Cochrane, 2020. Available from www.training.cochrane.org/handbook.">Higgins 2020</a>). </p> </section> <section id="CD012854-sec-0033"> <h4 class="title">Unit of analysis issues</h4> <p>No issues with unit of analysis were identified, as no cluster RCT designs or cross‐over designs were included </p> </section> <section id="CD012854-sec-0034"> <h4 class="title">Dealing with missing data</h4> <p>Any further information required from the original author was requested by written correspondence (e.g. emailing the corresponding author), and any relevant information obtained in this manner was included in the review. Evaluation of important numerical data such as screened, randomised patients, as well as intention‐to‐treat, as‐treated and per‐protocol population, was carefully performed. Attrition rates (e.g. drop‐outs, losses to follow‐up and withdrawals) were investigated. Issues of missing data and imputation methods (e.g. last‐observation‐carried‐forward) were critically appraised (<a href="./references#CD012854-bbs2-0095" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). Cochrane, 2020. Available from www.training.cochrane.org/handbook.">Higgins 2020</a>). </p> </section> <section id="CD012854-sec-0035"> <h4 class="title">Assessment of heterogeneity</h4> <p>Heterogeneity was assessed by visual inspection of the forest plot. We quantified statistical heterogeneity using the I² statistic, which describes the percentage of total variation across studies that is due to heterogeneity rather than sampling error (<a href="./references#CD012854-bbs2-0094" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta-analyses. BMJ2003;327(7414):557-60. [MEDLINE: 12958120]">Higgins 2003</a>). A guide to the interpretation of I² values was as follows. </p> <p> <ul id="CD012854-list-0011"> <li> <p>0% to 40%: might not be important</p> </li> <li> <p>30% to 60%: may represent moderate heterogeneity</p> </li> <li> <p>50% to 90%: may represent substantial heterogeneity</p> </li> <li> <p>75% to 100%: considerable heterogeneity.</p> </li> </ul> </p> <p>The importance of the observed value of I² depends on the magnitude and direction of treatment effects and the strength of evidence for heterogeneity (e.g. P‐value from the Chi² test or a CI for I²) (<a href="./references#CD012854-bbs2-0095" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). Cochrane, 2020. Available from www.training.cochrane.org/handbook.">Higgins 2020</a>). </p> </section> <section id="CD012854-sec-0036"> <h4 class="title">Assessment of reporting biases</h4> <p>Due to the small number of studies per comparison or outcome, we were unable to investigate the existence of small study bias using funnel plots. </p> </section> <section id="CD012854-sec-0037"> <h4 class="title">Data synthesis</h4> <p>Data were pooled using the random‐effects model to ensure the robustness of the model chosen and susceptibility to outliers. We summarised information for outcomes in which meta‐analysis was not possible due to insufficient observations using descriptive narrative synthesis. Narrative outcome reporting was included for all outcomes not included in the meta‐analyses and tabulated in the review. </p> </section> <section id="CD012854-sec-0038"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>There were insufficient observations to perform sub‐group analysis.</p> </section> <section id="CD012854-sec-0039"> <h4 class="title">Sensitivity analysis</h4> <p>There were insufficient observations to perform sensitivity analysis.</p> </section> <section id="CD012854-sec-0040"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>The main results of the review were presented in the 'Summary of findings' table. The table presents key information concerning the quality of the evidence, the magnitude of the effects of the interventions examined, and the sum of the available data for the main outcomes (<a href="./references#CD012854-bbs2-0112" title="SchünemannHJ , HigginsJP , VistGE , GlasziouP , AklEA , SkoetzN , et al. Chapter 14: Completing ‘Summary of findings’ tables and grading the certainty of the evidence. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). Cochrane, 2020. www.training.cochrane.org/handbook.">Schunemann 2020a</a>). The 'Summary of findings' table also includes an overall grading of the evidence related to each of the main outcomes using the GRADE (Grades of Recommendation, Assessment, Development and Evaluation) approach (<a href="./references#CD012854-bbs2-0091" title="GuyattGH , OxmanAD , VistGE , KunzR , Falck-YtterY , Alonso-CoelloP , et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ2008;336(7650):924-6. [MEDLINE: 18436948]">GRADE 2008</a>; <a href="./references#CD012854-bbs2-0092" title="GuyattG , OxmanAD , AklEA , KunzR , VistG , BrozekJ , et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology2011;64(4):383-94. [MEDLINE: 21195583]">GRADE 2011</a>). The GRADE approach defines the quality of a body of evidence as to the extent to which one can be confident that an estimate of effect or association is close to the true quantity of specific interest. The quality of a body of evidence involves consideration of within‐trial risk of bias (methodological quality), directness of evidence, heterogeneity, the precision of effect estimates and risk of publication bias (<a href="./references#CD012854-bbs2-0113" title="SchünemannHJ , VistGE , HigginsJP , SantessoN , DeeksJJ , GlasziouP , et al. Chapter 15: Interpreting results and drawing conclusions. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). Cochrane, 2020. Available from www.training.cochrane.org/handbook.">Schunemann 2020b</a>). We presented the following outcomes in the 'Summary of findings' table. </p> <p> <ul id="CD012854-list-0012"> <li> <p>Taking adherence</p> </li> <li> <p>Dosing adherence</p> </li> <li> <p>Timing adherence</p> </li> <li> <p>Drug holidays</p> </li> <li> <p>Self‐reported adherence (proportion)</p> </li> <li> <p>Self‐reported adherence (mean)</p> </li> <li> <p>Proportion of immunosuppressant trough concentration levels at target</p> </li> </ul> </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD012854-sec-0041" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD012854-sec-0041"></div> <section id="CD012854-sec-0042"> <h3 class="title">Description of studies</h3> <section id="CD012854-sec-0043"> <h4 class="title">Results of the search</h4> <p>After searching the Specialised Register, a total of 163 records were identified. After screening titles and abstracts and full‐text review, 40 studies (103 reports) were included, and eight studies (17 reports) were excluded. Twenty‐two ongoing studies were identified (37 records; 3172 proposed participants), and two studies are awaiting classification as no results are as yet available (76 proposed participants). These 24 studies will be assessed in a future update of this review (<a href="#CD012854-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD012854-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD012854-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_n/nCD012854-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD012854-sec-0044"> <h4 class="title">Included studies</h4> <p>We included 40 studies (103 reports, 3896 randomised participants, 3718 adults and 178 adolescents). Thirty‐nine studies were RCTs, and one study (<a href="./references#CD012854-bbs2-0016" title="JoostR , DorjeF , SchwitullaJ , EckardtKU , HugoC . Intensified pharmaceutical care is improving immunosuppressive medication adherence in kidney transplant recipients during the first post-transplant year: a quasi-experimental study. Nephrology Dialysis Transplantation2014;29(8):1597-607. [MEDLINE: 24914089]">Joost 2014</a>) was a prospective, controlled, open interventional study using a sequential control group design to avoid contamination, as the experimental or control intervention was offered and administered to all eligible patients who agreed to participate during alternating six‐month periods. Five studies (<a href="./references#CD012854-bbs2-0018" title="KaiserTE , EjazNS , TremblayS , ParrishNJ , BenavidesJ , ReheB , et al. Technology triggered adherence intervention: preliminary findings [abstract no: 185]. American Journal of Transplantation2019;19(Suppl 3):394. [EMBASE: 628454914]">Kaiser 2019</a>; <a href="./references#CD012854-bbs2-0019" title="KantachuvessiriS , InksatidA , SumethkulV , JirasirithamS , ThirapanichW . Adherence to immunosuppression after conversion of twice-daily tacrolimus to once-daily tacrolimus in stable kidney transplant patients in Thailand: a prospective study [abstract no: P.1515]. Transplantation2016;100(7 Suppl 1):S716. [EMBASE: 613004564]">Kantachuvessiri 2016</a>; <a href="./references#CD012854-bbs2-0022" title="LiuJ . Effect of WeChat-based peer education on medication compliance and quality of life in patients with liver transplantation: a pilot study [abstract no: P-576]. Transplantation2019;103(8 Suppl 1):380. [EMBASE: 629265854]">Liu 2019c</a>; <a href="./references#CD012854-bbs2-0028" title="AmaralS , FosterN , DashefskyH , KimJ , FurthS . Peers4path: challenges in measuring medication adherence in adolescent transplant recipients [abstract no: A485]. American Journal of Transplantation2014;14(Suppl 3):238. [EMBASE: 71544246]AmaralS , FosterN , DashefskyH , PaternoC , FurthS . Peers4Path: feasibility of medication adherence measures in adolescent transplant recipients [abstract no: FR-PO403]. Journal of the American Society of Nephrology2014;25(Abstracts):463A. [CENTRAL: CN-01657532] AmaralS , FosterN , YangA , ShultsJ , FurthS . Peers4Path: testing peer support as a mechanism to improve transplant outcomes among adolescents with solid organ transplants [abstract no: TH-PO1083]. Journal of the American Society of Nephrology2013;24(Abstracts):345-6A. [CENTRAL: CN-01657533] AmaralS , RogersR , PaternoC , FosterN , ShultsJ . Peers4path (promoting adolescent transplant health): a pilot study to test peer mentoring as an adherence intervention in adolescent transplant recipients [abstract no: 401.1]. Pediatric Transplantation2017;21(Suppl 1):33. [EMBASE: 616208171]StrachanC , PatonM , ReasonJ , AmaralS . Stakeholder perspectives in peer mentoring program for pediatric solid organ transplant recipients [abstract no: D323]. American Journal of Transplantation2019;19(Suppl 3):1153. [EMBASE: 628454820]">Peers4path 2014</a>; <a href="./references#CD012854-bbs2-0032" title="SantanaMJ , FeenyD , JacksonK , SchafenackerM , WeinkaufJ , LienD . Using patient-centred care to enhance adherence to medication and exercise in lung transplantation: a randomized controlled clinical trial [abstract no: 445]. In: Canadian Society of Transplantation Annual Scientific Meeting; 2011 Mar 2-5; Quebec, Canada. 2011:34. [CENTRAL: CN-01657760] ">Santana 2011</a>) had only abstracts from conference proceedings available. Two studies (<a href="./references#CD012854-bbs2-0038" title="BignallO , PaiA , AmaralS , FurthS , BergmanN , GoebelJ , et al. Differences in reported barriers to immunosuppression adherence among a cohort of pediatric renal transplant recipients from the United States and Canada [abstract no: D161]. American Journal of Transplantation2016;16(Suppl 3):751. [EMBASE: 611700425]BoucquemontJ , FosterB , TAKE-IT Investigators. Sex and age differences in medication adherence in adolescent and young adult kidney transplant recipients [abstract no: SA-PO404]. Journal of the American Society of Nephrology2016;27(Abstracts):721A. [CENTRAL: CN-01657535] BoucquemontJ , FosterB . Adherence patterns in adolescent and young adult kidney transplant recipients [abstract no: 229]. American Journal of Transplantation2016;16(Suppl 3):284. [EMBASE: 611700136]BoucquemontJ , PaiAL , DharnidharkaVR , HebertD , FurthSL , FosterBJ . Gender differences in medication adherence among adolescent and young adult kidney transplant recipients. Transplantation2019;103(4):798-806. [MEDLINE: 29994983]BoucquemontJ , PaiAL , DharnidharkaVR , HebertD , ZelikovskyN , AmaralS , et al. Association between day of the week and medication adherence among adolescent and young adult kidney transplant recipients. American Journal of Transplantation2020;20(1):274-81. [MEDLINE: 31507087]FosterB , PaiA , FurthS . The TAKE-IT intervention improves medication adherence in adolescent kidney transplant recipients [abstract no: 359]. American Journal of Transplantation2017;17(Suppl 3):332-3. [EMBASE: 615704529]FosterB , ZhaoH , PaiA , ZelikovskyN , HollyCD , SmithJM , et al. Medication adherence barrier burden predicts subsequent taking adherence in adolescent kidney transplant recipients in the TAKE-IT trial [abstract no: SA-PO1027]. Journal of the American Society of Nephrology2015;26(Abstracts):870A. [CENTRAL: CN-01657534] FosterBJ , PaiA , ZhaoH , FurthS , TAKE-IT Study Group. The TAKE-IT study: aims, design, and methods. BMC Nephrology2014;15:139. [MEDLINE: 25176317]FosterBJ , PaiAL , ZelikovskyN , AmaralS , BellL , DharnidharkaVR , et al. A randomized trial of a multicomponent intervention to promote medication adherence: the teen adherence in kidney transplant effectiveness of intervention trial (TAKE-IT) [Erratum in: Am J Kidney Dis. 2019 Apr;73(4):578]. American Journal of Kidney Diseases2018;72(1):30-41. [MEDLINE: 29602631]FosterBJ , ZhaoH , PaiA , ZelikovskyN , HollyCD , SmithJM , et al. Medication adherence barrier burden predicts subsequent adherence to dosing time schedule in adolescent kidney transplant recipients in the TAKE-IT Trial [abstract no: SA-PO1031]. Journal of the American Society of Nephrology2015;26(Abstracts):871A. [CENTRAL: CN-01657537] LadnerDP , WolfMS . Transplant regimen adherence for kidney recipients by engaging information technologies: the TAKE-IT trial [abstract no: D302]. American Journal of Transplantation2019;19(Suppl 3):1145. [EMBASE: 628453783]">TAKE‐IT 2014</a>, <a href="./references#CD012854-bbs2-0028" title="AmaralS , FosterN , DashefskyH , KimJ , FurthS . Peers4path: challenges in measuring medication adherence in adolescent transplant recipients [abstract no: A485]. American Journal of Transplantation2014;14(Suppl 3):238. [EMBASE: 71544246]AmaralS , FosterN , DashefskyH , PaternoC , FurthS . Peers4Path: feasibility of medication adherence measures in adolescent transplant recipients [abstract no: FR-PO403]. Journal of the American Society of Nephrology2014;25(Abstracts):463A. [CENTRAL: CN-01657532] AmaralS , FosterN , YangA , ShultsJ , FurthS . Peers4Path: testing peer support as a mechanism to improve transplant outcomes among adolescents with solid organ transplants [abstract no: TH-PO1083]. Journal of the American Society of Nephrology2013;24(Abstracts):345-6A. [CENTRAL: CN-01657533] AmaralS , RogersR , PaternoC , FosterN , ShultsJ . Peers4path (promoting adolescent transplant health): a pilot study to test peer mentoring as an adherence intervention in adolescent transplant recipients [abstract no: 401.1]. Pediatric Transplantation2017;21(Suppl 1):33. [EMBASE: 616208171]StrachanC , PatonM , ReasonJ , AmaralS . Stakeholder perspectives in peer mentoring program for pediatric solid organ transplant recipients [abstract no: D323]. American Journal of Transplantation2019;19(Suppl 3):1153. [EMBASE: 628454820]">Peers4path 2014</a>) included adolescent participants. Thirty‐two studies included kidney transplant recipients, six included lung transplant recipients, five included liver transplant recipients, four included heart transplant recipients, three included kidney/pancreas transplant recipients, and two included kidney/liver transplant recipients. The included studies were conducted between 2001 and 2021. Thirty‐nine studies were published in English, and one study was translated from Mandarin to English. The majority of the studies were conducted in an adult transplant population (38 studies). Studies were conducted in the Americas (20 studies), Europe (13), Asia (6 studies), Australia (1 study), or were not stated (2 studies). Intervention duration varied from eight weeks to 12 months, and the length of follow‐up varied from one month to 10 years (See <a href="./references#CD012854-sec-0097" title="">Characteristics of included studies</a>). </p> <p>There was significant heterogeneity in the types of interventions in the included studies, and 27 studies were multi‐component interventions. See <a href="./references#CD012854-sec-0097" title="">Characteristics of included studies</a>. </p> </section> <section id="CD012854-sec-0045"> <h4 class="title">Excluded studies</h4> <p>Eight studies (17 reports) were excluded during full‐text screening. The reasons for exclusion were six studies that did not measure our specified outcomes (<a href="./references#CD012854-bbs2-0041" title="ChisholmMA , MulloyLL , JagadeesanM , MartinBC , DiPiroJT . Effect of clinical pharmacy services on the blood pressure of African-American renal transplant patients. Ethnicity &amp; Disease2002;12(3):392-7. [MEDLINE: 12148711]">Chisholm 2002</a>; <a href="./references#CD012854-bbs2-0042" title="HilbrandsLB , DemackerPN , HoitsmaAJ , StalenhoefAF , KoeneRA . The effects of cyclosporine and prednisone on serum lipid and (apo)lipoprotein levels in renal transplant recipients. Journal of the American Society of Nephrology1995;5(12):2073-81. [MEDLINE: 7579056]HilbrandsLB , DemackerPN , HoitsmaAJ . Cyclosporin and serum lipids in renal transplant recipients. Lancet1993;341(8847):765-6. [MEDLINE: 8095674]HilbrandsLB , HoitsmaAJ , KoeneKA . Randomized, prospective trial of cyclosporine monotherapy versus azathioprine-prednisone from three months after renal transplantation. Transplantation1996;61(7):1038-46. [MEDLINE: 8623182]HilbrandsLB , HoitsmaAJ , KoeneRA . Costs of drugs used after renal transplantation. Transplant International1996;9(Suppl 1):S399-402. [MEDLINE: 8959872]HilbrandsLB , HoitsmaAJ , KoeneRA . Effect of immunosuppressive therapy on quality of life after renal transplantation [abstract]. Journal of the American Society of Nephrology1994;5(3):1011. [CENTRAL: CN-00615875] HilbrandsLB , HoitsmaAJ , KoeneRA . Medication compliance after renal transplantation. Transplantation1995;60(9):914-20. [MEDLINE: 7491693]HilbrandsLB , HoitsmaAJ , KoeneRA . The effect of immunosuppressive drugs on quality of life after renal transplantation. Transplantation1995;59(9):1263-70. [MEDLINE: 7762059]">Hilbrands 1993</a>; <a href="./references#CD012854-bbs2-0043" title="KorusM , CruchleyE , CalicM , GoldA , AnthonySJ , ParekhRS , et al. Assessing the acceptability and efficacy of teens taking charge: Transplant-A pilot randomized control trial. Pediatric Transplantation2020;24(1):e13612. [MEDLINE: 31743564]KorusM , CruchleyE , GoldA , StinsonJ , ParekhR , AnthonyS . A self-management website for teenagers who have undergone kidney or liver transplantation: A feasibility randomized controlled pilot trial [abstract no: 401.3]. Pediatric Transplantation2017;21(Suppl 1):33-4. [EMBASE: 616208183]">Korus 2020</a>; <a href="./references#CD012854-bbs2-0044" title="MitchellY , VolpendestaJ , Vongspanich-DrayJ . Evaluation of efficiency and patient perception of solid organ transplant medication education after pharmacist-created video education [abstract no: 206]. American Journal of Kidney Diseases2018;71(4):567. [EMBASE: 621595826]MitchellY , VolpendestaJ , Vongspanich-DrayJ . Evaluation of efficiency and patient perception of solid organ transplant medication education after pharmacist-created video education [abstract no: A385]. American Journal of Transplantation2018;18(Suppl 4):608. [EMBASE: 622280687]">Mitchell 2018</a>; <a href="./references#CD012854-bbs2-0045" title="MoroJA , AlmenarL , Martnez-DolzL , AgueroJ , Sanchez-LazaroI , IglesiasP , et al. Support program for heart transplant patients: initial experience. Transplantation Proceedings2008;40(9):3039-40. [MEDLINE: 19010185]">Moro 2008</a>; <a href="./references#CD012854-bbs2-0048" title="TzvetanovI , D'AmicoG , West-ThielkeP , JohnsenM , HahajG , HellerR , et al. An innovative rehabilitation program for obese kidney transplant recipients: impact of return to work rates [abstract no: D2729]. Transplantation2014;98(Suppl 1):843. [EMBASE: 71546415]TzvetanovI , West-ThielkeP , D'AmicoG , JohnsenM , LadikA , HachajG , et al. A novel and personalized rehabilitation program for obese kidney transplant recipients. Transplantation Proceedings2014;46(10):3431-7. [MEDLINE: 25498067]">Tzvetanov 2014</a>), and two studies were either withdrawn and merged with another study (<a href="./references#CD012854-bbs2-0046" title="HendersonM . A pilot study of mDOT for immunosuppressant adherence in adult liver transplant recipients [A pilot study of mobile directly observed therapy (mDOT) for immunosuppressant adherence in adult liver transplant recipients]. www.clinicaltrials.gov/show/NCT03515330 (first received 3 May 2018). ">NCT03515330</a>) or terminated due to slow recruitment (<a href="./references#CD012854-bbs2-0047" title="SöderdahlG . Medicine adherence and effects on transplants with Pilloxa's electronic pillbox [Improvement of medicine adherence and the following positive effects on transplants in patients after organ transplantation with Pilloxa's electronic pillbox]. www.clinicaltrials.gov/ct2/show/NCT03848585 (first received 21 February 2019). ">NCT03848585</a>). </p> </section> </section> <section id="CD012854-sec-0046"> <h3 class="title">Risk of bias in included studies</h3> <p>The risk of bias for the included studies is summarised in <a href="#CD012854-fig-0002">Figure 2</a>. The risk of bias for each assessed domain in individual studies is shown in <a href="#CD012854-fig-0003">Figure 3</a>. Methodological quality varied considerably, with some studies providing insufficient information to assess the risk of bias accurately. Overall, nine of the 40 studies reported all elements for risk of bias domains. Thirty‐three studies reported at least one domain with a high risk of bias, and in 31 studies, there was at least one domain classified as unclear due to insufficient information to permit assessment. </p> <div class="figure" id="CD012854-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD012854-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_n/nCD012854-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD012854-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012854-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_n/nCD012854-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD012854-sec-0047"> <h4 class="title">Allocation</h4> <section id="CD012854-sec-0048"> <h5 class="title">Random sequence generation</h5> <p>Random sequence generation was assessed as low risk of bias in 26 studies (<a href="./references#CD012854-bbs2-0001" title="KuypersDR , BonvoisinCA , PeetersP , SennesaelJJ , KiandaMN , VrijensB , et al. Superior medication adherence to tacrolimus modified release once-daily (QD) compared to tacrolimus twice-daily (BID) in stable renal transplant patients [abstract no: RO-256]. Transplant International2011;24(Suppl 2):199. [EMBASE: 70527785]KuypersDR , PeetersPC , SennesaelJJ , KiandaMN , VrijensB , KristantoP , et al. Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring. Transplantation2013;95(2):333-40. [MEDLINE: 23263559]">ADMIRAD 2013</a>; <a href="./references#CD012854-bbs2-0002" title="BessaA , MedinaJ , TedescoH , FelipeC . A prospective, randomised, controlled study to assess the effect of pharmaceutical intervention on compliance and knowledge of immunosuppression in kidney transplant recipients [abstract no: DI-090]. European Journal of Hospital Pharmacy2015;22(Suppl 1):A109-10. [EMBASE: 614322295]BessaAB , FelipeCR , HannunP , SayuriP , FelixMJ , RuppelP , et al. Prospective randomized trial investigating the influence of pharmaceutical care on the intra-individual variability of tacrolimus concentrations early after kidney transplant. Therapeutic Drug Monitoring2016;38(4):447-55. [MEDLINE: 27414973]">Bessa 2016</a>; <a href="./references#CD012854-bbs2-0003" title="Breu-DejeanN , DriotD , DupouyJ , Lapeyre-MestreM , RostaingL . Efficacy of psychoeducational intervention on allograft function in kidney transplant patients: 10-year results of a prospective randomized study. Experimental &amp; Clinical Transplantation2016;14(1):38-44. [MEDLINE: 26862823]Breu-DejeanN . Education program to reduce non-compliance after renal transplantation [doctorate thesis] [Effet d'une intervention psycho-éducationnelle sur l'observance thérapeutique chez les transplantés rénaux]. University of Toulouse2016. [CENTRAL: CN-01658149] Breu-DejeanNB , RontaingL , Lapeyre-MestreM , RogeB , DurandD . Educational program to reduce noncompliance after renal transplantation [abstract no: MO06]. In: 41st Congress. European Renal Association. European Dialysis and Transplantation Association; 2004 May 15-18; Lisbon, Portugal. 2004:214-5. [CENTRAL: CN-00636140] ">Breu‐Dejean 2016</a>; <a href="./references#CD012854-bbs2-0005" title="Chisholm-BurnsM , SpiveyC , Graff ZivinJ , LeeJ , SredzinskiE . Results of a behavioral contract intervention to improve adherence and healthcare outcomes among renal transplant recipients [abstract no: D1727]. American Journal of Transplantation2013;13(Suppl S5):540. [CENTRAL: CN-01007771] Chisholm-BurnsMA , EricksonS , SpiveyCA . Employment and health-related quality of life among renal transplant recipients [abstract no: 1140]. American Journal of Transplantation2011;11(Suppl 2):365. [EMBASE: 70406190]Chisholm-BurnsMA , SpiveyCA , GraffZJ , LeeJK , SredzinskiE , TolleyEA . Improving outcomes of renal transplant recipients with behavioral adherence contracts: a randomized controlled trial. American Journal of Transplantation2013;13(9):2364-73. [MEDLINE: 23819827]Chisholm-BurnsMA , SpiveyCA , SredzinskiE , ButlerS . Preliminary results of a behavioral contract intervention to improve adherence and quality of life among renal transplant recipients [abstract no: 1139]. American Journal of Transplantation2011;11(Suppl 2):365. [EMBASE: 70406189]Chisholm-BurnsMA , SpiveyCA , SredzinskiE , ButlerSL . Intervention toolbox to promote immunosuppressant therapy adherence in adult renal transplant recipients. Journal of the American Pharmacists Association: JAPhA2012;52(6):816-22. [MEDLINE: 23229970]">Chisholm‐Burns 2013</a>; <a href="./references#CD012854-bbs2-0006" title="CoteJ , FortinMC , AugerP , RouleauG , DuboisS , BoudreauN , et al. Web-based tailored intervention to support optimal medication adherence among kidney transplant recipients: pilot parallel-group randomized controlled trial. JMIR Formative Research2018;2(2):e14. [MEDLINE: 30684400]">Cote 2018</a>; <a href="./references#CD012854-bbs2-0007" title="CukorD , Ver HalenN , PencilleM , TedlaF , SalifuM . A pilot randomized controlled trial to promote immunosuppressant adherence in adult kidney transplant recipients. Nephron2017;135(1):6-14. [MEDLINE: 28049201]">Cukor 2017</a>; <a href="./references#CD012854-bbs2-0009" title="DeVito DabbsA , DewM , MyersBA , SongM , LiR , ZomakR , et al. Randomized controlled trial (RCT) of pocket path, an mhealth intervention to promote self-management after lung transplantation [abstract no: A5361]. American Journal of Respiratory &amp; Critical Care Medicine2014;189:A5361. [EMBASE: 72047364]DeVito DabbsA , SongMK , MyersBA , LiR , HawkinsRP , PilewskiJM , et al. A randomized controlled trial of a mobile health intervention to promote self-management after lung transplantation. American Journal of Transplantation2016;16(7):2172-80. [MEDLINE: 26729617]GeramitaEM , DeVito DabbsAJ , DiMartiniAF , PilewskiJM , SwitzerGE , PoslusznyDM , et al. Impact of a mobile health intervention on long-term nonadherence after lung transplantation: follow-up after a randomized controlled trial. Transplantation2020;104(3):640-51. [MEDLINE: 31335759]HuL , DeVito DabbsA , DewMA , SereikaSM , LinglerJH . Patterns and correlates of adherence to self-monitoring in lung transplant recipients during the first 12 months after discharge from transplant. Clinical Transplantation2017;31(8):e13014. [MEDLINE: 28517112]RosenbergerEM , Devito DabbsAJ , DiMartiniAF , LandsittelDP , PilewskiJM , DewMA . Long-term follow-up of a randomized controlled trial evaluating a mobile health intervention for self-management in lung transplant recipients. American Journal of Transplantation2017;17(5):1286-93. [MEDLINE: 27664940]">DeVito Dabbs 2016</a>; <a href="./references#CD012854-bbs2-0010" title="GarciaMF , BravinAM , GarciaPD , ConttiMM , NgaHS , TakaseHM , et al. Behavioral measures to reduce non-adherence in renal transplant recipients: a prospective randomized controlled trial. International Urology &amp; Nephrology2015;47(11):1899-905. [MEDLINE: 26377496]">Garcia 2015</a>; <a href="./references#CD012854-bbs2-0012" title="HarrisonJJ , BadrS , HamandiB , KimSJ . Randomized controlled trial of a computer-based education program in the home for solid organ transplant recipients: impact on medication knowledge, satisfaction, and adherence. Transplantation2017;101(6):1336-43. [MEDLINE: 27367473]">Harrison 2016</a>; <a href="./references#CD012854-bbs2-0013" title="HenrikssonJ , TydenG , HoijerJ , WadstromJ . A prospective randomized trial on the effect of using an electronic monitoring drug dispensing device to improve adherence and compliance. Transplantation2016;100(1):203-9. [MEDLINE: 26588006]HenrikssonJ , WadstromJ , HoijerJ , TydenG . A prospective randomized trial on the effect of using an electronic monitoring drug dispensary device to improve adherence and non-compliance [abstract no: BO220]. Transplant International2015;28(Suppl 4):204. [EMBASE: 72111815]">Henriksson 2016</a>; <a href="./references#CD012854-bbs2-0014" title="HuangY , YuX . Effect of healthy education on improving the drug compliance of patients after renal transplantation. Journal of Clinical Rehabilitative Tissue Engineering Research2007;11(43):8773-5. [EMBASE: 350081272]">Huang 2007b</a>; <a href="./references#CD012854-bbs2-0015" title="LowJK , ManiasE , CrawfordK , WalkerR , MulleyWR , ToussaintND , et al. Improving medication adherence in adult kidney transplantation (IMAKT): a pilot randomised controlled trial. Scientific Reports2019;9(1):7734. [MEDLINE: 31118485]">IMAKT 2019</a>; <a href="./references#CD012854-bbs2-0023" title="DobbelsF , De BleserL , BerbenL , KristantoP , DupontL , NevensF , et al. Efficacy of a medication adherence enhancing intervention in transplantation: the MAESTRO-Tx trial. Journal of Heart &amp; Lung Transplantation2017;36(5):499-508. [MEDLINE: 28162931]DobbelsF , De BleserL , BerbenL , KristantoP , DupontL , NevensF , et al. Testing the efficacy of a multicomponent theory-based tailored behavioral medication adherence intervention in transplantation: The MAESTRO-TX RCT [abstract no: 223]. Journal of Heart &amp; Lung Transplantation2016;35(4 Suppl):S90. [EMBASE: 72253342]DobbelsF , De BleserL , KristantoP , NevensF , VanhaeckeJ , VerledenG , et al. Electronic monitoring feedback and motivational interviewing improves medication adherence in heart, liver and lung transplant patients: results from the MAESTRO-TX RCT [abstract no: BO218]. Transplant International2015;28(Suppl 4):203. [EMBASE: 72111813]">MAESTRO‐Tx 2017</a>; <a href="./references#CD012854-bbs2-0024" title="AndrewsAM , ChengAL , Bartlett EllisRJ , EmersonAM , O'BrienT , RussellCL . SystemCHANGE TM solutions to improve medication adherence in kidney transplant recipients: a secondary data analysis. Nephrology Nursing Journal2021;48(4):389-417. [MEDLINE: 34463466]RussellCL , HathawayD , RemyLM , AholtD , ClarkD , MillerC , et al. Improving medication adherence and outcomes in adult kidney transplant patients using a personal systems approach: SystemCHANGE TM results of the MAGIC randomized clinical trial. American Journal of Transplantation2020;20(1):125-36. [MEDLINE: 31291507]RussellCL , MooreS , HathawayD , ChengAL , ChenG , GogginK . MAGIC Study: aims, design and methods using SystemCHANGE TM to improve immunosuppressive medication adherence in adult kidney transplant recipients. BMC Nephrology2016;17(1):84. [MEDLINE: 27421884]RussellCL . Improving medication adherence and outcomes in adult kidney transplant patients using a personal systems approach: SystemCHANGE.TM results of the MAGIC randomized clinical trial [abstract]. Peritoneal Dialysis International2020;40(1 Suppl):14S. [EMBASE: 632156503]WakefieldWR , AshbaughCM , RemyL , AholtD , MillerC , YeS , et al. Improving medication adherence and outcomes in adult kidney transplant patients using SYSTEMChangeTM: results of the Medication Adherence Given Individual Change (MAGIC) randomized clinical trial [abstract no: 523]. American Journal of Transplantation2019;19(Suppl 3):541-2. [EMBASE: 628454823]">MAGIC 2016</a>; <a href="./references#CD012854-bbs2-0027" title="PatersonTS , DemianM , ShapiroRJ , Loken ThorntonW . Impact of once- versus twice-daily tacrolimus dosing on medication adherence in stable renal transplant recipients: a Canadian single-center randomized controlled trial. Canadian Journal of Kidney Health &amp; Disease2019;6:2054358119867993. [MEDLINE: 31452902]ShapiroRJ , PatersonT , ThorntonW , HusseiniT , PartoviN , VishloffJ , et al. Medication adherence is tied to social support in renal transplant recipients [abstract no: 2501]. In: Canadian Society of Transplantation Annual Scientific Meeting; 2013 Mar 13-16; Alberta, Canada. 2013:38. ">Paterson 2019</a>; <a href="./references#CD012854-bbs2-0029" title="HanA , ChoMJ , ChoS , LeeCH , ChoiC , KimSY , et al. Use of mobile internet application to improve adherence to immunosuppressive medication adherence in kidney transplant recipients: preliminary results of the PRIMA (ImProving Adherence to Immunosuppressive Therapy by Mobile Internet application) study [abstract no: 420.4]. Transplantation2016;100(7 Suppl):S161. [EMBASE: 613004382]HanA , MinSI , AhnS , MinSK , HongHJ , HanN , et al. Mobile medication manager application to improve adherence with immunosuppressive therapy in renal transplant recipients: a randomized controlled trial. PLoS ONE [Electronic Resource]2019;14(11):e0224595. [MEDLINE: 31689320]KoH , KimHK , ChungC , HanA , MinSK , HaJ , et al. Association between medication adherence and intrapatient variability in tacrolimus concentration among stable kidney transplant recipients. Scientific Reports2021;11(1):5397. [MEDLINE: 33686160]">PRIMA 2019</a>; <a href="./references#CD012854-bbs2-0030" title="ReeseP , BloomR , Trofe-ClarkJ , MussellA , LeidyD , LevskyS , et al. Customized reminders and provider notification to improve adherence to immunosuppression [abstract no: 1074]. American Journal of Transplantation2015;15(Suppl 3). [EMBASE: 71953144]ReesePP , BloomRD , Trofe-ClarkJ , MussellA , LeidyD , LevskyS , et al. Automated reminders and physician notification to promote immunosuppression adherence among kidney transplant recipients: a randomized trial. American Journal of Kidney Diseases2017;69(3):400-9. [MEDLINE: 27940063]">Reese 2017</a>; <a href="./references#CD012854-bbs2-0031" title="RussellC , ConnV , AshbaughC , MadsenR , WakefieldM , WebbA , et al. Taking immunosuppressive medications effectively (TIMELink): a pilot randomized controlled trial in adult kidney transplant recipients. Clinical Transplantation2011;25(6):864-70. [MEDLINE: 21077956]RussellCL , ConnVS , AshbaughC , CoffeyD , WakefieldM . A pilot RCT to increase medication adherence in transplantation [abstract no: 1168]. American Journal of Transplantation2010;10(Suppl 4):376. [EMBASE: 70464544]">Russell 2011</a>; <a href="./references#CD012854-bbs2-0033" title="HilsS , SchmidA , BogatyrevaL , HauschkeD , Kramer-ZuckerA , PisarskiP . Telemedical supported aftercare after living kidney transplantation-a single center experience [abstract no: O179]. Transplant International2015;28(Suppl 4):69. [EMBASE: 72111423]HilsS , SchmidA , BogatyrevaL , HauschkeD , PisarskiP . Telemedical supported aftercare as an innovative project-study improves the quality of life after living kidney transplantation-a single center experience [abstract no: D2730]. Transplantation2014;98(Suppl 1):843. [EMBASE: 71546416]KaierK , HilsS , FetzerS , HehnP , SchmidA , HauschkeD , et al. Results of a randomized controlled trial analyzing telemedically supported case management in the first year after living donor kidney transplantation - a budget impact analysis from the healthcare perspective. Health Economics Review2017;7(1):1. [MEDLINE: 28092012]PisarskiP , HilsS , SchmidA , Kramer-ZuckerA , JanigenB . Telemedicin as an innovative project-study in adherence improvement after living kidney transplantation at the Transplantation Center Freiburg [abstract no: O162]. Transplant International2013;26(Suppl 2):73. [EMBASE: 71359226]SchmidA , HilsS , Kramer-ZuckerA , BogatyrevaL , HauschkeD , De GeestS , et al. Telemedically-supported case management of living-donor renal transplant recipients to optimize routine evidence-based aftercare: a single-center randomized controlled trial. American Journal of Transplantation2017;17(6):1594-605. [MEDLINE: 27873477]SchmidA , PisarskiP , HilsS , HauschkeD , BogatyrevaL . Telemedical supported after care in living kidney recipients-an innovative project-study at the Transplantation Center Freiburg interim results of a prospective ongoing study of 50 patients [abstract no: P84]. Transplant International2013;26(Suppl 1):43. [EMBASE: 71356349]">Schmid 2017</a>; <a href="./references#CD012854-bbs2-0034" title="De GeestS , DenhaerynckK , Schafer-KellerP , BockA , SteigerJ . Supporting medication adherence in renal transplantation--the SMART study. Swiss Medical Weekly2007;137 Suppl 155:125-7S. [MEDLINE: 17874516]De GeestS , Schafer-KellerP , DenhaerynckK , BockA , KoferS , ThannbergerN , et al. Supporting medication adherence in renal transplantation (SMART): a pilot study [abstract no: PO3.09]. Kidney &amp; Blood Pressure Research2004;27(5-6):327. [CENTRAL: CN-00615859] De GeestS , Schafer-KellerP , DenhaerynckK , ThannbergerN , KoferS , BockA , et al. Supporting medication adherence in renal transplantation (SMART): a pilot RCT to improve adherence to immunosuppressive regimens. Clinical Transplantation2006;20(3):359-68. [MEDLINE: 16824155]deGeestS , SchaferP , DenhaerynckK , BockA , SteigerJ . Supporting medication adherence in renal transplantation (SMART): a randomized controlled trial to improve adherence with immunosuppressive regimen [abstract no: PO-590]. Transplant International2005;18(Suppl):na. ">SMART 2006</a>; <a href="./references#CD012854-bbs2-0035" title="SuhlingH , RademacherJ , ZinowskyI , FugeJ , GreerM , WarneckeG , et al. Conventional vs. tablet computer-based patient education following lung transplantation--a randomized controlled trial. PLoS ONE [Electronic Resource]2014;9(6):e90828. [MEDLINE: 24608864]SuhlingH , RademacherJ , ZinowskyI , FugeJ , GreerM , WarneckeG . Patient education via tablet-pc vs. conventional to improve compliance with immunosuppressive drug regimen after lung transplantation - a randomized controlled trial [abstract no: 2844]. European Respiratory Journal2013;42(Suppl 57):565S. [EMBASE: 71843332]">Suhling 2014</a>; <a href="./references#CD012854-bbs2-0036" title="TaberDJ , PosadasMA , RaoV , McGillicuddyJ , RohanV , NadigSN , et al. The potential for improved medication adherence with a complete once daily immunosuppression regimen in kidney transplant: results of a randomized controlled study [abstract no: FR-PO1177]. Journal of the American Society of Nephrology2019;30(Abstract Suppl):750-1. [EMBASE: 633769114]TaberDJ , Posadas-SalasA , SuZ , RaoV , RohanV , NadigS , et al. Preliminary assessment of safety and adherence to a once-daily immunosuppression regimen in kidney transplantation: results of a randomized controlled pilot study. Clinical Transplantation2020;34(4):e13844. [MEDLINE: 32092187]">Taber 2020</a>; <a href="./references#CD012854-bbs2-0037" title="Van ZantenR , De WeerdA , BetjesM , Boer-VerschragenM , MasseyE . Medication adherence and fear of rejection after conversion from dual to monotherapy: A randomized controlled trial [abstract no: OP170]. Transplant International2021;34(Suppl 1):35. [EMBASE: 635968308]vanZantenR , deWeerdA , BetjesM , Boer-VerschragenM , MasseyEK . Is simplification of immunosuppressive medication a way to promote medication adherence of kidney transplant recipients? Findings from a randomized controlled trial. Transplant International2021;34(9):1703-11. [MEDLINE: 34448273]">TACmono 2021</a>; <a href="./references#CD012854-bbs2-0038" title="BignallO , PaiA , AmaralS , FurthS , BergmanN , GoebelJ , et al. Differences in reported barriers to immunosuppression adherence among a cohort of pediatric renal transplant recipients from the United States and Canada [abstract no: D161]. American Journal of Transplantation2016;16(Suppl 3):751. [EMBASE: 611700425]BoucquemontJ , FosterB , TAKE-IT Investigators. Sex and age differences in medication adherence in adolescent and young adult kidney transplant recipients [abstract no: SA-PO404]. Journal of the American Society of Nephrology2016;27(Abstracts):721A. [CENTRAL: CN-01657535] BoucquemontJ , FosterB . Adherence patterns in adolescent and young adult kidney transplant recipients [abstract no: 229]. American Journal of Transplantation2016;16(Suppl 3):284. [EMBASE: 611700136]BoucquemontJ , PaiAL , DharnidharkaVR , HebertD , FurthSL , FosterBJ . Gender differences in medication adherence among adolescent and young adult kidney transplant recipients. Transplantation2019;103(4):798-806. [MEDLINE: 29994983]BoucquemontJ , PaiAL , DharnidharkaVR , HebertD , ZelikovskyN , AmaralS , et al. Association between day of the week and medication adherence among adolescent and young adult kidney transplant recipients. American Journal of Transplantation2020;20(1):274-81. [MEDLINE: 31507087]FosterB , PaiA , FurthS . The TAKE-IT intervention improves medication adherence in adolescent kidney transplant recipients [abstract no: 359]. American Journal of Transplantation2017;17(Suppl 3):332-3. [EMBASE: 615704529]FosterB , ZhaoH , PaiA , ZelikovskyN , HollyCD , SmithJM , et al. Medication adherence barrier burden predicts subsequent taking adherence in adolescent kidney transplant recipients in the TAKE-IT trial [abstract no: SA-PO1027]. Journal of the American Society of Nephrology2015;26(Abstracts):870A. [CENTRAL: CN-01657534] FosterBJ , PaiA , ZhaoH , FurthS , TAKE-IT Study Group. The TAKE-IT study: aims, design, and methods. BMC Nephrology2014;15:139. [MEDLINE: 25176317]FosterBJ , PaiAL , ZelikovskyN , AmaralS , BellL , DharnidharkaVR , et al. A randomized trial of a multicomponent intervention to promote medication adherence: the teen adherence in kidney transplant effectiveness of intervention trial (TAKE-IT) [Erratum in: Am J Kidney Dis. 2019 Apr;73(4):578]. American Journal of Kidney Diseases2018;72(1):30-41. [MEDLINE: 29602631]FosterBJ , ZhaoH , PaiA , ZelikovskyN , HollyCD , SmithJM , et al. Medication adherence barrier burden predicts subsequent adherence to dosing time schedule in adolescent kidney transplant recipients in the TAKE-IT Trial [abstract no: SA-PO1031]. Journal of the American Society of Nephrology2015;26(Abstracts):871A. [CENTRAL: CN-01657537] LadnerDP , WolfMS . Transplant regimen adherence for kidney recipients by engaging information technologies: the TAKE-IT trial [abstract no: D302]. American Journal of Transplantation2019;19(Suppl 3):1145. [EMBASE: 628453783]">TAKE‐IT 2014</a>; <a href="./references#CD012854-bbs2-0039" title="FlemingJN , GebregziabherM , PosadasA , SuZ , McGillicuddyJW , TaberDJ . Impact of a pharmacist-led, mHealth-based intervention on tacrolimus trough variability in kidney transplant recipients: a report from the TRANSAFE Rx randomized controlled trial. American Journal of Health-System Pharmacy2021;78(14):1287-93. [MEDLINE: 33821958]FlemingJN , TreiberF , McGillicuddyJ , GebregziabherM , TaberDJ . Improving transplant medication safety through a pharmacist-empowered, patient-centered, mhealth-based intervention: TRANSAFE Rx study protocol. JMIR Research Protocols2018;7(3):e59. [MEDLINE: 29500161]GonzalesHM , FlemingJN , GebregziabherM , Posadas-SalasMA , SuZ , McGillicuddyJW , et al. Pharmacist-led mobile health intervention and transplant medication safety: a randomized controlled clinical trial. Clinical Journal of the American Society of Nephrology: CJASN2021;16(5):776-84. [MEDLINE: 33931415]TaberDJ , FlemingJN , SuZ , MauldinP , McGillicuddyJW , PosadasA , et al. Significant hospitalization cost savings to the payer with a pharmacist-led mobile health intervention to improve medication safety in kidney transplant recipients. American Journal of Transplantation2021;21(10):3428-35. [MEDLINE: 34197699]TaberDJ , PilchNA , McGillicuddyJW , MardisC , TreiberF , FlemingJN . Using informatics and mobile health to improve medication safety monitoring in kidney transplant recipients. American Journal of Health-System Pharmacy2019;76(15):1143-9. [MEDLINE: 31361870]">TRANSAFE‐Rx 2018</a>; <a href="./references#CD012854-bbs2-0040" title="UrstadKH , OyenO , AndersenMH , MoumT , WahlAK . The effect of an educational intervention for renal recipients: a randomized controlled trial. Clinical Transplantation2012;26(3):E246-53. [MEDLINE: 22686948]">Urstad 2012</a>), high risk in one study (<a href="./references#CD012854-bbs2-0021" title="LevineD , TorabiJ , ChoinskiK , RoccaJP , GrahamJA . Transplant surgery enters a new era: increasing immunosuppressive medication adherence through mobile apps and smart watches. American Journal of Surgery2019;218(1):18-20. [MEDLINE: 30799019]">Levine 2019</a>) and unclear in 13 studies <a href="./references#CD012854-bbs2-0004" title="ChisholmMA , MulloyL , JagadeesanM , DiPiroJT . Two-year economic evaluation of clinical pharmacy services in renal transplant clinic patients [abstract no: 588]. American Journal of Transplantation2002;2(Suppl 3):286. [CENTRAL: CN-00415424] ChisholmMA , MulloyLL , JagadeesanM , DiPiroJT . Impact of clinical pharmacy services on renal transplant patients' compliance with immunosuppressive medications. Clinical Transplantation2001;15(5):330-6. [MEDLINE: 11678959]">Chisholm 2001</a>; <a href="./references#CD012854-bbs2-0008" title="DeVito DabbsA , DewMA , MyersB , BegeyA , HawkinsR , RenD , et al. Evaluation of a hand-held, computer-based intervention to promote early self-care behaviors after lung transplant. Clinical Transplantation2009;23(4):537-45. [MEDLINE: 19473201]">DeVito Dabbs 2009</a>; <a href="./references#CD012854-bbs2-0011" title="HardstaffR , GreenK , TalbotD . Measurement of compliance posttransplantation--the results of a 12-month study using electronic monitoring. Transplantation Proceedings2003;35(2):796-7. [MEDLINE: 12644142]HardstaffR , GreenK , TalbotD . Noncompliance postrenal transplantation: measuring the extent of the problem using electronic surveillance and nurse practitioner interviews. Transplantation Proceedings2002;34(5):1608. [MEDLINE: 12176504]">Hardstaff 2002</a>; <a href="./references#CD012854-bbs2-0016" title="JoostR , DorjeF , SchwitullaJ , EckardtKU , HugoC . Intensified pharmaceutical care is improving immunosuppressive medication adherence in kidney transplant recipients during the first post-transplant year: a quasi-experimental study. Nephrology Dialysis Transplantation2014;29(8):1597-607. [MEDLINE: 24914089]">Joost 2014</a>; <a href="./references#CD012854-bbs2-0017" title="JungHY , JeonY , SeongSJ , SeoJJ , ChoiJY , ChoJH , et al. ICT-based adherence monitoring in kidney transplant recipients: a randomized controlled trial. BMC Medical Informatics &amp; Decision Making2020;20(1):105. [MEDLINE: 32522263]JungHY , JeonY , SeongSJ , SeoJJ , ChoiJY , ChoJH , et al. Information and communication technology-based centralized monitoring system to increase adherence to immunosuppressive medication in kidney transplant recipients: a randomized controlled trial [abstract no: P1734]. Nephrology Dialysis Transplantation2020;35(Suppl 3):iii252. [EMBASE: 633422975]JungHY , SeongSJ , ChoiJY , ChoJH , ParkSH , KimCD , et al. The efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trial. Trials [Electronic Resource]2017;18(1):480. [MEDLINE: 29037222]">Jung 2017</a>; <a href="./references#CD012854-bbs2-0018" title="KaiserTE , EjazNS , TremblayS , ParrishNJ , BenavidesJ , ReheB , et al. Technology triggered adherence intervention: preliminary findings [abstract no: 185]. American Journal of Transplantation2019;19(Suppl 3):394. [EMBASE: 628454914]">Kaiser 2019</a>; <a href="./references#CD012854-bbs2-0019" title="KantachuvessiriS , InksatidA , SumethkulV , JirasirithamS , ThirapanichW . Adherence to immunosuppression after conversion of twice-daily tacrolimus to once-daily tacrolimus in stable kidney transplant patients in Thailand: a prospective study [abstract no: P.1515]. Transplantation2016;100(7 Suppl 1):S716. [EMBASE: 613004564]">Kantachuvessiri 2016</a>; <a href="./references#CD012854-bbs2-0020" title="KleinA , KramerI . Influence of a pharmaceutical care program on liver transplant patients' compliance with immunosuppressive therapy: a prospective, randomized, controlled trial [Pharmazeutische betreuung lebertransplantierter patienten unter besonderer berucksichtigung der compliance mit der immunsuppressiven therapie: Eine prospektive, randomisierte, kontrollierte studie]. Krankenhauspharmazie2007;28(12):458-68. [EMBASE: 350287720]KleinA , OttoG , KramerI . Impact of a pharmaceutical care program on liver transplant patients' compliance with immunosuppressive medication: a prospective, randomized, controlled trial using electronic monitoring. Transplantation2009;87(6):839-47. [MEDLINE: 19300186]">Klein 2007</a>; <a href="./references#CD012854-bbs2-0022" title="LiuJ . Effect of WeChat-based peer education on medication compliance and quality of life in patients with liver transplantation: a pilot study [abstract no: P-576]. Transplantation2019;103(8 Suppl 1):380. [EMBASE: 629265854]">Liu 2019c</a>; <a href="./references#CD012854-bbs2-0025" title="McGillicuddyJW , GregoskiMJ , Brunner-JacksonBM , WeilandAK , PatelSK , RockRA , et al. Facilitating medication adherence and eliminating therapeutic inertia using wireless technology: proof of concept findings with uncontrolled hypertensives and kidney transplant recipients. In: WH '12 Proceedings of the Conference on Wireless Health; 2012 Oct 23-25; San Diego CA. 2012. [CENTRAL: CN-01658221] McGillicuddyJW , GregoskiMJ , WeilandAK , RockRA , Brunner-JacksonBM , PatelSK , et al. Mobile health medication adherence and blood pressure control in renal transplant recipients: a proof-of-concept randomized controlled trial. JMIR Research Protocols2013;2(2):e32. [MEDLINE: 24004517]McGillicuddyJW , TaberDJ , MuellerM , PatelS , BaligaPK , ChavinKD , et al. Sustainability of improvements in medication adherence through a mobile health intervention. Progress in Transplantation2015;25(3):217-23. [MEDLINE: 26308780]McGillicuddyJW . EHealth and transplantation [abstract no: PM-47]. American Journal of Transplantation2014;14(Suppl 2):54-5. [EMBASE: 71388189]">McGillicuddy 2013</a>; <a href="./references#CD012854-bbs2-0026" title="Gomis-PastorM , Mirabet PerezS , Roig MinguellE , Brossa LoidiV , Lopez LopezL , Ros AbarcaS , et al. Mobile health to improve adherence and patient experience in heart transplantation recipients: the mHeart trial. Healthcare2021;9(4):463. [MEDLINE: 33919899]Gomis-PastorM , MirabetS , RoigE , BrossaV , LopezL , RosS , et al. Improving patients' experience and medication adherence after heart transplant using a multilevel ehealth intervention: the mHeart clinical trial [abstract no: P-16.07]. Transplantation2020;104(Suppl 3):S578-9. [EMBASE: 633380991]">mHeart 2021</a>; <a href="./references#CD012854-bbs2-0028" title="AmaralS , FosterN , DashefskyH , KimJ , FurthS . Peers4path: challenges in measuring medication adherence in adolescent transplant recipients [abstract no: A485]. American Journal of Transplantation2014;14(Suppl 3):238. [EMBASE: 71544246]AmaralS , FosterN , DashefskyH , PaternoC , FurthS . Peers4Path: feasibility of medication adherence measures in adolescent transplant recipients [abstract no: FR-PO403]. Journal of the American Society of Nephrology2014;25(Abstracts):463A. [CENTRAL: CN-01657532] AmaralS , FosterN , YangA , ShultsJ , FurthS . Peers4Path: testing peer support as a mechanism to improve transplant outcomes among adolescents with solid organ transplants [abstract no: TH-PO1083]. Journal of the American Society of Nephrology2013;24(Abstracts):345-6A. [CENTRAL: CN-01657533] AmaralS , RogersR , PaternoC , FosterN , ShultsJ . Peers4path (promoting adolescent transplant health): a pilot study to test peer mentoring as an adherence intervention in adolescent transplant recipients [abstract no: 401.1]. Pediatric Transplantation2017;21(Suppl 1):33. [EMBASE: 616208171]StrachanC , PatonM , ReasonJ , AmaralS . Stakeholder perspectives in peer mentoring program for pediatric solid organ transplant recipients [abstract no: D323]. American Journal of Transplantation2019;19(Suppl 3):1153. [EMBASE: 628454820]">Peers4path 2014</a>; <a href="./references#CD012854-bbs2-0032" title="SantanaMJ , FeenyD , JacksonK , SchafenackerM , WeinkaufJ , LienD . Using patient-centred care to enhance adherence to medication and exercise in lung transplantation: a randomized controlled clinical trial [abstract no: 445]. In: Canadian Society of Transplantation Annual Scientific Meeting; 2011 Mar 2-5; Quebec, Canada. 2011:34. [CENTRAL: CN-01657760] ">Santana 2011</a>) due to insufficient information to permit assessment. </p> </section> <section id="CD012854-sec-0049"> <h5 class="title">Allocation concealment</h5> <p>Allocation concealment was assessed as low risk of bias in 12 studies (<a href="./references#CD012854-bbs2-0001" title="KuypersDR , BonvoisinCA , PeetersP , SennesaelJJ , KiandaMN , VrijensB , et al. Superior medication adherence to tacrolimus modified release once-daily (QD) compared to tacrolimus twice-daily (BID) in stable renal transplant patients [abstract no: RO-256]. Transplant International2011;24(Suppl 2):199. [EMBASE: 70527785]KuypersDR , PeetersPC , SennesaelJJ , KiandaMN , VrijensB , KristantoP , et al. Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring. Transplantation2013;95(2):333-40. [MEDLINE: 23263559]">ADMIRAD 2013</a>; <a href="./references#CD012854-bbs2-0002" title="BessaA , MedinaJ , TedescoH , FelipeC . A prospective, randomised, controlled study to assess the effect of pharmaceutical intervention on compliance and knowledge of immunosuppression in kidney transplant recipients [abstract no: DI-090]. European Journal of Hospital Pharmacy2015;22(Suppl 1):A109-10. [EMBASE: 614322295]BessaAB , FelipeCR , HannunP , SayuriP , FelixMJ , RuppelP , et al. Prospective randomized trial investigating the influence of pharmaceutical care on the intra-individual variability of tacrolimus concentrations early after kidney transplant. Therapeutic Drug Monitoring2016;38(4):447-55. [MEDLINE: 27414973]">Bessa 2016</a>; <a href="./references#CD012854-bbs2-0005" title="Chisholm-BurnsM , SpiveyC , Graff ZivinJ , LeeJ , SredzinskiE . Results of a behavioral contract intervention to improve adherence and healthcare outcomes among renal transplant recipients [abstract no: D1727]. American Journal of Transplantation2013;13(Suppl S5):540. [CENTRAL: CN-01007771] Chisholm-BurnsMA , EricksonS , SpiveyCA . Employment and health-related quality of life among renal transplant recipients [abstract no: 1140]. American Journal of Transplantation2011;11(Suppl 2):365. [EMBASE: 70406190]Chisholm-BurnsMA , SpiveyCA , GraffZJ , LeeJK , SredzinskiE , TolleyEA . Improving outcomes of renal transplant recipients with behavioral adherence contracts: a randomized controlled trial. American Journal of Transplantation2013;13(9):2364-73. [MEDLINE: 23819827]Chisholm-BurnsMA , SpiveyCA , SredzinskiE , ButlerS . Preliminary results of a behavioral contract intervention to improve adherence and quality of life among renal transplant recipients [abstract no: 1139]. American Journal of Transplantation2011;11(Suppl 2):365. [EMBASE: 70406189]Chisholm-BurnsMA , SpiveyCA , SredzinskiE , ButlerSL . Intervention toolbox to promote immunosuppressant therapy adherence in adult renal transplant recipients. Journal of the American Pharmacists Association: JAPhA2012;52(6):816-22. [MEDLINE: 23229970]">Chisholm‐Burns 2013</a>; <a href="./references#CD012854-bbs2-0006" title="CoteJ , FortinMC , AugerP , RouleauG , DuboisS , BoudreauN , et al. Web-based tailored intervention to support optimal medication adherence among kidney transplant recipients: pilot parallel-group randomized controlled trial. JMIR Formative Research2018;2(2):e14. [MEDLINE: 30684400]">Cote 2018</a>; <a href="./references#CD012854-bbs2-0007" title="CukorD , Ver HalenN , PencilleM , TedlaF , SalifuM . A pilot randomized controlled trial to promote immunosuppressant adherence in adult kidney transplant recipients. Nephron2017;135(1):6-14. [MEDLINE: 28049201]">Cukor 2017</a>; ,<a href="./references#CD012854-bbs2-0009" title="DeVito DabbsA , DewM , MyersBA , SongM , LiR , ZomakR , et al. Randomized controlled trial (RCT) of pocket path, an mhealth intervention to promote self-management after lung transplantation [abstract no: A5361]. American Journal of Respiratory &amp; Critical Care Medicine2014;189:A5361. [EMBASE: 72047364]DeVito DabbsA , SongMK , MyersBA , LiR , HawkinsRP , PilewskiJM , et al. A randomized controlled trial of a mobile health intervention to promote self-management after lung transplantation. American Journal of Transplantation2016;16(7):2172-80. [MEDLINE: 26729617]GeramitaEM , DeVito DabbsAJ , DiMartiniAF , PilewskiJM , SwitzerGE , PoslusznyDM , et al. Impact of a mobile health intervention on long-term nonadherence after lung transplantation: follow-up after a randomized controlled trial. Transplantation2020;104(3):640-51. [MEDLINE: 31335759]HuL , DeVito DabbsA , DewMA , SereikaSM , LinglerJH . Patterns and correlates of adherence to self-monitoring in lung transplant recipients during the first 12 months after discharge from transplant. Clinical Transplantation2017;31(8):e13014. [MEDLINE: 28517112]RosenbergerEM , Devito DabbsAJ , DiMartiniAF , LandsittelDP , PilewskiJM , DewMA . Long-term follow-up of a randomized controlled trial evaluating a mobile health intervention for self-management in lung transplant recipients. American Journal of Transplantation2017;17(5):1286-93. [MEDLINE: 27664940]">DeVito Dabbs 2016</a>; <a href="./references#CD012854-bbs2-0010" title="GarciaMF , BravinAM , GarciaPD , ConttiMM , NgaHS , TakaseHM , et al. Behavioral measures to reduce non-adherence in renal transplant recipients: a prospective randomized controlled trial. International Urology &amp; Nephrology2015;47(11):1899-905. [MEDLINE: 26377496]">Garcia 2015</a>; <a href="./references#CD012854-bbs2-0013" title="HenrikssonJ , TydenG , HoijerJ , WadstromJ . A prospective randomized trial on the effect of using an electronic monitoring drug dispensing device to improve adherence and compliance. Transplantation2016;100(1):203-9. [MEDLINE: 26588006]HenrikssonJ , WadstromJ , HoijerJ , TydenG . A prospective randomized trial on the effect of using an electronic monitoring drug dispensary device to improve adherence and non-compliance [abstract no: BO220]. Transplant International2015;28(Suppl 4):204. [EMBASE: 72111815]">Henriksson 2016</a>; <a href="./references#CD012854-bbs2-0023" title="DobbelsF , De BleserL , BerbenL , KristantoP , DupontL , NevensF , et al. Efficacy of a medication adherence enhancing intervention in transplantation: the MAESTRO-Tx trial. Journal of Heart &amp; Lung Transplantation2017;36(5):499-508. [MEDLINE: 28162931]DobbelsF , De BleserL , BerbenL , KristantoP , DupontL , NevensF , et al. Testing the efficacy of a multicomponent theory-based tailored behavioral medication adherence intervention in transplantation: The MAESTRO-TX RCT [abstract no: 223]. Journal of Heart &amp; Lung Transplantation2016;35(4 Suppl):S90. [EMBASE: 72253342]DobbelsF , De BleserL , KristantoP , NevensF , VanhaeckeJ , VerledenG , et al. Electronic monitoring feedback and motivational interviewing improves medication adherence in heart, liver and lung transplant patients: results from the MAESTRO-TX RCT [abstract no: BO218]. Transplant International2015;28(Suppl 4):203. [EMBASE: 72111813]">MAESTRO‐Tx 2017</a>; <a href="./references#CD012854-bbs2-0034" title="De GeestS , DenhaerynckK , Schafer-KellerP , BockA , SteigerJ . Supporting medication adherence in renal transplantation--the SMART study. Swiss Medical Weekly2007;137 Suppl 155:125-7S. [MEDLINE: 17874516]De GeestS , Schafer-KellerP , DenhaerynckK , BockA , KoferS , ThannbergerN , et al. Supporting medication adherence in renal transplantation (SMART): a pilot study [abstract no: PO3.09]. Kidney &amp; Blood Pressure Research2004;27(5-6):327. [CENTRAL: CN-00615859] De GeestS , Schafer-KellerP , DenhaerynckK , ThannbergerN , KoferS , BockA , et al. Supporting medication adherence in renal transplantation (SMART): a pilot RCT to improve adherence to immunosuppressive regimens. Clinical Transplantation2006;20(3):359-68. [MEDLINE: 16824155]deGeestS , SchaferP , DenhaerynckK , BockA , SteigerJ . Supporting medication adherence in renal transplantation (SMART): a randomized controlled trial to improve adherence with immunosuppressive regimen [abstract no: PO-590]. Transplant International2005;18(Suppl):na. ">SMART 2006</a>; <a href="./references#CD012854-bbs2-0037" title="Van ZantenR , De WeerdA , BetjesM , Boer-VerschragenM , MasseyE . Medication adherence and fear of rejection after conversion from dual to monotherapy: A randomized controlled trial [abstract no: OP170]. Transplant International2021;34(Suppl 1):35. [EMBASE: 635968308]vanZantenR , deWeerdA , BetjesM , Boer-VerschragenM , MasseyEK . Is simplification of immunosuppressive medication a way to promote medication adherence of kidney transplant recipients? Findings from a randomized controlled trial. Transplant International2021;34(9):1703-11. [MEDLINE: 34448273]">TACmono 2021</a>; <a href="./references#CD012854-bbs2-0038" title="BignallO , PaiA , AmaralS , FurthS , BergmanN , GoebelJ , et al. Differences in reported barriers to immunosuppression adherence among a cohort of pediatric renal transplant recipients from the United States and Canada [abstract no: D161]. American Journal of Transplantation2016;16(Suppl 3):751. [EMBASE: 611700425]BoucquemontJ , FosterB , TAKE-IT Investigators. Sex and age differences in medication adherence in adolescent and young adult kidney transplant recipients [abstract no: SA-PO404]. Journal of the American Society of Nephrology2016;27(Abstracts):721A. [CENTRAL: CN-01657535] BoucquemontJ , FosterB . Adherence patterns in adolescent and young adult kidney transplant recipients [abstract no: 229]. American Journal of Transplantation2016;16(Suppl 3):284. [EMBASE: 611700136]BoucquemontJ , PaiAL , DharnidharkaVR , HebertD , FurthSL , FosterBJ . Gender differences in medication adherence among adolescent and young adult kidney transplant recipients. Transplantation2019;103(4):798-806. [MEDLINE: 29994983]BoucquemontJ , PaiAL , DharnidharkaVR , HebertD , ZelikovskyN , AmaralS , et al. Association between day of the week and medication adherence among adolescent and young adult kidney transplant recipients. American Journal of Transplantation2020;20(1):274-81. [MEDLINE: 31507087]FosterB , PaiA , FurthS . The TAKE-IT intervention improves medication adherence in adolescent kidney transplant recipients [abstract no: 359]. American Journal of Transplantation2017;17(Suppl 3):332-3. [EMBASE: 615704529]FosterB , ZhaoH , PaiA , ZelikovskyN , HollyCD , SmithJM , et al. Medication adherence barrier burden predicts subsequent taking adherence in adolescent kidney transplant recipients in the TAKE-IT trial [abstract no: SA-PO1027]. Journal of the American Society of Nephrology2015;26(Abstracts):870A. [CENTRAL: CN-01657534] FosterBJ , PaiA , ZhaoH , FurthS , TAKE-IT Study Group. The TAKE-IT study: aims, design, and methods. BMC Nephrology2014;15:139. [MEDLINE: 25176317]FosterBJ , PaiAL , ZelikovskyN , AmaralS , BellL , DharnidharkaVR , et al. A randomized trial of a multicomponent intervention to promote medication adherence: the teen adherence in kidney transplant effectiveness of intervention trial (TAKE-IT) [Erratum in: Am J Kidney Dis. 2019 Apr;73(4):578]. American Journal of Kidney Diseases2018;72(1):30-41. [MEDLINE: 29602631]FosterBJ , ZhaoH , PaiA , ZelikovskyN , HollyCD , SmithJM , et al. Medication adherence barrier burden predicts subsequent adherence to dosing time schedule in adolescent kidney transplant recipients in the TAKE-IT Trial [abstract no: SA-PO1031]. Journal of the American Society of Nephrology2015;26(Abstracts):871A. [CENTRAL: CN-01657537] LadnerDP , WolfMS . Transplant regimen adherence for kidney recipients by engaging information technologies: the TAKE-IT trial [abstract no: D302]. American Journal of Transplantation2019;19(Suppl 3):1145. [EMBASE: 628453783]">TAKE‐IT 2014</a>), high risk in three studies (<a href="./references#CD012854-bbs2-0008" title="DeVito DabbsA , DewMA , MyersB , BegeyA , HawkinsR , RenD , et al. Evaluation of a hand-held, computer-based intervention to promote early self-care behaviors after lung transplant. Clinical Transplantation2009;23(4):537-45. [MEDLINE: 19473201]">DeVito Dabbs 2009</a>; <a href="./references#CD012854-bbs2-0016" title="JoostR , DorjeF , SchwitullaJ , EckardtKU , HugoC . Intensified pharmaceutical care is improving immunosuppressive medication adherence in kidney transplant recipients during the first post-transplant year: a quasi-experimental study. Nephrology Dialysis Transplantation2014;29(8):1597-607. [MEDLINE: 24914089]">Joost 2014</a>; <a href="./references#CD012854-bbs2-0024" title="AndrewsAM , ChengAL , Bartlett EllisRJ , EmersonAM , O'BrienT , RussellCL . SystemCHANGE TM solutions to improve medication adherence in kidney transplant recipients: a secondary data analysis. Nephrology Nursing Journal2021;48(4):389-417. [MEDLINE: 34463466]RussellCL , HathawayD , RemyLM , AholtD , ClarkD , MillerC , et al. Improving medication adherence and outcomes in adult kidney transplant patients using a personal systems approach: SystemCHANGE TM results of the MAGIC randomized clinical trial. American Journal of Transplantation2020;20(1):125-36. [MEDLINE: 31291507]RussellCL , MooreS , HathawayD , ChengAL , ChenG , GogginK . MAGIC Study: aims, design and methods using SystemCHANGE TM to improve immunosuppressive medication adherence in adult kidney transplant recipients. BMC Nephrology2016;17(1):84. [MEDLINE: 27421884]RussellCL . Improving medication adherence and outcomes in adult kidney transplant patients using a personal systems approach: SystemCHANGE.TM results of the MAGIC randomized clinical trial [abstract]. Peritoneal Dialysis International2020;40(1 Suppl):14S. [EMBASE: 632156503]WakefieldWR , AshbaughCM , RemyL , AholtD , MillerC , YeS , et al. Improving medication adherence and outcomes in adult kidney transplant patients using SYSTEMChangeTM: results of the Medication Adherence Given Individual Change (MAGIC) randomized clinical trial [abstract no: 523]. American Journal of Transplantation2019;19(Suppl 3):541-2. [EMBASE: 628454823]">MAGIC 2016</a>), and unclear risk in 25 studies (<a href="./references#CD012854-bbs2-0003" title="Breu-DejeanN , DriotD , DupouyJ , Lapeyre-MestreM , RostaingL . Efficacy of psychoeducational intervention on allograft function in kidney transplant patients: 10-year results of a prospective randomized study. Experimental &amp; Clinical Transplantation2016;14(1):38-44. [MEDLINE: 26862823]Breu-DejeanN . Education program to reduce non-compliance after renal transplantation [doctorate thesis] [Effet d'une intervention psycho-éducationnelle sur l'observance thérapeutique chez les transplantés rénaux]. University of Toulouse2016. [CENTRAL: CN-01658149] Breu-DejeanNB , RontaingL , Lapeyre-MestreM , RogeB , DurandD . Educational program to reduce noncompliance after renal transplantation [abstract no: MO06]. In: 41st Congress. European Renal Association. European Dialysis and Transplantation Association; 2004 May 15-18; Lisbon, Portugal. 2004:214-5. [CENTRAL: CN-00636140] ">Breu‐Dejean 2016</a>; <a href="./references#CD012854-bbs2-0004" title="ChisholmMA , MulloyL , JagadeesanM , DiPiroJT . Two-year economic evaluation of clinical pharmacy services in renal transplant clinic patients [abstract no: 588]. American Journal of Transplantation2002;2(Suppl 3):286. [CENTRAL: CN-00415424] ChisholmMA , MulloyLL , JagadeesanM , DiPiroJT . Impact of clinical pharmacy services on renal transplant patients' compliance with immunosuppressive medications. Clinical Transplantation2001;15(5):330-6. [MEDLINE: 11678959]">Chisholm 2001</a>; <a href="./references#CD012854-bbs2-0011" title="HardstaffR , GreenK , TalbotD . Measurement of compliance posttransplantation--the results of a 12-month study using electronic monitoring. Transplantation Proceedings2003;35(2):796-7. [MEDLINE: 12644142]HardstaffR , GreenK , TalbotD . Noncompliance postrenal transplantation: measuring the extent of the problem using electronic surveillance and nurse practitioner interviews. Transplantation Proceedings2002;34(5):1608. [MEDLINE: 12176504]">Hardstaff 2002</a>; <a href="./references#CD012854-bbs2-0012" title="HarrisonJJ , BadrS , HamandiB , KimSJ . Randomized controlled trial of a computer-based education program in the home for solid organ transplant recipients: impact on medication knowledge, satisfaction, and adherence. Transplantation2017;101(6):1336-43. [MEDLINE: 27367473]">Harrison 2016</a>; <a href="./references#CD012854-bbs2-0014" title="HuangY , YuX . Effect of healthy education on improving the drug compliance of patients after renal transplantation. Journal of Clinical Rehabilitative Tissue Engineering Research2007;11(43):8773-5. [EMBASE: 350081272]">Huang 2007b</a>; <a href="./references#CD012854-bbs2-0015" title="LowJK , ManiasE , CrawfordK , WalkerR , MulleyWR , ToussaintND , et al. Improving medication adherence in adult kidney transplantation (IMAKT): a pilot randomised controlled trial. Scientific Reports2019;9(1):7734. [MEDLINE: 31118485]">IMAKT 2019</a>; <a href="./references#CD012854-bbs2-0017" title="JungHY , JeonY , SeongSJ , SeoJJ , ChoiJY , ChoJH , et al. ICT-based adherence monitoring in kidney transplant recipients: a randomized controlled trial. BMC Medical Informatics &amp; Decision Making2020;20(1):105. [MEDLINE: 32522263]JungHY , JeonY , SeongSJ , SeoJJ , ChoiJY , ChoJH , et al. Information and communication technology-based centralized monitoring system to increase adherence to immunosuppressive medication in kidney transplant recipients: a randomized controlled trial [abstract no: P1734]. Nephrology Dialysis Transplantation2020;35(Suppl 3):iii252. [EMBASE: 633422975]JungHY , SeongSJ , ChoiJY , ChoJH , ParkSH , KimCD , et al. The efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trial. Trials [Electronic Resource]2017;18(1):480. [MEDLINE: 29037222]">Jung 2017</a>; <a href="./references#CD012854-bbs2-0018" title="KaiserTE , EjazNS , TremblayS , ParrishNJ , BenavidesJ , ReheB , et al. Technology triggered adherence intervention: preliminary findings [abstract no: 185]. American Journal of Transplantation2019;19(Suppl 3):394. [EMBASE: 628454914]">Kaiser 2019</a>; <a href="./references#CD012854-bbs2-0019" title="KantachuvessiriS , InksatidA , SumethkulV , JirasirithamS , ThirapanichW . Adherence to immunosuppression after conversion of twice-daily tacrolimus to once-daily tacrolimus in stable kidney transplant patients in Thailand: a prospective study [abstract no: P.1515]. Transplantation2016;100(7 Suppl 1):S716. [EMBASE: 613004564]">Kantachuvessiri 2016</a>; <a href="./references#CD012854-bbs2-0020" title="KleinA , KramerI . Influence of a pharmaceutical care program on liver transplant patients' compliance with immunosuppressive therapy: a prospective, randomized, controlled trial [Pharmazeutische betreuung lebertransplantierter patienten unter besonderer berucksichtigung der compliance mit der immunsuppressiven therapie: Eine prospektive, randomisierte, kontrollierte studie]. Krankenhauspharmazie2007;28(12):458-68. [EMBASE: 350287720]KleinA , OttoG , KramerI . Impact of a pharmaceutical care program on liver transplant patients' compliance with immunosuppressive medication: a prospective, randomized, controlled trial using electronic monitoring. Transplantation2009;87(6):839-47. [MEDLINE: 19300186]">Klein 2007</a>; <a href="./references#CD012854-bbs2-0021" title="LevineD , TorabiJ , ChoinskiK , RoccaJP , GrahamJA . Transplant surgery enters a new era: increasing immunosuppressive medication adherence through mobile apps and smart watches. American Journal of Surgery2019;218(1):18-20. [MEDLINE: 30799019]">Levine 2019</a>; <a href="./references#CD012854-bbs2-0022" title="LiuJ . Effect of WeChat-based peer education on medication compliance and quality of life in patients with liver transplantation: a pilot study [abstract no: P-576]. Transplantation2019;103(8 Suppl 1):380. [EMBASE: 629265854]">Liu 2019c</a>; <a href="./references#CD012854-bbs2-0025" title="McGillicuddyJW , GregoskiMJ , Brunner-JacksonBM , WeilandAK , PatelSK , RockRA , et al. Facilitating medication adherence and eliminating therapeutic inertia using wireless technology: proof of concept findings with uncontrolled hypertensives and kidney transplant recipients. In: WH '12 Proceedings of the Conference on Wireless Health; 2012 Oct 23-25; San Diego CA. 2012. [CENTRAL: CN-01658221] McGillicuddyJW , GregoskiMJ , WeilandAK , RockRA , Brunner-JacksonBM , PatelSK , et al. Mobile health medication adherence and blood pressure control in renal transplant recipients: a proof-of-concept randomized controlled trial. JMIR Research Protocols2013;2(2):e32. [MEDLINE: 24004517]McGillicuddyJW , TaberDJ , MuellerM , PatelS , BaligaPK , ChavinKD , et al. Sustainability of improvements in medication adherence through a mobile health intervention. Progress in Transplantation2015;25(3):217-23. [MEDLINE: 26308780]McGillicuddyJW . EHealth and transplantation [abstract no: PM-47]. American Journal of Transplantation2014;14(Suppl 2):54-5. [EMBASE: 71388189]">McGillicuddy 2013</a>; <a href="./references#CD012854-bbs2-0026" title="Gomis-PastorM , Mirabet PerezS , Roig MinguellE , Brossa LoidiV , Lopez LopezL , Ros AbarcaS , et al. Mobile health to improve adherence and patient experience in heart transplantation recipients: the mHeart trial. Healthcare2021;9(4):463. [MEDLINE: 33919899]Gomis-PastorM , MirabetS , RoigE , BrossaV , LopezL , RosS , et al. Improving patients' experience and medication adherence after heart transplant using a multilevel ehealth intervention: the mHeart clinical trial [abstract no: P-16.07]. Transplantation2020;104(Suppl 3):S578-9. [EMBASE: 633380991]">mHeart 2021</a>; <a href="./references#CD012854-bbs2-0027" title="PatersonTS , DemianM , ShapiroRJ , Loken ThorntonW . Impact of once- versus twice-daily tacrolimus dosing on medication adherence in stable renal transplant recipients: a Canadian single-center randomized controlled trial. Canadian Journal of Kidney Health &amp; Disease2019;6:2054358119867993. [MEDLINE: 31452902]ShapiroRJ , PatersonT , ThorntonW , HusseiniT , PartoviN , VishloffJ , et al. Medication adherence is tied to social support in renal transplant recipients [abstract no: 2501]. In: Canadian Society of Transplantation Annual Scientific Meeting; 2013 Mar 13-16; Alberta, Canada. 2013:38. ">Paterson 2019</a>; <a href="./references#CD012854-bbs2-0028" title="AmaralS , FosterN , DashefskyH , KimJ , FurthS . Peers4path: challenges in measuring medication adherence in adolescent transplant recipients [abstract no: A485]. American Journal of Transplantation2014;14(Suppl 3):238. [EMBASE: 71544246]AmaralS , FosterN , DashefskyH , PaternoC , FurthS . Peers4Path: feasibility of medication adherence measures in adolescent transplant recipients [abstract no: FR-PO403]. Journal of the American Society of Nephrology2014;25(Abstracts):463A. [CENTRAL: CN-01657532] AmaralS , FosterN , YangA , ShultsJ , FurthS . Peers4Path: testing peer support as a mechanism to improve transplant outcomes among adolescents with solid organ transplants [abstract no: TH-PO1083]. Journal of the American Society of Nephrology2013;24(Abstracts):345-6A. [CENTRAL: CN-01657533] AmaralS , RogersR , PaternoC , FosterN , ShultsJ . Peers4path (promoting adolescent transplant health): a pilot study to test peer mentoring as an adherence intervention in adolescent transplant recipients [abstract no: 401.1]. Pediatric Transplantation2017;21(Suppl 1):33. [EMBASE: 616208171]StrachanC , PatonM , ReasonJ , AmaralS . Stakeholder perspectives in peer mentoring program for pediatric solid organ transplant recipients [abstract no: D323]. American Journal of Transplantation2019;19(Suppl 3):1153. [EMBASE: 628454820]">Peers4path 2014</a>; <a href="./references#CD012854-bbs2-0029" title="HanA , ChoMJ , ChoS , LeeCH , ChoiC , KimSY , et al. Use of mobile internet application to improve adherence to immunosuppressive medication adherence in kidney transplant recipients: preliminary results of the PRIMA (ImProving Adherence to Immunosuppressive Therapy by Mobile Internet application) study [abstract no: 420.4]. Transplantation2016;100(7 Suppl):S161. [EMBASE: 613004382]HanA , MinSI , AhnS , MinSK , HongHJ , HanN , et al. Mobile medication manager application to improve adherence with immunosuppressive therapy in renal transplant recipients: a randomized controlled trial. PLoS ONE [Electronic Resource]2019;14(11):e0224595. [MEDLINE: 31689320]KoH , KimHK , ChungC , HanA , MinSK , HaJ , et al. Association between medication adherence and intrapatient variability in tacrolimus concentration among stable kidney transplant recipients. Scientific Reports2021;11(1):5397. [MEDLINE: 33686160]">PRIMA 2019</a>; <a href="./references#CD012854-bbs2-0030" title="ReeseP , BloomR , Trofe-ClarkJ , MussellA , LeidyD , LevskyS , et al. Customized reminders and provider notification to improve adherence to immunosuppression [abstract no: 1074]. American Journal of Transplantation2015;15(Suppl 3). [EMBASE: 71953144]ReesePP , BloomRD , Trofe-ClarkJ , MussellA , LeidyD , LevskyS , et al. Automated reminders and physician notification to promote immunosuppression adherence among kidney transplant recipients: a randomized trial. American Journal of Kidney Diseases2017;69(3):400-9. [MEDLINE: 27940063]">Reese 2017</a>; <a href="./references#CD012854-bbs2-0031" title="RussellC , ConnV , AshbaughC , MadsenR , WakefieldM , WebbA , et al. Taking immunosuppressive medications effectively (TIMELink): a pilot randomized controlled trial in adult kidney transplant recipients. Clinical Transplantation2011;25(6):864-70. [MEDLINE: 21077956]RussellCL , ConnVS , AshbaughC , CoffeyD , WakefieldM . A pilot RCT to increase medication adherence in transplantation [abstract no: 1168]. American Journal of Transplantation2010;10(Suppl 4):376. [EMBASE: 70464544]">Russell 2011</a>; <a href="./references#CD012854-bbs2-0032" title="SantanaMJ , FeenyD , JacksonK , SchafenackerM , WeinkaufJ , LienD . Using patient-centred care to enhance adherence to medication and exercise in lung transplantation: a randomized controlled clinical trial [abstract no: 445]. In: Canadian Society of Transplantation Annual Scientific Meeting; 2011 Mar 2-5; Quebec, Canada. 2011:34. [CENTRAL: CN-01657760] ">Santana 2011</a>; <a href="./references#CD012854-bbs2-0033" title="HilsS , SchmidA , BogatyrevaL , HauschkeD , Kramer-ZuckerA , PisarskiP . Telemedical supported aftercare after living kidney transplantation-a single center experience [abstract no: O179]. Transplant International2015;28(Suppl 4):69. [EMBASE: 72111423]HilsS , SchmidA , BogatyrevaL , HauschkeD , PisarskiP . Telemedical supported aftercare as an innovative project-study improves the quality of life after living kidney transplantation-a single center experience [abstract no: D2730]. Transplantation2014;98(Suppl 1):843. [EMBASE: 71546416]KaierK , HilsS , FetzerS , HehnP , SchmidA , HauschkeD , et al. Results of a randomized controlled trial analyzing telemedically supported case management in the first year after living donor kidney transplantation - a budget impact analysis from the healthcare perspective. Health Economics Review2017;7(1):1. [MEDLINE: 28092012]PisarskiP , HilsS , SchmidA , Kramer-ZuckerA , JanigenB . Telemedicin as an innovative project-study in adherence improvement after living kidney transplantation at the Transplantation Center Freiburg [abstract no: O162]. Transplant International2013;26(Suppl 2):73. [EMBASE: 71359226]SchmidA , HilsS , Kramer-ZuckerA , BogatyrevaL , HauschkeD , De GeestS , et al. Telemedically-supported case management of living-donor renal transplant recipients to optimize routine evidence-based aftercare: a single-center randomized controlled trial. American Journal of Transplantation2017;17(6):1594-605. [MEDLINE: 27873477]SchmidA , PisarskiP , HilsS , HauschkeD , BogatyrevaL . Telemedical supported after care in living kidney recipients-an innovative project-study at the Transplantation Center Freiburg interim results of a prospective ongoing study of 50 patients [abstract no: P84]. Transplant International2013;26(Suppl 1):43. [EMBASE: 71356349]">Schmid 2017</a>; <a href="./references#CD012854-bbs2-0035" title="SuhlingH , RademacherJ , ZinowskyI , FugeJ , GreerM , WarneckeG , et al. Conventional vs. tablet computer-based patient education following lung transplantation--a randomized controlled trial. PLoS ONE [Electronic Resource]2014;9(6):e90828. [MEDLINE: 24608864]SuhlingH , RademacherJ , ZinowskyI , FugeJ , GreerM , WarneckeG . Patient education via tablet-pc vs. conventional to improve compliance with immunosuppressive drug regimen after lung transplantation - a randomized controlled trial [abstract no: 2844]. European Respiratory Journal2013;42(Suppl 57):565S. [EMBASE: 71843332]">Suhling 2014</a>; <a href="./references#CD012854-bbs2-0036" title="TaberDJ , PosadasMA , RaoV , McGillicuddyJ , RohanV , NadigSN , et al. The potential for improved medication adherence with a complete once daily immunosuppression regimen in kidney transplant: results of a randomized controlled study [abstract no: FR-PO1177]. Journal of the American Society of Nephrology2019;30(Abstract Suppl):750-1. [EMBASE: 633769114]TaberDJ , Posadas-SalasA , SuZ , RaoV , RohanV , NadigS , et al. Preliminary assessment of safety and adherence to a once-daily immunosuppression regimen in kidney transplantation: results of a randomized controlled pilot study. Clinical Transplantation2020;34(4):e13844. [MEDLINE: 32092187]">Taber 2020</a>; <a href="./references#CD012854-bbs2-0039" title="FlemingJN , GebregziabherM , PosadasA , SuZ , McGillicuddyJW , TaberDJ . Impact of a pharmacist-led, mHealth-based intervention on tacrolimus trough variability in kidney transplant recipients: a report from the TRANSAFE Rx randomized controlled trial. American Journal of Health-System Pharmacy2021;78(14):1287-93. [MEDLINE: 33821958]FlemingJN , TreiberF , McGillicuddyJ , GebregziabherM , TaberDJ . Improving transplant medication safety through a pharmacist-empowered, patient-centered, mhealth-based intervention: TRANSAFE Rx study protocol. JMIR Research Protocols2018;7(3):e59. [MEDLINE: 29500161]GonzalesHM , FlemingJN , GebregziabherM , Posadas-SalasMA , SuZ , McGillicuddyJW , et al. Pharmacist-led mobile health intervention and transplant medication safety: a randomized controlled clinical trial. Clinical Journal of the American Society of Nephrology: CJASN2021;16(5):776-84. [MEDLINE: 33931415]TaberDJ , FlemingJN , SuZ , MauldinP , McGillicuddyJW , PosadasA , et al. Significant hospitalization cost savings to the payer with a pharmacist-led mobile health intervention to improve medication safety in kidney transplant recipients. American Journal of Transplantation2021;21(10):3428-35. [MEDLINE: 34197699]TaberDJ , PilchNA , McGillicuddyJW , MardisC , TreiberF , FlemingJN . Using informatics and mobile health to improve medication safety monitoring in kidney transplant recipients. American Journal of Health-System Pharmacy2019;76(15):1143-9. [MEDLINE: 31361870]">TRANSAFE‐Rx 2018</a>; <a href="./references#CD012854-bbs2-0040" title="UrstadKH , OyenO , AndersenMH , MoumT , WahlAK . The effect of an educational intervention for renal recipients: a randomized controlled trial. Clinical Transplantation2012;26(3):E246-53. [MEDLINE: 22686948]">Urstad 2012</a>) due to insufficient information to permit assessment. </p> </section> </section> <section id="CD012854-sec-0050"> <h4 class="title">Blinding</h4> <section id="CD012854-sec-0051"> <h5 class="title">Performance bias</h5> <p>Participants were not blinded in all studies; however, performance bias was judged to be low risk in nine studies (<a href="./references#CD012854-bbs2-0004" title="ChisholmMA , MulloyL , JagadeesanM , DiPiroJT . Two-year economic evaluation of clinical pharmacy services in renal transplant clinic patients [abstract no: 588]. American Journal of Transplantation2002;2(Suppl 3):286. [CENTRAL: CN-00415424] ChisholmMA , MulloyLL , JagadeesanM , DiPiroJT . Impact of clinical pharmacy services on renal transplant patients' compliance with immunosuppressive medications. Clinical Transplantation2001;15(5):330-6. [MEDLINE: 11678959]">Chisholm 2001</a>; <a href="./references#CD012854-bbs2-0006" title="CoteJ , FortinMC , AugerP , RouleauG , DuboisS , BoudreauN , et al. Web-based tailored intervention to support optimal medication adherence among kidney transplant recipients: pilot parallel-group randomized controlled trial. JMIR Formative Research2018;2(2):e14. [MEDLINE: 30684400]">Cote 2018</a>; <a href="./references#CD012854-bbs2-0012" title="HarrisonJJ , BadrS , HamandiB , KimSJ . Randomized controlled trial of a computer-based education program in the home for solid organ transplant recipients: impact on medication knowledge, satisfaction, and adherence. Transplantation2017;101(6):1336-43. [MEDLINE: 27367473]">Harrison 2016</a>; <a href="./references#CD012854-bbs2-0021" title="LevineD , TorabiJ , ChoinskiK , RoccaJP , GrahamJA . Transplant surgery enters a new era: increasing immunosuppressive medication adherence through mobile apps and smart watches. American Journal of Surgery2019;218(1):18-20. [MEDLINE: 30799019]">Levine 2019</a>; <a href="./references#CD012854-bbs2-0025" title="McGillicuddyJW , GregoskiMJ , Brunner-JacksonBM , WeilandAK , PatelSK , RockRA , et al. Facilitating medication adherence and eliminating therapeutic inertia using wireless technology: proof of concept findings with uncontrolled hypertensives and kidney transplant recipients. In: WH '12 Proceedings of the Conference on Wireless Health; 2012 Oct 23-25; San Diego CA. 2012. [CENTRAL: CN-01658221] McGillicuddyJW , GregoskiMJ , WeilandAK , RockRA , Brunner-JacksonBM , PatelSK , et al. Mobile health medication adherence and blood pressure control in renal transplant recipients: a proof-of-concept randomized controlled trial. JMIR Research Protocols2013;2(2):e32. [MEDLINE: 24004517]McGillicuddyJW , TaberDJ , MuellerM , PatelS , BaligaPK , ChavinKD , et al. Sustainability of improvements in medication adherence through a mobile health intervention. Progress in Transplantation2015;25(3):217-23. [MEDLINE: 26308780]McGillicuddyJW . EHealth and transplantation [abstract no: PM-47]. American Journal of Transplantation2014;14(Suppl 2):54-5. [EMBASE: 71388189]">McGillicuddy 2013</a>; <a href="./references#CD012854-bbs2-0030" title="ReeseP , BloomR , Trofe-ClarkJ , MussellA , LeidyD , LevskyS , et al. Customized reminders and provider notification to improve adherence to immunosuppression [abstract no: 1074]. American Journal of Transplantation2015;15(Suppl 3). [EMBASE: 71953144]ReesePP , BloomRD , Trofe-ClarkJ , MussellA , LeidyD , LevskyS , et al. Automated reminders and physician notification to promote immunosuppression adherence among kidney transplant recipients: a randomized trial. American Journal of Kidney Diseases2017;69(3):400-9. [MEDLINE: 27940063]">Reese 2017</a>; <a href="./references#CD012854-bbs2-0031" title="RussellC , ConnV , AshbaughC , MadsenR , WakefieldM , WebbA , et al. Taking immunosuppressive medications effectively (TIMELink): a pilot randomized controlled trial in adult kidney transplant recipients. Clinical Transplantation2011;25(6):864-70. [MEDLINE: 21077956]RussellCL , ConnVS , AshbaughC , CoffeyD , WakefieldM . A pilot RCT to increase medication adherence in transplantation [abstract no: 1168]. American Journal of Transplantation2010;10(Suppl 4):376. [EMBASE: 70464544]">Russell 2011</a>; <a href="./references#CD012854-bbs2-0034" title="De GeestS , DenhaerynckK , Schafer-KellerP , BockA , SteigerJ . Supporting medication adherence in renal transplantation--the SMART study. Swiss Medical Weekly2007;137 Suppl 155:125-7S. [MEDLINE: 17874516]De GeestS , Schafer-KellerP , DenhaerynckK , BockA , KoferS , ThannbergerN , et al. Supporting medication adherence in renal transplantation (SMART): a pilot study [abstract no: PO3.09]. Kidney &amp; Blood Pressure Research2004;27(5-6):327. [CENTRAL: CN-00615859] De GeestS , Schafer-KellerP , DenhaerynckK , ThannbergerN , KoferS , BockA , et al. Supporting medication adherence in renal transplantation (SMART): a pilot RCT to improve adherence to immunosuppressive regimens. Clinical Transplantation2006;20(3):359-68. [MEDLINE: 16824155]deGeestS , SchaferP , DenhaerynckK , BockA , SteigerJ . Supporting medication adherence in renal transplantation (SMART): a randomized controlled trial to improve adherence with immunosuppressive regimen [abstract no: PO-590]. Transplant International2005;18(Suppl):na. ">SMART 2006</a>; <a href="./references#CD012854-bbs2-0035" title="SuhlingH , RademacherJ , ZinowskyI , FugeJ , GreerM , WarneckeG , et al. Conventional vs. tablet computer-based patient education following lung transplantation--a randomized controlled trial. PLoS ONE [Electronic Resource]2014;9(6):e90828. [MEDLINE: 24608864]SuhlingH , RademacherJ , ZinowskyI , FugeJ , GreerM , WarneckeG . Patient education via tablet-pc vs. conventional to improve compliance with immunosuppressive drug regimen after lung transplantation - a randomized controlled trial [abstract no: 2844]. European Respiratory Journal2013;42(Suppl 57):565S. [EMBASE: 71843332]">Suhling 2014</a>) as study outcomes were unlikely to be affected by non‐blinding. Performance bias was judged to be high in 27 studies (<a href="./references#CD012854-bbs2-0001" title="KuypersDR , BonvoisinCA , PeetersP , SennesaelJJ , KiandaMN , VrijensB , et al. Superior medication adherence to tacrolimus modified release once-daily (QD) compared to tacrolimus twice-daily (BID) in stable renal transplant patients [abstract no: RO-256]. Transplant International2011;24(Suppl 2):199. [EMBASE: 70527785]KuypersDR , PeetersPC , SennesaelJJ , KiandaMN , VrijensB , KristantoP , et al. Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring. Transplantation2013;95(2):333-40. [MEDLINE: 23263559]">ADMIRAD 2013</a>; <a href="./references#CD012854-bbs2-0002" title="BessaA , MedinaJ , TedescoH , FelipeC . A prospective, randomised, controlled study to assess the effect of pharmaceutical intervention on compliance and knowledge of immunosuppression in kidney transplant recipients [abstract no: DI-090]. European Journal of Hospital Pharmacy2015;22(Suppl 1):A109-10. [EMBASE: 614322295]BessaAB , FelipeCR , HannunP , SayuriP , FelixMJ , RuppelP , et al. Prospective randomized trial investigating the influence of pharmaceutical care on the intra-individual variability of tacrolimus concentrations early after kidney transplant. Therapeutic Drug Monitoring2016;38(4):447-55. [MEDLINE: 27414973]">Bessa 2016</a>; <a href="./references#CD012854-bbs2-0003" title="Breu-DejeanN , DriotD , DupouyJ , Lapeyre-MestreM , RostaingL . Efficacy of psychoeducational intervention on allograft function in kidney transplant patients: 10-year results of a prospective randomized study. Experimental &amp; Clinical Transplantation2016;14(1):38-44. [MEDLINE: 26862823]Breu-DejeanN . Education program to reduce non-compliance after renal transplantation [doctorate thesis] [Effet d'une intervention psycho-éducationnelle sur l'observance thérapeutique chez les transplantés rénaux]. University of Toulouse2016. [CENTRAL: CN-01658149] Breu-DejeanNB , RontaingL , Lapeyre-MestreM , RogeB , DurandD . Educational program to reduce noncompliance after renal transplantation [abstract no: MO06]. In: 41st Congress. European Renal Association. European Dialysis and Transplantation Association; 2004 May 15-18; Lisbon, Portugal. 2004:214-5. [CENTRAL: CN-00636140] ">Breu‐Dejean 2016</a>; <a href="./references#CD012854-bbs2-0005" title="Chisholm-BurnsM , SpiveyC , Graff ZivinJ , LeeJ , SredzinskiE . Results of a behavioral contract intervention to improve adherence and healthcare outcomes among renal transplant recipients [abstract no: D1727]. American Journal of Transplantation2013;13(Suppl S5):540. [CENTRAL: CN-01007771] Chisholm-BurnsMA , EricksonS , SpiveyCA . Employment and health-related quality of life among renal transplant recipients [abstract no: 1140]. American Journal of Transplantation2011;11(Suppl 2):365. [EMBASE: 70406190]Chisholm-BurnsMA , SpiveyCA , GraffZJ , LeeJK , SredzinskiE , TolleyEA . Improving outcomes of renal transplant recipients with behavioral adherence contracts: a randomized controlled trial. American Journal of Transplantation2013;13(9):2364-73. [MEDLINE: 23819827]Chisholm-BurnsMA , SpiveyCA , SredzinskiE , ButlerS . Preliminary results of a behavioral contract intervention to improve adherence and quality of life among renal transplant recipients [abstract no: 1139]. American Journal of Transplantation2011;11(Suppl 2):365. [EMBASE: 70406189]Chisholm-BurnsMA , SpiveyCA , SredzinskiE , ButlerSL . Intervention toolbox to promote immunosuppressant therapy adherence in adult renal transplant recipients. Journal of the American Pharmacists Association: JAPhA2012;52(6):816-22. [MEDLINE: 23229970]">Chisholm‐Burns 2013</a>; <a href="./references#CD012854-bbs2-0007" title="CukorD , Ver HalenN , PencilleM , TedlaF , SalifuM . A pilot randomized controlled trial to promote immunosuppressant adherence in adult kidney transplant recipients. Nephron2017;135(1):6-14. [MEDLINE: 28049201]">Cukor 2017</a>; <a href="./references#CD012854-bbs2-0008" title="DeVito DabbsA , DewMA , MyersB , BegeyA , HawkinsR , RenD , et al. Evaluation of a hand-held, computer-based intervention to promote early self-care behaviors after lung transplant. Clinical Transplantation2009;23(4):537-45. [MEDLINE: 19473201]">DeVito Dabbs 2009</a>; <a href="./references#CD012854-bbs2-0009" title="DeVito DabbsA , DewM , MyersBA , SongM , LiR , ZomakR , et al. Randomized controlled trial (RCT) of pocket path, an mhealth intervention to promote self-management after lung transplantation [abstract no: A5361]. American Journal of Respiratory &amp; Critical Care Medicine2014;189:A5361. [EMBASE: 72047364]DeVito DabbsA , SongMK , MyersBA , LiR , HawkinsRP , PilewskiJM , et al. A randomized controlled trial of a mobile health intervention to promote self-management after lung transplantation. American Journal of Transplantation2016;16(7):2172-80. [MEDLINE: 26729617]GeramitaEM , DeVito DabbsAJ , DiMartiniAF , PilewskiJM , SwitzerGE , PoslusznyDM , et al. Impact of a mobile health intervention on long-term nonadherence after lung transplantation: follow-up after a randomized controlled trial. Transplantation2020;104(3):640-51. [MEDLINE: 31335759]HuL , DeVito DabbsA , DewMA , SereikaSM , LinglerJH . Patterns and correlates of adherence to self-monitoring in lung transplant recipients during the first 12 months after discharge from transplant. Clinical Transplantation2017;31(8):e13014. [MEDLINE: 28517112]RosenbergerEM , Devito DabbsAJ , DiMartiniAF , LandsittelDP , PilewskiJM , DewMA . Long-term follow-up of a randomized controlled trial evaluating a mobile health intervention for self-management in lung transplant recipients. American Journal of Transplantation2017;17(5):1286-93. [MEDLINE: 27664940]">DeVito Dabbs 2016</a>; <a href="./references#CD012854-bbs2-0010" title="GarciaMF , BravinAM , GarciaPD , ConttiMM , NgaHS , TakaseHM , et al. Behavioral measures to reduce non-adherence in renal transplant recipients: a prospective randomized controlled trial. International Urology &amp; Nephrology2015;47(11):1899-905. [MEDLINE: 26377496]">Garcia 2015</a>; <a href="./references#CD012854-bbs2-0013" title="HenrikssonJ , TydenG , HoijerJ , WadstromJ . A prospective randomized trial on the effect of using an electronic monitoring drug dispensing device to improve adherence and compliance. Transplantation2016;100(1):203-9. [MEDLINE: 26588006]HenrikssonJ , WadstromJ , HoijerJ , TydenG . A prospective randomized trial on the effect of using an electronic monitoring drug dispensary device to improve adherence and non-compliance [abstract no: BO220]. Transplant International2015;28(Suppl 4):204. [EMBASE: 72111815]">Henriksson 2016</a>; <a href="./references#CD012854-bbs2-0014" title="HuangY , YuX . Effect of healthy education on improving the drug compliance of patients after renal transplantation. Journal of Clinical Rehabilitative Tissue Engineering Research2007;11(43):8773-5. [EMBASE: 350081272]">Huang 2007b</a>; <a href="./references#CD012854-bbs2-0015" title="LowJK , ManiasE , CrawfordK , WalkerR , MulleyWR , ToussaintND , et al. Improving medication adherence in adult kidney transplantation (IMAKT): a pilot randomised controlled trial. Scientific Reports2019;9(1):7734. [MEDLINE: 31118485]">IMAKT 2019</a>; <a href="./references#CD012854-bbs2-0016" title="JoostR , DorjeF , SchwitullaJ , EckardtKU , HugoC . Intensified pharmaceutical care is improving immunosuppressive medication adherence in kidney transplant recipients during the first post-transplant year: a quasi-experimental study. Nephrology Dialysis Transplantation2014;29(8):1597-607. [MEDLINE: 24914089]">Joost 2014</a>; <a href="./references#CD012854-bbs2-0017" title="JungHY , JeonY , SeongSJ , SeoJJ , ChoiJY , ChoJH , et al. ICT-based adherence monitoring in kidney transplant recipients: a randomized controlled trial. BMC Medical Informatics &amp; Decision Making2020;20(1):105. [MEDLINE: 32522263]JungHY , JeonY , SeongSJ , SeoJJ , ChoiJY , ChoJH , et al. Information and communication technology-based centralized monitoring system to increase adherence to immunosuppressive medication in kidney transplant recipients: a randomized controlled trial [abstract no: P1734]. Nephrology Dialysis Transplantation2020;35(Suppl 3):iii252. [EMBASE: 633422975]JungHY , SeongSJ , ChoiJY , ChoJH , ParkSH , KimCD , et al. The efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trial. Trials [Electronic Resource]2017;18(1):480. [MEDLINE: 29037222]">Jung 2017</a>; <a href="./references#CD012854-bbs2-0018" title="KaiserTE , EjazNS , TremblayS , ParrishNJ , BenavidesJ , ReheB , et al. Technology triggered adherence intervention: preliminary findings [abstract no: 185]. American Journal of Transplantation2019;19(Suppl 3):394. [EMBASE: 628454914]">Kaiser 2019</a>; <a href="./references#CD012854-bbs2-0019" title="KantachuvessiriS , InksatidA , SumethkulV , JirasirithamS , ThirapanichW . Adherence to immunosuppression after conversion of twice-daily tacrolimus to once-daily tacrolimus in stable kidney transplant patients in Thailand: a prospective study [abstract no: P.1515]. Transplantation2016;100(7 Suppl 1):S716. [EMBASE: 613004564]">Kantachuvessiri 2016</a>; <a href="./references#CD012854-bbs2-0020" title="KleinA , KramerI . Influence of a pharmaceutical care program on liver transplant patients' compliance with immunosuppressive therapy: a prospective, randomized, controlled trial [Pharmazeutische betreuung lebertransplantierter patienten unter besonderer berucksichtigung der compliance mit der immunsuppressiven therapie: Eine prospektive, randomisierte, kontrollierte studie]. Krankenhauspharmazie2007;28(12):458-68. [EMBASE: 350287720]KleinA , OttoG , KramerI . Impact of a pharmaceutical care program on liver transplant patients' compliance with immunosuppressive medication: a prospective, randomized, controlled trial using electronic monitoring. Transplantation2009;87(6):839-47. [MEDLINE: 19300186]">Klein 2007</a>; <a href="./references#CD012854-bbs2-0023" title="DobbelsF , De BleserL , BerbenL , KristantoP , DupontL , NevensF , et al. Efficacy of a medication adherence enhancing intervention in transplantation: the MAESTRO-Tx trial. Journal of Heart &amp; Lung Transplantation2017;36(5):499-508. [MEDLINE: 28162931]DobbelsF , De BleserL , BerbenL , KristantoP , DupontL , NevensF , et al. Testing the efficacy of a multicomponent theory-based tailored behavioral medication adherence intervention in transplantation: The MAESTRO-TX RCT [abstract no: 223]. Journal of Heart &amp; Lung Transplantation2016;35(4 Suppl):S90. [EMBASE: 72253342]DobbelsF , De BleserL , KristantoP , NevensF , VanhaeckeJ , VerledenG , et al. Electronic monitoring feedback and motivational interviewing improves medication adherence in heart, liver and lung transplant patients: results from the MAESTRO-TX RCT [abstract no: BO218]. Transplant International2015;28(Suppl 4):203. [EMBASE: 72111813]">MAESTRO‐Tx 2017</a>; <a href="./references#CD012854-bbs2-0024" title="AndrewsAM , ChengAL , Bartlett EllisRJ , EmersonAM , O'BrienT , RussellCL . SystemCHANGE TM solutions to improve medication adherence in kidney transplant recipients: a secondary data analysis. Nephrology Nursing Journal2021;48(4):389-417. [MEDLINE: 34463466]RussellCL , HathawayD , RemyLM , AholtD , ClarkD , MillerC , et al. Improving medication adherence and outcomes in adult kidney transplant patients using a personal systems approach: SystemCHANGE TM results of the MAGIC randomized clinical trial. American Journal of Transplantation2020;20(1):125-36. [MEDLINE: 31291507]RussellCL , MooreS , HathawayD , ChengAL , ChenG , GogginK . MAGIC Study: aims, design and methods using SystemCHANGE TM to improve immunosuppressive medication adherence in adult kidney transplant recipients. BMC Nephrology2016;17(1):84. [MEDLINE: 27421884]RussellCL . Improving medication adherence and outcomes in adult kidney transplant patients using a personal systems approach: SystemCHANGE.TM results of the MAGIC randomized clinical trial [abstract]. Peritoneal Dialysis International2020;40(1 Suppl):14S. [EMBASE: 632156503]WakefieldWR , AshbaughCM , RemyL , AholtD , MillerC , YeS , et al. Improving medication adherence and outcomes in adult kidney transplant patients using SYSTEMChangeTM: results of the Medication Adherence Given Individual Change (MAGIC) randomized clinical trial [abstract no: 523]. American Journal of Transplantation2019;19(Suppl 3):541-2. [EMBASE: 628454823]">MAGIC 2016</a>; <a href="./references#CD012854-bbs2-0026" title="Gomis-PastorM , Mirabet PerezS , Roig MinguellE , Brossa LoidiV , Lopez LopezL , Ros AbarcaS , et al. Mobile health to improve adherence and patient experience in heart transplantation recipients: the mHeart trial. Healthcare2021;9(4):463. [MEDLINE: 33919899]Gomis-PastorM , MirabetS , RoigE , BrossaV , LopezL , RosS , et al. Improving patients' experience and medication adherence after heart transplant using a multilevel ehealth intervention: the mHeart clinical trial [abstract no: P-16.07]. Transplantation2020;104(Suppl 3):S578-9. [EMBASE: 633380991]">mHeart 2021</a>; <a href="./references#CD012854-bbs2-0027" title="PatersonTS , DemianM , ShapiroRJ , Loken ThorntonW . Impact of once- versus twice-daily tacrolimus dosing on medication adherence in stable renal transplant recipients: a Canadian single-center randomized controlled trial. Canadian Journal of Kidney Health &amp; Disease2019;6:2054358119867993. [MEDLINE: 31452902]ShapiroRJ , PatersonT , ThorntonW , HusseiniT , PartoviN , VishloffJ , et al. Medication adherence is tied to social support in renal transplant recipients [abstract no: 2501]. In: Canadian Society of Transplantation Annual Scientific Meeting; 2013 Mar 13-16; Alberta, Canada. 2013:38. ">Paterson 2019</a>; <a href="./references#CD012854-bbs2-0029" title="HanA , ChoMJ , ChoS , LeeCH , ChoiC , KimSY , et al. Use of mobile internet application to improve adherence to immunosuppressive medication adherence in kidney transplant recipients: preliminary results of the PRIMA (ImProving Adherence to Immunosuppressive Therapy by Mobile Internet application) study [abstract no: 420.4]. Transplantation2016;100(7 Suppl):S161. [EMBASE: 613004382]HanA , MinSI , AhnS , MinSK , HongHJ , HanN , et al. Mobile medication manager application to improve adherence with immunosuppressive therapy in renal transplant recipients: a randomized controlled trial. PLoS ONE [Electronic Resource]2019;14(11):e0224595. [MEDLINE: 31689320]KoH , KimHK , ChungC , HanA , MinSK , HaJ , et al. Association between medication adherence and intrapatient variability in tacrolimus concentration among stable kidney transplant recipients. Scientific Reports2021;11(1):5397. [MEDLINE: 33686160]">PRIMA 2019</a>; <a href="./references#CD012854-bbs2-0033" title="HilsS , SchmidA , BogatyrevaL , HauschkeD , Kramer-ZuckerA , PisarskiP . Telemedical supported aftercare after living kidney transplantation-a single center experience [abstract no: O179]. Transplant International2015;28(Suppl 4):69. [EMBASE: 72111423]HilsS , SchmidA , BogatyrevaL , HauschkeD , PisarskiP . Telemedical supported aftercare as an innovative project-study improves the quality of life after living kidney transplantation-a single center experience [abstract no: D2730]. Transplantation2014;98(Suppl 1):843. [EMBASE: 71546416]KaierK , HilsS , FetzerS , HehnP , SchmidA , HauschkeD , et al. Results of a randomized controlled trial analyzing telemedically supported case management in the first year after living donor kidney transplantation - a budget impact analysis from the healthcare perspective. Health Economics Review2017;7(1):1. [MEDLINE: 28092012]PisarskiP , HilsS , SchmidA , Kramer-ZuckerA , JanigenB . Telemedicin as an innovative project-study in adherence improvement after living kidney transplantation at the Transplantation Center Freiburg [abstract no: O162]. Transplant International2013;26(Suppl 2):73. [EMBASE: 71359226]SchmidA , HilsS , Kramer-ZuckerA , BogatyrevaL , HauschkeD , De GeestS , et al. Telemedically-supported case management of living-donor renal transplant recipients to optimize routine evidence-based aftercare: a single-center randomized controlled trial. American Journal of Transplantation2017;17(6):1594-605. [MEDLINE: 27873477]SchmidA , PisarskiP , HilsS , HauschkeD , BogatyrevaL . Telemedical supported after care in living kidney recipients-an innovative project-study at the Transplantation Center Freiburg interim results of a prospective ongoing study of 50 patients [abstract no: P84]. Transplant International2013;26(Suppl 1):43. [EMBASE: 71356349]">Schmid 2017</a>; <a href="./references#CD012854-bbs2-0036" title="TaberDJ , PosadasMA , RaoV , McGillicuddyJ , RohanV , NadigSN , et al. The potential for improved medication adherence with a complete once daily immunosuppression regimen in kidney transplant: results of a randomized controlled study [abstract no: FR-PO1177]. Journal of the American Society of Nephrology2019;30(Abstract Suppl):750-1. [EMBASE: 633769114]TaberDJ , Posadas-SalasA , SuZ , RaoV , RohanV , NadigS , et al. Preliminary assessment of safety and adherence to a once-daily immunosuppression regimen in kidney transplantation: results of a randomized controlled pilot study. Clinical Transplantation2020;34(4):e13844. [MEDLINE: 32092187]">Taber 2020</a>; <a href="./references#CD012854-bbs2-0037" title="Van ZantenR , De WeerdA , BetjesM , Boer-VerschragenM , MasseyE . Medication adherence and fear of rejection after conversion from dual to monotherapy: A randomized controlled trial [abstract no: OP170]. Transplant International2021;34(Suppl 1):35. [EMBASE: 635968308]vanZantenR , deWeerdA , BetjesM , Boer-VerschragenM , MasseyEK . Is simplification of immunosuppressive medication a way to promote medication adherence of kidney transplant recipients? Findings from a randomized controlled trial. Transplant International2021;34(9):1703-11. [MEDLINE: 34448273]">TACmono 2021</a>; <a href="./references#CD012854-bbs2-0038" title="BignallO , PaiA , AmaralS , FurthS , BergmanN , GoebelJ , et al. Differences in reported barriers to immunosuppression adherence among a cohort of pediatric renal transplant recipients from the United States and Canada [abstract no: D161]. American Journal of Transplantation2016;16(Suppl 3):751. [EMBASE: 611700425]BoucquemontJ , FosterB , TAKE-IT Investigators. Sex and age differences in medication adherence in adolescent and young adult kidney transplant recipients [abstract no: SA-PO404]. Journal of the American Society of Nephrology2016;27(Abstracts):721A. [CENTRAL: CN-01657535] BoucquemontJ , FosterB . Adherence patterns in adolescent and young adult kidney transplant recipients [abstract no: 229]. American Journal of Transplantation2016;16(Suppl 3):284. [EMBASE: 611700136]BoucquemontJ , PaiAL , DharnidharkaVR , HebertD , FurthSL , FosterBJ . Gender differences in medication adherence among adolescent and young adult kidney transplant recipients. Transplantation2019;103(4):798-806. [MEDLINE: 29994983]BoucquemontJ , PaiAL , DharnidharkaVR , HebertD , ZelikovskyN , AmaralS , et al. Association between day of the week and medication adherence among adolescent and young adult kidney transplant recipients. American Journal of Transplantation2020;20(1):274-81. [MEDLINE: 31507087]FosterB , PaiA , FurthS . The TAKE-IT intervention improves medication adherence in adolescent kidney transplant recipients [abstract no: 359]. American Journal of Transplantation2017;17(Suppl 3):332-3. [EMBASE: 615704529]FosterB , ZhaoH , PaiA , ZelikovskyN , HollyCD , SmithJM , et al. Medication adherence barrier burden predicts subsequent taking adherence in adolescent kidney transplant recipients in the TAKE-IT trial [abstract no: SA-PO1027]. Journal of the American Society of Nephrology2015;26(Abstracts):870A. [CENTRAL: CN-01657534] FosterBJ , PaiA , ZhaoH , FurthS , TAKE-IT Study Group. The TAKE-IT study: aims, design, and methods. BMC Nephrology2014;15:139. [MEDLINE: 25176317]FosterBJ , PaiAL , ZelikovskyN , AmaralS , BellL , DharnidharkaVR , et al. A randomized trial of a multicomponent intervention to promote medication adherence: the teen adherence in kidney transplant effectiveness of intervention trial (TAKE-IT) [Erratum in: Am J Kidney Dis. 2019 Apr;73(4):578]. American Journal of Kidney Diseases2018;72(1):30-41. [MEDLINE: 29602631]FosterBJ , ZhaoH , PaiA , ZelikovskyN , HollyCD , SmithJM , et al. Medication adherence barrier burden predicts subsequent adherence to dosing time schedule in adolescent kidney transplant recipients in the TAKE-IT Trial [abstract no: SA-PO1031]. Journal of the American Society of Nephrology2015;26(Abstracts):871A. [CENTRAL: CN-01657537] LadnerDP , WolfMS . Transplant regimen adherence for kidney recipients by engaging information technologies: the TAKE-IT trial [abstract no: D302]. American Journal of Transplantation2019;19(Suppl 3):1145. [EMBASE: 628453783]">TAKE‐IT 2014</a>; <a href="./references#CD012854-bbs2-0039" title="FlemingJN , GebregziabherM , PosadasA , SuZ , McGillicuddyJW , TaberDJ . Impact of a pharmacist-led, mHealth-based intervention on tacrolimus trough variability in kidney transplant recipients: a report from the TRANSAFE Rx randomized controlled trial. American Journal of Health-System Pharmacy2021;78(14):1287-93. [MEDLINE: 33821958]FlemingJN , TreiberF , McGillicuddyJ , GebregziabherM , TaberDJ . Improving transplant medication safety through a pharmacist-empowered, patient-centered, mhealth-based intervention: TRANSAFE Rx study protocol. JMIR Research Protocols2018;7(3):e59. [MEDLINE: 29500161]GonzalesHM , FlemingJN , GebregziabherM , Posadas-SalasMA , SuZ , McGillicuddyJW , et al. Pharmacist-led mobile health intervention and transplant medication safety: a randomized controlled clinical trial. Clinical Journal of the American Society of Nephrology: CJASN2021;16(5):776-84. [MEDLINE: 33931415]TaberDJ , FlemingJN , SuZ , MauldinP , McGillicuddyJW , PosadasA , et al. Significant hospitalization cost savings to the payer with a pharmacist-led mobile health intervention to improve medication safety in kidney transplant recipients. American Journal of Transplantation2021;21(10):3428-35. [MEDLINE: 34197699]TaberDJ , PilchNA , McGillicuddyJW , MardisC , TreiberF , FlemingJN . Using informatics and mobile health to improve medication safety monitoring in kidney transplant recipients. American Journal of Health-System Pharmacy2019;76(15):1143-9. [MEDLINE: 31361870]">TRANSAFE‐Rx 2018</a>; <a href="./references#CD012854-bbs2-0040" title="UrstadKH , OyenO , AndersenMH , MoumT , WahlAK . The effect of an educational intervention for renal recipients: a randomized controlled trial. Clinical Transplantation2012;26(3):E246-53. [MEDLINE: 22686948]">Urstad 2012</a>) and unclear in four studies (<a href="./references#CD012854-bbs2-0011" title="HardstaffR , GreenK , TalbotD . Measurement of compliance posttransplantation--the results of a 12-month study using electronic monitoring. Transplantation Proceedings2003;35(2):796-7. [MEDLINE: 12644142]HardstaffR , GreenK , TalbotD . Noncompliance postrenal transplantation: measuring the extent of the problem using electronic surveillance and nurse practitioner interviews. Transplantation Proceedings2002;34(5):1608. [MEDLINE: 12176504]">Hardstaff 2002</a>; <a href="./references#CD012854-bbs2-0022" title="LiuJ . Effect of WeChat-based peer education on medication compliance and quality of life in patients with liver transplantation: a pilot study [abstract no: P-576]. Transplantation2019;103(8 Suppl 1):380. [EMBASE: 629265854]">Liu 2019c</a>; <a href="./references#CD012854-bbs2-0028" title="AmaralS , FosterN , DashefskyH , KimJ , FurthS . Peers4path: challenges in measuring medication adherence in adolescent transplant recipients [abstract no: A485]. American Journal of Transplantation2014;14(Suppl 3):238. [EMBASE: 71544246]AmaralS , FosterN , DashefskyH , PaternoC , FurthS . Peers4Path: feasibility of medication adherence measures in adolescent transplant recipients [abstract no: FR-PO403]. Journal of the American Society of Nephrology2014;25(Abstracts):463A. [CENTRAL: CN-01657532] AmaralS , FosterN , YangA , ShultsJ , FurthS . Peers4Path: testing peer support as a mechanism to improve transplant outcomes among adolescents with solid organ transplants [abstract no: TH-PO1083]. Journal of the American Society of Nephrology2013;24(Abstracts):345-6A. [CENTRAL: CN-01657533] AmaralS , RogersR , PaternoC , FosterN , ShultsJ . Peers4path (promoting adolescent transplant health): a pilot study to test peer mentoring as an adherence intervention in adolescent transplant recipients [abstract no: 401.1]. Pediatric Transplantation2017;21(Suppl 1):33. [EMBASE: 616208171]StrachanC , PatonM , ReasonJ , AmaralS . Stakeholder perspectives in peer mentoring program for pediatric solid organ transplant recipients [abstract no: D323]. American Journal of Transplantation2019;19(Suppl 3):1153. [EMBASE: 628454820]">Peers4path 2014</a>; <a href="./references#CD012854-bbs2-0032" title="SantanaMJ , FeenyD , JacksonK , SchafenackerM , WeinkaufJ , LienD . Using patient-centred care to enhance adherence to medication and exercise in lung transplantation: a randomized controlled clinical trial [abstract no: 445]. In: Canadian Society of Transplantation Annual Scientific Meeting; 2011 Mar 2-5; Quebec, Canada. 2011:34. [CENTRAL: CN-01657760] ">Santana 2011</a>) due to insufficient information to permit assessment. </p> </section> <section id="CD012854-sec-0052"> <h5 class="title">Detection bias</h5> <p>Detection bias was assessed as low risk of bias in 17 studies (<a href="./references#CD012854-bbs2-0001" title="KuypersDR , BonvoisinCA , PeetersP , SennesaelJJ , KiandaMN , VrijensB , et al. Superior medication adherence to tacrolimus modified release once-daily (QD) compared to tacrolimus twice-daily (BID) in stable renal transplant patients [abstract no: RO-256]. Transplant International2011;24(Suppl 2):199. [EMBASE: 70527785]KuypersDR , PeetersPC , SennesaelJJ , KiandaMN , VrijensB , KristantoP , et al. Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring. Transplantation2013;95(2):333-40. [MEDLINE: 23263559]">ADMIRAD 2013</a>; <a href="./references#CD012854-bbs2-0002" title="BessaA , MedinaJ , TedescoH , FelipeC . A prospective, randomised, controlled study to assess the effect of pharmaceutical intervention on compliance and knowledge of immunosuppression in kidney transplant recipients [abstract no: DI-090]. European Journal of Hospital Pharmacy2015;22(Suppl 1):A109-10. [EMBASE: 614322295]BessaAB , FelipeCR , HannunP , SayuriP , FelixMJ , RuppelP , et al. Prospective randomized trial investigating the influence of pharmaceutical care on the intra-individual variability of tacrolimus concentrations early after kidney transplant. Therapeutic Drug Monitoring2016;38(4):447-55. [MEDLINE: 27414973]">Bessa 2016</a>; <a href="./references#CD012854-bbs2-0003" title="Breu-DejeanN , DriotD , DupouyJ , Lapeyre-MestreM , RostaingL . Efficacy of psychoeducational intervention on allograft function in kidney transplant patients: 10-year results of a prospective randomized study. Experimental &amp; Clinical Transplantation2016;14(1):38-44. [MEDLINE: 26862823]Breu-DejeanN . Education program to reduce non-compliance after renal transplantation [doctorate thesis] [Effet d'une intervention psycho-éducationnelle sur l'observance thérapeutique chez les transplantés rénaux]. University of Toulouse2016. [CENTRAL: CN-01658149] Breu-DejeanNB , RontaingL , Lapeyre-MestreM , RogeB , DurandD . Educational program to reduce noncompliance after renal transplantation [abstract no: MO06]. In: 41st Congress. European Renal Association. European Dialysis and Transplantation Association; 2004 May 15-18; Lisbon, Portugal. 2004:214-5. [CENTRAL: CN-00636140] ">Breu‐Dejean 2016</a>; <a href="./references#CD012854-bbs2-0004" title="ChisholmMA , MulloyL , JagadeesanM , DiPiroJT . Two-year economic evaluation of clinical pharmacy services in renal transplant clinic patients [abstract no: 588]. American Journal of Transplantation2002;2(Suppl 3):286. [CENTRAL: CN-00415424] ChisholmMA , MulloyLL , JagadeesanM , DiPiroJT . Impact of clinical pharmacy services on renal transplant patients' compliance with immunosuppressive medications. Clinical Transplantation2001;15(5):330-6. [MEDLINE: 11678959]">Chisholm 2001</a>; <a href="./references#CD012854-bbs2-0005" title="Chisholm-BurnsM , SpiveyC , Graff ZivinJ , LeeJ , SredzinskiE . Results of a behavioral contract intervention to improve adherence and healthcare outcomes among renal transplant recipients [abstract no: D1727]. American Journal of Transplantation2013;13(Suppl S5):540. [CENTRAL: CN-01007771] Chisholm-BurnsMA , EricksonS , SpiveyCA . Employment and health-related quality of life among renal transplant recipients [abstract no: 1140]. American Journal of Transplantation2011;11(Suppl 2):365. [EMBASE: 70406190]Chisholm-BurnsMA , SpiveyCA , GraffZJ , LeeJK , SredzinskiE , TolleyEA . Improving outcomes of renal transplant recipients with behavioral adherence contracts: a randomized controlled trial. American Journal of Transplantation2013;13(9):2364-73. [MEDLINE: 23819827]Chisholm-BurnsMA , SpiveyCA , SredzinskiE , ButlerS . Preliminary results of a behavioral contract intervention to improve adherence and quality of life among renal transplant recipients [abstract no: 1139]. American Journal of Transplantation2011;11(Suppl 2):365. [EMBASE: 70406189]Chisholm-BurnsMA , SpiveyCA , SredzinskiE , ButlerSL . Intervention toolbox to promote immunosuppressant therapy adherence in adult renal transplant recipients. Journal of the American Pharmacists Association: JAPhA2012;52(6):816-22. [MEDLINE: 23229970]">Chisholm‐Burns 2013</a>; <a href="./references#CD012854-bbs2-0006" title="CoteJ , FortinMC , AugerP , RouleauG , DuboisS , BoudreauN , et al. Web-based tailored intervention to support optimal medication adherence among kidney transplant recipients: pilot parallel-group randomized controlled trial. JMIR Formative Research2018;2(2):e14. [MEDLINE: 30684400]">Cote 2018</a>; <a href="./references#CD012854-bbs2-0013" title="HenrikssonJ , TydenG , HoijerJ , WadstromJ . A prospective randomized trial on the effect of using an electronic monitoring drug dispensing device to improve adherence and compliance. Transplantation2016;100(1):203-9. [MEDLINE: 26588006]HenrikssonJ , WadstromJ , HoijerJ , TydenG . A prospective randomized trial on the effect of using an electronic monitoring drug dispensary device to improve adherence and non-compliance [abstract no: BO220]. Transplant International2015;28(Suppl 4):204. [EMBASE: 72111815]">Henriksson 2016</a>; <a href="./references#CD012854-bbs2-0015" title="LowJK , ManiasE , CrawfordK , WalkerR , MulleyWR , ToussaintND , et al. Improving medication adherence in adult kidney transplantation (IMAKT): a pilot randomised controlled trial. Scientific Reports2019;9(1):7734. [MEDLINE: 31118485]">IMAKT 2019</a>; <a href="./references#CD012854-bbs2-0021" title="LevineD , TorabiJ , ChoinskiK , RoccaJP , GrahamJA . Transplant surgery enters a new era: increasing immunosuppressive medication adherence through mobile apps and smart watches. American Journal of Surgery2019;218(1):18-20. [MEDLINE: 30799019]">Levine 2019</a>; <a href="./references#CD012854-bbs2-0024" title="AndrewsAM , ChengAL , Bartlett EllisRJ , EmersonAM , O'BrienT , RussellCL . SystemCHANGE TM solutions to improve medication adherence in kidney transplant recipients: a secondary data analysis. Nephrology Nursing Journal2021;48(4):389-417. [MEDLINE: 34463466]RussellCL , HathawayD , RemyLM , AholtD , ClarkD , MillerC , et al. Improving medication adherence and outcomes in adult kidney transplant patients using a personal systems approach: SystemCHANGE TM results of the MAGIC randomized clinical trial. American Journal of Transplantation2020;20(1):125-36. [MEDLINE: 31291507]RussellCL , MooreS , HathawayD , ChengAL , ChenG , GogginK . MAGIC Study: aims, design and methods using SystemCHANGE TM to improve immunosuppressive medication adherence in adult kidney transplant recipients. BMC Nephrology2016;17(1):84. [MEDLINE: 27421884]RussellCL . Improving medication adherence and outcomes in adult kidney transplant patients using a personal systems approach: SystemCHANGE.TM results of the MAGIC randomized clinical trial [abstract]. Peritoneal Dialysis International2020;40(1 Suppl):14S. [EMBASE: 632156503]WakefieldWR , AshbaughCM , RemyL , AholtD , MillerC , YeS , et al. Improving medication adherence and outcomes in adult kidney transplant patients using SYSTEMChangeTM: results of the Medication Adherence Given Individual Change (MAGIC) randomized clinical trial [abstract no: 523]. American Journal of Transplantation2019;19(Suppl 3):541-2. [EMBASE: 628454823]">MAGIC 2016</a>; <a href="./references#CD012854-bbs2-0025" title="McGillicuddyJW , GregoskiMJ , Brunner-JacksonBM , WeilandAK , PatelSK , RockRA , et al. Facilitating medication adherence and eliminating therapeutic inertia using wireless technology: proof of concept findings with uncontrolled hypertensives and kidney transplant recipients. In: WH '12 Proceedings of the Conference on Wireless Health; 2012 Oct 23-25; San Diego CA. 2012. [CENTRAL: CN-01658221] McGillicuddyJW , GregoskiMJ , WeilandAK , RockRA , Brunner-JacksonBM , PatelSK , et al. Mobile health medication adherence and blood pressure control in renal transplant recipients: a proof-of-concept randomized controlled trial. JMIR Research Protocols2013;2(2):e32. [MEDLINE: 24004517]McGillicuddyJW , TaberDJ , MuellerM , PatelS , BaligaPK , ChavinKD , et al. Sustainability of improvements in medication adherence through a mobile health intervention. Progress in Transplantation2015;25(3):217-23. [MEDLINE: 26308780]McGillicuddyJW . EHealth and transplantation [abstract no: PM-47]. American Journal of Transplantation2014;14(Suppl 2):54-5. [EMBASE: 71388189]">McGillicuddy 2013</a>; <a href="./references#CD012854-bbs2-0029" title="HanA , ChoMJ , ChoS , LeeCH , ChoiC , KimSY , et al. Use of mobile internet application to improve adherence to immunosuppressive medication adherence in kidney transplant recipients: preliminary results of the PRIMA (ImProving Adherence to Immunosuppressive Therapy by Mobile Internet application) study [abstract no: 420.4]. Transplantation2016;100(7 Suppl):S161. [EMBASE: 613004382]HanA , MinSI , AhnS , MinSK , HongHJ , HanN , et al. Mobile medication manager application to improve adherence with immunosuppressive therapy in renal transplant recipients: a randomized controlled trial. PLoS ONE [Electronic Resource]2019;14(11):e0224595. [MEDLINE: 31689320]KoH , KimHK , ChungC , HanA , MinSK , HaJ , et al. Association between medication adherence and intrapatient variability in tacrolimus concentration among stable kidney transplant recipients. Scientific Reports2021;11(1):5397. [MEDLINE: 33686160]">PRIMA 2019</a>; <a href="./references#CD012854-bbs2-0030" title="ReeseP , BloomR , Trofe-ClarkJ , MussellA , LeidyD , LevskyS , et al. Customized reminders and provider notification to improve adherence to immunosuppression [abstract no: 1074]. American Journal of Transplantation2015;15(Suppl 3). [EMBASE: 71953144]ReesePP , BloomRD , Trofe-ClarkJ , MussellA , LeidyD , LevskyS , et al. Automated reminders and physician notification to promote immunosuppression adherence among kidney transplant recipients: a randomized trial. American Journal of Kidney Diseases2017;69(3):400-9. [MEDLINE: 27940063]">Reese 2017</a>; <a href="./references#CD012854-bbs2-0031" title="RussellC , ConnV , AshbaughC , MadsenR , WakefieldM , WebbA , et al. Taking immunosuppressive medications effectively (TIMELink): a pilot randomized controlled trial in adult kidney transplant recipients. Clinical Transplantation2011;25(6):864-70. [MEDLINE: 21077956]RussellCL , ConnVS , AshbaughC , CoffeyD , WakefieldM . A pilot RCT to increase medication adherence in transplantation [abstract no: 1168]. American Journal of Transplantation2010;10(Suppl 4):376. [EMBASE: 70464544]">Russell 2011</a>; <a href="./references#CD012854-bbs2-0035" title="SuhlingH , RademacherJ , ZinowskyI , FugeJ , GreerM , WarneckeG , et al. Conventional vs. tablet computer-based patient education following lung transplantation--a randomized controlled trial. PLoS ONE [Electronic Resource]2014;9(6):e90828. [MEDLINE: 24608864]SuhlingH , RademacherJ , ZinowskyI , FugeJ , GreerM , WarneckeG . Patient education via tablet-pc vs. conventional to improve compliance with immunosuppressive drug regimen after lung transplantation - a randomized controlled trial [abstract no: 2844]. European Respiratory Journal2013;42(Suppl 57):565S. [EMBASE: 71843332]">Suhling 2014</a>; <a href="./references#CD012854-bbs2-0038" title="BignallO , PaiA , AmaralS , FurthS , BergmanN , GoebelJ , et al. Differences in reported barriers to immunosuppression adherence among a cohort of pediatric renal transplant recipients from the United States and Canada [abstract no: D161]. American Journal of Transplantation2016;16(Suppl 3):751. [EMBASE: 611700425]BoucquemontJ , FosterB , TAKE-IT Investigators. Sex and age differences in medication adherence in adolescent and young adult kidney transplant recipients [abstract no: SA-PO404]. Journal of the American Society of Nephrology2016;27(Abstracts):721A. [CENTRAL: CN-01657535] BoucquemontJ , FosterB . Adherence patterns in adolescent and young adult kidney transplant recipients [abstract no: 229]. American Journal of Transplantation2016;16(Suppl 3):284. [EMBASE: 611700136]BoucquemontJ , PaiAL , DharnidharkaVR , HebertD , FurthSL , FosterBJ . Gender differences in medication adherence among adolescent and young adult kidney transplant recipients. Transplantation2019;103(4):798-806. [MEDLINE: 29994983]BoucquemontJ , PaiAL , DharnidharkaVR , HebertD , ZelikovskyN , AmaralS , et al. Association between day of the week and medication adherence among adolescent and young adult kidney transplant recipients. American Journal of Transplantation2020;20(1):274-81. [MEDLINE: 31507087]FosterB , PaiA , FurthS . The TAKE-IT intervention improves medication adherence in adolescent kidney transplant recipients [abstract no: 359]. American Journal of Transplantation2017;17(Suppl 3):332-3. [EMBASE: 615704529]FosterB , ZhaoH , PaiA , ZelikovskyN , HollyCD , SmithJM , et al. Medication adherence barrier burden predicts subsequent taking adherence in adolescent kidney transplant recipients in the TAKE-IT trial [abstract no: SA-PO1027]. Journal of the American Society of Nephrology2015;26(Abstracts):870A. [CENTRAL: CN-01657534] FosterBJ , PaiA , ZhaoH , FurthS , TAKE-IT Study Group. The TAKE-IT study: aims, design, and methods. BMC Nephrology2014;15:139. [MEDLINE: 25176317]FosterBJ , PaiAL , ZelikovskyN , AmaralS , BellL , DharnidharkaVR , et al. A randomized trial of a multicomponent intervention to promote medication adherence: the teen adherence in kidney transplant effectiveness of intervention trial (TAKE-IT) [Erratum in: Am J Kidney Dis. 2019 Apr;73(4):578]. American Journal of Kidney Diseases2018;72(1):30-41. [MEDLINE: 29602631]FosterBJ , ZhaoH , PaiA , ZelikovskyN , HollyCD , SmithJM , et al. Medication adherence barrier burden predicts subsequent adherence to dosing time schedule in adolescent kidney transplant recipients in the TAKE-IT Trial [abstract no: SA-PO1031]. Journal of the American Society of Nephrology2015;26(Abstracts):871A. [CENTRAL: CN-01657537] LadnerDP , WolfMS . Transplant regimen adherence for kidney recipients by engaging information technologies: the TAKE-IT trial [abstract no: D302]. American Journal of Transplantation2019;19(Suppl 3):1145. [EMBASE: 628453783]">TAKE‐IT 2014</a>; <a href="./references#CD012854-bbs2-0039" title="FlemingJN , GebregziabherM , PosadasA , SuZ , McGillicuddyJW , TaberDJ . Impact of a pharmacist-led, mHealth-based intervention on tacrolimus trough variability in kidney transplant recipients: a report from the TRANSAFE Rx randomized controlled trial. American Journal of Health-System Pharmacy2021;78(14):1287-93. [MEDLINE: 33821958]FlemingJN , TreiberF , McGillicuddyJ , GebregziabherM , TaberDJ . Improving transplant medication safety through a pharmacist-empowered, patient-centered, mhealth-based intervention: TRANSAFE Rx study protocol. JMIR Research Protocols2018;7(3):e59. [MEDLINE: 29500161]GonzalesHM , FlemingJN , GebregziabherM , Posadas-SalasMA , SuZ , McGillicuddyJW , et al. Pharmacist-led mobile health intervention and transplant medication safety: a randomized controlled clinical trial. Clinical Journal of the American Society of Nephrology: CJASN2021;16(5):776-84. [MEDLINE: 33931415]TaberDJ , FlemingJN , SuZ , MauldinP , McGillicuddyJW , PosadasA , et al. Significant hospitalization cost savings to the payer with a pharmacist-led mobile health intervention to improve medication safety in kidney transplant recipients. American Journal of Transplantation2021;21(10):3428-35. [MEDLINE: 34197699]TaberDJ , PilchNA , McGillicuddyJW , MardisC , TreiberF , FlemingJN . Using informatics and mobile health to improve medication safety monitoring in kidney transplant recipients. American Journal of Health-System Pharmacy2019;76(15):1143-9. [MEDLINE: 31361870]">TRANSAFE‐Rx 2018</a>), high risk of bias in 18 studies (<a href="./references#CD012854-bbs2-0007" title="CukorD , Ver HalenN , PencilleM , TedlaF , SalifuM . A pilot randomized controlled trial to promote immunosuppressant adherence in adult kidney transplant recipients. Nephron2017;135(1):6-14. [MEDLINE: 28049201]">Cukor 2017</a>; <a href="./references#CD012854-bbs2-0008" title="DeVito DabbsA , DewMA , MyersB , BegeyA , HawkinsR , RenD , et al. Evaluation of a hand-held, computer-based intervention to promote early self-care behaviors after lung transplant. Clinical Transplantation2009;23(4):537-45. [MEDLINE: 19473201]">DeVito Dabbs 2009</a>; <a href="./references#CD012854-bbs2-0009" title="DeVito DabbsA , DewM , MyersBA , SongM , LiR , ZomakR , et al. Randomized controlled trial (RCT) of pocket path, an mhealth intervention to promote self-management after lung transplantation [abstract no: A5361]. American Journal of Respiratory &amp; Critical Care Medicine2014;189:A5361. [EMBASE: 72047364]DeVito DabbsA , SongMK , MyersBA , LiR , HawkinsRP , PilewskiJM , et al. A randomized controlled trial of a mobile health intervention to promote self-management after lung transplantation. American Journal of Transplantation2016;16(7):2172-80. [MEDLINE: 26729617]GeramitaEM , DeVito DabbsAJ , DiMartiniAF , PilewskiJM , SwitzerGE , PoslusznyDM , et al. Impact of a mobile health intervention on long-term nonadherence after lung transplantation: follow-up after a randomized controlled trial. Transplantation2020;104(3):640-51. [MEDLINE: 31335759]HuL , DeVito DabbsA , DewMA , SereikaSM , LinglerJH . Patterns and correlates of adherence to self-monitoring in lung transplant recipients during the first 12 months after discharge from transplant. Clinical Transplantation2017;31(8):e13014. [MEDLINE: 28517112]RosenbergerEM , Devito DabbsAJ , DiMartiniAF , LandsittelDP , PilewskiJM , DewMA . Long-term follow-up of a randomized controlled trial evaluating a mobile health intervention for self-management in lung transplant recipients. American Journal of Transplantation2017;17(5):1286-93. [MEDLINE: 27664940]">DeVito Dabbs 2016</a>; <a href="./references#CD012854-bbs2-0010" title="GarciaMF , BravinAM , GarciaPD , ConttiMM , NgaHS , TakaseHM , et al. Behavioral measures to reduce non-adherence in renal transplant recipients: a prospective randomized controlled trial. International Urology &amp; Nephrology2015;47(11):1899-905. [MEDLINE: 26377496]">Garcia 2015</a>; <a href="./references#CD012854-bbs2-0012" title="HarrisonJJ , BadrS , HamandiB , KimSJ . Randomized controlled trial of a computer-based education program in the home for solid organ transplant recipients: impact on medication knowledge, satisfaction, and adherence. Transplantation2017;101(6):1336-43. [MEDLINE: 27367473]">Harrison 2016</a>; <a href="./references#CD012854-bbs2-0014" title="HuangY , YuX . Effect of healthy education on improving the drug compliance of patients after renal transplantation. Journal of Clinical Rehabilitative Tissue Engineering Research2007;11(43):8773-5. [EMBASE: 350081272]">Huang 2007b</a>; <a href="./references#CD012854-bbs2-0016" title="JoostR , DorjeF , SchwitullaJ , EckardtKU , HugoC . Intensified pharmaceutical care is improving immunosuppressive medication adherence in kidney transplant recipients during the first post-transplant year: a quasi-experimental study. Nephrology Dialysis Transplantation2014;29(8):1597-607. [MEDLINE: 24914089]">Joost 2014</a>; <a href="./references#CD012854-bbs2-0017" title="JungHY , JeonY , SeongSJ , SeoJJ , ChoiJY , ChoJH , et al. ICT-based adherence monitoring in kidney transplant recipients: a randomized controlled trial. BMC Medical Informatics &amp; Decision Making2020;20(1):105. [MEDLINE: 32522263]JungHY , JeonY , SeongSJ , SeoJJ , ChoiJY , ChoJH , et al. Information and communication technology-based centralized monitoring system to increase adherence to immunosuppressive medication in kidney transplant recipients: a randomized controlled trial [abstract no: P1734]. Nephrology Dialysis Transplantation2020;35(Suppl 3):iii252. [EMBASE: 633422975]JungHY , SeongSJ , ChoiJY , ChoJH , ParkSH , KimCD , et al. The efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trial. Trials [Electronic Resource]2017;18(1):480. [MEDLINE: 29037222]">Jung 2017</a>; <a href="./references#CD012854-bbs2-0018" title="KaiserTE , EjazNS , TremblayS , ParrishNJ , BenavidesJ , ReheB , et al. Technology triggered adherence intervention: preliminary findings [abstract no: 185]. American Journal of Transplantation2019;19(Suppl 3):394. [EMBASE: 628454914]">Kaiser 2019</a>; <a href="./references#CD012854-bbs2-0019" title="KantachuvessiriS , InksatidA , SumethkulV , JirasirithamS , ThirapanichW . Adherence to immunosuppression after conversion of twice-daily tacrolimus to once-daily tacrolimus in stable kidney transplant patients in Thailand: a prospective study [abstract no: P.1515]. Transplantation2016;100(7 Suppl 1):S716. [EMBASE: 613004564]">Kantachuvessiri 2016</a>; <a href="./references#CD012854-bbs2-0020" title="KleinA , KramerI . Influence of a pharmaceutical care program on liver transplant patients' compliance with immunosuppressive therapy: a prospective, randomized, controlled trial [Pharmazeutische betreuung lebertransplantierter patienten unter besonderer berucksichtigung der compliance mit der immunsuppressiven therapie: Eine prospektive, randomisierte, kontrollierte studie]. Krankenhauspharmazie2007;28(12):458-68. [EMBASE: 350287720]KleinA , OttoG , KramerI . Impact of a pharmaceutical care program on liver transplant patients' compliance with immunosuppressive medication: a prospective, randomized, controlled trial using electronic monitoring. Transplantation2009;87(6):839-47. [MEDLINE: 19300186]">Klein 2007</a>; <a href="./references#CD012854-bbs2-0023" title="DobbelsF , De BleserL , BerbenL , KristantoP , DupontL , NevensF , et al. Efficacy of a medication adherence enhancing intervention in transplantation: the MAESTRO-Tx trial. Journal of Heart &amp; Lung Transplantation2017;36(5):499-508. [MEDLINE: 28162931]DobbelsF , De BleserL , BerbenL , KristantoP , DupontL , NevensF , et al. Testing the efficacy of a multicomponent theory-based tailored behavioral medication adherence intervention in transplantation: The MAESTRO-TX RCT [abstract no: 223]. Journal of Heart &amp; Lung Transplantation2016;35(4 Suppl):S90. [EMBASE: 72253342]DobbelsF , De BleserL , KristantoP , NevensF , VanhaeckeJ , VerledenG , et al. Electronic monitoring feedback and motivational interviewing improves medication adherence in heart, liver and lung transplant patients: results from the MAESTRO-TX RCT [abstract no: BO218]. Transplant International2015;28(Suppl 4):203. [EMBASE: 72111813]">MAESTRO‐Tx 2017</a>; <a href="./references#CD012854-bbs2-0026" title="Gomis-PastorM , Mirabet PerezS , Roig MinguellE , Brossa LoidiV , Lopez LopezL , Ros AbarcaS , et al. Mobile health to improve adherence and patient experience in heart transplantation recipients: the mHeart trial. Healthcare2021;9(4):463. [MEDLINE: 33919899]Gomis-PastorM , MirabetS , RoigE , BrossaV , LopezL , RosS , et al. Improving patients' experience and medication adherence after heart transplant using a multilevel ehealth intervention: the mHeart clinical trial [abstract no: P-16.07]. Transplantation2020;104(Suppl 3):S578-9. [EMBASE: 633380991]">mHeart 2021</a>; <a href="./references#CD012854-bbs2-0027" title="PatersonTS , DemianM , ShapiroRJ , Loken ThorntonW . Impact of once- versus twice-daily tacrolimus dosing on medication adherence in stable renal transplant recipients: a Canadian single-center randomized controlled trial. Canadian Journal of Kidney Health &amp; Disease2019;6:2054358119867993. [MEDLINE: 31452902]ShapiroRJ , PatersonT , ThorntonW , HusseiniT , PartoviN , VishloffJ , et al. Medication adherence is tied to social support in renal transplant recipients [abstract no: 2501]. In: Canadian Society of Transplantation Annual Scientific Meeting; 2013 Mar 13-16; Alberta, Canada. 2013:38. ">Paterson 2019</a>; <a href="./references#CD012854-bbs2-0033" title="HilsS , SchmidA , BogatyrevaL , HauschkeD , Kramer-ZuckerA , PisarskiP . Telemedical supported aftercare after living kidney transplantation-a single center experience [abstract no: O179]. Transplant International2015;28(Suppl 4):69. [EMBASE: 72111423]HilsS , SchmidA , BogatyrevaL , HauschkeD , PisarskiP . Telemedical supported aftercare as an innovative project-study improves the quality of life after living kidney transplantation-a single center experience [abstract no: D2730]. Transplantation2014;98(Suppl 1):843. [EMBASE: 71546416]KaierK , HilsS , FetzerS , HehnP , SchmidA , HauschkeD , et al. Results of a randomized controlled trial analyzing telemedically supported case management in the first year after living donor kidney transplantation - a budget impact analysis from the healthcare perspective. Health Economics Review2017;7(1):1. [MEDLINE: 28092012]PisarskiP , HilsS , SchmidA , Kramer-ZuckerA , JanigenB . Telemedicin as an innovative project-study in adherence improvement after living kidney transplantation at the Transplantation Center Freiburg [abstract no: O162]. Transplant International2013;26(Suppl 2):73. [EMBASE: 71359226]SchmidA , HilsS , Kramer-ZuckerA , BogatyrevaL , HauschkeD , De GeestS , et al. Telemedically-supported case management of living-donor renal transplant recipients to optimize routine evidence-based aftercare: a single-center randomized controlled trial. American Journal of Transplantation2017;17(6):1594-605. [MEDLINE: 27873477]SchmidA , PisarskiP , HilsS , HauschkeD , BogatyrevaL . Telemedical supported after care in living kidney recipients-an innovative project-study at the Transplantation Center Freiburg interim results of a prospective ongoing study of 50 patients [abstract no: P84]. Transplant International2013;26(Suppl 1):43. [EMBASE: 71356349]">Schmid 2017</a>; <a href="./references#CD012854-bbs2-0036" title="TaberDJ , PosadasMA , RaoV , McGillicuddyJ , RohanV , NadigSN , et al. The potential for improved medication adherence with a complete once daily immunosuppression regimen in kidney transplant: results of a randomized controlled study [abstract no: FR-PO1177]. Journal of the American Society of Nephrology2019;30(Abstract Suppl):750-1. [EMBASE: 633769114]TaberDJ , Posadas-SalasA , SuZ , RaoV , RohanV , NadigS , et al. Preliminary assessment of safety and adherence to a once-daily immunosuppression regimen in kidney transplantation: results of a randomized controlled pilot study. Clinical Transplantation2020;34(4):e13844. [MEDLINE: 32092187]">Taber 2020</a>; <a href="./references#CD012854-bbs2-0037" title="Van ZantenR , De WeerdA , BetjesM , Boer-VerschragenM , MasseyE . Medication adherence and fear of rejection after conversion from dual to monotherapy: A randomized controlled trial [abstract no: OP170]. Transplant International2021;34(Suppl 1):35. [EMBASE: 635968308]vanZantenR , deWeerdA , BetjesM , Boer-VerschragenM , MasseyEK . Is simplification of immunosuppressive medication a way to promote medication adherence of kidney transplant recipients? Findings from a randomized controlled trial. Transplant International2021;34(9):1703-11. [MEDLINE: 34448273]">TACmono 2021</a>; <a href="./references#CD012854-bbs2-0040" title="UrstadKH , OyenO , AndersenMH , MoumT , WahlAK . The effect of an educational intervention for renal recipients: a randomized controlled trial. Clinical Transplantation2012;26(3):E246-53. [MEDLINE: 22686948]">Urstad 2012</a>) and unclear in five studies (<a href="./references#CD012854-bbs2-0011" title="HardstaffR , GreenK , TalbotD . Measurement of compliance posttransplantation--the results of a 12-month study using electronic monitoring. Transplantation Proceedings2003;35(2):796-7. [MEDLINE: 12644142]HardstaffR , GreenK , TalbotD . Noncompliance postrenal transplantation: measuring the extent of the problem using electronic surveillance and nurse practitioner interviews. Transplantation Proceedings2002;34(5):1608. [MEDLINE: 12176504]">Hardstaff 2002</a>; <a href="./references#CD012854-bbs2-0022" title="LiuJ . Effect of WeChat-based peer education on medication compliance and quality of life in patients with liver transplantation: a pilot study [abstract no: P-576]. Transplantation2019;103(8 Suppl 1):380. [EMBASE: 629265854]">Liu 2019c</a>; <a href="./references#CD012854-bbs2-0028" title="AmaralS , FosterN , DashefskyH , KimJ , FurthS . Peers4path: challenges in measuring medication adherence in adolescent transplant recipients [abstract no: A485]. American Journal of Transplantation2014;14(Suppl 3):238. [EMBASE: 71544246]AmaralS , FosterN , DashefskyH , PaternoC , FurthS . Peers4Path: feasibility of medication adherence measures in adolescent transplant recipients [abstract no: FR-PO403]. Journal of the American Society of Nephrology2014;25(Abstracts):463A. [CENTRAL: CN-01657532] AmaralS , FosterN , YangA , ShultsJ , FurthS . Peers4Path: testing peer support as a mechanism to improve transplant outcomes among adolescents with solid organ transplants [abstract no: TH-PO1083]. Journal of the American Society of Nephrology2013;24(Abstracts):345-6A. [CENTRAL: CN-01657533] AmaralS , RogersR , PaternoC , FosterN , ShultsJ . Peers4path (promoting adolescent transplant health): a pilot study to test peer mentoring as an adherence intervention in adolescent transplant recipients [abstract no: 401.1]. Pediatric Transplantation2017;21(Suppl 1):33. [EMBASE: 616208171]StrachanC , PatonM , ReasonJ , AmaralS . Stakeholder perspectives in peer mentoring program for pediatric solid organ transplant recipients [abstract no: D323]. American Journal of Transplantation2019;19(Suppl 3):1153. [EMBASE: 628454820]">Peers4path 2014</a>; <a href="./references#CD012854-bbs2-0032" title="SantanaMJ , FeenyD , JacksonK , SchafenackerM , WeinkaufJ , LienD . Using patient-centred care to enhance adherence to medication and exercise in lung transplantation: a randomized controlled clinical trial [abstract no: 445]. In: Canadian Society of Transplantation Annual Scientific Meeting; 2011 Mar 2-5; Quebec, Canada. 2011:34. [CENTRAL: CN-01657760] ">Santana 2011</a>; <a href="./references#CD012854-bbs2-0034" title="De GeestS , DenhaerynckK , Schafer-KellerP , BockA , SteigerJ . Supporting medication adherence in renal transplantation--the SMART study. Swiss Medical Weekly2007;137 Suppl 155:125-7S. [MEDLINE: 17874516]De GeestS , Schafer-KellerP , DenhaerynckK , BockA , KoferS , ThannbergerN , et al. Supporting medication adherence in renal transplantation (SMART): a pilot study [abstract no: PO3.09]. Kidney &amp; Blood Pressure Research2004;27(5-6):327. [CENTRAL: CN-00615859] De GeestS , Schafer-KellerP , DenhaerynckK , ThannbergerN , KoferS , BockA , et al. Supporting medication adherence in renal transplantation (SMART): a pilot RCT to improve adherence to immunosuppressive regimens. Clinical Transplantation2006;20(3):359-68. [MEDLINE: 16824155]deGeestS , SchaferP , DenhaerynckK , BockA , SteigerJ . Supporting medication adherence in renal transplantation (SMART): a randomized controlled trial to improve adherence with immunosuppressive regimen [abstract no: PO-590]. Transplant International2005;18(Suppl):na. ">SMART 2006</a>) due to insufficient information to permit assessment. </p> </section> </section> <section id="CD012854-sec-0053"> <h4 class="title">Incomplete outcome data</h4> <p>Attrition bias was assessed as low risk of bias in 23 studies (<a href="./references#CD012854-bbs2-0001" title="KuypersDR , BonvoisinCA , PeetersP , SennesaelJJ , KiandaMN , VrijensB , et al. Superior medication adherence to tacrolimus modified release once-daily (QD) compared to tacrolimus twice-daily (BID) in stable renal transplant patients [abstract no: RO-256]. Transplant International2011;24(Suppl 2):199. [EMBASE: 70527785]KuypersDR , PeetersPC , SennesaelJJ , KiandaMN , VrijensB , KristantoP , et al. Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring. Transplantation2013;95(2):333-40. [MEDLINE: 23263559]">ADMIRAD 2013</a>; <a href="./references#CD012854-bbs2-0002" title="BessaA , MedinaJ , TedescoH , FelipeC . A prospective, randomised, controlled study to assess the effect of pharmaceutical intervention on compliance and knowledge of immunosuppression in kidney transplant recipients [abstract no: DI-090]. European Journal of Hospital Pharmacy2015;22(Suppl 1):A109-10. [EMBASE: 614322295]BessaAB , FelipeCR , HannunP , SayuriP , FelixMJ , RuppelP , et al. Prospective randomized trial investigating the influence of pharmaceutical care on the intra-individual variability of tacrolimus concentrations early after kidney transplant. Therapeutic Drug Monitoring2016;38(4):447-55. [MEDLINE: 27414973]">Bessa 2016</a>; <a href="./references#CD012854-bbs2-0003" title="Breu-DejeanN , DriotD , DupouyJ , Lapeyre-MestreM , RostaingL . Efficacy of psychoeducational intervention on allograft function in kidney transplant patients: 10-year results of a prospective randomized study. Experimental &amp; Clinical Transplantation2016;14(1):38-44. [MEDLINE: 26862823]Breu-DejeanN . Education program to reduce non-compliance after renal transplantation [doctorate thesis] [Effet d'une intervention psycho-éducationnelle sur l'observance thérapeutique chez les transplantés rénaux]. University of Toulouse2016. [CENTRAL: CN-01658149] Breu-DejeanNB , RontaingL , Lapeyre-MestreM , RogeB , DurandD . Educational program to reduce noncompliance after renal transplantation [abstract no: MO06]. In: 41st Congress. European Renal Association. European Dialysis and Transplantation Association; 2004 May 15-18; Lisbon, Portugal. 2004:214-5. [CENTRAL: CN-00636140] ">Breu‐Dejean 2016</a>; <a href="./references#CD012854-bbs2-0004" title="ChisholmMA , MulloyL , JagadeesanM , DiPiroJT . Two-year economic evaluation of clinical pharmacy services in renal transplant clinic patients [abstract no: 588]. American Journal of Transplantation2002;2(Suppl 3):286. [CENTRAL: CN-00415424] ChisholmMA , MulloyLL , JagadeesanM , DiPiroJT . Impact of clinical pharmacy services on renal transplant patients' compliance with immunosuppressive medications. Clinical Transplantation2001;15(5):330-6. [MEDLINE: 11678959]">Chisholm 2001</a>; <a href="./references#CD012854-bbs2-0005" title="Chisholm-BurnsM , SpiveyC , Graff ZivinJ , LeeJ , SredzinskiE . Results of a behavioral contract intervention to improve adherence and healthcare outcomes among renal transplant recipients [abstract no: D1727]. American Journal of Transplantation2013;13(Suppl S5):540. [CENTRAL: CN-01007771] Chisholm-BurnsMA , EricksonS , SpiveyCA . Employment and health-related quality of life among renal transplant recipients [abstract no: 1140]. American Journal of Transplantation2011;11(Suppl 2):365. [EMBASE: 70406190]Chisholm-BurnsMA , SpiveyCA , GraffZJ , LeeJK , SredzinskiE , TolleyEA . Improving outcomes of renal transplant recipients with behavioral adherence contracts: a randomized controlled trial. American Journal of Transplantation2013;13(9):2364-73. [MEDLINE: 23819827]Chisholm-BurnsMA , SpiveyCA , SredzinskiE , ButlerS . Preliminary results of a behavioral contract intervention to improve adherence and quality of life among renal transplant recipients [abstract no: 1139]. American Journal of Transplantation2011;11(Suppl 2):365. [EMBASE: 70406189]Chisholm-BurnsMA , SpiveyCA , SredzinskiE , ButlerSL . Intervention toolbox to promote immunosuppressant therapy adherence in adult renal transplant recipients. Journal of the American Pharmacists Association: JAPhA2012;52(6):816-22. [MEDLINE: 23229970]">Chisholm‐Burns 2013</a>; <a href="./references#CD012854-bbs2-0007" title="CukorD , Ver HalenN , PencilleM , TedlaF , SalifuM . A pilot randomized controlled trial to promote immunosuppressant adherence in adult kidney transplant recipients. Nephron2017;135(1):6-14. [MEDLINE: 28049201]">Cukor 2017</a>; <a href="./references#CD012854-bbs2-0008" title="DeVito DabbsA , DewMA , MyersB , BegeyA , HawkinsR , RenD , et al. Evaluation of a hand-held, computer-based intervention to promote early self-care behaviors after lung transplant. Clinical Transplantation2009;23(4):537-45. [MEDLINE: 19473201]">DeVito Dabbs 2009</a>; <a href="./references#CD012854-bbs2-0009" title="DeVito DabbsA , DewM , MyersBA , SongM , LiR , ZomakR , et al. Randomized controlled trial (RCT) of pocket path, an mhealth intervention to promote self-management after lung transplantation [abstract no: A5361]. American Journal of Respiratory &amp; Critical Care Medicine2014;189:A5361. [EMBASE: 72047364]DeVito DabbsA , SongMK , MyersBA , LiR , HawkinsRP , PilewskiJM , et al. A randomized controlled trial of a mobile health intervention to promote self-management after lung transplantation. American Journal of Transplantation2016;16(7):2172-80. [MEDLINE: 26729617]GeramitaEM , DeVito DabbsAJ , DiMartiniAF , PilewskiJM , SwitzerGE , PoslusznyDM , et al. Impact of a mobile health intervention on long-term nonadherence after lung transplantation: follow-up after a randomized controlled trial. Transplantation2020;104(3):640-51. [MEDLINE: 31335759]HuL , DeVito DabbsA , DewMA , SereikaSM , LinglerJH . Patterns and correlates of adherence to self-monitoring in lung transplant recipients during the first 12 months after discharge from transplant. Clinical Transplantation2017;31(8):e13014. [MEDLINE: 28517112]RosenbergerEM , Devito DabbsAJ , DiMartiniAF , LandsittelDP , PilewskiJM , DewMA . Long-term follow-up of a randomized controlled trial evaluating a mobile health intervention for self-management in lung transplant recipients. American Journal of Transplantation2017;17(5):1286-93. [MEDLINE: 27664940]">DeVito Dabbs 2016</a>; <a href="./references#CD012854-bbs2-0010" title="GarciaMF , BravinAM , GarciaPD , ConttiMM , NgaHS , TakaseHM , et al. Behavioral measures to reduce non-adherence in renal transplant recipients: a prospective randomized controlled trial. International Urology &amp; Nephrology2015;47(11):1899-905. [MEDLINE: 26377496]">Garcia 2015</a>; <a href="./references#CD012854-bbs2-0014" title="HuangY , YuX . Effect of healthy education on improving the drug compliance of patients after renal transplantation. Journal of Clinical Rehabilitative Tissue Engineering Research2007;11(43):8773-5. [EMBASE: 350081272]">Huang 2007b</a>; <a href="./references#CD012854-bbs2-0015" title="LowJK , ManiasE , CrawfordK , WalkerR , MulleyWR , ToussaintND , et al. Improving medication adherence in adult kidney transplantation (IMAKT): a pilot randomised controlled trial. Scientific Reports2019;9(1):7734. [MEDLINE: 31118485]">IMAKT 2019</a>; <a href="./references#CD012854-bbs2-0016" title="JoostR , DorjeF , SchwitullaJ , EckardtKU , HugoC . Intensified pharmaceutical care is improving immunosuppressive medication adherence in kidney transplant recipients during the first post-transplant year: a quasi-experimental study. Nephrology Dialysis Transplantation2014;29(8):1597-607. [MEDLINE: 24914089]">Joost 2014</a>; <a href="./references#CD012854-bbs2-0020" title="KleinA , KramerI . Influence of a pharmaceutical care program on liver transplant patients' compliance with immunosuppressive therapy: a prospective, randomized, controlled trial [Pharmazeutische betreuung lebertransplantierter patienten unter besonderer berucksichtigung der compliance mit der immunsuppressiven therapie: Eine prospektive, randomisierte, kontrollierte studie]. Krankenhauspharmazie2007;28(12):458-68. [EMBASE: 350287720]KleinA , OttoG , KramerI . Impact of a pharmaceutical care program on liver transplant patients' compliance with immunosuppressive medication: a prospective, randomized, controlled trial using electronic monitoring. Transplantation2009;87(6):839-47. [MEDLINE: 19300186]">Klein 2007</a>; <a href="./references#CD012854-bbs2-0021" title="LevineD , TorabiJ , ChoinskiK , RoccaJP , GrahamJA . Transplant surgery enters a new era: increasing immunosuppressive medication adherence through mobile apps and smart watches. American Journal of Surgery2019;218(1):18-20. [MEDLINE: 30799019]">Levine 2019</a>; <a href="./references#CD012854-bbs2-0025" title="McGillicuddyJW , GregoskiMJ , Brunner-JacksonBM , WeilandAK , PatelSK , RockRA , et al. Facilitating medication adherence and eliminating therapeutic inertia using wireless technology: proof of concept findings with uncontrolled hypertensives and kidney transplant recipients. In: WH '12 Proceedings of the Conference on Wireless Health; 2012 Oct 23-25; San Diego CA. 2012. [CENTRAL: CN-01658221] McGillicuddyJW , GregoskiMJ , WeilandAK , RockRA , Brunner-JacksonBM , PatelSK , et al. Mobile health medication adherence and blood pressure control in renal transplant recipients: a proof-of-concept randomized controlled trial. JMIR Research Protocols2013;2(2):e32. [MEDLINE: 24004517]McGillicuddyJW , TaberDJ , MuellerM , PatelS , BaligaPK , ChavinKD , et al. Sustainability of improvements in medication adherence through a mobile health intervention. Progress in Transplantation2015;25(3):217-23. [MEDLINE: 26308780]McGillicuddyJW . EHealth and transplantation [abstract no: PM-47]. American Journal of Transplantation2014;14(Suppl 2):54-5. [EMBASE: 71388189]">McGillicuddy 2013</a>; <a href="./references#CD012854-bbs2-0026" title="Gomis-PastorM , Mirabet PerezS , Roig MinguellE , Brossa LoidiV , Lopez LopezL , Ros AbarcaS , et al. Mobile health to improve adherence and patient experience in heart transplantation recipients: the mHeart trial. Healthcare2021;9(4):463. [MEDLINE: 33919899]Gomis-PastorM , MirabetS , RoigE , BrossaV , LopezL , RosS , et al. Improving patients' experience and medication adherence after heart transplant using a multilevel ehealth intervention: the mHeart clinical trial [abstract no: P-16.07]. Transplantation2020;104(Suppl 3):S578-9. [EMBASE: 633380991]">mHeart 2021</a>; <a href="./references#CD012854-bbs2-0030" title="ReeseP , BloomR , Trofe-ClarkJ , MussellA , LeidyD , LevskyS , et al. Customized reminders and provider notification to improve adherence to immunosuppression [abstract no: 1074]. American Journal of Transplantation2015;15(Suppl 3). [EMBASE: 71953144]ReesePP , BloomRD , Trofe-ClarkJ , MussellA , LeidyD , LevskyS , et al. Automated reminders and physician notification to promote immunosuppression adherence among kidney transplant recipients: a randomized trial. American Journal of Kidney Diseases2017;69(3):400-9. [MEDLINE: 27940063]">Reese 2017</a>; <a href="./references#CD012854-bbs2-0031" title="RussellC , ConnV , AshbaughC , MadsenR , WakefieldM , WebbA , et al. Taking immunosuppressive medications effectively (TIMELink): a pilot randomized controlled trial in adult kidney transplant recipients. Clinical Transplantation2011;25(6):864-70. [MEDLINE: 21077956]RussellCL , ConnVS , AshbaughC , CoffeyD , WakefieldM . A pilot RCT to increase medication adherence in transplantation [abstract no: 1168]. American Journal of Transplantation2010;10(Suppl 4):376. [EMBASE: 70464544]">Russell 2011</a>; <a href="./references#CD012854-bbs2-0033" title="HilsS , SchmidA , BogatyrevaL , HauschkeD , Kramer-ZuckerA , PisarskiP . Telemedical supported aftercare after living kidney transplantation-a single center experience [abstract no: O179]. Transplant International2015;28(Suppl 4):69. [EMBASE: 72111423]HilsS , SchmidA , BogatyrevaL , HauschkeD , PisarskiP . Telemedical supported aftercare as an innovative project-study improves the quality of life after living kidney transplantation-a single center experience [abstract no: D2730]. Transplantation2014;98(Suppl 1):843. [EMBASE: 71546416]KaierK , HilsS , FetzerS , HehnP , SchmidA , HauschkeD , et al. Results of a randomized controlled trial analyzing telemedically supported case management in the first year after living donor kidney transplantation - a budget impact analysis from the healthcare perspective. Health Economics Review2017;7(1):1. [MEDLINE: 28092012]PisarskiP , HilsS , SchmidA , Kramer-ZuckerA , JanigenB . Telemedicin as an innovative project-study in adherence improvement after living kidney transplantation at the Transplantation Center Freiburg [abstract no: O162]. Transplant International2013;26(Suppl 2):73. [EMBASE: 71359226]SchmidA , HilsS , Kramer-ZuckerA , BogatyrevaL , HauschkeD , De GeestS , et al. Telemedically-supported case management of living-donor renal transplant recipients to optimize routine evidence-based aftercare: a single-center randomized controlled trial. American Journal of Transplantation2017;17(6):1594-605. [MEDLINE: 27873477]SchmidA , PisarskiP , HilsS , HauschkeD , BogatyrevaL . Telemedical supported after care in living kidney recipients-an innovative project-study at the Transplantation Center Freiburg interim results of a prospective ongoing study of 50 patients [abstract no: P84]. Transplant International2013;26(Suppl 1):43. [EMBASE: 71356349]">Schmid 2017</a>; <a href="./references#CD012854-bbs2-0035" title="SuhlingH , RademacherJ , ZinowskyI , FugeJ , GreerM , WarneckeG , et al. Conventional vs. tablet computer-based patient education following lung transplantation--a randomized controlled trial. PLoS ONE [Electronic Resource]2014;9(6):e90828. [MEDLINE: 24608864]SuhlingH , RademacherJ , ZinowskyI , FugeJ , GreerM , WarneckeG . Patient education via tablet-pc vs. conventional to improve compliance with immunosuppressive drug regimen after lung transplantation - a randomized controlled trial [abstract no: 2844]. European Respiratory Journal2013;42(Suppl 57):565S. [EMBASE: 71843332]">Suhling 2014</a>; <a href="./references#CD012854-bbs2-0036" title="TaberDJ , PosadasMA , RaoV , McGillicuddyJ , RohanV , NadigSN , et al. The potential for improved medication adherence with a complete once daily immunosuppression regimen in kidney transplant: results of a randomized controlled study [abstract no: FR-PO1177]. Journal of the American Society of Nephrology2019;30(Abstract Suppl):750-1. [EMBASE: 633769114]TaberDJ , Posadas-SalasA , SuZ , RaoV , RohanV , NadigS , et al. Preliminary assessment of safety and adherence to a once-daily immunosuppression regimen in kidney transplantation: results of a randomized controlled pilot study. Clinical Transplantation2020;34(4):e13844. [MEDLINE: 32092187]">Taber 2020</a>; <a href="./references#CD012854-bbs2-0037" title="Van ZantenR , De WeerdA , BetjesM , Boer-VerschragenM , MasseyE . Medication adherence and fear of rejection after conversion from dual to monotherapy: A randomized controlled trial [abstract no: OP170]. Transplant International2021;34(Suppl 1):35. [EMBASE: 635968308]vanZantenR , deWeerdA , BetjesM , Boer-VerschragenM , MasseyEK . Is simplification of immunosuppressive medication a way to promote medication adherence of kidney transplant recipients? Findings from a randomized controlled trial. Transplant International2021;34(9):1703-11. [MEDLINE: 34448273]">TACmono 2021</a>; <a href="./references#CD012854-bbs2-0039" title="FlemingJN , GebregziabherM , PosadasA , SuZ , McGillicuddyJW , TaberDJ . Impact of a pharmacist-led, mHealth-based intervention on tacrolimus trough variability in kidney transplant recipients: a report from the TRANSAFE Rx randomized controlled trial. American Journal of Health-System Pharmacy2021;78(14):1287-93. [MEDLINE: 33821958]FlemingJN , TreiberF , McGillicuddyJ , GebregziabherM , TaberDJ . Improving transplant medication safety through a pharmacist-empowered, patient-centered, mhealth-based intervention: TRANSAFE Rx study protocol. JMIR Research Protocols2018;7(3):e59. [MEDLINE: 29500161]GonzalesHM , FlemingJN , GebregziabherM , Posadas-SalasMA , SuZ , McGillicuddyJW , et al. Pharmacist-led mobile health intervention and transplant medication safety: a randomized controlled clinical trial. Clinical Journal of the American Society of Nephrology: CJASN2021;16(5):776-84. [MEDLINE: 33931415]TaberDJ , FlemingJN , SuZ , MauldinP , McGillicuddyJW , PosadasA , et al. Significant hospitalization cost savings to the payer with a pharmacist-led mobile health intervention to improve medication safety in kidney transplant recipients. American Journal of Transplantation2021;21(10):3428-35. [MEDLINE: 34197699]TaberDJ , PilchNA , McGillicuddyJW , MardisC , TreiberF , FlemingJN . Using informatics and mobile health to improve medication safety monitoring in kidney transplant recipients. American Journal of Health-System Pharmacy2019;76(15):1143-9. [MEDLINE: 31361870]">TRANSAFE‐Rx 2018</a>), high risk of bias in 12 studies (<a href="./references#CD012854-bbs2-0006" title="CoteJ , FortinMC , AugerP , RouleauG , DuboisS , BoudreauN , et al. Web-based tailored intervention to support optimal medication adherence among kidney transplant recipients: pilot parallel-group randomized controlled trial. JMIR Formative Research2018;2(2):e14. [MEDLINE: 30684400]">Cote 2018</a>; <a href="./references#CD012854-bbs2-0011" title="HardstaffR , GreenK , TalbotD . Measurement of compliance posttransplantation--the results of a 12-month study using electronic monitoring. Transplantation Proceedings2003;35(2):796-7. [MEDLINE: 12644142]HardstaffR , GreenK , TalbotD . Noncompliance postrenal transplantation: measuring the extent of the problem using electronic surveillance and nurse practitioner interviews. Transplantation Proceedings2002;34(5):1608. [MEDLINE: 12176504]">Hardstaff 2002</a>; <a href="./references#CD012854-bbs2-0012" title="HarrisonJJ , BadrS , HamandiB , KimSJ . Randomized controlled trial of a computer-based education program in the home for solid organ transplant recipients: impact on medication knowledge, satisfaction, and adherence. Transplantation2017;101(6):1336-43. [MEDLINE: 27367473]">Harrison 2016</a>; <a href="./references#CD012854-bbs2-0013" title="HenrikssonJ , TydenG , HoijerJ , WadstromJ . A prospective randomized trial on the effect of using an electronic monitoring drug dispensing device to improve adherence and compliance. Transplantation2016;100(1):203-9. [MEDLINE: 26588006]HenrikssonJ , WadstromJ , HoijerJ , TydenG . A prospective randomized trial on the effect of using an electronic monitoring drug dispensary device to improve adherence and non-compliance [abstract no: BO220]. Transplant International2015;28(Suppl 4):204. [EMBASE: 72111815]">Henriksson 2016</a>; <a href="./references#CD012854-bbs2-0017" title="JungHY , JeonY , SeongSJ , SeoJJ , ChoiJY , ChoJH , et al. ICT-based adherence monitoring in kidney transplant recipients: a randomized controlled trial. BMC Medical Informatics &amp; Decision Making2020;20(1):105. [MEDLINE: 32522263]JungHY , JeonY , SeongSJ , SeoJJ , ChoiJY , ChoJH , et al. Information and communication technology-based centralized monitoring system to increase adherence to immunosuppressive medication in kidney transplant recipients: a randomized controlled trial [abstract no: P1734]. Nephrology Dialysis Transplantation2020;35(Suppl 3):iii252. [EMBASE: 633422975]JungHY , SeongSJ , ChoiJY , ChoJH , ParkSH , KimCD , et al. The efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trial. Trials [Electronic Resource]2017;18(1):480. [MEDLINE: 29037222]">Jung 2017</a>; <a href="./references#CD012854-bbs2-0023" title="DobbelsF , De BleserL , BerbenL , KristantoP , DupontL , NevensF , et al. Efficacy of a medication adherence enhancing intervention in transplantation: the MAESTRO-Tx trial. Journal of Heart &amp; Lung Transplantation2017;36(5):499-508. [MEDLINE: 28162931]DobbelsF , De BleserL , BerbenL , KristantoP , DupontL , NevensF , et al. Testing the efficacy of a multicomponent theory-based tailored behavioral medication adherence intervention in transplantation: The MAESTRO-TX RCT [abstract no: 223]. Journal of Heart &amp; Lung Transplantation2016;35(4 Suppl):S90. [EMBASE: 72253342]DobbelsF , De BleserL , KristantoP , NevensF , VanhaeckeJ , VerledenG , et al. Electronic monitoring feedback and motivational interviewing improves medication adherence in heart, liver and lung transplant patients: results from the MAESTRO-TX RCT [abstract no: BO218]. Transplant International2015;28(Suppl 4):203. [EMBASE: 72111813]">MAESTRO‐Tx 2017</a>; <a href="./references#CD012854-bbs2-0024" title="AndrewsAM , ChengAL , Bartlett EllisRJ , EmersonAM , O'BrienT , RussellCL . SystemCHANGE TM solutions to improve medication adherence in kidney transplant recipients: a secondary data analysis. Nephrology Nursing Journal2021;48(4):389-417. [MEDLINE: 34463466]RussellCL , HathawayD , RemyLM , AholtD , ClarkD , MillerC , et al. Improving medication adherence and outcomes in adult kidney transplant patients using a personal systems approach: SystemCHANGE TM results of the MAGIC randomized clinical trial. American Journal of Transplantation2020;20(1):125-36. [MEDLINE: 31291507]RussellCL , MooreS , HathawayD , ChengAL , ChenG , GogginK . MAGIC Study: aims, design and methods using SystemCHANGE TM to improve immunosuppressive medication adherence in adult kidney transplant recipients. BMC Nephrology2016;17(1):84. [MEDLINE: 27421884]RussellCL . Improving medication adherence and outcomes in adult kidney transplant patients using a personal systems approach: SystemCHANGE.TM results of the MAGIC randomized clinical trial [abstract]. Peritoneal Dialysis International2020;40(1 Suppl):14S. [EMBASE: 632156503]WakefieldWR , AshbaughCM , RemyL , AholtD , MillerC , YeS , et al. Improving medication adherence and outcomes in adult kidney transplant patients using SYSTEMChangeTM: results of the Medication Adherence Given Individual Change (MAGIC) randomized clinical trial [abstract no: 523]. American Journal of Transplantation2019;19(Suppl 3):541-2. [EMBASE: 628454823]">MAGIC 2016</a>; <a href="./references#CD012854-bbs2-0027" title="PatersonTS , DemianM , ShapiroRJ , Loken ThorntonW . Impact of once- versus twice-daily tacrolimus dosing on medication adherence in stable renal transplant recipients: a Canadian single-center randomized controlled trial. Canadian Journal of Kidney Health &amp; Disease2019;6:2054358119867993. [MEDLINE: 31452902]ShapiroRJ , PatersonT , ThorntonW , HusseiniT , PartoviN , VishloffJ , et al. Medication adherence is tied to social support in renal transplant recipients [abstract no: 2501]. In: Canadian Society of Transplantation Annual Scientific Meeting; 2013 Mar 13-16; Alberta, Canada. 2013:38. ">Paterson 2019</a>; <a href="./references#CD012854-bbs2-0029" title="HanA , ChoMJ , ChoS , LeeCH , ChoiC , KimSY , et al. Use of mobile internet application to improve adherence to immunosuppressive medication adherence in kidney transplant recipients: preliminary results of the PRIMA (ImProving Adherence to Immunosuppressive Therapy by Mobile Internet application) study [abstract no: 420.4]. Transplantation2016;100(7 Suppl):S161. [EMBASE: 613004382]HanA , MinSI , AhnS , MinSK , HongHJ , HanN , et al. Mobile medication manager application to improve adherence with immunosuppressive therapy in renal transplant recipients: a randomized controlled trial. PLoS ONE [Electronic Resource]2019;14(11):e0224595. [MEDLINE: 31689320]KoH , KimHK , ChungC , HanA , MinSK , HaJ , et al. Association between medication adherence and intrapatient variability in tacrolimus concentration among stable kidney transplant recipients. Scientific Reports2021;11(1):5397. [MEDLINE: 33686160]">PRIMA 2019</a>; <a href="./references#CD012854-bbs2-0034" title="De GeestS , DenhaerynckK , Schafer-KellerP , BockA , SteigerJ . Supporting medication adherence in renal transplantation--the SMART study. Swiss Medical Weekly2007;137 Suppl 155:125-7S. [MEDLINE: 17874516]De GeestS , Schafer-KellerP , DenhaerynckK , BockA , KoferS , ThannbergerN , et al. Supporting medication adherence in renal transplantation (SMART): a pilot study [abstract no: PO3.09]. Kidney &amp; Blood Pressure Research2004;27(5-6):327. [CENTRAL: CN-00615859] De GeestS , Schafer-KellerP , DenhaerynckK , ThannbergerN , KoferS , BockA , et al. Supporting medication adherence in renal transplantation (SMART): a pilot RCT to improve adherence to immunosuppressive regimens. Clinical Transplantation2006;20(3):359-68. [MEDLINE: 16824155]deGeestS , SchaferP , DenhaerynckK , BockA , SteigerJ . Supporting medication adherence in renal transplantation (SMART): a randomized controlled trial to improve adherence with immunosuppressive regimen [abstract no: PO-590]. Transplant International2005;18(Suppl):na. ">SMART 2006</a>; <a href="./references#CD012854-bbs2-0038" title="BignallO , PaiA , AmaralS , FurthS , BergmanN , GoebelJ , et al. Differences in reported barriers to immunosuppression adherence among a cohort of pediatric renal transplant recipients from the United States and Canada [abstract no: D161]. American Journal of Transplantation2016;16(Suppl 3):751. [EMBASE: 611700425]BoucquemontJ , FosterB , TAKE-IT Investigators. Sex and age differences in medication adherence in adolescent and young adult kidney transplant recipients [abstract no: SA-PO404]. Journal of the American Society of Nephrology2016;27(Abstracts):721A. [CENTRAL: CN-01657535] BoucquemontJ , FosterB . Adherence patterns in adolescent and young adult kidney transplant recipients [abstract no: 229]. American Journal of Transplantation2016;16(Suppl 3):284. [EMBASE: 611700136]BoucquemontJ , PaiAL , DharnidharkaVR , HebertD , FurthSL , FosterBJ . Gender differences in medication adherence among adolescent and young adult kidney transplant recipients. Transplantation2019;103(4):798-806. [MEDLINE: 29994983]BoucquemontJ , PaiAL , DharnidharkaVR , HebertD , ZelikovskyN , AmaralS , et al. Association between day of the week and medication adherence among adolescent and young adult kidney transplant recipients. American Journal of Transplantation2020;20(1):274-81. [MEDLINE: 31507087]FosterB , PaiA , FurthS . The TAKE-IT intervention improves medication adherence in adolescent kidney transplant recipients [abstract no: 359]. American Journal of Transplantation2017;17(Suppl 3):332-3. [EMBASE: 615704529]FosterB , ZhaoH , PaiA , ZelikovskyN , HollyCD , SmithJM , et al. Medication adherence barrier burden predicts subsequent taking adherence in adolescent kidney transplant recipients in the TAKE-IT trial [abstract no: SA-PO1027]. Journal of the American Society of Nephrology2015;26(Abstracts):870A. [CENTRAL: CN-01657534] FosterBJ , PaiA , ZhaoH , FurthS , TAKE-IT Study Group. The TAKE-IT study: aims, design, and methods. BMC Nephrology2014;15:139. [MEDLINE: 25176317]FosterBJ , PaiAL , ZelikovskyN , AmaralS , BellL , DharnidharkaVR , et al. A randomized trial of a multicomponent intervention to promote medication adherence: the teen adherence in kidney transplant effectiveness of intervention trial (TAKE-IT) [Erratum in: Am J Kidney Dis. 2019 Apr;73(4):578]. American Journal of Kidney Diseases2018;72(1):30-41. [MEDLINE: 29602631]FosterBJ , ZhaoH , PaiA , ZelikovskyN , HollyCD , SmithJM , et al. Medication adherence barrier burden predicts subsequent adherence to dosing time schedule in adolescent kidney transplant recipients in the TAKE-IT Trial [abstract no: SA-PO1031]. Journal of the American Society of Nephrology2015;26(Abstracts):871A. [CENTRAL: CN-01657537] LadnerDP , WolfMS . Transplant regimen adherence for kidney recipients by engaging information technologies: the TAKE-IT trial [abstract no: D302]. American Journal of Transplantation2019;19(Suppl 3):1145. [EMBASE: 628453783]">TAKE‐IT 2014</a>; <a href="./references#CD012854-bbs2-0040" title="UrstadKH , OyenO , AndersenMH , MoumT , WahlAK . The effect of an educational intervention for renal recipients: a randomized controlled trial. Clinical Transplantation2012;26(3):E246-53. [MEDLINE: 22686948]">Urstad 2012</a>) and unclear in five studies (<a href="./references#CD012854-bbs2-0018" title="KaiserTE , EjazNS , TremblayS , ParrishNJ , BenavidesJ , ReheB , et al. Technology triggered adherence intervention: preliminary findings [abstract no: 185]. American Journal of Transplantation2019;19(Suppl 3):394. [EMBASE: 628454914]">Kaiser 2019</a>; <a href="./references#CD012854-bbs2-0019" title="KantachuvessiriS , InksatidA , SumethkulV , JirasirithamS , ThirapanichW . Adherence to immunosuppression after conversion of twice-daily tacrolimus to once-daily tacrolimus in stable kidney transplant patients in Thailand: a prospective study [abstract no: P.1515]. Transplantation2016;100(7 Suppl 1):S716. [EMBASE: 613004564]">Kantachuvessiri 2016</a>; <a href="./references#CD012854-bbs2-0022" title="LiuJ . Effect of WeChat-based peer education on medication compliance and quality of life in patients with liver transplantation: a pilot study [abstract no: P-576]. Transplantation2019;103(8 Suppl 1):380. [EMBASE: 629265854]">Liu 2019c</a>; <a href="./references#CD012854-bbs2-0028" title="AmaralS , FosterN , DashefskyH , KimJ , FurthS . Peers4path: challenges in measuring medication adherence in adolescent transplant recipients [abstract no: A485]. American Journal of Transplantation2014;14(Suppl 3):238. [EMBASE: 71544246]AmaralS , FosterN , DashefskyH , PaternoC , FurthS . Peers4Path: feasibility of medication adherence measures in adolescent transplant recipients [abstract no: FR-PO403]. Journal of the American Society of Nephrology2014;25(Abstracts):463A. [CENTRAL: CN-01657532] AmaralS , FosterN , YangA , ShultsJ , FurthS . Peers4Path: testing peer support as a mechanism to improve transplant outcomes among adolescents with solid organ transplants [abstract no: TH-PO1083]. Journal of the American Society of Nephrology2013;24(Abstracts):345-6A. [CENTRAL: CN-01657533] AmaralS , RogersR , PaternoC , FosterN , ShultsJ . Peers4path (promoting adolescent transplant health): a pilot study to test peer mentoring as an adherence intervention in adolescent transplant recipients [abstract no: 401.1]. Pediatric Transplantation2017;21(Suppl 1):33. [EMBASE: 616208171]StrachanC , PatonM , ReasonJ , AmaralS . Stakeholder perspectives in peer mentoring program for pediatric solid organ transplant recipients [abstract no: D323]. American Journal of Transplantation2019;19(Suppl 3):1153. [EMBASE: 628454820]">Peers4path 2014</a>; <a href="./references#CD012854-bbs2-0032" title="SantanaMJ , FeenyD , JacksonK , SchafenackerM , WeinkaufJ , LienD . Using patient-centred care to enhance adherence to medication and exercise in lung transplantation: a randomized controlled clinical trial [abstract no: 445]. In: Canadian Society of Transplantation Annual Scientific Meeting; 2011 Mar 2-5; Quebec, Canada. 2011:34. [CENTRAL: CN-01657760] ">Santana 2011</a>) due to insufficient information to permit assessment. </p> </section> <section id="CD012854-sec-0054"> <h4 class="title">Selective reporting</h4> <p>Reporting bias was assessed as low risk of bias in 34 studies (<a href="./references#CD012854-bbs2-0001" title="KuypersDR , BonvoisinCA , PeetersP , SennesaelJJ , KiandaMN , VrijensB , et al. Superior medication adherence to tacrolimus modified release once-daily (QD) compared to tacrolimus twice-daily (BID) in stable renal transplant patients [abstract no: RO-256]. Transplant International2011;24(Suppl 2):199. [EMBASE: 70527785]KuypersDR , PeetersPC , SennesaelJJ , KiandaMN , VrijensB , KristantoP , et al. Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring. Transplantation2013;95(2):333-40. [MEDLINE: 23263559]">ADMIRAD 2013</a>; <a href="./references#CD012854-bbs2-0002" title="BessaA , MedinaJ , TedescoH , FelipeC . A prospective, randomised, controlled study to assess the effect of pharmaceutical intervention on compliance and knowledge of immunosuppression in kidney transplant recipients [abstract no: DI-090]. European Journal of Hospital Pharmacy2015;22(Suppl 1):A109-10. [EMBASE: 614322295]BessaAB , FelipeCR , HannunP , SayuriP , FelixMJ , RuppelP , et al. Prospective randomized trial investigating the influence of pharmaceutical care on the intra-individual variability of tacrolimus concentrations early after kidney transplant. Therapeutic Drug Monitoring2016;38(4):447-55. [MEDLINE: 27414973]">Bessa 2016</a>; <a href="./references#CD012854-bbs2-0003" title="Breu-DejeanN , DriotD , DupouyJ , Lapeyre-MestreM , RostaingL . Efficacy of psychoeducational intervention on allograft function in kidney transplant patients: 10-year results of a prospective randomized study. Experimental &amp; Clinical Transplantation2016;14(1):38-44. [MEDLINE: 26862823]Breu-DejeanN . Education program to reduce non-compliance after renal transplantation [doctorate thesis] [Effet d'une intervention psycho-éducationnelle sur l'observance thérapeutique chez les transplantés rénaux]. University of Toulouse2016. [CENTRAL: CN-01658149] Breu-DejeanNB , RontaingL , Lapeyre-MestreM , RogeB , DurandD . Educational program to reduce noncompliance after renal transplantation [abstract no: MO06]. In: 41st Congress. European Renal Association. European Dialysis and Transplantation Association; 2004 May 15-18; Lisbon, Portugal. 2004:214-5. [CENTRAL: CN-00636140] ">Breu‐Dejean 2016</a>; <a href="./references#CD012854-bbs2-0004" title="ChisholmMA , MulloyL , JagadeesanM , DiPiroJT . Two-year economic evaluation of clinical pharmacy services in renal transplant clinic patients [abstract no: 588]. American Journal of Transplantation2002;2(Suppl 3):286. [CENTRAL: CN-00415424] ChisholmMA , MulloyLL , JagadeesanM , DiPiroJT . Impact of clinical pharmacy services on renal transplant patients' compliance with immunosuppressive medications. Clinical Transplantation2001;15(5):330-6. [MEDLINE: 11678959]">Chisholm 2001</a>; <a href="./references#CD012854-bbs2-0005" title="Chisholm-BurnsM , SpiveyC , Graff ZivinJ , LeeJ , SredzinskiE . Results of a behavioral contract intervention to improve adherence and healthcare outcomes among renal transplant recipients [abstract no: D1727]. American Journal of Transplantation2013;13(Suppl S5):540. [CENTRAL: CN-01007771] Chisholm-BurnsMA , EricksonS , SpiveyCA . Employment and health-related quality of life among renal transplant recipients [abstract no: 1140]. American Journal of Transplantation2011;11(Suppl 2):365. [EMBASE: 70406190]Chisholm-BurnsMA , SpiveyCA , GraffZJ , LeeJK , SredzinskiE , TolleyEA . Improving outcomes of renal transplant recipients with behavioral adherence contracts: a randomized controlled trial. American Journal of Transplantation2013;13(9):2364-73. [MEDLINE: 23819827]Chisholm-BurnsMA , SpiveyCA , SredzinskiE , ButlerS . Preliminary results of a behavioral contract intervention to improve adherence and quality of life among renal transplant recipients [abstract no: 1139]. American Journal of Transplantation2011;11(Suppl 2):365. [EMBASE: 70406189]Chisholm-BurnsMA , SpiveyCA , SredzinskiE , ButlerSL . Intervention toolbox to promote immunosuppressant therapy adherence in adult renal transplant recipients. Journal of the American Pharmacists Association: JAPhA2012;52(6):816-22. [MEDLINE: 23229970]">Chisholm‐Burns 2013</a>; <a href="./references#CD012854-bbs2-0006" title="CoteJ , FortinMC , AugerP , RouleauG , DuboisS , BoudreauN , et al. Web-based tailored intervention to support optimal medication adherence among kidney transplant recipients: pilot parallel-group randomized controlled trial. JMIR Formative Research2018;2(2):e14. [MEDLINE: 30684400]">Cote 2018</a>; <a href="./references#CD012854-bbs2-0007" title="CukorD , Ver HalenN , PencilleM , TedlaF , SalifuM . A pilot randomized controlled trial to promote immunosuppressant adherence in adult kidney transplant recipients. Nephron2017;135(1):6-14. [MEDLINE: 28049201]">Cukor 2017</a>; <a href="./references#CD012854-bbs2-0008" title="DeVito DabbsA , DewMA , MyersB , BegeyA , HawkinsR , RenD , et al. Evaluation of a hand-held, computer-based intervention to promote early self-care behaviors after lung transplant. Clinical Transplantation2009;23(4):537-45. [MEDLINE: 19473201]">DeVito Dabbs 2009</a>; <a href="./references#CD012854-bbs2-0009" title="DeVito DabbsA , DewM , MyersBA , SongM , LiR , ZomakR , et al. Randomized controlled trial (RCT) of pocket path, an mhealth intervention to promote self-management after lung transplantation [abstract no: A5361]. American Journal of Respiratory &amp; Critical Care Medicine2014;189:A5361. [EMBASE: 72047364]DeVito DabbsA , SongMK , MyersBA , LiR , HawkinsRP , PilewskiJM , et al. A randomized controlled trial of a mobile health intervention to promote self-management after lung transplantation. American Journal of Transplantation2016;16(7):2172-80. [MEDLINE: 26729617]GeramitaEM , DeVito DabbsAJ , DiMartiniAF , PilewskiJM , SwitzerGE , PoslusznyDM , et al. Impact of a mobile health intervention on long-term nonadherence after lung transplantation: follow-up after a randomized controlled trial. Transplantation2020;104(3):640-51. [MEDLINE: 31335759]HuL , DeVito DabbsA , DewMA , SereikaSM , LinglerJH . Patterns and correlates of adherence to self-monitoring in lung transplant recipients during the first 12 months after discharge from transplant. Clinical Transplantation2017;31(8):e13014. [MEDLINE: 28517112]RosenbergerEM , Devito DabbsAJ , DiMartiniAF , LandsittelDP , PilewskiJM , DewMA . Long-term follow-up of a randomized controlled trial evaluating a mobile health intervention for self-management in lung transplant recipients. American Journal of Transplantation2017;17(5):1286-93. [MEDLINE: 27664940]">DeVito Dabbs 2016</a>; <a href="./references#CD012854-bbs2-0010" title="GarciaMF , BravinAM , GarciaPD , ConttiMM , NgaHS , TakaseHM , et al. Behavioral measures to reduce non-adherence in renal transplant recipients: a prospective randomized controlled trial. International Urology &amp; Nephrology2015;47(11):1899-905. [MEDLINE: 26377496]">Garcia 2015</a>; <a href="./references#CD012854-bbs2-0011" title="HardstaffR , GreenK , TalbotD . Measurement of compliance posttransplantation--the results of a 12-month study using electronic monitoring. Transplantation Proceedings2003;35(2):796-7. [MEDLINE: 12644142]HardstaffR , GreenK , TalbotD . Noncompliance postrenal transplantation: measuring the extent of the problem using electronic surveillance and nurse practitioner interviews. Transplantation Proceedings2002;34(5):1608. [MEDLINE: 12176504]">Hardstaff 2002</a>; <a href="./references#CD012854-bbs2-0012" title="HarrisonJJ , BadrS , HamandiB , KimSJ . Randomized controlled trial of a computer-based education program in the home for solid organ transplant recipients: impact on medication knowledge, satisfaction, and adherence. Transplantation2017;101(6):1336-43. [MEDLINE: 27367473]">Harrison 2016</a>; <a href="./references#CD012854-bbs2-0013" title="HenrikssonJ , TydenG , HoijerJ , WadstromJ . A prospective randomized trial on the effect of using an electronic monitoring drug dispensing device to improve adherence and compliance. Transplantation2016;100(1):203-9. [MEDLINE: 26588006]HenrikssonJ , WadstromJ , HoijerJ , TydenG . A prospective randomized trial on the effect of using an electronic monitoring drug dispensary device to improve adherence and non-compliance [abstract no: BO220]. Transplant International2015;28(Suppl 4):204. [EMBASE: 72111815]">Henriksson 2016</a>; <a href="./references#CD012854-bbs2-0014" title="HuangY , YuX . Effect of healthy education on improving the drug compliance of patients after renal transplantation. Journal of Clinical Rehabilitative Tissue Engineering Research2007;11(43):8773-5. [EMBASE: 350081272]">Huang 2007b</a>; <a href="./references#CD012854-bbs2-0015" title="LowJK , ManiasE , CrawfordK , WalkerR , MulleyWR , ToussaintND , et al. Improving medication adherence in adult kidney transplantation (IMAKT): a pilot randomised controlled trial. Scientific Reports2019;9(1):7734. [MEDLINE: 31118485]">IMAKT 2019</a>; <a href="./references#CD012854-bbs2-0016" title="JoostR , DorjeF , SchwitullaJ , EckardtKU , HugoC . Intensified pharmaceutical care is improving immunosuppressive medication adherence in kidney transplant recipients during the first post-transplant year: a quasi-experimental study. Nephrology Dialysis Transplantation2014;29(8):1597-607. [MEDLINE: 24914089]">Joost 2014</a>; <a href="./references#CD012854-bbs2-0018" title="KaiserTE , EjazNS , TremblayS , ParrishNJ , BenavidesJ , ReheB , et al. Technology triggered adherence intervention: preliminary findings [abstract no: 185]. American Journal of Transplantation2019;19(Suppl 3):394. [EMBASE: 628454914]">Kaiser 2019</a>; <a href="./references#CD012854-bbs2-0019" title="KantachuvessiriS , InksatidA , SumethkulV , JirasirithamS , ThirapanichW . Adherence to immunosuppression after conversion of twice-daily tacrolimus to once-daily tacrolimus in stable kidney transplant patients in Thailand: a prospective study [abstract no: P.1515]. Transplantation2016;100(7 Suppl 1):S716. [EMBASE: 613004564]">Kantachuvessiri 2016</a>; <a href="./references#CD012854-bbs2-0020" title="KleinA , KramerI . Influence of a pharmaceutical care program on liver transplant patients' compliance with immunosuppressive therapy: a prospective, randomized, controlled trial [Pharmazeutische betreuung lebertransplantierter patienten unter besonderer berucksichtigung der compliance mit der immunsuppressiven therapie: Eine prospektive, randomisierte, kontrollierte studie]. Krankenhauspharmazie2007;28(12):458-68. [EMBASE: 350287720]KleinA , OttoG , KramerI . Impact of a pharmaceutical care program on liver transplant patients' compliance with immunosuppressive medication: a prospective, randomized, controlled trial using electronic monitoring. Transplantation2009;87(6):839-47. [MEDLINE: 19300186]">Klein 2007</a>; <a href="./references#CD012854-bbs2-0021" title="LevineD , TorabiJ , ChoinskiK , RoccaJP , GrahamJA . Transplant surgery enters a new era: increasing immunosuppressive medication adherence through mobile apps and smart watches. American Journal of Surgery2019;218(1):18-20. [MEDLINE: 30799019]">Levine 2019</a>; <a href="./references#CD012854-bbs2-0024" title="AndrewsAM , ChengAL , Bartlett EllisRJ , EmersonAM , O'BrienT , RussellCL . SystemCHANGE TM solutions to improve medication adherence in kidney transplant recipients: a secondary data analysis. Nephrology Nursing Journal2021;48(4):389-417. [MEDLINE: 34463466]RussellCL , HathawayD , RemyLM , AholtD , ClarkD , MillerC , et al. Improving medication adherence and outcomes in adult kidney transplant patients using a personal systems approach: SystemCHANGE TM results of the MAGIC randomized clinical trial. American Journal of Transplantation2020;20(1):125-36. [MEDLINE: 31291507]RussellCL , MooreS , HathawayD , ChengAL , ChenG , GogginK . MAGIC Study: aims, design and methods using SystemCHANGE TM to improve immunosuppressive medication adherence in adult kidney transplant recipients. BMC Nephrology2016;17(1):84. [MEDLINE: 27421884]RussellCL . Improving medication adherence and outcomes in adult kidney transplant patients using a personal systems approach: SystemCHANGE.TM results of the MAGIC randomized clinical trial [abstract]. Peritoneal Dialysis International2020;40(1 Suppl):14S. [EMBASE: 632156503]WakefieldWR , AshbaughCM , RemyL , AholtD , MillerC , YeS , et al. Improving medication adherence and outcomes in adult kidney transplant patients using SYSTEMChangeTM: results of the Medication Adherence Given Individual Change (MAGIC) randomized clinical trial [abstract no: 523]. American Journal of Transplantation2019;19(Suppl 3):541-2. [EMBASE: 628454823]">MAGIC 2016</a>; <a href="./references#CD012854-bbs2-0025" title="McGillicuddyJW , GregoskiMJ , Brunner-JacksonBM , WeilandAK , PatelSK , RockRA , et al. Facilitating medication adherence and eliminating therapeutic inertia using wireless technology: proof of concept findings with uncontrolled hypertensives and kidney transplant recipients. In: WH '12 Proceedings of the Conference on Wireless Health; 2012 Oct 23-25; San Diego CA. 2012. [CENTRAL: CN-01658221] McGillicuddyJW , GregoskiMJ , WeilandAK , RockRA , Brunner-JacksonBM , PatelSK , et al. Mobile health medication adherence and blood pressure control in renal transplant recipients: a proof-of-concept randomized controlled trial. JMIR Research Protocols2013;2(2):e32. [MEDLINE: 24004517]McGillicuddyJW , TaberDJ , MuellerM , PatelS , BaligaPK , ChavinKD , et al. Sustainability of improvements in medication adherence through a mobile health intervention. Progress in Transplantation2015;25(3):217-23. [MEDLINE: 26308780]McGillicuddyJW . EHealth and transplantation [abstract no: PM-47]. American Journal of Transplantation2014;14(Suppl 2):54-5. [EMBASE: 71388189]">McGillicuddy 2013</a>; <a href="./references#CD012854-bbs2-0027" title="PatersonTS , DemianM , ShapiroRJ , Loken ThorntonW . Impact of once- versus twice-daily tacrolimus dosing on medication adherence in stable renal transplant recipients: a Canadian single-center randomized controlled trial. Canadian Journal of Kidney Health &amp; Disease2019;6:2054358119867993. [MEDLINE: 31452902]ShapiroRJ , PatersonT , ThorntonW , HusseiniT , PartoviN , VishloffJ , et al. Medication adherence is tied to social support in renal transplant recipients [abstract no: 2501]. In: Canadian Society of Transplantation Annual Scientific Meeting; 2013 Mar 13-16; Alberta, Canada. 2013:38. ">Paterson 2019</a>; <a href="./references#CD012854-bbs2-0029" title="HanA , ChoMJ , ChoS , LeeCH , ChoiC , KimSY , et al. Use of mobile internet application to improve adherence to immunosuppressive medication adherence in kidney transplant recipients: preliminary results of the PRIMA (ImProving Adherence to Immunosuppressive Therapy by Mobile Internet application) study [abstract no: 420.4]. Transplantation2016;100(7 Suppl):S161. [EMBASE: 613004382]HanA , MinSI , AhnS , MinSK , HongHJ , HanN , et al. Mobile medication manager application to improve adherence with immunosuppressive therapy in renal transplant recipients: a randomized controlled trial. PLoS ONE [Electronic Resource]2019;14(11):e0224595. [MEDLINE: 31689320]KoH , KimHK , ChungC , HanA , MinSK , HaJ , et al. Association between medication adherence and intrapatient variability in tacrolimus concentration among stable kidney transplant recipients. Scientific Reports2021;11(1):5397. [MEDLINE: 33686160]">PRIMA 2019</a>; <a href="./references#CD012854-bbs2-0030" title="ReeseP , BloomR , Trofe-ClarkJ , MussellA , LeidyD , LevskyS , et al. Customized reminders and provider notification to improve adherence to immunosuppression [abstract no: 1074]. American Journal of Transplantation2015;15(Suppl 3). [EMBASE: 71953144]ReesePP , BloomRD , Trofe-ClarkJ , MussellA , LeidyD , LevskyS , et al. Automated reminders and physician notification to promote immunosuppression adherence among kidney transplant recipients: a randomized trial. American Journal of Kidney Diseases2017;69(3):400-9. [MEDLINE: 27940063]">Reese 2017</a>; <a href="./references#CD012854-bbs2-0031" title="RussellC , ConnV , AshbaughC , MadsenR , WakefieldM , WebbA , et al. Taking immunosuppressive medications effectively (TIMELink): a pilot randomized controlled trial in adult kidney transplant recipients. Clinical Transplantation2011;25(6):864-70. [MEDLINE: 21077956]RussellCL , ConnVS , AshbaughC , CoffeyD , WakefieldM . A pilot RCT to increase medication adherence in transplantation [abstract no: 1168]. American Journal of Transplantation2010;10(Suppl 4):376. [EMBASE: 70464544]">Russell 2011</a>; <a href="./references#CD012854-bbs2-0032" title="SantanaMJ , FeenyD , JacksonK , SchafenackerM , WeinkaufJ , LienD . Using patient-centred care to enhance adherence to medication and exercise in lung transplantation: a randomized controlled clinical trial [abstract no: 445]. In: Canadian Society of Transplantation Annual Scientific Meeting; 2011 Mar 2-5; Quebec, Canada. 2011:34. [CENTRAL: CN-01657760] ">Santana 2011</a>; <a href="./references#CD012854-bbs2-0033" title="HilsS , SchmidA , BogatyrevaL , HauschkeD , Kramer-ZuckerA , PisarskiP . Telemedical supported aftercare after living kidney transplantation-a single center experience [abstract no: O179]. Transplant International2015;28(Suppl 4):69. [EMBASE: 72111423]HilsS , SchmidA , BogatyrevaL , HauschkeD , PisarskiP . Telemedical supported aftercare as an innovative project-study improves the quality of life after living kidney transplantation-a single center experience [abstract no: D2730]. Transplantation2014;98(Suppl 1):843. [EMBASE: 71546416]KaierK , HilsS , FetzerS , HehnP , SchmidA , HauschkeD , et al. Results of a randomized controlled trial analyzing telemedically supported case management in the first year after living donor kidney transplantation - a budget impact analysis from the healthcare perspective. Health Economics Review2017;7(1):1. [MEDLINE: 28092012]PisarskiP , HilsS , SchmidA , Kramer-ZuckerA , JanigenB . Telemedicin as an innovative project-study in adherence improvement after living kidney transplantation at the Transplantation Center Freiburg [abstract no: O162]. Transplant International2013;26(Suppl 2):73. [EMBASE: 71359226]SchmidA , HilsS , Kramer-ZuckerA , BogatyrevaL , HauschkeD , De GeestS , et al. Telemedically-supported case management of living-donor renal transplant recipients to optimize routine evidence-based aftercare: a single-center randomized controlled trial. American Journal of Transplantation2017;17(6):1594-605. [MEDLINE: 27873477]SchmidA , PisarskiP , HilsS , HauschkeD , BogatyrevaL . Telemedical supported after care in living kidney recipients-an innovative project-study at the Transplantation Center Freiburg interim results of a prospective ongoing study of 50 patients [abstract no: P84]. Transplant International2013;26(Suppl 1):43. [EMBASE: 71356349]">Schmid 2017</a>; <a href="./references#CD012854-bbs2-0034" title="De GeestS , DenhaerynckK , Schafer-KellerP , BockA , SteigerJ . Supporting medication adherence in renal transplantation--the SMART study. Swiss Medical Weekly2007;137 Suppl 155:125-7S. [MEDLINE: 17874516]De GeestS , Schafer-KellerP , DenhaerynckK , BockA , KoferS , ThannbergerN , et al. Supporting medication adherence in renal transplantation (SMART): a pilot study [abstract no: PO3.09]. Kidney &amp; Blood Pressure Research2004;27(5-6):327. [CENTRAL: CN-00615859] De GeestS , Schafer-KellerP , DenhaerynckK , ThannbergerN , KoferS , BockA , et al. Supporting medication adherence in renal transplantation (SMART): a pilot RCT to improve adherence to immunosuppressive regimens. Clinical Transplantation2006;20(3):359-68. [MEDLINE: 16824155]deGeestS , SchaferP , DenhaerynckK , BockA , SteigerJ . Supporting medication adherence in renal transplantation (SMART): a randomized controlled trial to improve adherence with immunosuppressive regimen [abstract no: PO-590]. Transplant International2005;18(Suppl):na. ">SMART 2006</a>; <a href="./references#CD012854-bbs2-0035" title="SuhlingH , RademacherJ , ZinowskyI , FugeJ , GreerM , WarneckeG , et al. Conventional vs. tablet computer-based patient education following lung transplantation--a randomized controlled trial. PLoS ONE [Electronic Resource]2014;9(6):e90828. [MEDLINE: 24608864]SuhlingH , RademacherJ , ZinowskyI , FugeJ , GreerM , WarneckeG . Patient education via tablet-pc vs. conventional to improve compliance with immunosuppressive drug regimen after lung transplantation - a randomized controlled trial [abstract no: 2844]. European Respiratory Journal2013;42(Suppl 57):565S. [EMBASE: 71843332]">Suhling 2014</a>; <a href="./references#CD012854-bbs2-0036" title="TaberDJ , PosadasMA , RaoV , McGillicuddyJ , RohanV , NadigSN , et al. The potential for improved medication adherence with a complete once daily immunosuppression regimen in kidney transplant: results of a randomized controlled study [abstract no: FR-PO1177]. Journal of the American Society of Nephrology2019;30(Abstract Suppl):750-1. [EMBASE: 633769114]TaberDJ , Posadas-SalasA , SuZ , RaoV , RohanV , NadigS , et al. Preliminary assessment of safety and adherence to a once-daily immunosuppression regimen in kidney transplantation: results of a randomized controlled pilot study. Clinical Transplantation2020;34(4):e13844. [MEDLINE: 32092187]">Taber 2020</a>; <a href="./references#CD012854-bbs2-0037" title="Van ZantenR , De WeerdA , BetjesM , Boer-VerschragenM , MasseyE . Medication adherence and fear of rejection after conversion from dual to monotherapy: A randomized controlled trial [abstract no: OP170]. Transplant International2021;34(Suppl 1):35. [EMBASE: 635968308]vanZantenR , deWeerdA , BetjesM , Boer-VerschragenM , MasseyEK . Is simplification of immunosuppressive medication a way to promote medication adherence of kidney transplant recipients? Findings from a randomized controlled trial. Transplant International2021;34(9):1703-11. [MEDLINE: 34448273]">TACmono 2021</a>; <a href="./references#CD012854-bbs2-0039" title="FlemingJN , GebregziabherM , PosadasA , SuZ , McGillicuddyJW , TaberDJ . Impact of a pharmacist-led, mHealth-based intervention on tacrolimus trough variability in kidney transplant recipients: a report from the TRANSAFE Rx randomized controlled trial. American Journal of Health-System Pharmacy2021;78(14):1287-93. [MEDLINE: 33821958]FlemingJN , TreiberF , McGillicuddyJ , GebregziabherM , TaberDJ . Improving transplant medication safety through a pharmacist-empowered, patient-centered, mhealth-based intervention: TRANSAFE Rx study protocol. JMIR Research Protocols2018;7(3):e59. [MEDLINE: 29500161]GonzalesHM , FlemingJN , GebregziabherM , Posadas-SalasMA , SuZ , McGillicuddyJW , et al. Pharmacist-led mobile health intervention and transplant medication safety: a randomized controlled clinical trial. Clinical Journal of the American Society of Nephrology: CJASN2021;16(5):776-84. [MEDLINE: 33931415]TaberDJ , FlemingJN , SuZ , MauldinP , McGillicuddyJW , PosadasA , et al. Significant hospitalization cost savings to the payer with a pharmacist-led mobile health intervention to improve medication safety in kidney transplant recipients. American Journal of Transplantation2021;21(10):3428-35. [MEDLINE: 34197699]TaberDJ , PilchNA , McGillicuddyJW , MardisC , TreiberF , FlemingJN . Using informatics and mobile health to improve medication safety monitoring in kidney transplant recipients. American Journal of Health-System Pharmacy2019;76(15):1143-9. [MEDLINE: 31361870]">TRANSAFE‐Rx 2018</a>; <a href="./references#CD012854-bbs2-0040" title="UrstadKH , OyenO , AndersenMH , MoumT , WahlAK . The effect of an educational intervention for renal recipients: a randomized controlled trial. Clinical Transplantation2012;26(3):E246-53. [MEDLINE: 22686948]">Urstad 2012</a>) high risk in three studies (<a href="./references#CD012854-bbs2-0028" title="AmaralS , FosterN , DashefskyH , KimJ , FurthS . Peers4path: challenges in measuring medication adherence in adolescent transplant recipients [abstract no: A485]. American Journal of Transplantation2014;14(Suppl 3):238. [EMBASE: 71544246]AmaralS , FosterN , DashefskyH , PaternoC , FurthS . Peers4Path: feasibility of medication adherence measures in adolescent transplant recipients [abstract no: FR-PO403]. Journal of the American Society of Nephrology2014;25(Abstracts):463A. [CENTRAL: CN-01657532] AmaralS , FosterN , YangA , ShultsJ , FurthS . Peers4Path: testing peer support as a mechanism to improve transplant outcomes among adolescents with solid organ transplants [abstract no: TH-PO1083]. Journal of the American Society of Nephrology2013;24(Abstracts):345-6A. [CENTRAL: CN-01657533] AmaralS , RogersR , PaternoC , FosterN , ShultsJ . Peers4path (promoting adolescent transplant health): a pilot study to test peer mentoring as an adherence intervention in adolescent transplant recipients [abstract no: 401.1]. Pediatric Transplantation2017;21(Suppl 1):33. [EMBASE: 616208171]StrachanC , PatonM , ReasonJ , AmaralS . Stakeholder perspectives in peer mentoring program for pediatric solid organ transplant recipients [abstract no: D323]. American Journal of Transplantation2019;19(Suppl 3):1153. [EMBASE: 628454820]">Peers4path 2014</a>; <a href="./references#CD012854-bbs2-0017" title="JungHY , JeonY , SeongSJ , SeoJJ , ChoiJY , ChoJH , et al. ICT-based adherence monitoring in kidney transplant recipients: a randomized controlled trial. BMC Medical Informatics &amp; Decision Making2020;20(1):105. [MEDLINE: 32522263]JungHY , JeonY , SeongSJ , SeoJJ , ChoiJY , ChoJH , et al. Information and communication technology-based centralized monitoring system to increase adherence to immunosuppressive medication in kidney transplant recipients: a randomized controlled trial [abstract no: P1734]. Nephrology Dialysis Transplantation2020;35(Suppl 3):iii252. [EMBASE: 633422975]JungHY , SeongSJ , ChoiJY , ChoJH , ParkSH , KimCD , et al. The efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trial. Trials [Electronic Resource]2017;18(1):480. [MEDLINE: 29037222]">Jung 2017</a>; <a href="./references#CD012854-bbs2-0023" title="DobbelsF , De BleserL , BerbenL , KristantoP , DupontL , NevensF , et al. Efficacy of a medication adherence enhancing intervention in transplantation: the MAESTRO-Tx trial. Journal of Heart &amp; Lung Transplantation2017;36(5):499-508. [MEDLINE: 28162931]DobbelsF , De BleserL , BerbenL , KristantoP , DupontL , NevensF , et al. Testing the efficacy of a multicomponent theory-based tailored behavioral medication adherence intervention in transplantation: The MAESTRO-TX RCT [abstract no: 223]. Journal of Heart &amp; Lung Transplantation2016;35(4 Suppl):S90. [EMBASE: 72253342]DobbelsF , De BleserL , KristantoP , NevensF , VanhaeckeJ , VerledenG , et al. Electronic monitoring feedback and motivational interviewing improves medication adherence in heart, liver and lung transplant patients: results from the MAESTRO-TX RCT [abstract no: BO218]. Transplant International2015;28(Suppl 4):203. [EMBASE: 72111813]">MAESTRO‐Tx 2017</a>), and unclear in three studies (<a href="./references#CD012854-bbs2-0022" title="LiuJ . Effect of WeChat-based peer education on medication compliance and quality of life in patients with liver transplantation: a pilot study [abstract no: P-576]. Transplantation2019;103(8 Suppl 1):380. [EMBASE: 629265854]">Liu 2019c</a>; <a href="./references#CD012854-bbs2-0026" title="Gomis-PastorM , Mirabet PerezS , Roig MinguellE , Brossa LoidiV , Lopez LopezL , Ros AbarcaS , et al. Mobile health to improve adherence and patient experience in heart transplantation recipients: the mHeart trial. Healthcare2021;9(4):463. [MEDLINE: 33919899]Gomis-PastorM , MirabetS , RoigE , BrossaV , LopezL , RosS , et al. Improving patients' experience and medication adherence after heart transplant using a multilevel ehealth intervention: the mHeart clinical trial [abstract no: P-16.07]. Transplantation2020;104(Suppl 3):S578-9. [EMBASE: 633380991]">mHeart 2021</a>; <a href="./references#CD012854-bbs2-0038" title="BignallO , PaiA , AmaralS , FurthS , BergmanN , GoebelJ , et al. Differences in reported barriers to immunosuppression adherence among a cohort of pediatric renal transplant recipients from the United States and Canada [abstract no: D161]. American Journal of Transplantation2016;16(Suppl 3):751. [EMBASE: 611700425]BoucquemontJ , FosterB , TAKE-IT Investigators. Sex and age differences in medication adherence in adolescent and young adult kidney transplant recipients [abstract no: SA-PO404]. Journal of the American Society of Nephrology2016;27(Abstracts):721A. [CENTRAL: CN-01657535] BoucquemontJ , FosterB . Adherence patterns in adolescent and young adult kidney transplant recipients [abstract no: 229]. American Journal of Transplantation2016;16(Suppl 3):284. [EMBASE: 611700136]BoucquemontJ , PaiAL , DharnidharkaVR , HebertD , FurthSL , FosterBJ . Gender differences in medication adherence among adolescent and young adult kidney transplant recipients. Transplantation2019;103(4):798-806. [MEDLINE: 29994983]BoucquemontJ , PaiAL , DharnidharkaVR , HebertD , ZelikovskyN , AmaralS , et al. Association between day of the week and medication adherence among adolescent and young adult kidney transplant recipients. American Journal of Transplantation2020;20(1):274-81. [MEDLINE: 31507087]FosterB , PaiA , FurthS . The TAKE-IT intervention improves medication adherence in adolescent kidney transplant recipients [abstract no: 359]. American Journal of Transplantation2017;17(Suppl 3):332-3. [EMBASE: 615704529]FosterB , ZhaoH , PaiA , ZelikovskyN , HollyCD , SmithJM , et al. Medication adherence barrier burden predicts subsequent taking adherence in adolescent kidney transplant recipients in the TAKE-IT trial [abstract no: SA-PO1027]. Journal of the American Society of Nephrology2015;26(Abstracts):870A. [CENTRAL: CN-01657534] FosterBJ , PaiA , ZhaoH , FurthS , TAKE-IT Study Group. The TAKE-IT study: aims, design, and methods. BMC Nephrology2014;15:139. [MEDLINE: 25176317]FosterBJ , PaiAL , ZelikovskyN , AmaralS , BellL , DharnidharkaVR , et al. A randomized trial of a multicomponent intervention to promote medication adherence: the teen adherence in kidney transplant effectiveness of intervention trial (TAKE-IT) [Erratum in: Am J Kidney Dis. 2019 Apr;73(4):578]. American Journal of Kidney Diseases2018;72(1):30-41. [MEDLINE: 29602631]FosterBJ , ZhaoH , PaiA , ZelikovskyN , HollyCD , SmithJM , et al. Medication adherence barrier burden predicts subsequent adherence to dosing time schedule in adolescent kidney transplant recipients in the TAKE-IT Trial [abstract no: SA-PO1031]. Journal of the American Society of Nephrology2015;26(Abstracts):871A. [CENTRAL: CN-01657537] LadnerDP , WolfMS . Transplant regimen adherence for kidney recipients by engaging information technologies: the TAKE-IT trial [abstract no: D302]. American Journal of Transplantation2019;19(Suppl 3):1145. [EMBASE: 628453783]">TAKE‐IT 2014</a>) due to insufficient information to permit assessment. </p> </section> <section id="CD012854-sec-0055"> <h4 class="title">Other potential sources of bias</h4> <p>Other potential threats to validity were assessed. Twenty studies were judged to be at low risk of other potential biases (<a href="./references#CD012854-bbs2-0002" title="BessaA , MedinaJ , TedescoH , FelipeC . A prospective, randomised, controlled study to assess the effect of pharmaceutical intervention on compliance and knowledge of immunosuppression in kidney transplant recipients [abstract no: DI-090]. European Journal of Hospital Pharmacy2015;22(Suppl 1):A109-10. [EMBASE: 614322295]BessaAB , FelipeCR , HannunP , SayuriP , FelixMJ , RuppelP , et al. Prospective randomized trial investigating the influence of pharmaceutical care on the intra-individual variability of tacrolimus concentrations early after kidney transplant. Therapeutic Drug Monitoring2016;38(4):447-55. [MEDLINE: 27414973]">Bessa 2016</a>; <a href="./references#CD012854-bbs2-0003" title="Breu-DejeanN , DriotD , DupouyJ , Lapeyre-MestreM , RostaingL . Efficacy of psychoeducational intervention on allograft function in kidney transplant patients: 10-year results of a prospective randomized study. Experimental &amp; Clinical Transplantation2016;14(1):38-44. [MEDLINE: 26862823]Breu-DejeanN . Education program to reduce non-compliance after renal transplantation [doctorate thesis] [Effet d'une intervention psycho-éducationnelle sur l'observance thérapeutique chez les transplantés rénaux]. University of Toulouse2016. [CENTRAL: CN-01658149] Breu-DejeanNB , RontaingL , Lapeyre-MestreM , RogeB , DurandD . Educational program to reduce noncompliance after renal transplantation [abstract no: MO06]. In: 41st Congress. European Renal Association. European Dialysis and Transplantation Association; 2004 May 15-18; Lisbon, Portugal. 2004:214-5. [CENTRAL: CN-00636140] ">Breu‐Dejean 2016</a>; <a href="./references#CD012854-bbs2-0005" title="Chisholm-BurnsM , SpiveyC , Graff ZivinJ , LeeJ , SredzinskiE . Results of a behavioral contract intervention to improve adherence and healthcare outcomes among renal transplant recipients [abstract no: D1727]. American Journal of Transplantation2013;13(Suppl S5):540. [CENTRAL: CN-01007771] Chisholm-BurnsMA , EricksonS , SpiveyCA . Employment and health-related quality of life among renal transplant recipients [abstract no: 1140]. American Journal of Transplantation2011;11(Suppl 2):365. [EMBASE: 70406190]Chisholm-BurnsMA , SpiveyCA , GraffZJ , LeeJK , SredzinskiE , TolleyEA . Improving outcomes of renal transplant recipients with behavioral adherence contracts: a randomized controlled trial. American Journal of Transplantation2013;13(9):2364-73. [MEDLINE: 23819827]Chisholm-BurnsMA , SpiveyCA , SredzinskiE , ButlerS . Preliminary results of a behavioral contract intervention to improve adherence and quality of life among renal transplant recipients [abstract no: 1139]. American Journal of Transplantation2011;11(Suppl 2):365. [EMBASE: 70406189]Chisholm-BurnsMA , SpiveyCA , SredzinskiE , ButlerSL . Intervention toolbox to promote immunosuppressant therapy adherence in adult renal transplant recipients. Journal of the American Pharmacists Association: JAPhA2012;52(6):816-22. [MEDLINE: 23229970]">Chisholm‐Burns 2013</a>; <a href="./references#CD012854-bbs2-0007" title="CukorD , Ver HalenN , PencilleM , TedlaF , SalifuM . A pilot randomized controlled trial to promote immunosuppressant adherence in adult kidney transplant recipients. Nephron2017;135(1):6-14. [MEDLINE: 28049201]">Cukor 2017</a>; <a href="./references#CD012854-bbs2-0008" title="DeVito DabbsA , DewMA , MyersB , BegeyA , HawkinsR , RenD , et al. Evaluation of a hand-held, computer-based intervention to promote early self-care behaviors after lung transplant. Clinical Transplantation2009;23(4):537-45. [MEDLINE: 19473201]">DeVito Dabbs 2009</a>; <a href="./references#CD012854-bbs2-0012" title="HarrisonJJ , BadrS , HamandiB , KimSJ . Randomized controlled trial of a computer-based education program in the home for solid organ transplant recipients: impact on medication knowledge, satisfaction, and adherence. Transplantation2017;101(6):1336-43. [MEDLINE: 27367473]">Harrison 2016</a>; <a href="./references#CD012854-bbs2-0013" title="HenrikssonJ , TydenG , HoijerJ , WadstromJ . A prospective randomized trial on the effect of using an electronic monitoring drug dispensing device to improve adherence and compliance. Transplantation2016;100(1):203-9. [MEDLINE: 26588006]HenrikssonJ , WadstromJ , HoijerJ , TydenG . A prospective randomized trial on the effect of using an electronic monitoring drug dispensary device to improve adherence and non-compliance [abstract no: BO220]. Transplant International2015;28(Suppl 4):204. [EMBASE: 72111815]">Henriksson 2016</a>; <a href="./references#CD012854-bbs2-0016" title="JoostR , DorjeF , SchwitullaJ , EckardtKU , HugoC . Intensified pharmaceutical care is improving immunosuppressive medication adherence in kidney transplant recipients during the first post-transplant year: a quasi-experimental study. Nephrology Dialysis Transplantation2014;29(8):1597-607. [MEDLINE: 24914089]">Joost 2014</a>; <a href="./references#CD012854-bbs2-0023" title="DobbelsF , De BleserL , BerbenL , KristantoP , DupontL , NevensF , et al. Efficacy of a medication adherence enhancing intervention in transplantation: the MAESTRO-Tx trial. Journal of Heart &amp; Lung Transplantation2017;36(5):499-508. [MEDLINE: 28162931]DobbelsF , De BleserL , BerbenL , KristantoP , DupontL , NevensF , et al. Testing the efficacy of a multicomponent theory-based tailored behavioral medication adherence intervention in transplantation: The MAESTRO-TX RCT [abstract no: 223]. Journal of Heart &amp; Lung Transplantation2016;35(4 Suppl):S90. [EMBASE: 72253342]DobbelsF , De BleserL , KristantoP , NevensF , VanhaeckeJ , VerledenG , et al. Electronic monitoring feedback and motivational interviewing improves medication adherence in heart, liver and lung transplant patients: results from the MAESTRO-TX RCT [abstract no: BO218]. Transplant International2015;28(Suppl 4):203. [EMBASE: 72111813]">MAESTRO‐Tx 2017</a>; <a href="./references#CD012854-bbs2-0026" title="Gomis-PastorM , Mirabet PerezS , Roig MinguellE , Brossa LoidiV , Lopez LopezL , Ros AbarcaS , et al. Mobile health to improve adherence and patient experience in heart transplantation recipients: the mHeart trial. Healthcare2021;9(4):463. [MEDLINE: 33919899]Gomis-PastorM , MirabetS , RoigE , BrossaV , LopezL , RosS , et al. Improving patients' experience and medication adherence after heart transplant using a multilevel ehealth intervention: the mHeart clinical trial [abstract no: P-16.07]. Transplantation2020;104(Suppl 3):S578-9. [EMBASE: 633380991]">mHeart 2021</a>; <a href="./references#CD012854-bbs2-0027" title="PatersonTS , DemianM , ShapiroRJ , Loken ThorntonW . Impact of once- versus twice-daily tacrolimus dosing on medication adherence in stable renal transplant recipients: a Canadian single-center randomized controlled trial. Canadian Journal of Kidney Health &amp; Disease2019;6:2054358119867993. [MEDLINE: 31452902]ShapiroRJ , PatersonT , ThorntonW , HusseiniT , PartoviN , VishloffJ , et al. Medication adherence is tied to social support in renal transplant recipients [abstract no: 2501]. In: Canadian Society of Transplantation Annual Scientific Meeting; 2013 Mar 13-16; Alberta, Canada. 2013:38. ">Paterson 2019</a>; <a href="./references#CD012854-bbs2-0029" title="HanA , ChoMJ , ChoS , LeeCH , ChoiC , KimSY , et al. Use of mobile internet application to improve adherence to immunosuppressive medication adherence in kidney transplant recipients: preliminary results of the PRIMA (ImProving Adherence to Immunosuppressive Therapy by Mobile Internet application) study [abstract no: 420.4]. Transplantation2016;100(7 Suppl):S161. [EMBASE: 613004382]HanA , MinSI , AhnS , MinSK , HongHJ , HanN , et al. Mobile medication manager application to improve adherence with immunosuppressive therapy in renal transplant recipients: a randomized controlled trial. PLoS ONE [Electronic Resource]2019;14(11):e0224595. [MEDLINE: 31689320]KoH , KimHK , ChungC , HanA , MinSK , HaJ , et al. Association between medication adherence and intrapatient variability in tacrolimus concentration among stable kidney transplant recipients. Scientific Reports2021;11(1):5397. [MEDLINE: 33686160]">PRIMA 2019</a>; <a href="./references#CD012854-bbs2-0030" title="ReeseP , BloomR , Trofe-ClarkJ , MussellA , LeidyD , LevskyS , et al. Customized reminders and provider notification to improve adherence to immunosuppression [abstract no: 1074]. American Journal of Transplantation2015;15(Suppl 3). [EMBASE: 71953144]ReesePP , BloomRD , Trofe-ClarkJ , MussellA , LeidyD , LevskyS , et al. Automated reminders and physician notification to promote immunosuppression adherence among kidney transplant recipients: a randomized trial. American Journal of Kidney Diseases2017;69(3):400-9. [MEDLINE: 27940063]">Reese 2017</a>; <a href="./references#CD012854-bbs2-0031" title="RussellC , ConnV , AshbaughC , MadsenR , WakefieldM , WebbA , et al. Taking immunosuppressive medications effectively (TIMELink): a pilot randomized controlled trial in adult kidney transplant recipients. Clinical Transplantation2011;25(6):864-70. [MEDLINE: 21077956]RussellCL , ConnVS , AshbaughC , CoffeyD , WakefieldM . A pilot RCT to increase medication adherence in transplantation [abstract no: 1168]. American Journal of Transplantation2010;10(Suppl 4):376. [EMBASE: 70464544]">Russell 2011</a>; <a href="./references#CD012854-bbs2-0033" title="HilsS , SchmidA , BogatyrevaL , HauschkeD , Kramer-ZuckerA , PisarskiP . Telemedical supported aftercare after living kidney transplantation-a single center experience [abstract no: O179]. Transplant International2015;28(Suppl 4):69. [EMBASE: 72111423]HilsS , SchmidA , BogatyrevaL , HauschkeD , PisarskiP . Telemedical supported aftercare as an innovative project-study improves the quality of life after living kidney transplantation-a single center experience [abstract no: D2730]. Transplantation2014;98(Suppl 1):843. [EMBASE: 71546416]KaierK , HilsS , FetzerS , HehnP , SchmidA , HauschkeD , et al. Results of a randomized controlled trial analyzing telemedically supported case management in the first year after living donor kidney transplantation - a budget impact analysis from the healthcare perspective. Health Economics Review2017;7(1):1. [MEDLINE: 28092012]PisarskiP , HilsS , SchmidA , Kramer-ZuckerA , JanigenB . Telemedicin as an innovative project-study in adherence improvement after living kidney transplantation at the Transplantation Center Freiburg [abstract no: O162]. Transplant International2013;26(Suppl 2):73. [EMBASE: 71359226]SchmidA , HilsS , Kramer-ZuckerA , BogatyrevaL , HauschkeD , De GeestS , et al. Telemedically-supported case management of living-donor renal transplant recipients to optimize routine evidence-based aftercare: a single-center randomized controlled trial. American Journal of Transplantation2017;17(6):1594-605. [MEDLINE: 27873477]SchmidA , PisarskiP , HilsS , HauschkeD , BogatyrevaL . Telemedical supported after care in living kidney recipients-an innovative project-study at the Transplantation Center Freiburg interim results of a prospective ongoing study of 50 patients [abstract no: P84]. Transplant International2013;26(Suppl 1):43. [EMBASE: 71356349]">Schmid 2017</a>; <a href="./references#CD012854-bbs2-0035" title="SuhlingH , RademacherJ , ZinowskyI , FugeJ , GreerM , WarneckeG , et al. Conventional vs. tablet computer-based patient education following lung transplantation--a randomized controlled trial. PLoS ONE [Electronic Resource]2014;9(6):e90828. [MEDLINE: 24608864]SuhlingH , RademacherJ , ZinowskyI , FugeJ , GreerM , WarneckeG . Patient education via tablet-pc vs. conventional to improve compliance with immunosuppressive drug regimen after lung transplantation - a randomized controlled trial [abstract no: 2844]. European Respiratory Journal2013;42(Suppl 57):565S. [EMBASE: 71843332]">Suhling 2014</a>; <a href="./references#CD012854-bbs2-0036" title="TaberDJ , PosadasMA , RaoV , McGillicuddyJ , RohanV , NadigSN , et al. The potential for improved medication adherence with a complete once daily immunosuppression regimen in kidney transplant: results of a randomized controlled study [abstract no: FR-PO1177]. Journal of the American Society of Nephrology2019;30(Abstract Suppl):750-1. [EMBASE: 633769114]TaberDJ , Posadas-SalasA , SuZ , RaoV , RohanV , NadigS , et al. Preliminary assessment of safety and adherence to a once-daily immunosuppression regimen in kidney transplantation: results of a randomized controlled pilot study. Clinical Transplantation2020;34(4):e13844. [MEDLINE: 32092187]">Taber 2020</a>; <a href="./references#CD012854-bbs2-0037" title="Van ZantenR , De WeerdA , BetjesM , Boer-VerschragenM , MasseyE . Medication adherence and fear of rejection after conversion from dual to monotherapy: A randomized controlled trial [abstract no: OP170]. Transplant International2021;34(Suppl 1):35. [EMBASE: 635968308]vanZantenR , deWeerdA , BetjesM , Boer-VerschragenM , MasseyEK . Is simplification of immunosuppressive medication a way to promote medication adherence of kidney transplant recipients? Findings from a randomized controlled trial. Transplant International2021;34(9):1703-11. [MEDLINE: 34448273]">TACmono 2021</a>; <a href="./references#CD012854-bbs2-0039" title="FlemingJN , GebregziabherM , PosadasA , SuZ , McGillicuddyJW , TaberDJ . Impact of a pharmacist-led, mHealth-based intervention on tacrolimus trough variability in kidney transplant recipients: a report from the TRANSAFE Rx randomized controlled trial. American Journal of Health-System Pharmacy2021;78(14):1287-93. [MEDLINE: 33821958]FlemingJN , TreiberF , McGillicuddyJ , GebregziabherM , TaberDJ . Improving transplant medication safety through a pharmacist-empowered, patient-centered, mhealth-based intervention: TRANSAFE Rx study protocol. JMIR Research Protocols2018;7(3):e59. [MEDLINE: 29500161]GonzalesHM , FlemingJN , GebregziabherM , Posadas-SalasMA , SuZ , McGillicuddyJW , et al. Pharmacist-led mobile health intervention and transplant medication safety: a randomized controlled clinical trial. Clinical Journal of the American Society of Nephrology: CJASN2021;16(5):776-84. [MEDLINE: 33931415]TaberDJ , FlemingJN , SuZ , MauldinP , McGillicuddyJW , PosadasA , et al. Significant hospitalization cost savings to the payer with a pharmacist-led mobile health intervention to improve medication safety in kidney transplant recipients. American Journal of Transplantation2021;21(10):3428-35. [MEDLINE: 34197699]TaberDJ , PilchNA , McGillicuddyJW , MardisC , TreiberF , FlemingJN . Using informatics and mobile health to improve medication safety monitoring in kidney transplant recipients. American Journal of Health-System Pharmacy2019;76(15):1143-9. [MEDLINE: 31361870]">TRANSAFE‐Rx 2018</a>; <a href="./references#CD012854-bbs2-0040" title="UrstadKH , OyenO , AndersenMH , MoumT , WahlAK . The effect of an educational intervention for renal recipients: a randomized controlled trial. Clinical Transplantation2012;26(3):E246-53. [MEDLINE: 22686948]">Urstad 2012</a>), 11 studies were judged to be high risk (<a href="./references#CD012854-bbs2-0006" title="CoteJ , FortinMC , AugerP , RouleauG , DuboisS , BoudreauN , et al. Web-based tailored intervention to support optimal medication adherence among kidney transplant recipients: pilot parallel-group randomized controlled trial. JMIR Formative Research2018;2(2):e14. [MEDLINE: 30684400]">Cote 2018</a>; <a href="./references#CD012854-bbs2-0009" title="DeVito DabbsA , DewM , MyersBA , SongM , LiR , ZomakR , et al. Randomized controlled trial (RCT) of pocket path, an mhealth intervention to promote self-management after lung transplantation [abstract no: A5361]. American Journal of Respiratory &amp; Critical Care Medicine2014;189:A5361. [EMBASE: 72047364]DeVito DabbsA , SongMK , MyersBA , LiR , HawkinsRP , PilewskiJM , et al. A randomized controlled trial of a mobile health intervention to promote self-management after lung transplantation. American Journal of Transplantation2016;16(7):2172-80. [MEDLINE: 26729617]GeramitaEM , DeVito DabbsAJ , DiMartiniAF , PilewskiJM , SwitzerGE , PoslusznyDM , et al. Impact of a mobile health intervention on long-term nonadherence after lung transplantation: follow-up after a randomized controlled trial. Transplantation2020;104(3):640-51. [MEDLINE: 31335759]HuL , DeVito DabbsA , DewMA , SereikaSM , LinglerJH . Patterns and correlates of adherence to self-monitoring in lung transplant recipients during the first 12 months after discharge from transplant. Clinical Transplantation2017;31(8):e13014. [MEDLINE: 28517112]RosenbergerEM , Devito DabbsAJ , DiMartiniAF , LandsittelDP , PilewskiJM , DewMA . Long-term follow-up of a randomized controlled trial evaluating a mobile health intervention for self-management in lung transplant recipients. American Journal of Transplantation2017;17(5):1286-93. [MEDLINE: 27664940]">DeVito Dabbs 2016</a>; <a href="./references#CD012854-bbs2-0011" title="HardstaffR , GreenK , TalbotD . Measurement of compliance posttransplantation--the results of a 12-month study using electronic monitoring. Transplantation Proceedings2003;35(2):796-7. [MEDLINE: 12644142]HardstaffR , GreenK , TalbotD . Noncompliance postrenal transplantation: measuring the extent of the problem using electronic surveillance and nurse practitioner interviews. Transplantation Proceedings2002;34(5):1608. [MEDLINE: 12176504]">Hardstaff 2002</a>; <a href="./references#CD012854-bbs2-0014" title="HuangY , YuX . Effect of healthy education on improving the drug compliance of patients after renal transplantation. Journal of Clinical Rehabilitative Tissue Engineering Research2007;11(43):8773-5. [EMBASE: 350081272]">Huang 2007b</a>; <a href="./references#CD012854-bbs2-0015" title="LowJK , ManiasE , CrawfordK , WalkerR , MulleyWR , ToussaintND , et al. Improving medication adherence in adult kidney transplantation (IMAKT): a pilot randomised controlled trial. Scientific Reports2019;9(1):7734. [MEDLINE: 31118485]">IMAKT 2019</a>; <a href="./references#CD012854-bbs2-0017" title="JungHY , JeonY , SeongSJ , SeoJJ , ChoiJY , ChoJH , et al. ICT-based adherence monitoring in kidney transplant recipients: a randomized controlled trial. BMC Medical Informatics &amp; Decision Making2020;20(1):105. [MEDLINE: 32522263]JungHY , JeonY , SeongSJ , SeoJJ , ChoiJY , ChoJH , et al. Information and communication technology-based centralized monitoring system to increase adherence to immunosuppressive medication in kidney transplant recipients: a randomized controlled trial [abstract no: P1734]. Nephrology Dialysis Transplantation2020;35(Suppl 3):iii252. [EMBASE: 633422975]JungHY , SeongSJ , ChoiJY , ChoJH , ParkSH , KimCD , et al. The efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trial. Trials [Electronic Resource]2017;18(1):480. [MEDLINE: 29037222]">Jung 2017</a>; <a href="./references#CD012854-bbs2-0020" title="KleinA , KramerI . Influence of a pharmaceutical care program on liver transplant patients' compliance with immunosuppressive therapy: a prospective, randomized, controlled trial [Pharmazeutische betreuung lebertransplantierter patienten unter besonderer berucksichtigung der compliance mit der immunsuppressiven therapie: Eine prospektive, randomisierte, kontrollierte studie]. Krankenhauspharmazie2007;28(12):458-68. [EMBASE: 350287720]KleinA , OttoG , KramerI . Impact of a pharmaceutical care program on liver transplant patients' compliance with immunosuppressive medication: a prospective, randomized, controlled trial using electronic monitoring. Transplantation2009;87(6):839-47. [MEDLINE: 19300186]">Klein 2007</a>; <a href="./references#CD012854-bbs2-0021" title="LevineD , TorabiJ , ChoinskiK , RoccaJP , GrahamJA . Transplant surgery enters a new era: increasing immunosuppressive medication adherence through mobile apps and smart watches. American Journal of Surgery2019;218(1):18-20. [MEDLINE: 30799019]">Levine 2019</a>; <a href="./references#CD012854-bbs2-0024" title="AndrewsAM , ChengAL , Bartlett EllisRJ , EmersonAM , O'BrienT , RussellCL . SystemCHANGE TM solutions to improve medication adherence in kidney transplant recipients: a secondary data analysis. Nephrology Nursing Journal2021;48(4):389-417. [MEDLINE: 34463466]RussellCL , HathawayD , RemyLM , AholtD , ClarkD , MillerC , et al. Improving medication adherence and outcomes in adult kidney transplant patients using a personal systems approach: SystemCHANGE TM results of the MAGIC randomized clinical trial. American Journal of Transplantation2020;20(1):125-36. [MEDLINE: 31291507]RussellCL , MooreS , HathawayD , ChengAL , ChenG , GogginK . MAGIC Study: aims, design and methods using SystemCHANGE TM to improve immunosuppressive medication adherence in adult kidney transplant recipients. BMC Nephrology2016;17(1):84. [MEDLINE: 27421884]RussellCL . Improving medication adherence and outcomes in adult kidney transplant patients using a personal systems approach: SystemCHANGE.TM results of the MAGIC randomized clinical trial [abstract]. Peritoneal Dialysis International2020;40(1 Suppl):14S. [EMBASE: 632156503]WakefieldWR , AshbaughCM , RemyL , AholtD , MillerC , YeS , et al. Improving medication adherence and outcomes in adult kidney transplant patients using SYSTEMChangeTM: results of the Medication Adherence Given Individual Change (MAGIC) randomized clinical trial [abstract no: 523]. American Journal of Transplantation2019;19(Suppl 3):541-2. [EMBASE: 628454823]">MAGIC 2016</a>; <a href="./references#CD012854-bbs2-0034" title="De GeestS , DenhaerynckK , Schafer-KellerP , BockA , SteigerJ . Supporting medication adherence in renal transplantation--the SMART study. Swiss Medical Weekly2007;137 Suppl 155:125-7S. [MEDLINE: 17874516]De GeestS , Schafer-KellerP , DenhaerynckK , BockA , KoferS , ThannbergerN , et al. Supporting medication adherence in renal transplantation (SMART): a pilot study [abstract no: PO3.09]. Kidney &amp; Blood Pressure Research2004;27(5-6):327. [CENTRAL: CN-00615859] De GeestS , Schafer-KellerP , DenhaerynckK , ThannbergerN , KoferS , BockA , et al. Supporting medication adherence in renal transplantation (SMART): a pilot RCT to improve adherence to immunosuppressive regimens. Clinical Transplantation2006;20(3):359-68. [MEDLINE: 16824155]deGeestS , SchaferP , DenhaerynckK , BockA , SteigerJ . Supporting medication adherence in renal transplantation (SMART): a randomized controlled trial to improve adherence with immunosuppressive regimen [abstract no: PO-590]. Transplant International2005;18(Suppl):na. ">SMART 2006</a>; <a href="./references#CD012854-bbs2-0038" title="BignallO , PaiA , AmaralS , FurthS , BergmanN , GoebelJ , et al. Differences in reported barriers to immunosuppression adherence among a cohort of pediatric renal transplant recipients from the United States and Canada [abstract no: D161]. American Journal of Transplantation2016;16(Suppl 3):751. [EMBASE: 611700425]BoucquemontJ , FosterB , TAKE-IT Investigators. Sex and age differences in medication adherence in adolescent and young adult kidney transplant recipients [abstract no: SA-PO404]. Journal of the American Society of Nephrology2016;27(Abstracts):721A. [CENTRAL: CN-01657535] BoucquemontJ , FosterB . Adherence patterns in adolescent and young adult kidney transplant recipients [abstract no: 229]. American Journal of Transplantation2016;16(Suppl 3):284. [EMBASE: 611700136]BoucquemontJ , PaiAL , DharnidharkaVR , HebertD , FurthSL , FosterBJ . Gender differences in medication adherence among adolescent and young adult kidney transplant recipients. Transplantation2019;103(4):798-806. [MEDLINE: 29994983]BoucquemontJ , PaiAL , DharnidharkaVR , HebertD , ZelikovskyN , AmaralS , et al. Association between day of the week and medication adherence among adolescent and young adult kidney transplant recipients. American Journal of Transplantation2020;20(1):274-81. [MEDLINE: 31507087]FosterB , PaiA , FurthS . The TAKE-IT intervention improves medication adherence in adolescent kidney transplant recipients [abstract no: 359]. American Journal of Transplantation2017;17(Suppl 3):332-3. [EMBASE: 615704529]FosterB , ZhaoH , PaiA , ZelikovskyN , HollyCD , SmithJM , et al. Medication adherence barrier burden predicts subsequent taking adherence in adolescent kidney transplant recipients in the TAKE-IT trial [abstract no: SA-PO1027]. Journal of the American Society of Nephrology2015;26(Abstracts):870A. [CENTRAL: CN-01657534] FosterBJ , PaiA , ZhaoH , FurthS , TAKE-IT Study Group. The TAKE-IT study: aims, design, and methods. BMC Nephrology2014;15:139. [MEDLINE: 25176317]FosterBJ , PaiAL , ZelikovskyN , AmaralS , BellL , DharnidharkaVR , et al. A randomized trial of a multicomponent intervention to promote medication adherence: the teen adherence in kidney transplant effectiveness of intervention trial (TAKE-IT) [Erratum in: Am J Kidney Dis. 2019 Apr;73(4):578]. American Journal of Kidney Diseases2018;72(1):30-41. [MEDLINE: 29602631]FosterBJ , ZhaoH , PaiA , ZelikovskyN , HollyCD , SmithJM , et al. Medication adherence barrier burden predicts subsequent adherence to dosing time schedule in adolescent kidney transplant recipients in the TAKE-IT Trial [abstract no: SA-PO1031]. Journal of the American Society of Nephrology2015;26(Abstracts):871A. [CENTRAL: CN-01657537] LadnerDP , WolfMS . Transplant regimen adherence for kidney recipients by engaging information technologies: the TAKE-IT trial [abstract no: D302]. American Journal of Transplantation2019;19(Suppl 3):1145. [EMBASE: 628453783]">TAKE‐IT 2014</a>), and nine were judged to be unclear (<a href="./references#CD012854-bbs2-0001" title="KuypersDR , BonvoisinCA , PeetersP , SennesaelJJ , KiandaMN , VrijensB , et al. Superior medication adherence to tacrolimus modified release once-daily (QD) compared to tacrolimus twice-daily (BID) in stable renal transplant patients [abstract no: RO-256]. Transplant International2011;24(Suppl 2):199. [EMBASE: 70527785]KuypersDR , PeetersPC , SennesaelJJ , KiandaMN , VrijensB , KristantoP , et al. Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring. Transplantation2013;95(2):333-40. [MEDLINE: 23263559]">ADMIRAD 2013</a>; <a href="./references#CD012854-bbs2-0004" title="ChisholmMA , MulloyL , JagadeesanM , DiPiroJT . Two-year economic evaluation of clinical pharmacy services in renal transplant clinic patients [abstract no: 588]. American Journal of Transplantation2002;2(Suppl 3):286. [CENTRAL: CN-00415424] ChisholmMA , MulloyLL , JagadeesanM , DiPiroJT . Impact of clinical pharmacy services on renal transplant patients' compliance with immunosuppressive medications. Clinical Transplantation2001;15(5):330-6. [MEDLINE: 11678959]">Chisholm 2001</a>; <a href="./references#CD012854-bbs2-0010" title="GarciaMF , BravinAM , GarciaPD , ConttiMM , NgaHS , TakaseHM , et al. Behavioral measures to reduce non-adherence in renal transplant recipients: a prospective randomized controlled trial. International Urology &amp; Nephrology2015;47(11):1899-905. [MEDLINE: 26377496]">Garcia 2015</a>; <a href="./references#CD012854-bbs2-0018" title="KaiserTE , EjazNS , TremblayS , ParrishNJ , BenavidesJ , ReheB , et al. Technology triggered adherence intervention: preliminary findings [abstract no: 185]. American Journal of Transplantation2019;19(Suppl 3):394. [EMBASE: 628454914]">Kaiser 2019</a>; <a href="./references#CD012854-bbs2-0019" title="KantachuvessiriS , InksatidA , SumethkulV , JirasirithamS , ThirapanichW . Adherence to immunosuppression after conversion of twice-daily tacrolimus to once-daily tacrolimus in stable kidney transplant patients in Thailand: a prospective study [abstract no: P.1515]. Transplantation2016;100(7 Suppl 1):S716. [EMBASE: 613004564]">Kantachuvessiri 2016</a>; <a href="./references#CD012854-bbs2-0022" title="LiuJ . Effect of WeChat-based peer education on medication compliance and quality of life in patients with liver transplantation: a pilot study [abstract no: P-576]. Transplantation2019;103(8 Suppl 1):380. [EMBASE: 629265854]">Liu 2019c</a>; <a href="./references#CD012854-bbs2-0025" title="McGillicuddyJW , GregoskiMJ , Brunner-JacksonBM , WeilandAK , PatelSK , RockRA , et al. Facilitating medication adherence and eliminating therapeutic inertia using wireless technology: proof of concept findings with uncontrolled hypertensives and kidney transplant recipients. In: WH '12 Proceedings of the Conference on Wireless Health; 2012 Oct 23-25; San Diego CA. 2012. [CENTRAL: CN-01658221] McGillicuddyJW , GregoskiMJ , WeilandAK , RockRA , Brunner-JacksonBM , PatelSK , et al. Mobile health medication adherence and blood pressure control in renal transplant recipients: a proof-of-concept randomized controlled trial. JMIR Research Protocols2013;2(2):e32. [MEDLINE: 24004517]McGillicuddyJW , TaberDJ , MuellerM , PatelS , BaligaPK , ChavinKD , et al. Sustainability of improvements in medication adherence through a mobile health intervention. Progress in Transplantation2015;25(3):217-23. [MEDLINE: 26308780]McGillicuddyJW . EHealth and transplantation [abstract no: PM-47]. American Journal of Transplantation2014;14(Suppl 2):54-5. [EMBASE: 71388189]">McGillicuddy 2013</a>; <a href="./references#CD012854-bbs2-0028" title="AmaralS , FosterN , DashefskyH , KimJ , FurthS . Peers4path: challenges in measuring medication adherence in adolescent transplant recipients [abstract no: A485]. American Journal of Transplantation2014;14(Suppl 3):238. [EMBASE: 71544246]AmaralS , FosterN , DashefskyH , PaternoC , FurthS . Peers4Path: feasibility of medication adherence measures in adolescent transplant recipients [abstract no: FR-PO403]. Journal of the American Society of Nephrology2014;25(Abstracts):463A. [CENTRAL: CN-01657532] AmaralS , FosterN , YangA , ShultsJ , FurthS . Peers4Path: testing peer support as a mechanism to improve transplant outcomes among adolescents with solid organ transplants [abstract no: TH-PO1083]. Journal of the American Society of Nephrology2013;24(Abstracts):345-6A. [CENTRAL: CN-01657533] AmaralS , RogersR , PaternoC , FosterN , ShultsJ . Peers4path (promoting adolescent transplant health): a pilot study to test peer mentoring as an adherence intervention in adolescent transplant recipients [abstract no: 401.1]. Pediatric Transplantation2017;21(Suppl 1):33. [EMBASE: 616208171]StrachanC , PatonM , ReasonJ , AmaralS . Stakeholder perspectives in peer mentoring program for pediatric solid organ transplant recipients [abstract no: D323]. American Journal of Transplantation2019;19(Suppl 3):1153. [EMBASE: 628454820]">Peers4path 2014</a>; <a href="./references#CD012854-bbs2-0032" title="SantanaMJ , FeenyD , JacksonK , SchafenackerM , WeinkaufJ , LienD . Using patient-centred care to enhance adherence to medication and exercise in lung transplantation: a randomized controlled clinical trial [abstract no: 445]. In: Canadian Society of Transplantation Annual Scientific Meeting; 2011 Mar 2-5; Quebec, Canada. 2011:34. [CENTRAL: CN-01657760] ">Santana 2011</a>) due to insufficient information to permit assessment. </p> </section> </section> <section id="CD012854-sec-0056"> <h3 class="title" id="CD012854-sec-0056">Effects of interventions</h3> <p>See: <a href="./full#CD012854-tbl-0001"><b>Summary of findings 1</b> Interventions for increasing immunosuppressant medication adherence versus standard care in solid organ transplant recipients</a> </p> <section id="CD012854-sec-0057"> <h4 class="title">Initiation of immunosuppressant medication regimen</h4> <p>No studies examined the initiation of the immunosuppressant medication regimen.</p> </section> <section id="CD012854-sec-0058"> <h4 class="title">Implementation of immunosuppressant medication adherence</h4> <p>Thirteen studies reported implementation of immunosuppressant medication adherence (<a href="./references#CD012854-bbs2-0001" title="KuypersDR , BonvoisinCA , PeetersP , SennesaelJJ , KiandaMN , VrijensB , et al. Superior medication adherence to tacrolimus modified release once-daily (QD) compared to tacrolimus twice-daily (BID) in stable renal transplant patients [abstract no: RO-256]. Transplant International2011;24(Suppl 2):199. [EMBASE: 70527785]KuypersDR , PeetersPC , SennesaelJJ , KiandaMN , VrijensB , KristantoP , et al. Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring. Transplantation2013;95(2):333-40. [MEDLINE: 23263559]">ADMIRAD 2013</a>; <a href="./references#CD012854-bbs2-0005" title="Chisholm-BurnsM , SpiveyC , Graff ZivinJ , LeeJ , SredzinskiE . Results of a behavioral contract intervention to improve adherence and healthcare outcomes among renal transplant recipients [abstract no: D1727]. American Journal of Transplantation2013;13(Suppl S5):540. [CENTRAL: CN-01007771] Chisholm-BurnsMA , EricksonS , SpiveyCA . Employment and health-related quality of life among renal transplant recipients [abstract no: 1140]. American Journal of Transplantation2011;11(Suppl 2):365. [EMBASE: 70406190]Chisholm-BurnsMA , SpiveyCA , GraffZJ , LeeJK , SredzinskiE , TolleyEA . Improving outcomes of renal transplant recipients with behavioral adherence contracts: a randomized controlled trial. American Journal of Transplantation2013;13(9):2364-73. [MEDLINE: 23819827]Chisholm-BurnsMA , SpiveyCA , SredzinskiE , ButlerS . Preliminary results of a behavioral contract intervention to improve adherence and quality of life among renal transplant recipients [abstract no: 1139]. American Journal of Transplantation2011;11(Suppl 2):365. [EMBASE: 70406189]Chisholm-BurnsMA , SpiveyCA , SredzinskiE , ButlerSL . Intervention toolbox to promote immunosuppressant therapy adherence in adult renal transplant recipients. Journal of the American Pharmacists Association: JAPhA2012;52(6):816-22. [MEDLINE: 23229970]">Chisholm‐Burns 2013</a>; <a href="./references#CD012854-bbs2-0007" title="CukorD , Ver HalenN , PencilleM , TedlaF , SalifuM . A pilot randomized controlled trial to promote immunosuppressant adherence in adult kidney transplant recipients. Nephron2017;135(1):6-14. [MEDLINE: 28049201]">Cukor 2017</a>; <a href="./references#CD012854-bbs2-0011" title="HardstaffR , GreenK , TalbotD . Measurement of compliance posttransplantation--the results of a 12-month study using electronic monitoring. Transplantation Proceedings2003;35(2):796-7. [MEDLINE: 12644142]HardstaffR , GreenK , TalbotD . Noncompliance postrenal transplantation: measuring the extent of the problem using electronic surveillance and nurse practitioner interviews. Transplantation Proceedings2002;34(5):1608. [MEDLINE: 12176504]">Hardstaff 2002</a>; <a href="./references#CD012854-bbs2-0013" title="HenrikssonJ , TydenG , HoijerJ , WadstromJ . A prospective randomized trial on the effect of using an electronic monitoring drug dispensing device to improve adherence and compliance. Transplantation2016;100(1):203-9. [MEDLINE: 26588006]HenrikssonJ , WadstromJ , HoijerJ , TydenG . A prospective randomized trial on the effect of using an electronic monitoring drug dispensary device to improve adherence and non-compliance [abstract no: BO220]. Transplant International2015;28(Suppl 4):204. [EMBASE: 72111815]">Henriksson 2016</a>; <a href="./references#CD012854-bbs2-0015" title="LowJK , ManiasE , CrawfordK , WalkerR , MulleyWR , ToussaintND , et al. Improving medication adherence in adult kidney transplantation (IMAKT): a pilot randomised controlled trial. Scientific Reports2019;9(1):7734. [MEDLINE: 31118485]">IMAKT 2019</a>; <a href="./references#CD012854-bbs2-0016" title="JoostR , DorjeF , SchwitullaJ , EckardtKU , HugoC . Intensified pharmaceutical care is improving immunosuppressive medication adherence in kidney transplant recipients during the first post-transplant year: a quasi-experimental study. Nephrology Dialysis Transplantation2014;29(8):1597-607. [MEDLINE: 24914089]">Joost 2014</a>; <a href="./references#CD012854-bbs2-0017" title="JungHY , JeonY , SeongSJ , SeoJJ , ChoiJY , ChoJH , et al. ICT-based adherence monitoring in kidney transplant recipients: a randomized controlled trial. BMC Medical Informatics &amp; Decision Making2020;20(1):105. [MEDLINE: 32522263]JungHY , JeonY , SeongSJ , SeoJJ , ChoiJY , ChoJH , et al. Information and communication technology-based centralized monitoring system to increase adherence to immunosuppressive medication in kidney transplant recipients: a randomized controlled trial [abstract no: P1734]. Nephrology Dialysis Transplantation2020;35(Suppl 3):iii252. [EMBASE: 633422975]JungHY , SeongSJ , ChoiJY , ChoJH , ParkSH , KimCD , et al. The efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trial. Trials [Electronic Resource]2017;18(1):480. [MEDLINE: 29037222]">Jung 2017</a>; <a href="./references#CD012854-bbs2-0020" title="KleinA , KramerI . Influence of a pharmaceutical care program on liver transplant patients' compliance with immunosuppressive therapy: a prospective, randomized, controlled trial [Pharmazeutische betreuung lebertransplantierter patienten unter besonderer berucksichtigung der compliance mit der immunsuppressiven therapie: Eine prospektive, randomisierte, kontrollierte studie]. Krankenhauspharmazie2007;28(12):458-68. [EMBASE: 350287720]KleinA , OttoG , KramerI . Impact of a pharmaceutical care program on liver transplant patients' compliance with immunosuppressive medication: a prospective, randomized, controlled trial using electronic monitoring. Transplantation2009;87(6):839-47. [MEDLINE: 19300186]">Klein 2007</a>; <a href="./references#CD012854-bbs2-0023" title="DobbelsF , De BleserL , BerbenL , KristantoP , DupontL , NevensF , et al. Efficacy of a medication adherence enhancing intervention in transplantation: the MAESTRO-Tx trial. Journal of Heart &amp; Lung Transplantation2017;36(5):499-508. [MEDLINE: 28162931]DobbelsF , De BleserL , BerbenL , KristantoP , DupontL , NevensF , et al. Testing the efficacy of a multicomponent theory-based tailored behavioral medication adherence intervention in transplantation: The MAESTRO-TX RCT [abstract no: 223]. Journal of Heart &amp; Lung Transplantation2016;35(4 Suppl):S90. [EMBASE: 72253342]DobbelsF , De BleserL , KristantoP , NevensF , VanhaeckeJ , VerledenG , et al. Electronic monitoring feedback and motivational interviewing improves medication adherence in heart, liver and lung transplant patients: results from the MAESTRO-TX RCT [abstract no: BO218]. Transplant International2015;28(Suppl 4):203. [EMBASE: 72111813]">MAESTRO‐Tx 2017</a>; <a href="./references#CD012854-bbs2-0027" title="PatersonTS , DemianM , ShapiroRJ , Loken ThorntonW . Impact of once- versus twice-daily tacrolimus dosing on medication adherence in stable renal transplant recipients: a Canadian single-center randomized controlled trial. Canadian Journal of Kidney Health &amp; Disease2019;6:2054358119867993. [MEDLINE: 31452902]ShapiroRJ , PatersonT , ThorntonW , HusseiniT , PartoviN , VishloffJ , et al. Medication adherence is tied to social support in renal transplant recipients [abstract no: 2501]. In: Canadian Society of Transplantation Annual Scientific Meeting; 2013 Mar 13-16; Alberta, Canada. 2013:38. ">Paterson 2019</a>; <a href="./references#CD012854-bbs2-0029" title="HanA , ChoMJ , ChoS , LeeCH , ChoiC , KimSY , et al. Use of mobile internet application to improve adherence to immunosuppressive medication adherence in kidney transplant recipients: preliminary results of the PRIMA (ImProving Adherence to Immunosuppressive Therapy by Mobile Internet application) study [abstract no: 420.4]. Transplantation2016;100(7 Suppl):S161. [EMBASE: 613004382]HanA , MinSI , AhnS , MinSK , HongHJ , HanN , et al. Mobile medication manager application to improve adherence with immunosuppressive therapy in renal transplant recipients: a randomized controlled trial. PLoS ONE [Electronic Resource]2019;14(11):e0224595. [MEDLINE: 31689320]KoH , KimHK , ChungC , HanA , MinSK , HaJ , et al. Association between medication adherence and intrapatient variability in tacrolimus concentration among stable kidney transplant recipients. Scientific Reports2021;11(1):5397. [MEDLINE: 33686160]">PRIMA 2019</a>; <a href="./references#CD012854-bbs2-0030" title="ReeseP , BloomR , Trofe-ClarkJ , MussellA , LeidyD , LevskyS , et al. Customized reminders and provider notification to improve adherence to immunosuppression [abstract no: 1074]. American Journal of Transplantation2015;15(Suppl 3). [EMBASE: 71953144]ReesePP , BloomRD , Trofe-ClarkJ , MussellA , LeidyD , LevskyS , et al. Automated reminders and physician notification to promote immunosuppression adherence among kidney transplant recipients: a randomized trial. American Journal of Kidney Diseases2017;69(3):400-9. [MEDLINE: 27940063]">Reese 2017</a>). The findings for the sub‐categories of implementation are reported below. </p> <section id="CD012854-sec-0059"> <h5 class="title">Primary outcomes</h5> <section id="CD012854-sec-0060"> <h6 class="title">Taking adherence</h6> <p>Nine studies included taking immunosuppressant medication adherence. Four studies reported the proportion of participants classified as adherent and were included in the meta‐analysis (<a href="./references#CD012854-bbs2-0001" title="KuypersDR , BonvoisinCA , PeetersP , SennesaelJJ , KiandaMN , VrijensB , et al. Superior medication adherence to tacrolimus modified release once-daily (QD) compared to tacrolimus twice-daily (BID) in stable renal transplant patients [abstract no: RO-256]. Transplant International2011;24(Suppl 2):199. [EMBASE: 70527785]KuypersDR , PeetersPC , SennesaelJJ , KiandaMN , VrijensB , KristantoP , et al. Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring. Transplantation2013;95(2):333-40. [MEDLINE: 23263559]">ADMIRAD 2013</a>; <a href="./references#CD012854-bbs2-0016" title="JoostR , DorjeF , SchwitullaJ , EckardtKU , HugoC . Intensified pharmaceutical care is improving immunosuppressive medication adherence in kidney transplant recipients during the first post-transplant year: a quasi-experimental study. Nephrology Dialysis Transplantation2014;29(8):1597-607. [MEDLINE: 24914089]">Joost 2014</a>; <a href="./references#CD012854-bbs2-0020" title="KleinA , KramerI . Influence of a pharmaceutical care program on liver transplant patients' compliance with immunosuppressive therapy: a prospective, randomized, controlled trial [Pharmazeutische betreuung lebertransplantierter patienten unter besonderer berucksichtigung der compliance mit der immunsuppressiven therapie: Eine prospektive, randomisierte, kontrollierte studie]. Krankenhauspharmazie2007;28(12):458-68. [EMBASE: 350287720]KleinA , OttoG , KramerI . Impact of a pharmaceutical care program on liver transplant patients' compliance with immunosuppressive medication: a prospective, randomized, controlled trial using electronic monitoring. Transplantation2009;87(6):839-47. [MEDLINE: 19300186]">Klein 2007</a>; <a href="./references#CD012854-bbs2-0029" title="HanA , ChoMJ , ChoS , LeeCH , ChoiC , KimSY , et al. Use of mobile internet application to improve adherence to immunosuppressive medication adherence in kidney transplant recipients: preliminary results of the PRIMA (ImProving Adherence to Immunosuppressive Therapy by Mobile Internet application) study [abstract no: 420.4]. Transplantation2016;100(7 Suppl):S161. [EMBASE: 613004382]HanA , MinSI , AhnS , MinSK , HongHJ , HanN , et al. Mobile medication manager application to improve adherence with immunosuppressive therapy in renal transplant recipients: a randomized controlled trial. PLoS ONE [Electronic Resource]2019;14(11):e0224595. [MEDLINE: 31689320]KoH , KimHK , ChungC , HanA , MinSK , HaJ , et al. Association between medication adherence and intrapatient variability in tacrolimus concentration among stable kidney transplant recipients. Scientific Reports2021;11(1):5397. [MEDLINE: 33686160]">PRIMA 2019</a>). There is uncertain evidence of an association between immunosuppressant medication adherence interventions and the proportion of participants classified as adherent to taking immunosuppressant medication (<a href="./references#CD012854-fig-0004" title="">Analysis 1.1</a> (4 studies, 445 participants): RR 1.09, 95% CI 0.95 to 1.20; I² = 78%). There was very marked heterogeneity in treatment effects between the four studies evaluating taking adherence, which may have been due to the different types of interventions used. <a href="./references#CD012854-bbs2-0011" title="HardstaffR , GreenK , TalbotD . Measurement of compliance posttransplantation--the results of a 12-month study using electronic monitoring. Transplantation Proceedings2003;35(2):796-7. [MEDLINE: 12644142]HardstaffR , GreenK , TalbotD . Noncompliance postrenal transplantation: measuring the extent of the problem using electronic surveillance and nurse practitioner interviews. Transplantation Proceedings2002;34(5):1608. [MEDLINE: 12176504]">Hardstaff 2002</a> reported findings from the intervention group only and reported that 83% missed at least one dose in the 12‐month study period. <a href="./references#CD012854-bbs2-0013" title="HenrikssonJ , TydenG , HoijerJ , WadstromJ . A prospective randomized trial on the effect of using an electronic monitoring drug dispensing device to improve adherence and compliance. Transplantation2016;100(1):203-9. [MEDLINE: 26588006]HenrikssonJ , WadstromJ , HoijerJ , TydenG . A prospective randomized trial on the effect of using an electronic monitoring drug dispensary device to improve adherence and non-compliance [abstract no: BO220]. Transplant International2015;28(Suppl 4):204. [EMBASE: 72111815]">Henriksson 2016</a> reported findings from the intervention group only and reported that 97.8% took immunosuppressant medication during the study period. </p> <p><a href="./references#CD012854-bbs2-0038" title="BignallO , PaiA , AmaralS , FurthS , BergmanN , GoebelJ , et al. Differences in reported barriers to immunosuppression adherence among a cohort of pediatric renal transplant recipients from the United States and Canada [abstract no: D161]. American Journal of Transplantation2016;16(Suppl 3):751. [EMBASE: 611700425]BoucquemontJ , FosterB , TAKE-IT Investigators. Sex and age differences in medication adherence in adolescent and young adult kidney transplant recipients [abstract no: SA-PO404]. Journal of the American Society of Nephrology2016;27(Abstracts):721A. [CENTRAL: CN-01657535] BoucquemontJ , FosterB . Adherence patterns in adolescent and young adult kidney transplant recipients [abstract no: 229]. American Journal of Transplantation2016;16(Suppl 3):284. [EMBASE: 611700136]BoucquemontJ , PaiAL , DharnidharkaVR , HebertD , FurthSL , FosterBJ . Gender differences in medication adherence among adolescent and young adult kidney transplant recipients. Transplantation2019;103(4):798-806. [MEDLINE: 29994983]BoucquemontJ , PaiAL , DharnidharkaVR , HebertD , ZelikovskyN , AmaralS , et al. Association between day of the week and medication adherence among adolescent and young adult kidney transplant recipients. American Journal of Transplantation2020;20(1):274-81. [MEDLINE: 31507087]FosterB , PaiA , FurthS . The TAKE-IT intervention improves medication adherence in adolescent kidney transplant recipients [abstract no: 359]. American Journal of Transplantation2017;17(Suppl 3):332-3. [EMBASE: 615704529]FosterB , ZhaoH , PaiA , ZelikovskyN , HollyCD , SmithJM , et al. Medication adherence barrier burden predicts subsequent taking adherence in adolescent kidney transplant recipients in the TAKE-IT trial [abstract no: SA-PO1027]. Journal of the American Society of Nephrology2015;26(Abstracts):870A. [CENTRAL: CN-01657534] FosterBJ , PaiA , ZhaoH , FurthS , TAKE-IT Study Group. The TAKE-IT study: aims, design, and methods. BMC Nephrology2014;15:139. [MEDLINE: 25176317]FosterBJ , PaiAL , ZelikovskyN , AmaralS , BellL , DharnidharkaVR , et al. A randomized trial of a multicomponent intervention to promote medication adherence: the teen adherence in kidney transplant effectiveness of intervention trial (TAKE-IT) [Erratum in: Am J Kidney Dis. 2019 Apr;73(4):578]. American Journal of Kidney Diseases2018;72(1):30-41. [MEDLINE: 29602631]FosterBJ , ZhaoH , PaiA , ZelikovskyN , HollyCD , SmithJM , et al. Medication adherence barrier burden predicts subsequent adherence to dosing time schedule in adolescent kidney transplant recipients in the TAKE-IT Trial [abstract no: SA-PO1031]. Journal of the American Society of Nephrology2015;26(Abstracts):871A. [CENTRAL: CN-01657537] LadnerDP , WolfMS . Transplant regimen adherence for kidney recipients by engaging information technologies: the TAKE-IT trial [abstract no: D302]. American Journal of Transplantation2019;19(Suppl 3):1145. [EMBASE: 628453783]">TAKE‐IT 2014</a> measured taking adherence for paediatric participants and reported 100% taking adherence on 78% of days for the intervention group versus 100% taking adherence on 68% of days for the control group (OR = 1.66; 95% CI 1.15 to 2.39; P = 0.006). <a href="./references#CD012854-bbs2-0015" title="LowJK , ManiasE , CrawfordK , WalkerR , MulleyWR , ToussaintND , et al. Improving medication adherence in adult kidney transplantation (IMAKT): a pilot randomised controlled trial. Scientific Reports2019;9(1):7734. [MEDLINE: 31118485]">IMAKT 2019</a> reported no difference in median taking adherence over 12 months, with high adherence in both groups (89.5% (47.7, 98.5) versus 92.6% (59.5, 96.1)). <a href="./references#CD012854-bbs2-0017" title="JungHY , JeonY , SeongSJ , SeoJJ , ChoiJY , ChoJH , et al. ICT-based adherence monitoring in kidney transplant recipients: a randomized controlled trial. BMC Medical Informatics &amp; Decision Making2020;20(1):105. [MEDLINE: 32522263]JungHY , JeonY , SeongSJ , SeoJJ , ChoiJY , ChoJH , et al. Information and communication technology-based centralized monitoring system to increase adherence to immunosuppressive medication in kidney transplant recipients: a randomized controlled trial [abstract no: P1734]. Nephrology Dialysis Transplantation2020;35(Suppl 3):iii252. [EMBASE: 633422975]JungHY , SeongSJ , ChoiJY , ChoJH , ParkSH , KimCD , et al. The efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trial. Trials [Electronic Resource]2017;18(1):480. [MEDLINE: 29037222]">Jung 2017</a> reported that taking adherence did not differ between intervention and control groups. </p> </section> <section id="CD012854-sec-0061"> <h6 class="title">Dosing adherence</h6> <p>Ten studies included dosing immunosuppressant medication adherence. Eight studies reported the proportion of participants classified as adherent to correct dosing and were included in the meta‐analysis (<a href="./references#CD012854-bbs2-0005" title="Chisholm-BurnsM , SpiveyC , Graff ZivinJ , LeeJ , SredzinskiE . Results of a behavioral contract intervention to improve adherence and healthcare outcomes among renal transplant recipients [abstract no: D1727]. American Journal of Transplantation2013;13(Suppl S5):540. [CENTRAL: CN-01007771] Chisholm-BurnsMA , EricksonS , SpiveyCA . Employment and health-related quality of life among renal transplant recipients [abstract no: 1140]. American Journal of Transplantation2011;11(Suppl 2):365. [EMBASE: 70406190]Chisholm-BurnsMA , SpiveyCA , GraffZJ , LeeJK , SredzinskiE , TolleyEA . Improving outcomes of renal transplant recipients with behavioral adherence contracts: a randomized controlled trial. American Journal of Transplantation2013;13(9):2364-73. [MEDLINE: 23819827]Chisholm-BurnsMA , SpiveyCA , SredzinskiE , ButlerS . Preliminary results of a behavioral contract intervention to improve adherence and quality of life among renal transplant recipients [abstract no: 1139]. American Journal of Transplantation2011;11(Suppl 2):365. [EMBASE: 70406189]Chisholm-BurnsMA , SpiveyCA , SredzinskiE , ButlerSL . Intervention toolbox to promote immunosuppressant therapy adherence in adult renal transplant recipients. Journal of the American Pharmacists Association: JAPhA2012;52(6):816-22. [MEDLINE: 23229970]">Chisholm‐Burns 2013</a>; <a href="./references#CD012854-bbs2-0007" title="CukorD , Ver HalenN , PencilleM , TedlaF , SalifuM . A pilot randomized controlled trial to promote immunosuppressant adherence in adult kidney transplant recipients. Nephron2017;135(1):6-14. [MEDLINE: 28049201]">Cukor 2017</a>; <a href="./references#CD012854-bbs2-0016" title="JoostR , DorjeF , SchwitullaJ , EckardtKU , HugoC . Intensified pharmaceutical care is improving immunosuppressive medication adherence in kidney transplant recipients during the first post-transplant year: a quasi-experimental study. Nephrology Dialysis Transplantation2014;29(8):1597-607. [MEDLINE: 24914089]">Joost 2014</a>; <a href="./references#CD012854-bbs2-0020" title="KleinA , KramerI . Influence of a pharmaceutical care program on liver transplant patients' compliance with immunosuppressive therapy: a prospective, randomized, controlled trial [Pharmazeutische betreuung lebertransplantierter patienten unter besonderer berucksichtigung der compliance mit der immunsuppressiven therapie: Eine prospektive, randomisierte, kontrollierte studie]. Krankenhauspharmazie2007;28(12):458-68. [EMBASE: 350287720]KleinA , OttoG , KramerI . Impact of a pharmaceutical care program on liver transplant patients' compliance with immunosuppressive medication: a prospective, randomized, controlled trial using electronic monitoring. Transplantation2009;87(6):839-47. [MEDLINE: 19300186]">Klein 2007</a>; <a href="./references#CD012854-bbs2-0023" title="DobbelsF , De BleserL , BerbenL , KristantoP , DupontL , NevensF , et al. Efficacy of a medication adherence enhancing intervention in transplantation: the MAESTRO-Tx trial. Journal of Heart &amp; Lung Transplantation2017;36(5):499-508. [MEDLINE: 28162931]DobbelsF , De BleserL , BerbenL , KristantoP , DupontL , NevensF , et al. Testing the efficacy of a multicomponent theory-based tailored behavioral medication adherence intervention in transplantation: The MAESTRO-TX RCT [abstract no: 223]. Journal of Heart &amp; Lung Transplantation2016;35(4 Suppl):S90. [EMBASE: 72253342]DobbelsF , De BleserL , KristantoP , NevensF , VanhaeckeJ , VerledenG , et al. Electronic monitoring feedback and motivational interviewing improves medication adherence in heart, liver and lung transplant patients: results from the MAESTRO-TX RCT [abstract no: BO218]. Transplant International2015;28(Suppl 4):203. [EMBASE: 72111813]">MAESTRO‐Tx 2017</a>; <a href="./references#CD012854-bbs2-0027" title="PatersonTS , DemianM , ShapiroRJ , Loken ThorntonW . Impact of once- versus twice-daily tacrolimus dosing on medication adherence in stable renal transplant recipients: a Canadian single-center randomized controlled trial. Canadian Journal of Kidney Health &amp; Disease2019;6:2054358119867993. [MEDLINE: 31452902]ShapiroRJ , PatersonT , ThorntonW , HusseiniT , PartoviN , VishloffJ , et al. Medication adherence is tied to social support in renal transplant recipients [abstract no: 2501]. In: Canadian Society of Transplantation Annual Scientific Meeting; 2013 Mar 13-16; Alberta, Canada. 2013:38. ">Paterson 2019</a>; <a href="./references#CD012854-bbs2-0029" title="HanA , ChoMJ , ChoS , LeeCH , ChoiC , KimSY , et al. Use of mobile internet application to improve adherence to immunosuppressive medication adherence in kidney transplant recipients: preliminary results of the PRIMA (ImProving Adherence to Immunosuppressive Therapy by Mobile Internet application) study [abstract no: 420.4]. Transplantation2016;100(7 Suppl):S161. [EMBASE: 613004382]HanA , MinSI , AhnS , MinSK , HongHJ , HanN , et al. Mobile medication manager application to improve adherence with immunosuppressive therapy in renal transplant recipients: a randomized controlled trial. PLoS ONE [Electronic Resource]2019;14(11):e0224595. [MEDLINE: 31689320]KoH , KimHK , ChungC , HanA , MinSK , HaJ , et al. Association between medication adherence and intrapatient variability in tacrolimus concentration among stable kidney transplant recipients. Scientific Reports2021;11(1):5397. [MEDLINE: 33686160]">PRIMA 2019</a>; <a href="./references#CD012854-bbs2-0030" title="ReeseP , BloomR , Trofe-ClarkJ , MussellA , LeidyD , LevskyS , et al. Customized reminders and provider notification to improve adherence to immunosuppression [abstract no: 1074]. American Journal of Transplantation2015;15(Suppl 3). [EMBASE: 71953144]ReesePP , BloomRD , Trofe-ClarkJ , MussellA , LeidyD , LevskyS , et al. Automated reminders and physician notification to promote immunosuppression adherence among kidney transplant recipients: a randomized trial. American Journal of Kidney Diseases2017;69(3):400-9. [MEDLINE: 27940063]">Reese 2017</a>). <a href="./references#CD012854-bbs2-0030" title="ReeseP , BloomR , Trofe-ClarkJ , MussellA , LeidyD , LevskyS , et al. Customized reminders and provider notification to improve adherence to immunosuppression [abstract no: 1074]. American Journal of Transplantation2015;15(Suppl 3). [EMBASE: 71953144]ReesePP , BloomRD , Trofe-ClarkJ , MussellA , LeidyD , LevskyS , et al. Automated reminders and physician notification to promote immunosuppression adherence among kidney transplant recipients: a randomized trial. American Journal of Kidney Diseases2017;69(3):400-9. [MEDLINE: 27940063]">Reese 2017</a> was a three‐arm study, and data for arm one versus control and arm two versus control were included separately. There was low certainty evidence of an association between immunosuppressant medication adherence interventions and the proportion of participants classified as adherent to correct dosing of immunosuppressant medication (<a href="./references#CD012854-fig-0005" title="">Analysis 1.2</a> (8 studies, 713 participants): RR 1.14, 95% CI 1.03 to 1.26; I² = 61%), although there was very marked heterogeneity in treatment effects between the eight studies evaluating taking adherence, which may have been due to the different types of interventions included. <a href="./references#CD012854-bbs2-0011" title="HardstaffR , GreenK , TalbotD . Measurement of compliance posttransplantation--the results of a 12-month study using electronic monitoring. Transplantation Proceedings2003;35(2):796-7. [MEDLINE: 12644142]HardstaffR , GreenK , TalbotD . Noncompliance postrenal transplantation: measuring the extent of the problem using electronic surveillance and nurse practitioner interviews. Transplantation Proceedings2002;34(5):1608. [MEDLINE: 12176504]">Hardstaff 2002</a> reported findings from the intervention group only and reported that 3% took the correct dose of immunosuppressant medication 100% of the time. <a href="./references#CD012854-bbs2-0017" title="JungHY , JeonY , SeongSJ , SeoJJ , ChoiJY , ChoJH , et al. ICT-based adherence monitoring in kidney transplant recipients: a randomized controlled trial. BMC Medical Informatics &amp; Decision Making2020;20(1):105. [MEDLINE: 32522263]JungHY , JeonY , SeongSJ , SeoJJ , ChoiJY , ChoJH , et al. Information and communication technology-based centralized monitoring system to increase adherence to immunosuppressive medication in kidney transplant recipients: a randomized controlled trial [abstract no: P1734]. Nephrology Dialysis Transplantation2020;35(Suppl 3):iii252. [EMBASE: 633422975]JungHY , SeongSJ , ChoiJY , ChoJH , ParkSH , KimCD , et al. The efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trial. Trials [Electronic Resource]2017;18(1):480. [MEDLINE: 29037222]">Jung 2017</a> reported that dosing adherence did not differ between intervention and control groups. </p> </section> <section id="CD012854-sec-0062"> <h6 class="title">Timing adherence</h6> <p>Ten studies included the timing of immunosuppressant medication adherence, and six were included in the meta‐analysis (<a href="./references#CD012854-bbs2-0001" title="KuypersDR , BonvoisinCA , PeetersP , SennesaelJJ , KiandaMN , VrijensB , et al. Superior medication adherence to tacrolimus modified release once-daily (QD) compared to tacrolimus twice-daily (BID) in stable renal transplant patients [abstract no: RO-256]. Transplant International2011;24(Suppl 2):199. [EMBASE: 70527785]KuypersDR , PeetersPC , SennesaelJJ , KiandaMN , VrijensB , KristantoP , et al. Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring. Transplantation2013;95(2):333-40. [MEDLINE: 23263559]">ADMIRAD 2013</a>; <a href="./references#CD012854-bbs2-0016" title="JoostR , DorjeF , SchwitullaJ , EckardtKU , HugoC . Intensified pharmaceutical care is improving immunosuppressive medication adherence in kidney transplant recipients during the first post-transplant year: a quasi-experimental study. Nephrology Dialysis Transplantation2014;29(8):1597-607. [MEDLINE: 24914089]">Joost 2014</a>; <a href="./references#CD012854-bbs2-0020" title="KleinA , KramerI . Influence of a pharmaceutical care program on liver transplant patients' compliance with immunosuppressive therapy: a prospective, randomized, controlled trial [Pharmazeutische betreuung lebertransplantierter patienten unter besonderer berucksichtigung der compliance mit der immunsuppressiven therapie: Eine prospektive, randomisierte, kontrollierte studie]. Krankenhauspharmazie2007;28(12):458-68. [EMBASE: 350287720]KleinA , OttoG , KramerI . Impact of a pharmaceutical care program on liver transplant patients' compliance with immunosuppressive medication: a prospective, randomized, controlled trial using electronic monitoring. Transplantation2009;87(6):839-47. [MEDLINE: 19300186]">Klein 2007</a>; <a href="./references#CD012854-bbs2-0023" title="DobbelsF , De BleserL , BerbenL , KristantoP , DupontL , NevensF , et al. Efficacy of a medication adherence enhancing intervention in transplantation: the MAESTRO-Tx trial. Journal of Heart &amp; Lung Transplantation2017;36(5):499-508. [MEDLINE: 28162931]DobbelsF , De BleserL , BerbenL , KristantoP , DupontL , NevensF , et al. Testing the efficacy of a multicomponent theory-based tailored behavioral medication adherence intervention in transplantation: The MAESTRO-TX RCT [abstract no: 223]. Journal of Heart &amp; Lung Transplantation2016;35(4 Suppl):S90. [EMBASE: 72253342]DobbelsF , De BleserL , KristantoP , NevensF , VanhaeckeJ , VerledenG , et al. Electronic monitoring feedback and motivational interviewing improves medication adherence in heart, liver and lung transplant patients: results from the MAESTRO-TX RCT [abstract no: BO218]. Transplant International2015;28(Suppl 4):203. [EMBASE: 72111813]">MAESTRO‐Tx 2017</a>; <a href="./references#CD012854-bbs2-0027" title="PatersonTS , DemianM , ShapiroRJ , Loken ThorntonW . Impact of once- versus twice-daily tacrolimus dosing on medication adherence in stable renal transplant recipients: a Canadian single-center randomized controlled trial. Canadian Journal of Kidney Health &amp; Disease2019;6:2054358119867993. [MEDLINE: 31452902]ShapiroRJ , PatersonT , ThorntonW , HusseiniT , PartoviN , VishloffJ , et al. Medication adherence is tied to social support in renal transplant recipients [abstract no: 2501]. In: Canadian Society of Transplantation Annual Scientific Meeting; 2013 Mar 13-16; Alberta, Canada. 2013:38. ">Paterson 2019</a>; <a href="./references#CD012854-bbs2-0029" title="HanA , ChoMJ , ChoS , LeeCH , ChoiC , KimSY , et al. Use of mobile internet application to improve adherence to immunosuppressive medication adherence in kidney transplant recipients: preliminary results of the PRIMA (ImProving Adherence to Immunosuppressive Therapy by Mobile Internet application) study [abstract no: 420.4]. Transplantation2016;100(7 Suppl):S161. [EMBASE: 613004382]HanA , MinSI , AhnS , MinSK , HongHJ , HanN , et al. Mobile medication manager application to improve adherence with immunosuppressive therapy in renal transplant recipients: a randomized controlled trial. PLoS ONE [Electronic Resource]2019;14(11):e0224595. [MEDLINE: 31689320]KoH , KimHK , ChungC , HanA , MinSK , HaJ , et al. Association between medication adherence and intrapatient variability in tacrolimus concentration among stable kidney transplant recipients. Scientific Reports2021;11(1):5397. [MEDLINE: 33686160]">PRIMA 2019</a>). It is uncertain whether an intervention to increase adherence to immunosuppressant medication reduces the proportion of participants classified as adherent to the correct timing of immunosuppressant medication (<a href="./references#CD012854-fig-0006" title="">Analysis 1.3</a> (6 studies, 632 participants): RR 1.10, 95% CI 0.98 to 1.23; I² = 63%; low certainty evidence). <a href="./references#CD012854-bbs2-0013" title="HenrikssonJ , TydenG , HoijerJ , WadstromJ . A prospective randomized trial on the effect of using an electronic monitoring drug dispensing device to improve adherence and compliance. Transplantation2016;100(1):203-9. [MEDLINE: 26588006]HenrikssonJ , WadstromJ , HoijerJ , TydenG . A prospective randomized trial on the effect of using an electronic monitoring drug dispensary device to improve adherence and non-compliance [abstract no: BO220]. Transplant International2015;28(Suppl 4):204. [EMBASE: 72111815]">Henriksson 2016</a> reported findings from the intervention group only and reported that 15% of the intervention group took their medication at the right time during the full intervention. </p> <p><a href="./references#CD012854-bbs2-0038" title="BignallO , PaiA , AmaralS , FurthS , BergmanN , GoebelJ , et al. Differences in reported barriers to immunosuppression adherence among a cohort of pediatric renal transplant recipients from the United States and Canada [abstract no: D161]. American Journal of Transplantation2016;16(Suppl 3):751. [EMBASE: 611700425]BoucquemontJ , FosterB , TAKE-IT Investigators. Sex and age differences in medication adherence in adolescent and young adult kidney transplant recipients [abstract no: SA-PO404]. Journal of the American Society of Nephrology2016;27(Abstracts):721A. [CENTRAL: CN-01657535] BoucquemontJ , FosterB . Adherence patterns in adolescent and young adult kidney transplant recipients [abstract no: 229]. American Journal of Transplantation2016;16(Suppl 3):284. [EMBASE: 611700136]BoucquemontJ , PaiAL , DharnidharkaVR , HebertD , FurthSL , FosterBJ . Gender differences in medication adherence among adolescent and young adult kidney transplant recipients. Transplantation2019;103(4):798-806. [MEDLINE: 29994983]BoucquemontJ , PaiAL , DharnidharkaVR , HebertD , ZelikovskyN , AmaralS , et al. Association between day of the week and medication adherence among adolescent and young adult kidney transplant recipients. American Journal of Transplantation2020;20(1):274-81. [MEDLINE: 31507087]FosterB , PaiA , FurthS . The TAKE-IT intervention improves medication adherence in adolescent kidney transplant recipients [abstract no: 359]. American Journal of Transplantation2017;17(Suppl 3):332-3. [EMBASE: 615704529]FosterB , ZhaoH , PaiA , ZelikovskyN , HollyCD , SmithJM , et al. Medication adherence barrier burden predicts subsequent taking adherence in adolescent kidney transplant recipients in the TAKE-IT trial [abstract no: SA-PO1027]. Journal of the American Society of Nephrology2015;26(Abstracts):870A. [CENTRAL: CN-01657534] FosterBJ , PaiA , ZhaoH , FurthS , TAKE-IT Study Group. The TAKE-IT study: aims, design, and methods. BMC Nephrology2014;15:139. [MEDLINE: 25176317]FosterBJ , PaiAL , ZelikovskyN , AmaralS , BellL , DharnidharkaVR , et al. A randomized trial of a multicomponent intervention to promote medication adherence: the teen adherence in kidney transplant effectiveness of intervention trial (TAKE-IT) [Erratum in: Am J Kidney Dis. 2019 Apr;73(4):578]. American Journal of Kidney Diseases2018;72(1):30-41. [MEDLINE: 29602631]FosterBJ , ZhaoH , PaiA , ZelikovskyN , HollyCD , SmithJM , et al. Medication adherence barrier burden predicts subsequent adherence to dosing time schedule in adolescent kidney transplant recipients in the TAKE-IT Trial [abstract no: SA-PO1031]. Journal of the American Society of Nephrology2015;26(Abstracts):871A. [CENTRAL: CN-01657537] LadnerDP , WolfMS . Transplant regimen adherence for kidney recipients by engaging information technologies: the TAKE-IT trial [abstract no: D302]. American Journal of Transplantation2019;19(Suppl 3):1145. [EMBASE: 628453783]">TAKE‐IT 2014</a> measured timing adherence for paediatric participants and reported 100% timing adherence on 73% of days for the intervention group versus 100% timing adherence on 61% of days for the control group (OR = 1.74; 95% CI 1.21 to 2.5; P = 0.003). <a href="./references#CD012854-bbs2-0015" title="LowJK , ManiasE , CrawfordK , WalkerR , MulleyWR , ToussaintND , et al. Improving medication adherence in adult kidney transplantation (IMAKT): a pilot randomised controlled trial. Scientific Reports2019;9(1):7734. [MEDLINE: 31118485]">IMAKT 2019</a> reported no difference in median timing adherence over 12 months, with high adherence in both groups (89.5% (46.7 to 97) versus 87.6% (53.7 to 94.1)). <a href="./references#CD012854-bbs2-0017" title="JungHY , JeonY , SeongSJ , SeoJJ , ChoiJY , ChoJH , et al. ICT-based adherence monitoring in kidney transplant recipients: a randomized controlled trial. BMC Medical Informatics &amp; Decision Making2020;20(1):105. [MEDLINE: 32522263]JungHY , JeonY , SeongSJ , SeoJJ , ChoiJY , ChoJH , et al. Information and communication technology-based centralized monitoring system to increase adherence to immunosuppressive medication in kidney transplant recipients: a randomized controlled trial [abstract no: P1734]. Nephrology Dialysis Transplantation2020;35(Suppl 3):iii252. [EMBASE: 633422975]JungHY , SeongSJ , ChoiJY , ChoJH , ParkSH , KimCD , et al. The efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trial. Trials [Electronic Resource]2017;18(1):480. [MEDLINE: 29037222]">Jung 2017</a> reported that timing adherence did not differ between intervention and control groups. </p> </section> <section id="CD012854-sec-0063"> <h6 class="title">Drug holidays</h6> <p>Five studies included drug holidays from immunosuppressant medication adherence, and four were included in the meta‐analysis (<a href="./references#CD012854-bbs2-0001" title="KuypersDR , BonvoisinCA , PeetersP , SennesaelJJ , KiandaMN , VrijensB , et al. Superior medication adherence to tacrolimus modified release once-daily (QD) compared to tacrolimus twice-daily (BID) in stable renal transplant patients [abstract no: RO-256]. Transplant International2011;24(Suppl 2):199. [EMBASE: 70527785]KuypersDR , PeetersPC , SennesaelJJ , KiandaMN , VrijensB , KristantoP , et al. Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring. Transplantation2013;95(2):333-40. [MEDLINE: 23263559]">ADMIRAD 2013</a>; <a href="./references#CD012854-bbs2-0016" title="JoostR , DorjeF , SchwitullaJ , EckardtKU , HugoC . Intensified pharmaceutical care is improving immunosuppressive medication adherence in kidney transplant recipients during the first post-transplant year: a quasi-experimental study. Nephrology Dialysis Transplantation2014;29(8):1597-607. [MEDLINE: 24914089]">Joost 2014</a>; <a href="./references#CD012854-bbs2-0020" title="KleinA , KramerI . Influence of a pharmaceutical care program on liver transplant patients' compliance with immunosuppressive therapy: a prospective, randomized, controlled trial [Pharmazeutische betreuung lebertransplantierter patienten unter besonderer berucksichtigung der compliance mit der immunsuppressiven therapie: Eine prospektive, randomisierte, kontrollierte studie]. Krankenhauspharmazie2007;28(12):458-68. [EMBASE: 350287720]KleinA , OttoG , KramerI . Impact of a pharmaceutical care program on liver transplant patients' compliance with immunosuppressive medication: a prospective, randomized, controlled trial using electronic monitoring. Transplantation2009;87(6):839-47. [MEDLINE: 19300186]">Klein 2007</a>; <a href="./references#CD012854-bbs2-0029" title="HanA , ChoMJ , ChoS , LeeCH , ChoiC , KimSY , et al. Use of mobile internet application to improve adherence to immunosuppressive medication adherence in kidney transplant recipients: preliminary results of the PRIMA (ImProving Adherence to Immunosuppressive Therapy by Mobile Internet application) study [abstract no: 420.4]. Transplantation2016;100(7 Suppl):S161. [EMBASE: 613004382]HanA , MinSI , AhnS , MinSK , HongHJ , HanN , et al. Mobile medication manager application to improve adherence with immunosuppressive therapy in renal transplant recipients: a randomized controlled trial. PLoS ONE [Electronic Resource]2019;14(11):e0224595. [MEDLINE: 31689320]KoH , KimHK , ChungC , HanA , MinSK , HaJ , et al. Association between medication adherence and intrapatient variability in tacrolimus concentration among stable kidney transplant recipients. Scientific Reports2021;11(1):5397. [MEDLINE: 33686160]">PRIMA 2019</a>). It is uncertain whether an intervention to increase adherence to immunosuppressant medication reduces the number of drug holidays from immunosuppressant medication (<a href="./references#CD012854-fig-0007" title="">Analysis 1.4</a> (4 studies, 445 participants): RR 1.12, 95% CI 0.77 to 1.62; I² = 87%; low certainty evidence). <a href="./references#CD012854-bbs2-0017" title="JungHY , JeonY , SeongSJ , SeoJJ , ChoiJY , ChoJH , et al. ICT-based adherence monitoring in kidney transplant recipients: a randomized controlled trial. BMC Medical Informatics &amp; Decision Making2020;20(1):105. [MEDLINE: 32522263]JungHY , JeonY , SeongSJ , SeoJJ , ChoiJY , ChoJH , et al. Information and communication technology-based centralized monitoring system to increase adherence to immunosuppressive medication in kidney transplant recipients: a randomized controlled trial [abstract no: P1734]. Nephrology Dialysis Transplantation2020;35(Suppl 3):iii252. [EMBASE: 633422975]JungHY , SeongSJ , ChoiJY , ChoJH , ParkSH , KimCD , et al. The efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trial. Trials [Electronic Resource]2017;18(1):480. [MEDLINE: 29037222]">Jung 2017</a> reported that dosing adherence did not differ between intervention and control groups. </p> </section> <section id="CD012854-sec-0064"> <h6 class="title">Persistence</h6> <p>Two studies included persistence with immunosuppressant medication adherence. <a href="./references#CD012854-bbs2-0001" title="KuypersDR , BonvoisinCA , PeetersP , SennesaelJJ , KiandaMN , VrijensB , et al. Superior medication adherence to tacrolimus modified release once-daily (QD) compared to tacrolimus twice-daily (BID) in stable renal transplant patients [abstract no: RO-256]. Transplant International2011;24(Suppl 2):199. [EMBASE: 70527785]KuypersDR , PeetersPC , SennesaelJJ , KiandaMN , VrijensB , KristantoP , et al. Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring. Transplantation2013;95(2):333-40. [MEDLINE: 23263559]">ADMIRAD 2013</a> reported a marginally higher persistence rate in the intervention group (85.1% versus 71.9%; P = 0.08). <a href="./references#CD012854-bbs2-0004" title="ChisholmMA , MulloyL , JagadeesanM , DiPiroJT . Two-year economic evaluation of clinical pharmacy services in renal transplant clinic patients [abstract no: 588]. American Journal of Transplantation2002;2(Suppl 3):286. [CENTRAL: CN-00415424] ChisholmMA , MulloyLL , JagadeesanM , DiPiroJT . Impact of clinical pharmacy services on renal transplant patients' compliance with immunosuppressive medications. Clinical Transplantation2001;15(5):330-6. [MEDLINE: 11678959]">Chisholm 2001</a> reported a difference in persistence with immunosuppressant medication treatment between the intervention and control group (75% versus 33.3%, P &lt; 0.05)<i>.</i> </p> </section> </section> <section id="CD012854-sec-0065"> <h5 class="title">Secondary outcomes ‐ subjective measures of immunosuppressant medication adherence</h5> <section id="CD012854-sec-0066"> <h6 class="title">Self‐reported adherence</h6> <p>Twenty studies included self‐reported immunosuppressant medication adherence (<a href="./references#CD012854-bbs2-0002" title="BessaA , MedinaJ , TedescoH , FelipeC . A prospective, randomised, controlled study to assess the effect of pharmaceutical intervention on compliance and knowledge of immunosuppression in kidney transplant recipients [abstract no: DI-090]. European Journal of Hospital Pharmacy2015;22(Suppl 1):A109-10. [EMBASE: 614322295]BessaAB , FelipeCR , HannunP , SayuriP , FelixMJ , RuppelP , et al. Prospective randomized trial investigating the influence of pharmaceutical care on the intra-individual variability of tacrolimus concentrations early after kidney transplant. Therapeutic Drug Monitoring2016;38(4):447-55. [MEDLINE: 27414973]">Bessa 2016</a>; <a href="./references#CD012854-bbs2-0006" title="CoteJ , FortinMC , AugerP , RouleauG , DuboisS , BoudreauN , et al. Web-based tailored intervention to support optimal medication adherence among kidney transplant recipients: pilot parallel-group randomized controlled trial. JMIR Formative Research2018;2(2):e14. [MEDLINE: 30684400]">Cote 2018</a>; <a href="./references#CD012854-bbs2-0010" title="GarciaMF , BravinAM , GarciaPD , ConttiMM , NgaHS , TakaseHM , et al. Behavioral measures to reduce non-adherence in renal transplant recipients: a prospective randomized controlled trial. International Urology &amp; Nephrology2015;47(11):1899-905. [MEDLINE: 26377496]">Garcia 2015</a>; <a href="./references#CD012854-bbs2-0012" title="HarrisonJJ , BadrS , HamandiB , KimSJ . Randomized controlled trial of a computer-based education program in the home for solid organ transplant recipients: impact on medication knowledge, satisfaction, and adherence. Transplantation2017;101(6):1336-43. [MEDLINE: 27367473]">Harrison 2016</a>; <a href="./references#CD012854-bbs2-0014" title="HuangY , YuX . Effect of healthy education on improving the drug compliance of patients after renal transplantation. Journal of Clinical Rehabilitative Tissue Engineering Research2007;11(43):8773-5. [EMBASE: 350081272]">Huang 2007b</a>; <a href="./references#CD012854-bbs2-0015" title="LowJK , ManiasE , CrawfordK , WalkerR , MulleyWR , ToussaintND , et al. Improving medication adherence in adult kidney transplantation (IMAKT): a pilot randomised controlled trial. Scientific Reports2019;9(1):7734. [MEDLINE: 31118485]">IMAKT 2019</a>; <a href="./references#CD012854-bbs2-0016" title="JoostR , DorjeF , SchwitullaJ , EckardtKU , HugoC . Intensified pharmaceutical care is improving immunosuppressive medication adherence in kidney transplant recipients during the first post-transplant year: a quasi-experimental study. Nephrology Dialysis Transplantation2014;29(8):1597-607. [MEDLINE: 24914089]">Joost 2014</a>; <a href="./references#CD012854-bbs2-0018" title="KaiserTE , EjazNS , TremblayS , ParrishNJ , BenavidesJ , ReheB , et al. Technology triggered adherence intervention: preliminary findings [abstract no: 185]. American Journal of Transplantation2019;19(Suppl 3):394. [EMBASE: 628454914]">Kaiser 2019</a>; <a href="./references#CD012854-bbs2-0020" title="KleinA , KramerI . Influence of a pharmaceutical care program on liver transplant patients' compliance with immunosuppressive therapy: a prospective, randomized, controlled trial [Pharmazeutische betreuung lebertransplantierter patienten unter besonderer berucksichtigung der compliance mit der immunsuppressiven therapie: Eine prospektive, randomisierte, kontrollierte studie]. Krankenhauspharmazie2007;28(12):458-68. [EMBASE: 350287720]KleinA , OttoG , KramerI . Impact of a pharmaceutical care program on liver transplant patients' compliance with immunosuppressive medication: a prospective, randomized, controlled trial using electronic monitoring. Transplantation2009;87(6):839-47. [MEDLINE: 19300186]">Klein 2007</a>; <a href="./references#CD012854-bbs2-0023" title="DobbelsF , De BleserL , BerbenL , KristantoP , DupontL , NevensF , et al. Efficacy of a medication adherence enhancing intervention in transplantation: the MAESTRO-Tx trial. Journal of Heart &amp; Lung Transplantation2017;36(5):499-508. [MEDLINE: 28162931]DobbelsF , De BleserL , BerbenL , KristantoP , DupontL , NevensF , et al. Testing the efficacy of a multicomponent theory-based tailored behavioral medication adherence intervention in transplantation: The MAESTRO-TX RCT [abstract no: 223]. Journal of Heart &amp; Lung Transplantation2016;35(4 Suppl):S90. [EMBASE: 72253342]DobbelsF , De BleserL , KristantoP , NevensF , VanhaeckeJ , VerledenG , et al. Electronic monitoring feedback and motivational interviewing improves medication adherence in heart, liver and lung transplant patients: results from the MAESTRO-TX RCT [abstract no: BO218]. Transplant International2015;28(Suppl 4):203. [EMBASE: 72111813]">MAESTRO‐Tx 2017</a>; <a href="./references#CD012854-bbs2-0026" title="Gomis-PastorM , Mirabet PerezS , Roig MinguellE , Brossa LoidiV , Lopez LopezL , Ros AbarcaS , et al. Mobile health to improve adherence and patient experience in heart transplantation recipients: the mHeart trial. Healthcare2021;9(4):463. [MEDLINE: 33919899]Gomis-PastorM , MirabetS , RoigE , BrossaV , LopezL , RosS , et al. Improving patients' experience and medication adherence after heart transplant using a multilevel ehealth intervention: the mHeart clinical trial [abstract no: P-16.07]. Transplantation2020;104(Suppl 3):S578-9. [EMBASE: 633380991]">mHeart 2021</a>; <a href="./references#CD012854-bbs2-0027" title="PatersonTS , DemianM , ShapiroRJ , Loken ThorntonW . Impact of once- versus twice-daily tacrolimus dosing on medication adherence in stable renal transplant recipients: a Canadian single-center randomized controlled trial. Canadian Journal of Kidney Health &amp; Disease2019;6:2054358119867993. [MEDLINE: 31452902]ShapiroRJ , PatersonT , ThorntonW , HusseiniT , PartoviN , VishloffJ , et al. Medication adherence is tied to social support in renal transplant recipients [abstract no: 2501]. In: Canadian Society of Transplantation Annual Scientific Meeting; 2013 Mar 13-16; Alberta, Canada. 2013:38. ">Paterson 2019</a>; <a href="./references#CD012854-bbs2-0029" title="HanA , ChoMJ , ChoS , LeeCH , ChoiC , KimSY , et al. Use of mobile internet application to improve adherence to immunosuppressive medication adherence in kidney transplant recipients: preliminary results of the PRIMA (ImProving Adherence to Immunosuppressive Therapy by Mobile Internet application) study [abstract no: 420.4]. Transplantation2016;100(7 Suppl):S161. [EMBASE: 613004382]HanA , MinSI , AhnS , MinSK , HongHJ , HanN , et al. Mobile medication manager application to improve adherence with immunosuppressive therapy in renal transplant recipients: a randomized controlled trial. PLoS ONE [Electronic Resource]2019;14(11):e0224595. [MEDLINE: 31689320]KoH , KimHK , ChungC , HanA , MinSK , HaJ , et al. Association between medication adherence and intrapatient variability in tacrolimus concentration among stable kidney transplant recipients. Scientific Reports2021;11(1):5397. [MEDLINE: 33686160]">PRIMA 2019</a>; <a href="./references#CD012854-bbs2-0030" title="ReeseP , BloomR , Trofe-ClarkJ , MussellA , LeidyD , LevskyS , et al. Customized reminders and provider notification to improve adherence to immunosuppression [abstract no: 1074]. American Journal of Transplantation2015;15(Suppl 3). [EMBASE: 71953144]ReesePP , BloomRD , Trofe-ClarkJ , MussellA , LeidyD , LevskyS , et al. Automated reminders and physician notification to promote immunosuppression adherence among kidney transplant recipients: a randomized trial. American Journal of Kidney Diseases2017;69(3):400-9. [MEDLINE: 27940063]">Reese 2017</a>; <a href="./references#CD012854-bbs2-0032" title="SantanaMJ , FeenyD , JacksonK , SchafenackerM , WeinkaufJ , LienD . Using patient-centred care to enhance adherence to medication and exercise in lung transplantation: a randomized controlled clinical trial [abstract no: 445]. In: Canadian Society of Transplantation Annual Scientific Meeting; 2011 Mar 2-5; Quebec, Canada. 2011:34. [CENTRAL: CN-01657760] ">Santana 2011</a>; <a href="./references#CD012854-bbs2-0033" title="HilsS , SchmidA , BogatyrevaL , HauschkeD , Kramer-ZuckerA , PisarskiP . Telemedical supported aftercare after living kidney transplantation-a single center experience [abstract no: O179]. Transplant International2015;28(Suppl 4):69. [EMBASE: 72111423]HilsS , SchmidA , BogatyrevaL , HauschkeD , PisarskiP . Telemedical supported aftercare as an innovative project-study improves the quality of life after living kidney transplantation-a single center experience [abstract no: D2730]. Transplantation2014;98(Suppl 1):843. [EMBASE: 71546416]KaierK , HilsS , FetzerS , HehnP , SchmidA , HauschkeD , et al. Results of a randomized controlled trial analyzing telemedically supported case management in the first year after living donor kidney transplantation - a budget impact analysis from the healthcare perspective. Health Economics Review2017;7(1):1. [MEDLINE: 28092012]PisarskiP , HilsS , SchmidA , Kramer-ZuckerA , JanigenB . Telemedicin as an innovative project-study in adherence improvement after living kidney transplantation at the Transplantation Center Freiburg [abstract no: O162]. Transplant International2013;26(Suppl 2):73. [EMBASE: 71359226]SchmidA , HilsS , Kramer-ZuckerA , BogatyrevaL , HauschkeD , De GeestS , et al. Telemedically-supported case management of living-donor renal transplant recipients to optimize routine evidence-based aftercare: a single-center randomized controlled trial. American Journal of Transplantation2017;17(6):1594-605. [MEDLINE: 27873477]SchmidA , PisarskiP , HilsS , HauschkeD , BogatyrevaL . Telemedical supported after care in living kidney recipients-an innovative project-study at the Transplantation Center Freiburg interim results of a prospective ongoing study of 50 patients [abstract no: P84]. Transplant International2013;26(Suppl 1):43. [EMBASE: 71356349]">Schmid 2017</a>; <a href="./references#CD012854-bbs2-0035" title="SuhlingH , RademacherJ , ZinowskyI , FugeJ , GreerM , WarneckeG , et al. Conventional vs. tablet computer-based patient education following lung transplantation--a randomized controlled trial. PLoS ONE [Electronic Resource]2014;9(6):e90828. [MEDLINE: 24608864]SuhlingH , RademacherJ , ZinowskyI , FugeJ , GreerM , WarneckeG . Patient education via tablet-pc vs. conventional to improve compliance with immunosuppressive drug regimen after lung transplantation - a randomized controlled trial [abstract no: 2844]. European Respiratory Journal2013;42(Suppl 57):565S. [EMBASE: 71843332]">Suhling 2014</a>, <a href="./references#CD012854-bbs2-0036" title="TaberDJ , PosadasMA , RaoV , McGillicuddyJ , RohanV , NadigSN , et al. The potential for improved medication adherence with a complete once daily immunosuppression regimen in kidney transplant: results of a randomized controlled study [abstract no: FR-PO1177]. Journal of the American Society of Nephrology2019;30(Abstract Suppl):750-1. [EMBASE: 633769114]TaberDJ , Posadas-SalasA , SuZ , RaoV , RohanV , NadigS , et al. Preliminary assessment of safety and adherence to a once-daily immunosuppression regimen in kidney transplantation: results of a randomized controlled pilot study. Clinical Transplantation2020;34(4):e13844. [MEDLINE: 32092187]">Taber 2020</a>; <a href="./references#CD012854-bbs2-0037" title="Van ZantenR , De WeerdA , BetjesM , Boer-VerschragenM , MasseyE . Medication adherence and fear of rejection after conversion from dual to monotherapy: A randomized controlled trial [abstract no: OP170]. Transplant International2021;34(Suppl 1):35. [EMBASE: 635968308]vanZantenR , deWeerdA , BetjesM , Boer-VerschragenM , MasseyEK . Is simplification of immunosuppressive medication a way to promote medication adherence of kidney transplant recipients? Findings from a randomized controlled trial. Transplant International2021;34(9):1703-11. [MEDLINE: 34448273]">TACmono 2021</a>; <a href="./references#CD012854-bbs2-0038" title="BignallO , PaiA , AmaralS , FurthS , BergmanN , GoebelJ , et al. Differences in reported barriers to immunosuppression adherence among a cohort of pediatric renal transplant recipients from the United States and Canada [abstract no: D161]. American Journal of Transplantation2016;16(Suppl 3):751. [EMBASE: 611700425]BoucquemontJ , FosterB , TAKE-IT Investigators. Sex and age differences in medication adherence in adolescent and young adult kidney transplant recipients [abstract no: SA-PO404]. Journal of the American Society of Nephrology2016;27(Abstracts):721A. [CENTRAL: CN-01657535] BoucquemontJ , FosterB . Adherence patterns in adolescent and young adult kidney transplant recipients [abstract no: 229]. American Journal of Transplantation2016;16(Suppl 3):284. [EMBASE: 611700136]BoucquemontJ , PaiAL , DharnidharkaVR , HebertD , FurthSL , FosterBJ . Gender differences in medication adherence among adolescent and young adult kidney transplant recipients. Transplantation2019;103(4):798-806. [MEDLINE: 29994983]BoucquemontJ , PaiAL , DharnidharkaVR , HebertD , ZelikovskyN , AmaralS , et al. Association between day of the week and medication adherence among adolescent and young adult kidney transplant recipients. American Journal of Transplantation2020;20(1):274-81. [MEDLINE: 31507087]FosterB , PaiA , FurthS . The TAKE-IT intervention improves medication adherence in adolescent kidney transplant recipients [abstract no: 359]. American Journal of Transplantation2017;17(Suppl 3):332-3. [EMBASE: 615704529]FosterB , ZhaoH , PaiA , ZelikovskyN , HollyCD , SmithJM , et al. Medication adherence barrier burden predicts subsequent taking adherence in adolescent kidney transplant recipients in the TAKE-IT trial [abstract no: SA-PO1027]. Journal of the American Society of Nephrology2015;26(Abstracts):870A. [CENTRAL: CN-01657534] FosterBJ , PaiA , ZhaoH , FurthS , TAKE-IT Study Group. The TAKE-IT study: aims, design, and methods. BMC Nephrology2014;15:139. [MEDLINE: 25176317]FosterBJ , PaiAL , ZelikovskyN , AmaralS , BellL , DharnidharkaVR , et al. A randomized trial of a multicomponent intervention to promote medication adherence: the teen adherence in kidney transplant effectiveness of intervention trial (TAKE-IT) [Erratum in: Am J Kidney Dis. 2019 Apr;73(4):578]. American Journal of Kidney Diseases2018;72(1):30-41. [MEDLINE: 29602631]FosterBJ , ZhaoH , PaiA , ZelikovskyN , HollyCD , SmithJM , et al. Medication adherence barrier burden predicts subsequent adherence to dosing time schedule in adolescent kidney transplant recipients in the TAKE-IT Trial [abstract no: SA-PO1031]. Journal of the American Society of Nephrology2015;26(Abstracts):871A. [CENTRAL: CN-01657537] LadnerDP , WolfMS . Transplant regimen adherence for kidney recipients by engaging information technologies: the TAKE-IT trial [abstract no: D302]. American Journal of Transplantation2019;19(Suppl 3):1145. [EMBASE: 628453783]">TAKE‐IT 2014</a>). Nine studies reported the proportion of participants classified as adherent and were included in the meta‐analysis. It is uncertain whether an intervention to increase adherence to immunosuppressant medication increases the proportion of participants classified as medically adherent measured by self‐reported adherence measures (<a href="./references#CD012854-fig-0008" title="">Analysis 2.1</a> (9 studies, 755 participants): RR 1.21, 95% CI 0.99 to 1.49; I² = 74%; very low certainty evidence). </p> <p>Five studies reported mean self‐reported immunosuppressant medication adherence scores and were included in the meta‐analysis. It is uncertain whether an intervention to increase adherence to immunosuppressant medication increases the mean adherence score on self‐reported adherence measures (<a href="./references#CD012854-fig-0009" title="">Analysis 2.2</a> (5 studies, 471 participants): SMD 0.65, 95% CI ‐0.31 to 1.60; I² = 96%; very low certainty evidence). <a href="./references#CD012854-bbs2-0006" title="CoteJ , FortinMC , AugerP , RouleauG , DuboisS , BoudreauN , et al. Web-based tailored intervention to support optimal medication adherence among kidney transplant recipients: pilot parallel-group randomized controlled trial. JMIR Formative Research2018;2(2):e14. [MEDLINE: 30684400]">Cote 2018</a> and <a href="./references#CD012854-bbs2-0029" title="HanA , ChoMJ , ChoS , LeeCH , ChoiC , KimSY , et al. Use of mobile internet application to improve adherence to immunosuppressive medication adherence in kidney transplant recipients: preliminary results of the PRIMA (ImProving Adherence to Immunosuppressive Therapy by Mobile Internet application) study [abstract no: 420.4]. Transplantation2016;100(7 Suppl):S161. [EMBASE: 613004382]HanA , MinSI , AhnS , MinSK , HongHJ , HanN , et al. Mobile medication manager application to improve adherence with immunosuppressive therapy in renal transplant recipients: a randomized controlled trial. PLoS ONE [Electronic Resource]2019;14(11):e0224595. [MEDLINE: 31689320]KoH , KimHK , ChungC , HanA , MinSK , HaJ , et al. Association between medication adherence and intrapatient variability in tacrolimus concentration among stable kidney transplant recipients. Scientific Reports2021;11(1):5397. [MEDLINE: 33686160]">PRIMA 2019</a> also reported self‐reported adherence using a Visual Analogue Scale and reported no difference in self‐reported adherence between the intervention and control groups. </p> <p>Eight studies did not provide sufficient detail to be included in the meta‐analysis. <a href="./references#CD012854-bbs2-0006" title="CoteJ , FortinMC , AugerP , RouleauG , DuboisS , BoudreauN , et al. Web-based tailored intervention to support optimal medication adherence among kidney transplant recipients: pilot parallel-group randomized controlled trial. JMIR Formative Research2018;2(2):e14. [MEDLINE: 30684400]">Cote 2018</a>, <a href="./references#CD012854-bbs2-0023" title="DobbelsF , De BleserL , BerbenL , KristantoP , DupontL , NevensF , et al. Efficacy of a medication adherence enhancing intervention in transplantation: the MAESTRO-Tx trial. Journal of Heart &amp; Lung Transplantation2017;36(5):499-508. [MEDLINE: 28162931]DobbelsF , De BleserL , BerbenL , KristantoP , DupontL , NevensF , et al. Testing the efficacy of a multicomponent theory-based tailored behavioral medication adherence intervention in transplantation: The MAESTRO-TX RCT [abstract no: 223]. Journal of Heart &amp; Lung Transplantation2016;35(4 Suppl):S90. [EMBASE: 72253342]DobbelsF , De BleserL , KristantoP , NevensF , VanhaeckeJ , VerledenG , et al. Electronic monitoring feedback and motivational interviewing improves medication adherence in heart, liver and lung transplant patients: results from the MAESTRO-TX RCT [abstract no: BO218]. Transplant International2015;28(Suppl 4):203. [EMBASE: 72111813]">MAESTRO‐Tx 2017</a> and <a href="./references#CD012854-bbs2-0032" title="SantanaMJ , FeenyD , JacksonK , SchafenackerM , WeinkaufJ , LienD . Using patient-centred care to enhance adherence to medication and exercise in lung transplantation: a randomized controlled clinical trial [abstract no: 445]. In: Canadian Society of Transplantation Annual Scientific Meeting; 2011 Mar 2-5; Quebec, Canada. 2011:34. [CENTRAL: CN-01657760] ">Santana 2011</a> reported no difference in self‐reported adherence between the intervention and control groups. <a href="./references#CD012854-bbs2-0015" title="LowJK , ManiasE , CrawfordK , WalkerR , MulleyWR , ToussaintND , et al. Improving medication adherence in adult kidney transplantation (IMAKT): a pilot randomised controlled trial. Scientific Reports2019;9(1):7734. [MEDLINE: 31118485]">IMAKT 2019</a> reported a reduction in the percentage of adherent participants in the control group from 3 to 12 months (P &lt; 0.001), with no change in the percentage of adherent participants over time in the intervention group. <a href="./references#CD012854-bbs2-0018" title="KaiserTE , EjazNS , TremblayS , ParrishNJ , BenavidesJ , ReheB , et al. Technology triggered adherence intervention: preliminary findings [abstract no: 185]. American Journal of Transplantation2019;19(Suppl 3):394. [EMBASE: 628454914]">Kaiser 2019</a> reported a decrease in self‐reported adherence over time; however, the rate of change or change per group wasn't specified. <a href="./references#CD012854-bbs2-0012" title="HarrisonJJ , BadrS , HamandiB , KimSJ . Randomized controlled trial of a computer-based education program in the home for solid organ transplant recipients: impact on medication knowledge, satisfaction, and adherence. Transplantation2017;101(6):1336-43. [MEDLINE: 27367473]">Harrison 2016</a> and <a href="./references#CD012854-bbs2-0033" title="HilsS , SchmidA , BogatyrevaL , HauschkeD , Kramer-ZuckerA , PisarskiP . Telemedical supported aftercare after living kidney transplantation-a single center experience [abstract no: O179]. Transplant International2015;28(Suppl 4):69. [EMBASE: 72111423]HilsS , SchmidA , BogatyrevaL , HauschkeD , PisarskiP . Telemedical supported aftercare as an innovative project-study improves the quality of life after living kidney transplantation-a single center experience [abstract no: D2730]. Transplantation2014;98(Suppl 1):843. [EMBASE: 71546416]KaierK , HilsS , FetzerS , HehnP , SchmidA , HauschkeD , et al. Results of a randomized controlled trial analyzing telemedically supported case management in the first year after living donor kidney transplantation - a budget impact analysis from the healthcare perspective. Health Economics Review2017;7(1):1. [MEDLINE: 28092012]PisarskiP , HilsS , SchmidA , Kramer-ZuckerA , JanigenB . Telemedicin as an innovative project-study in adherence improvement after living kidney transplantation at the Transplantation Center Freiburg [abstract no: O162]. Transplant International2013;26(Suppl 2):73. [EMBASE: 71359226]SchmidA , HilsS , Kramer-ZuckerA , BogatyrevaL , HauschkeD , De GeestS , et al. Telemedically-supported case management of living-donor renal transplant recipients to optimize routine evidence-based aftercare: a single-center randomized controlled trial. American Journal of Transplantation2017;17(6):1594-605. [MEDLINE: 27873477]SchmidA , PisarskiP , HilsS , HauschkeD , BogatyrevaL . Telemedical supported after care in living kidney recipients-an innovative project-study at the Transplantation Center Freiburg interim results of a prospective ongoing study of 50 patients [abstract no: P84]. Transplant International2013;26(Suppl 1):43. [EMBASE: 71356349]">Schmid 2017</a> included self‐reported adherence only as part of a combined composite adherence score. </p> <p><a href="./references#CD012854-bbs2-0038" title="BignallO , PaiA , AmaralS , FurthS , BergmanN , GoebelJ , et al. Differences in reported barriers to immunosuppression adherence among a cohort of pediatric renal transplant recipients from the United States and Canada [abstract no: D161]. American Journal of Transplantation2016;16(Suppl 3):751. [EMBASE: 611700425]BoucquemontJ , FosterB , TAKE-IT Investigators. Sex and age differences in medication adherence in adolescent and young adult kidney transplant recipients [abstract no: SA-PO404]. Journal of the American Society of Nephrology2016;27(Abstracts):721A. [CENTRAL: CN-01657535] BoucquemontJ , FosterB . Adherence patterns in adolescent and young adult kidney transplant recipients [abstract no: 229]. American Journal of Transplantation2016;16(Suppl 3):284. [EMBASE: 611700136]BoucquemontJ , PaiAL , DharnidharkaVR , HebertD , FurthSL , FosterBJ . Gender differences in medication adherence among adolescent and young adult kidney transplant recipients. Transplantation2019;103(4):798-806. [MEDLINE: 29994983]BoucquemontJ , PaiAL , DharnidharkaVR , HebertD , ZelikovskyN , AmaralS , et al. Association between day of the week and medication adherence among adolescent and young adult kidney transplant recipients. American Journal of Transplantation2020;20(1):274-81. [MEDLINE: 31507087]FosterB , PaiA , FurthS . The TAKE-IT intervention improves medication adherence in adolescent kidney transplant recipients [abstract no: 359]. American Journal of Transplantation2017;17(Suppl 3):332-3. [EMBASE: 615704529]FosterB , ZhaoH , PaiA , ZelikovskyN , HollyCD , SmithJM , et al. Medication adherence barrier burden predicts subsequent taking adherence in adolescent kidney transplant recipients in the TAKE-IT trial [abstract no: SA-PO1027]. Journal of the American Society of Nephrology2015;26(Abstracts):870A. [CENTRAL: CN-01657534] FosterBJ , PaiA , ZhaoH , FurthS , TAKE-IT Study Group. The TAKE-IT study: aims, design, and methods. BMC Nephrology2014;15:139. [MEDLINE: 25176317]FosterBJ , PaiAL , ZelikovskyN , AmaralS , BellL , DharnidharkaVR , et al. A randomized trial of a multicomponent intervention to promote medication adherence: the teen adherence in kidney transplant effectiveness of intervention trial (TAKE-IT) [Erratum in: Am J Kidney Dis. 2019 Apr;73(4):578]. American Journal of Kidney Diseases2018;72(1):30-41. [MEDLINE: 29602631]FosterBJ , ZhaoH , PaiA , ZelikovskyN , HollyCD , SmithJM , et al. Medication adherence barrier burden predicts subsequent adherence to dosing time schedule in adolescent kidney transplant recipients in the TAKE-IT Trial [abstract no: SA-PO1031]. Journal of the American Society of Nephrology2015;26(Abstracts):871A. [CENTRAL: CN-01657537] LadnerDP , WolfMS . Transplant regimen adherence for kidney recipients by engaging information technologies: the TAKE-IT trial [abstract no: D302]. American Journal of Transplantation2019;19(Suppl 3):1145. [EMBASE: 628453783]">TAKE‐IT 2014</a> was not included in the meta‐analysis as it included self‐reported adherence measures for paediatric participants. <a href="./references#CD012854-bbs2-0038" title="BignallO , PaiA , AmaralS , FurthS , BergmanN , GoebelJ , et al. Differences in reported barriers to immunosuppression adherence among a cohort of pediatric renal transplant recipients from the United States and Canada [abstract no: D161]. American Journal of Transplantation2016;16(Suppl 3):751. [EMBASE: 611700425]BoucquemontJ , FosterB , TAKE-IT Investigators. Sex and age differences in medication adherence in adolescent and young adult kidney transplant recipients [abstract no: SA-PO404]. Journal of the American Society of Nephrology2016;27(Abstracts):721A. [CENTRAL: CN-01657535] BoucquemontJ , FosterB . Adherence patterns in adolescent and young adult kidney transplant recipients [abstract no: 229]. American Journal of Transplantation2016;16(Suppl 3):284. [EMBASE: 611700136]BoucquemontJ , PaiAL , DharnidharkaVR , HebertD , FurthSL , FosterBJ . Gender differences in medication adherence among adolescent and young adult kidney transplant recipients. Transplantation2019;103(4):798-806. [MEDLINE: 29994983]BoucquemontJ , PaiAL , DharnidharkaVR , HebertD , ZelikovskyN , AmaralS , et al. Association between day of the week and medication adherence among adolescent and young adult kidney transplant recipients. American Journal of Transplantation2020;20(1):274-81. [MEDLINE: 31507087]FosterB , PaiA , FurthS . The TAKE-IT intervention improves medication adherence in adolescent kidney transplant recipients [abstract no: 359]. American Journal of Transplantation2017;17(Suppl 3):332-3. [EMBASE: 615704529]FosterB , ZhaoH , PaiA , ZelikovskyN , HollyCD , SmithJM , et al. Medication adherence barrier burden predicts subsequent taking adherence in adolescent kidney transplant recipients in the TAKE-IT trial [abstract no: SA-PO1027]. Journal of the American Society of Nephrology2015;26(Abstracts):870A. [CENTRAL: CN-01657534] FosterBJ , PaiA , ZhaoH , FurthS , TAKE-IT Study Group. The TAKE-IT study: aims, design, and methods. BMC Nephrology2014;15:139. [MEDLINE: 25176317]FosterBJ , PaiAL , ZelikovskyN , AmaralS , BellL , DharnidharkaVR , et al. A randomized trial of a multicomponent intervention to promote medication adherence: the teen adherence in kidney transplant effectiveness of intervention trial (TAKE-IT) [Erratum in: Am J Kidney Dis. 2019 Apr;73(4):578]. American Journal of Kidney Diseases2018;72(1):30-41. [MEDLINE: 29602631]FosterBJ , ZhaoH , PaiA , ZelikovskyN , HollyCD , SmithJM , et al. Medication adherence barrier burden predicts subsequent adherence to dosing time schedule in adolescent kidney transplant recipients in the TAKE-IT Trial [abstract no: SA-PO1031]. Journal of the American Society of Nephrology2015;26(Abstracts):871A. [CENTRAL: CN-01657537] LadnerDP , WolfMS . Transplant regimen adherence for kidney recipients by engaging information technologies: the TAKE-IT trial [abstract no: D302]. American Journal of Transplantation2019;19(Suppl 3):1145. [EMBASE: 628453783]">TAKE‐IT 2014</a> reported that self‐reported adherence on the MAM‐MM was high overall and did not differ between intervention and control groups (self‐reported taking adherence: 98.3 ± 4.5 versus (97.1 ± 6, P = 0.2); self‐reported timing adherence: 95 ± 7.9 versus 92.9 ± 9.3; P = 0.2). </p> </section> </section> <section id="CD012854-sec-0067"> <h5 class="title">Secondary outcomes ‐ objective surrogate measures of adherence to immunosuppressant medication adherence </h5> <section id="CD012854-sec-0068"> <h6 class="title">Immunosuppressant trough concentration levels</h6> <p>Seventeen studies reported immunosuppressant trough concentration levels (<a href="./references#CD012854-bbs2-0001" title="KuypersDR , BonvoisinCA , PeetersP , SennesaelJJ , KiandaMN , VrijensB , et al. Superior medication adherence to tacrolimus modified release once-daily (QD) compared to tacrolimus twice-daily (BID) in stable renal transplant patients [abstract no: RO-256]. Transplant International2011;24(Suppl 2):199. [EMBASE: 70527785]KuypersDR , PeetersPC , SennesaelJJ , KiandaMN , VrijensB , KristantoP , et al. Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring. Transplantation2013;95(2):333-40. [MEDLINE: 23263559]">ADMIRAD 2013</a>; <a href="./references#CD012854-bbs2-0002" title="BessaA , MedinaJ , TedescoH , FelipeC . A prospective, randomised, controlled study to assess the effect of pharmaceutical intervention on compliance and knowledge of immunosuppression in kidney transplant recipients [abstract no: DI-090]. European Journal of Hospital Pharmacy2015;22(Suppl 1):A109-10. [EMBASE: 614322295]BessaAB , FelipeCR , HannunP , SayuriP , FelixMJ , RuppelP , et al. Prospective randomized trial investigating the influence of pharmaceutical care on the intra-individual variability of tacrolimus concentrations early after kidney transplant. Therapeutic Drug Monitoring2016;38(4):447-55. [MEDLINE: 27414973]">Bessa 2016</a>; <a href="./references#CD012854-bbs2-0004" title="ChisholmMA , MulloyL , JagadeesanM , DiPiroJT . Two-year economic evaluation of clinical pharmacy services in renal transplant clinic patients [abstract no: 588]. American Journal of Transplantation2002;2(Suppl 3):286. [CENTRAL: CN-00415424] ChisholmMA , MulloyLL , JagadeesanM , DiPiroJT . Impact of clinical pharmacy services on renal transplant patients' compliance with immunosuppressive medications. Clinical Transplantation2001;15(5):330-6. [MEDLINE: 11678959]">Chisholm 2001</a>; <a href="./references#CD012854-bbs2-0010" title="GarciaMF , BravinAM , GarciaPD , ConttiMM , NgaHS , TakaseHM , et al. Behavioral measures to reduce non-adherence in renal transplant recipients: a prospective randomized controlled trial. International Urology &amp; Nephrology2015;47(11):1899-905. [MEDLINE: 26377496]">Garcia 2015</a>; <a href="./references#CD012854-bbs2-0007" title="CukorD , Ver HalenN , PencilleM , TedlaF , SalifuM . A pilot randomized controlled trial to promote immunosuppressant adherence in adult kidney transplant recipients. Nephron2017;135(1):6-14. [MEDLINE: 28049201]">Cukor 2017</a>; <a href="./references#CD012854-bbs2-0012" title="HarrisonJJ , BadrS , HamandiB , KimSJ . Randomized controlled trial of a computer-based education program in the home for solid organ transplant recipients: impact on medication knowledge, satisfaction, and adherence. Transplantation2017;101(6):1336-43. [MEDLINE: 27367473]">Harrison 2016</a>; <a href="./references#CD012854-bbs2-0015" title="LowJK , ManiasE , CrawfordK , WalkerR , MulleyWR , ToussaintND , et al. Improving medication adherence in adult kidney transplantation (IMAKT): a pilot randomised controlled trial. Scientific Reports2019;9(1):7734. [MEDLINE: 31118485]">IMAKT 2019</a>; <a href="./references#CD012854-bbs2-0017" title="JungHY , JeonY , SeongSJ , SeoJJ , ChoiJY , ChoJH , et al. ICT-based adherence monitoring in kidney transplant recipients: a randomized controlled trial. BMC Medical Informatics &amp; Decision Making2020;20(1):105. [MEDLINE: 32522263]JungHY , JeonY , SeongSJ , SeoJJ , ChoiJY , ChoJH , et al. Information and communication technology-based centralized monitoring system to increase adherence to immunosuppressive medication in kidney transplant recipients: a randomized controlled trial [abstract no: P1734]. Nephrology Dialysis Transplantation2020;35(Suppl 3):iii252. [EMBASE: 633422975]JungHY , SeongSJ , ChoiJY , ChoJH , ParkSH , KimCD , et al. The efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trial. Trials [Electronic Resource]2017;18(1):480. [MEDLINE: 29037222]">Jung 2017</a>; <a href="./references#CD012854-bbs2-0020" title="KleinA , KramerI . Influence of a pharmaceutical care program on liver transplant patients' compliance with immunosuppressive therapy: a prospective, randomized, controlled trial [Pharmazeutische betreuung lebertransplantierter patienten unter besonderer berucksichtigung der compliance mit der immunsuppressiven therapie: Eine prospektive, randomisierte, kontrollierte studie]. Krankenhauspharmazie2007;28(12):458-68. [EMBASE: 350287720]KleinA , OttoG , KramerI . Impact of a pharmaceutical care program on liver transplant patients' compliance with immunosuppressive medication: a prospective, randomized, controlled trial using electronic monitoring. Transplantation2009;87(6):839-47. [MEDLINE: 19300186]">Klein 2007</a>; <a href="./references#CD012854-bbs2-0018" title="KaiserTE , EjazNS , TremblayS , ParrishNJ , BenavidesJ , ReheB , et al. Technology triggered adherence intervention: preliminary findings [abstract no: 185]. American Journal of Transplantation2019;19(Suppl 3):394. [EMBASE: 628454914]">Kaiser 2019</a>; <a href="./references#CD012854-bbs2-0021" title="LevineD , TorabiJ , ChoinskiK , RoccaJP , GrahamJA . Transplant surgery enters a new era: increasing immunosuppressive medication adherence through mobile apps and smart watches. American Journal of Surgery2019;218(1):18-20. [MEDLINE: 30799019]">Levine 2019</a>; <a href="./references#CD012854-bbs2-0026" title="Gomis-PastorM , Mirabet PerezS , Roig MinguellE , Brossa LoidiV , Lopez LopezL , Ros AbarcaS , et al. Mobile health to improve adherence and patient experience in heart transplantation recipients: the mHeart trial. Healthcare2021;9(4):463. [MEDLINE: 33919899]Gomis-PastorM , MirabetS , RoigE , BrossaV , LopezL , RosS , et al. Improving patients' experience and medication adherence after heart transplant using a multilevel ehealth intervention: the mHeart clinical trial [abstract no: P-16.07]. Transplantation2020;104(Suppl 3):S578-9. [EMBASE: 633380991]">mHeart 2021</a>; <a href="./references#CD012854-bbs2-0027" title="PatersonTS , DemianM , ShapiroRJ , Loken ThorntonW . Impact of once- versus twice-daily tacrolimus dosing on medication adherence in stable renal transplant recipients: a Canadian single-center randomized controlled trial. Canadian Journal of Kidney Health &amp; Disease2019;6:2054358119867993. [MEDLINE: 31452902]ShapiroRJ , PatersonT , ThorntonW , HusseiniT , PartoviN , VishloffJ , et al. Medication adherence is tied to social support in renal transplant recipients [abstract no: 2501]. In: Canadian Society of Transplantation Annual Scientific Meeting; 2013 Mar 13-16; Alberta, Canada. 2013:38. ">Paterson 2019</a>; <a href="./references#CD012854-bbs2-0029" title="HanA , ChoMJ , ChoS , LeeCH , ChoiC , KimSY , et al. Use of mobile internet application to improve adherence to immunosuppressive medication adherence in kidney transplant recipients: preliminary results of the PRIMA (ImProving Adherence to Immunosuppressive Therapy by Mobile Internet application) study [abstract no: 420.4]. Transplantation2016;100(7 Suppl):S161. [EMBASE: 613004382]HanA , MinSI , AhnS , MinSK , HongHJ , HanN , et al. Mobile medication manager application to improve adherence with immunosuppressive therapy in renal transplant recipients: a randomized controlled trial. PLoS ONE [Electronic Resource]2019;14(11):e0224595. [MEDLINE: 31689320]KoH , KimHK , ChungC , HanA , MinSK , HaJ , et al. Association between medication adherence and intrapatient variability in tacrolimus concentration among stable kidney transplant recipients. Scientific Reports2021;11(1):5397. [MEDLINE: 33686160]">PRIMA 2019</a>; <a href="./references#CD012854-bbs2-0030" title="ReeseP , BloomR , Trofe-ClarkJ , MussellA , LeidyD , LevskyS , et al. Customized reminders and provider notification to improve adherence to immunosuppression [abstract no: 1074]. American Journal of Transplantation2015;15(Suppl 3). [EMBASE: 71953144]ReesePP , BloomRD , Trofe-ClarkJ , MussellA , LeidyD , LevskyS , et al. Automated reminders and physician notification to promote immunosuppression adherence among kidney transplant recipients: a randomized trial. American Journal of Kidney Diseases2017;69(3):400-9. [MEDLINE: 27940063]">Reese 2017</a>; <a href="./references#CD012854-bbs2-0035" title="SuhlingH , RademacherJ , ZinowskyI , FugeJ , GreerM , WarneckeG , et al. Conventional vs. tablet computer-based patient education following lung transplantation--a randomized controlled trial. PLoS ONE [Electronic Resource]2014;9(6):e90828. [MEDLINE: 24608864]SuhlingH , RademacherJ , ZinowskyI , FugeJ , GreerM , WarneckeG . Patient education via tablet-pc vs. conventional to improve compliance with immunosuppressive drug regimen after lung transplantation - a randomized controlled trial [abstract no: 2844]. European Respiratory Journal2013;42(Suppl 57):565S. [EMBASE: 71843332]">Suhling 2014</a>; <a href="./references#CD012854-bbs2-0038" title="BignallO , PaiA , AmaralS , FurthS , BergmanN , GoebelJ , et al. Differences in reported barriers to immunosuppression adherence among a cohort of pediatric renal transplant recipients from the United States and Canada [abstract no: D161]. American Journal of Transplantation2016;16(Suppl 3):751. [EMBASE: 611700425]BoucquemontJ , FosterB , TAKE-IT Investigators. Sex and age differences in medication adherence in adolescent and young adult kidney transplant recipients [abstract no: SA-PO404]. Journal of the American Society of Nephrology2016;27(Abstracts):721A. [CENTRAL: CN-01657535] BoucquemontJ , FosterB . Adherence patterns in adolescent and young adult kidney transplant recipients [abstract no: 229]. American Journal of Transplantation2016;16(Suppl 3):284. [EMBASE: 611700136]BoucquemontJ , PaiAL , DharnidharkaVR , HebertD , FurthSL , FosterBJ . Gender differences in medication adherence among adolescent and young adult kidney transplant recipients. Transplantation2019;103(4):798-806. [MEDLINE: 29994983]BoucquemontJ , PaiAL , DharnidharkaVR , HebertD , ZelikovskyN , AmaralS , et al. Association between day of the week and medication adherence among adolescent and young adult kidney transplant recipients. American Journal of Transplantation2020;20(1):274-81. [MEDLINE: 31507087]FosterB , PaiA , FurthS . The TAKE-IT intervention improves medication adherence in adolescent kidney transplant recipients [abstract no: 359]. American Journal of Transplantation2017;17(Suppl 3):332-3. [EMBASE: 615704529]FosterB , ZhaoH , PaiA , ZelikovskyN , HollyCD , SmithJM , et al. Medication adherence barrier burden predicts subsequent taking adherence in adolescent kidney transplant recipients in the TAKE-IT trial [abstract no: SA-PO1027]. Journal of the American Society of Nephrology2015;26(Abstracts):870A. [CENTRAL: CN-01657534] FosterBJ , PaiA , ZhaoH , FurthS , TAKE-IT Study Group. The TAKE-IT study: aims, design, and methods. BMC Nephrology2014;15:139. [MEDLINE: 25176317]FosterBJ , PaiAL , ZelikovskyN , AmaralS , BellL , DharnidharkaVR , et al. A randomized trial of a multicomponent intervention to promote medication adherence: the teen adherence in kidney transplant effectiveness of intervention trial (TAKE-IT) [Erratum in: Am J Kidney Dis. 2019 Apr;73(4):578]. American Journal of Kidney Diseases2018;72(1):30-41. [MEDLINE: 29602631]FosterBJ , ZhaoH , PaiA , ZelikovskyN , HollyCD , SmithJM , et al. Medication adherence barrier burden predicts subsequent adherence to dosing time schedule in adolescent kidney transplant recipients in the TAKE-IT Trial [abstract no: SA-PO1031]. Journal of the American Society of Nephrology2015;26(Abstracts):871A. [CENTRAL: CN-01657537] LadnerDP , WolfMS . Transplant regimen adherence for kidney recipients by engaging information technologies: the TAKE-IT trial [abstract no: D302]. American Journal of Transplantation2019;19(Suppl 3):1145. [EMBASE: 628453783]">TAKE‐IT 2014</a>). </p> <p>Four studies reported the proportion of participants with immunosuppressant trough concentration levels at target and were included in the meta‐analysis. It is uncertain whether an intervention to increase adherence to immunosuppressant medication increases the proportion of participants who reach target immunosuppressant trough concentration levels (<a href="./references#CD012854-fig-0010" title="">Analysis 3.1</a> (4 studies, 348 participants): RR 0.98, 95% CI 0.68 to 1.40; I² = 40%, very low certainty evidence). <a href="./references#CD012854-bbs2-0020" title="KleinA , KramerI . Influence of a pharmaceutical care program on liver transplant patients' compliance with immunosuppressive therapy: a prospective, randomized, controlled trial [Pharmazeutische betreuung lebertransplantierter patienten unter besonderer berucksichtigung der compliance mit der immunsuppressiven therapie: Eine prospektive, randomisierte, kontrollierte studie]. Krankenhauspharmazie2007;28(12):458-68. [EMBASE: 350287720]KleinA , OttoG , KramerI . Impact of a pharmaceutical care program on liver transplant patients' compliance with immunosuppressive medication: a prospective, randomized, controlled trial using electronic monitoring. Transplantation2009;87(6):839-47. [MEDLINE: 19300186]">Klein 2007</a> reported serum concentration levels at the group level only and reported a difference between the percentage of serum concentrations at target levels between the intervention and control groups (98/125 (78%) versus 62/121 (51%), P &lt; 0.001). </p> <p>Thirteen studies reported mean immunosuppressant trough concentration levels.</p> <p> <ul id="CD012854-list-0013"> <li> <p><a href="./references#CD012854-bbs2-0001" title="KuypersDR , BonvoisinCA , PeetersP , SennesaelJJ , KiandaMN , VrijensB , et al. Superior medication adherence to tacrolimus modified release once-daily (QD) compared to tacrolimus twice-daily (BID) in stable renal transplant patients [abstract no: RO-256]. Transplant International2011;24(Suppl 2):199. [EMBASE: 70527785]KuypersDR , PeetersPC , SennesaelJJ , KiandaMN , VrijensB , KristantoP , et al. Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring. Transplantation2013;95(2):333-40. [MEDLINE: 23263559]">ADMIRAD 2013</a> examined dose simplification from twice‐daily TAC to once‐daily TAC and reported evidence for a difference in mean immunosuppressant trough concentration levels. Average TAC concentrations in the once‐daily and twice‐daily groups were 7.2 ± 1.8 ng/mL 1.8 and 8.1 ± 1.9 ng/mL (P = 0.0004). </p> </li> <li> <p><a href="./references#CD012854-bbs2-0027" title="PatersonTS , DemianM , ShapiroRJ , Loken ThorntonW . Impact of once- versus twice-daily tacrolimus dosing on medication adherence in stable renal transplant recipients: a Canadian single-center randomized controlled trial. Canadian Journal of Kidney Health &amp; Disease2019;6:2054358119867993. [MEDLINE: 31452902]ShapiroRJ , PatersonT , ThorntonW , HusseiniT , PartoviN , VishloffJ , et al. Medication adherence is tied to social support in renal transplant recipients [abstract no: 2501]. In: Canadian Society of Transplantation Annual Scientific Meeting; 2013 Mar 13-16; Alberta, Canada. 2013:38. ">Paterson 2019</a> examined dose simplification from twice‐daily TAC to once‐daily TAC and reported evidence for a difference in mean immunosuppressant trough concentration levels. Mean TAC concentrations in the once‐daily and twice‐daily groups were 4.83 ± 1.44 ng/mL and 6.2 ± 1.08 ng/mL ng/mL (P = 0.002). </p> </li> <li> <p><a href="./references#CD012854-bbs2-0002" title="BessaA , MedinaJ , TedescoH , FelipeC . A prospective, randomised, controlled study to assess the effect of pharmaceutical intervention on compliance and knowledge of immunosuppression in kidney transplant recipients [abstract no: DI-090]. European Journal of Hospital Pharmacy2015;22(Suppl 1):A109-10. [EMBASE: 614322295]BessaAB , FelipeCR , HannunP , SayuriP , FelixMJ , RuppelP , et al. Prospective randomized trial investigating the influence of pharmaceutical care on the intra-individual variability of tacrolimus concentrations early after kidney transplant. Therapeutic Drug Monitoring2016;38(4):447-55. [MEDLINE: 27414973]">Bessa 2016</a> reported no evidence for a difference in mean TAC trough levels (9.4 ± 4.1 ng/mL versus 9.8 ± 3.2 ng/mL; P &gt; 0.05). </p> </li> <li> <p><a href="./references#CD012854-bbs2-0007" title="CukorD , Ver HalenN , PencilleM , TedlaF , SalifuM . A pilot randomized controlled trial to promote immunosuppressant adherence in adult kidney transplant recipients. Nephron2017;135(1):6-14. [MEDLINE: 28049201]">Cukor 2017</a> reported no evidence for a difference in mean TAC trough levels (5.7 ± 1.8 ng/mL versus 6.4 ± 3.5 ng/mL; P = 0.5). </p> </li> <li> <p><a href="./references#CD012854-bbs2-0010" title="GarciaMF , BravinAM , GarciaPD , ConttiMM , NgaHS , TakaseHM , et al. Behavioral measures to reduce non-adherence in renal transplant recipients: a prospective randomized controlled trial. International Urology &amp; Nephrology2015;47(11):1899-905. [MEDLINE: 26377496]">Garcia 2015</a> reported uncertainty of differences in mean serum levels of TAC over three months (8.74 ± 1.56 ng/mL versus 8.78 ± 1.8 ng/mL). </p> </li> <li> <p><a href="./references#CD012854-bbs2-0030" title="ReeseP , BloomR , Trofe-ClarkJ , MussellA , LeidyD , LevskyS , et al. Customized reminders and provider notification to improve adherence to immunosuppression [abstract no: 1074]. American Journal of Transplantation2015;15(Suppl 3). [EMBASE: 71953144]ReesePP , BloomRD , Trofe-ClarkJ , MussellA , LeidyD , LevskyS , et al. Automated reminders and physician notification to promote immunosuppression adherence among kidney transplant recipients: a randomized trial. American Journal of Kidney Diseases2017;69(3):400-9. [MEDLINE: 27940063]">Reese 2017</a> reported no evidence for a difference in mean TAC trough levels (9.17 ± 1.41 ng/mL versus 9.08 ± 1.42 ng/mL; P = 0.14). </p> </li> <li> <p><a href="./references#CD012854-bbs2-0017" title="JungHY , JeonY , SeongSJ , SeoJJ , ChoiJY , ChoJH , et al. ICT-based adherence monitoring in kidney transplant recipients: a randomized controlled trial. BMC Medical Informatics &amp; Decision Making2020;20(1):105. [MEDLINE: 32522263]JungHY , JeonY , SeongSJ , SeoJJ , ChoiJY , ChoJH , et al. Information and communication technology-based centralized monitoring system to increase adherence to immunosuppressive medication in kidney transplant recipients: a randomized controlled trial [abstract no: P1734]. Nephrology Dialysis Transplantation2020;35(Suppl 3):iii252. [EMBASE: 633422975]JungHY , SeongSJ , ChoiJY , ChoJH , ParkSH , KimCD , et al. The efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trial. Trials [Electronic Resource]2017;18(1):480. [MEDLINE: 29037222]">Jung 2017</a> reported no evidence for a difference in mean immunosuppressant trough concentration levels (5.3 ± 1.2 ng/mL versus 5.0 ± 1.2 ng/mL; P = 0.282). </p> </li> <li> <p><a href="./references#CD012854-bbs2-0029" title="HanA , ChoMJ , ChoS , LeeCH , ChoiC , KimSY , et al. Use of mobile internet application to improve adherence to immunosuppressive medication adherence in kidney transplant recipients: preliminary results of the PRIMA (ImProving Adherence to Immunosuppressive Therapy by Mobile Internet application) study [abstract no: 420.4]. Transplantation2016;100(7 Suppl):S161. [EMBASE: 613004382]HanA , MinSI , AhnS , MinSK , HongHJ , HanN , et al. Mobile medication manager application to improve adherence with immunosuppressive therapy in renal transplant recipients: a randomized controlled trial. PLoS ONE [Electronic Resource]2019;14(11):e0224595. [MEDLINE: 31689320]KoH , KimHK , ChungC , HanA , MinSK , HaJ , et al. Association between medication adherence and intrapatient variability in tacrolimus concentration among stable kidney transplant recipients. Scientific Reports2021;11(1):5397. [MEDLINE: 33686160]">PRIMA 2019</a> reported uncertainty of differences in intra‐individual variability of serum trough levels of the index medication between the intervention and control group (12.5 (8.2 to 18.4) versus 13.3 (8.4 to 18.7); P <i>=</i> 0.906, η² = 0.0001). </p> </li> <li> <p><a href="./references#CD012854-bbs2-0026" title="Gomis-PastorM , Mirabet PerezS , Roig MinguellE , Brossa LoidiV , Lopez LopezL , Ros AbarcaS , et al. Mobile health to improve adherence and patient experience in heart transplantation recipients: the mHeart trial. Healthcare2021;9(4):463. [MEDLINE: 33919899]Gomis-PastorM , MirabetS , RoigE , BrossaV , LopezL , RosS , et al. Improving patients' experience and medication adherence after heart transplant using a multilevel ehealth intervention: the mHeart clinical trial [abstract no: P-16.07]. Transplantation2020;104(Suppl 3):S578-9. [EMBASE: 633380991]">mHeart 2021</a> reported no difference in TAC concentration variability (CV &gt; 30%) between the intervention and control groups (41% versus 47%; P = 0.526). </p> </li> <li> <p><a href="./references#CD012854-bbs2-0015" title="LowJK , ManiasE , CrawfordK , WalkerR , MulleyWR , ToussaintND , et al. Improving medication adherence in adult kidney transplantation (IMAKT): a pilot randomised controlled trial. Scientific Reports2019;9(1):7734. [MEDLINE: 31118485]">IMAKT 2019</a> reported no difference in TAC SD between the intervention and control group (2.1 (1.18 to 2.5) versus 2.3 (1.6 to 2.9)). </p> </li> <li> <p><a href="./references#CD012854-bbs2-0018" title="KaiserTE , EjazNS , TremblayS , ParrishNJ , BenavidesJ , ReheB , et al. Technology triggered adherence intervention: preliminary findings [abstract no: 185]. American Journal of Transplantation2019;19(Suppl 3):394. [EMBASE: 628454914]">Kaiser 2019</a> reported no evidence for a difference in TAC concentration variability between the intervention and control groups. </p> </li> <li> <p><a href="./references#CD012854-bbs2-0021" title="LevineD , TorabiJ , ChoinskiK , RoccaJP , GrahamJA . Transplant surgery enters a new era: increasing immunosuppressive medication adherence through mobile apps and smart watches. American Journal of Surgery2019;218(1):18-20. [MEDLINE: 30799019]">Levine 2019</a>, in a three‐arm study, reported no evidence for a difference in coefficient of variability of TAC levels between intervention 1 (mobile app + smartwatch) and control groups at three months (33.8 versus 32.8; P <i>=</i> 0.81) and no evidence for a difference between intervention 2 (mobile app) and control groups at three months (33 versus 32.8; P <i>=</i> 0.45). </p> </li> <li> <p><a href="./references#CD012854-bbs2-0012" title="HarrisonJJ , BadrS , HamandiB , KimSJ . Randomized controlled trial of a computer-based education program in the home for solid organ transplant recipients: impact on medication knowledge, satisfaction, and adherence. Transplantation2017;101(6):1336-43. [MEDLINE: 27367473]">Harrison 2016</a> reported immunosuppressant trough concentration levels as part of a combined composite adherence score. </p> </li> <li> <p><a href="./references#CD012854-bbs2-0038" title="BignallO , PaiA , AmaralS , FurthS , BergmanN , GoebelJ , et al. Differences in reported barriers to immunosuppression adherence among a cohort of pediatric renal transplant recipients from the United States and Canada [abstract no: D161]. American Journal of Transplantation2016;16(Suppl 3):751. [EMBASE: 611700425]BoucquemontJ , FosterB , TAKE-IT Investigators. Sex and age differences in medication adherence in adolescent and young adult kidney transplant recipients [abstract no: SA-PO404]. Journal of the American Society of Nephrology2016;27(Abstracts):721A. [CENTRAL: CN-01657535] BoucquemontJ , FosterB . Adherence patterns in adolescent and young adult kidney transplant recipients [abstract no: 229]. American Journal of Transplantation2016;16(Suppl 3):284. [EMBASE: 611700136]BoucquemontJ , PaiAL , DharnidharkaVR , HebertD , FurthSL , FosterBJ . Gender differences in medication adherence among adolescent and young adult kidney transplant recipients. Transplantation2019;103(4):798-806. [MEDLINE: 29994983]BoucquemontJ , PaiAL , DharnidharkaVR , HebertD , ZelikovskyN , AmaralS , et al. Association between day of the week and medication adherence among adolescent and young adult kidney transplant recipients. American Journal of Transplantation2020;20(1):274-81. [MEDLINE: 31507087]FosterB , PaiA , FurthS . The TAKE-IT intervention improves medication adherence in adolescent kidney transplant recipients [abstract no: 359]. American Journal of Transplantation2017;17(Suppl 3):332-3. [EMBASE: 615704529]FosterB , ZhaoH , PaiA , ZelikovskyN , HollyCD , SmithJM , et al. Medication adherence barrier burden predicts subsequent taking adherence in adolescent kidney transplant recipients in the TAKE-IT trial [abstract no: SA-PO1027]. Journal of the American Society of Nephrology2015;26(Abstracts):870A. [CENTRAL: CN-01657534] FosterBJ , PaiA , ZhaoH , FurthS , TAKE-IT Study Group. The TAKE-IT study: aims, design, and methods. BMC Nephrology2014;15:139. [MEDLINE: 25176317]FosterBJ , PaiAL , ZelikovskyN , AmaralS , BellL , DharnidharkaVR , et al. A randomized trial of a multicomponent intervention to promote medication adherence: the teen adherence in kidney transplant effectiveness of intervention trial (TAKE-IT) [Erratum in: Am J Kidney Dis. 2019 Apr;73(4):578]. American Journal of Kidney Diseases2018;72(1):30-41. [MEDLINE: 29602631]FosterBJ , ZhaoH , PaiA , ZelikovskyN , HollyCD , SmithJM , et al. Medication adherence barrier burden predicts subsequent adherence to dosing time schedule in adolescent kidney transplant recipients in the TAKE-IT Trial [abstract no: SA-PO1031]. Journal of the American Society of Nephrology2015;26(Abstracts):871A. [CENTRAL: CN-01657537] LadnerDP , WolfMS . Transplant regimen adherence for kidney recipients by engaging information technologies: the TAKE-IT trial [abstract no: D302]. American Journal of Transplantation2019;19(Suppl 3):1145. [EMBASE: 628453783]">TAKE‐IT 2014</a> included mean immunosuppressant trough concentration levels for paediatric participants and reported no difference between intervention and control groups for the SD of TAC trough concentration levels (1.6 (0.9 to 2.5) versus 1.4 (0.9 to 2.1); P = 0.5). </p> </li> </ul> </p> </section> <section id="CD012854-sec-0069"> <h6 class="title">Acute graft rejection</h6> <p>Eleven studies (<a href="./references#CD012854-bbs2-0001" title="KuypersDR , BonvoisinCA , PeetersP , SennesaelJJ , KiandaMN , VrijensB , et al. Superior medication adherence to tacrolimus modified release once-daily (QD) compared to tacrolimus twice-daily (BID) in stable renal transplant patients [abstract no: RO-256]. Transplant International2011;24(Suppl 2):199. [EMBASE: 70527785]KuypersDR , PeetersPC , SennesaelJJ , KiandaMN , VrijensB , KristantoP , et al. Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring. Transplantation2013;95(2):333-40. [MEDLINE: 23263559]">ADMIRAD 2013</a>; <a href="./references#CD012854-bbs2-0002" title="BessaA , MedinaJ , TedescoH , FelipeC . A prospective, randomised, controlled study to assess the effect of pharmaceutical intervention on compliance and knowledge of immunosuppression in kidney transplant recipients [abstract no: DI-090]. European Journal of Hospital Pharmacy2015;22(Suppl 1):A109-10. [EMBASE: 614322295]BessaAB , FelipeCR , HannunP , SayuriP , FelixMJ , RuppelP , et al. Prospective randomized trial investigating the influence of pharmaceutical care on the intra-individual variability of tacrolimus concentrations early after kidney transplant. Therapeutic Drug Monitoring2016;38(4):447-55. [MEDLINE: 27414973]">Bessa 2016</a>; <a href="./references#CD012854-bbs2-0010" title="GarciaMF , BravinAM , GarciaPD , ConttiMM , NgaHS , TakaseHM , et al. Behavioral measures to reduce non-adherence in renal transplant recipients: a prospective randomized controlled trial. International Urology &amp; Nephrology2015;47(11):1899-905. [MEDLINE: 26377496]">Garcia 2015</a>; <a href="./references#CD012854-bbs2-0013" title="HenrikssonJ , TydenG , HoijerJ , WadstromJ . A prospective randomized trial on the effect of using an electronic monitoring drug dispensing device to improve adherence and compliance. Transplantation2016;100(1):203-9. [MEDLINE: 26588006]HenrikssonJ , WadstromJ , HoijerJ , TydenG . A prospective randomized trial on the effect of using an electronic monitoring drug dispensary device to improve adherence and non-compliance [abstract no: BO220]. Transplant International2015;28(Suppl 4):204. [EMBASE: 72111815]">Henriksson 2016</a>; <a href="./references#CD012854-bbs2-0016" title="JoostR , DorjeF , SchwitullaJ , EckardtKU , HugoC . Intensified pharmaceutical care is improving immunosuppressive medication adherence in kidney transplant recipients during the first post-transplant year: a quasi-experimental study. Nephrology Dialysis Transplantation2014;29(8):1597-607. [MEDLINE: 24914089]">Joost 2014</a>; <a href="./references#CD012854-bbs2-0017" title="JungHY , JeonY , SeongSJ , SeoJJ , ChoiJY , ChoJH , et al. ICT-based adherence monitoring in kidney transplant recipients: a randomized controlled trial. BMC Medical Informatics &amp; Decision Making2020;20(1):105. [MEDLINE: 32522263]JungHY , JeonY , SeongSJ , SeoJJ , ChoiJY , ChoJH , et al. Information and communication technology-based centralized monitoring system to increase adherence to immunosuppressive medication in kidney transplant recipients: a randomized controlled trial [abstract no: P1734]. Nephrology Dialysis Transplantation2020;35(Suppl 3):iii252. [EMBASE: 633422975]JungHY , SeongSJ , ChoiJY , ChoJH , ParkSH , KimCD , et al. The efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trial. Trials [Electronic Resource]2017;18(1):480. [MEDLINE: 29037222]">Jung 2017</a>; <a href="./references#CD012854-bbs2-0020" title="KleinA , KramerI . Influence of a pharmaceutical care program on liver transplant patients' compliance with immunosuppressive therapy: a prospective, randomized, controlled trial [Pharmazeutische betreuung lebertransplantierter patienten unter besonderer berucksichtigung der compliance mit der immunsuppressiven therapie: Eine prospektive, randomisierte, kontrollierte studie]. Krankenhauspharmazie2007;28(12):458-68. [EMBASE: 350287720]KleinA , OttoG , KramerI . Impact of a pharmaceutical care program on liver transplant patients' compliance with immunosuppressive medication: a prospective, randomized, controlled trial using electronic monitoring. Transplantation2009;87(6):839-47. [MEDLINE: 19300186]">Klein 2007</a>; <a href="./references#CD012854-bbs2-0019" title="KantachuvessiriS , InksatidA , SumethkulV , JirasirithamS , ThirapanichW . Adherence to immunosuppression after conversion of twice-daily tacrolimus to once-daily tacrolimus in stable kidney transplant patients in Thailand: a prospective study [abstract no: P.1515]. Transplantation2016;100(7 Suppl 1):S716. [EMBASE: 613004564]">Kantachuvessiri 2016</a>; <a href="./references#CD012854-bbs2-0038" title="BignallO , PaiA , AmaralS , FurthS , BergmanN , GoebelJ , et al. Differences in reported barriers to immunosuppression adherence among a cohort of pediatric renal transplant recipients from the United States and Canada [abstract no: D161]. American Journal of Transplantation2016;16(Suppl 3):751. [EMBASE: 611700425]BoucquemontJ , FosterB , TAKE-IT Investigators. Sex and age differences in medication adherence in adolescent and young adult kidney transplant recipients [abstract no: SA-PO404]. Journal of the American Society of Nephrology2016;27(Abstracts):721A. [CENTRAL: CN-01657535] BoucquemontJ , FosterB . Adherence patterns in adolescent and young adult kidney transplant recipients [abstract no: 229]. American Journal of Transplantation2016;16(Suppl 3):284. [EMBASE: 611700136]BoucquemontJ , PaiAL , DharnidharkaVR , HebertD , FurthSL , FosterBJ . Gender differences in medication adherence among adolescent and young adult kidney transplant recipients. Transplantation2019;103(4):798-806. [MEDLINE: 29994983]BoucquemontJ , PaiAL , DharnidharkaVR , HebertD , ZelikovskyN , AmaralS , et al. Association between day of the week and medication adherence among adolescent and young adult kidney transplant recipients. American Journal of Transplantation2020;20(1):274-81. [MEDLINE: 31507087]FosterB , PaiA , FurthS . The TAKE-IT intervention improves medication adherence in adolescent kidney transplant recipients [abstract no: 359]. American Journal of Transplantation2017;17(Suppl 3):332-3. [EMBASE: 615704529]FosterB , ZhaoH , PaiA , ZelikovskyN , HollyCD , SmithJM , et al. Medication adherence barrier burden predicts subsequent taking adherence in adolescent kidney transplant recipients in the TAKE-IT trial [abstract no: SA-PO1027]. Journal of the American Society of Nephrology2015;26(Abstracts):870A. [CENTRAL: CN-01657534] FosterBJ , PaiA , ZhaoH , FurthS , TAKE-IT Study Group. The TAKE-IT study: aims, design, and methods. BMC Nephrology2014;15:139. [MEDLINE: 25176317]FosterBJ , PaiAL , ZelikovskyN , AmaralS , BellL , DharnidharkaVR , et al. A randomized trial of a multicomponent intervention to promote medication adherence: the teen adherence in kidney transplant effectiveness of intervention trial (TAKE-IT) [Erratum in: Am J Kidney Dis. 2019 Apr;73(4):578]. American Journal of Kidney Diseases2018;72(1):30-41. [MEDLINE: 29602631]FosterBJ , ZhaoH , PaiA , ZelikovskyN , HollyCD , SmithJM , et al. Medication adherence barrier burden predicts subsequent adherence to dosing time schedule in adolescent kidney transplant recipients in the TAKE-IT Trial [abstract no: SA-PO1031]. Journal of the American Society of Nephrology2015;26(Abstracts):871A. [CENTRAL: CN-01657537] LadnerDP , WolfMS . Transplant regimen adherence for kidney recipients by engaging information technologies: the TAKE-IT trial [abstract no: D302]. American Journal of Transplantation2019;19(Suppl 3):1145. [EMBASE: 628453783]">TAKE‐IT 2014</a>; <a href="./references#CD012854-bbs2-0029" title="HanA , ChoMJ , ChoS , LeeCH , ChoiC , KimSY , et al. Use of mobile internet application to improve adherence to immunosuppressive medication adherence in kidney transplant recipients: preliminary results of the PRIMA (ImProving Adherence to Immunosuppressive Therapy by Mobile Internet application) study [abstract no: 420.4]. Transplantation2016;100(7 Suppl):S161. [EMBASE: 613004382]HanA , MinSI , AhnS , MinSK , HongHJ , HanN , et al. Mobile medication manager application to improve adherence with immunosuppressive therapy in renal transplant recipients: a randomized controlled trial. PLoS ONE [Electronic Resource]2019;14(11):e0224595. [MEDLINE: 31689320]KoH , KimHK , ChungC , HanA , MinSK , HaJ , et al. Association between medication adherence and intrapatient variability in tacrolimus concentration among stable kidney transplant recipients. Scientific Reports2021;11(1):5397. [MEDLINE: 33686160]">PRIMA 2019</a>; <a href="./references#CD012854-bbs2-0036" title="TaberDJ , PosadasMA , RaoV , McGillicuddyJ , RohanV , NadigSN , et al. The potential for improved medication adherence with a complete once daily immunosuppression regimen in kidney transplant: results of a randomized controlled study [abstract no: FR-PO1177]. Journal of the American Society of Nephrology2019;30(Abstract Suppl):750-1. [EMBASE: 633769114]TaberDJ , Posadas-SalasA , SuZ , RaoV , RohanV , NadigS , et al. Preliminary assessment of safety and adherence to a once-daily immunosuppression regimen in kidney transplantation: results of a randomized controlled pilot study. Clinical Transplantation2020;34(4):e13844. [MEDLINE: 32092187]">Taber 2020</a>) reported acute rejection episode events, and eight were included in the meta‐analysis. It is uncertain whether an intervention to increase adherence to immunosuppressant adherence reduces acute graft rejection (<a href="./references#CD012854-fig-0011" title="">Analysis 4.1</a> (8 studies, 820 participants): RR 0.75, 95% CI 0.33 to 1.71; I² = 69%; low certainty evidence). <a href="./references#CD012854-bbs2-0019" title="KantachuvessiriS , InksatidA , SumethkulV , JirasirithamS , ThirapanichW . Adherence to immunosuppression after conversion of twice-daily tacrolimus to once-daily tacrolimus in stable kidney transplant patients in Thailand: a prospective study [abstract no: P.1515]. Transplantation2016;100(7 Suppl 1):S716. [EMBASE: 613004564]">Kantachuvessiri 2016</a> reported no evidence of a difference in organ rejection between the intervention and control group (data not presented in the abstract). <a href="./references#CD012854-bbs2-0017" title="JungHY , JeonY , SeongSJ , SeoJJ , ChoiJY , ChoJH , et al. ICT-based adherence monitoring in kidney transplant recipients: a randomized controlled trial. BMC Medical Informatics &amp; Decision Making2020;20(1):105. [MEDLINE: 32522263]JungHY , JeonY , SeongSJ , SeoJJ , ChoiJY , ChoJH , et al. Information and communication technology-based centralized monitoring system to increase adherence to immunosuppressive medication in kidney transplant recipients: a randomized controlled trial [abstract no: P1734]. Nephrology Dialysis Transplantation2020;35(Suppl 3):iii252. [EMBASE: 633422975]JungHY , SeongSJ , ChoiJY , ChoJH , ParkSH , KimCD , et al. The efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trial. Trials [Electronic Resource]2017;18(1):480. [MEDLINE: 29037222]">Jung 2017</a> reported acute graft rejection events in intervention or control groups. <a href="./references#CD012854-bbs2-0038" title="BignallO , PaiA , AmaralS , FurthS , BergmanN , GoebelJ , et al. Differences in reported barriers to immunosuppression adherence among a cohort of pediatric renal transplant recipients from the United States and Canada [abstract no: D161]. American Journal of Transplantation2016;16(Suppl 3):751. [EMBASE: 611700425]BoucquemontJ , FosterB , TAKE-IT Investigators. Sex and age differences in medication adherence in adolescent and young adult kidney transplant recipients [abstract no: SA-PO404]. Journal of the American Society of Nephrology2016;27(Abstracts):721A. [CENTRAL: CN-01657535] BoucquemontJ , FosterB . Adherence patterns in adolescent and young adult kidney transplant recipients [abstract no: 229]. American Journal of Transplantation2016;16(Suppl 3):284. [EMBASE: 611700136]BoucquemontJ , PaiAL , DharnidharkaVR , HebertD , FurthSL , FosterBJ . Gender differences in medication adherence among adolescent and young adult kidney transplant recipients. Transplantation2019;103(4):798-806. [MEDLINE: 29994983]BoucquemontJ , PaiAL , DharnidharkaVR , HebertD , ZelikovskyN , AmaralS , et al. Association between day of the week and medication adherence among adolescent and young adult kidney transplant recipients. American Journal of Transplantation2020;20(1):274-81. [MEDLINE: 31507087]FosterB , PaiA , FurthS . The TAKE-IT intervention improves medication adherence in adolescent kidney transplant recipients [abstract no: 359]. American Journal of Transplantation2017;17(Suppl 3):332-3. [EMBASE: 615704529]FosterB , ZhaoH , PaiA , ZelikovskyN , HollyCD , SmithJM , et al. Medication adherence barrier burden predicts subsequent taking adherence in adolescent kidney transplant recipients in the TAKE-IT trial [abstract no: SA-PO1027]. Journal of the American Society of Nephrology2015;26(Abstracts):870A. [CENTRAL: CN-01657534] FosterBJ , PaiA , ZhaoH , FurthS , TAKE-IT Study Group. The TAKE-IT study: aims, design, and methods. BMC Nephrology2014;15:139. [MEDLINE: 25176317]FosterBJ , PaiAL , ZelikovskyN , AmaralS , BellL , DharnidharkaVR , et al. A randomized trial of a multicomponent intervention to promote medication adherence: the teen adherence in kidney transplant effectiveness of intervention trial (TAKE-IT) [Erratum in: Am J Kidney Dis. 2019 Apr;73(4):578]. American Journal of Kidney Diseases2018;72(1):30-41. [MEDLINE: 29602631]FosterBJ , ZhaoH , PaiA , ZelikovskyN , HollyCD , SmithJM , et al. Medication adherence barrier burden predicts subsequent adherence to dosing time schedule in adolescent kidney transplant recipients in the TAKE-IT Trial [abstract no: SA-PO1031]. Journal of the American Society of Nephrology2015;26(Abstracts):871A. [CENTRAL: CN-01657537] LadnerDP , WolfMS . Transplant regimen adherence for kidney recipients by engaging information technologies: the TAKE-IT trial [abstract no: D302]. American Journal of Transplantation2019;19(Suppl 3):1145. [EMBASE: 628453783]">TAKE‐IT 2014</a> was not included in the meta‐analysis as it included acute graft rejection episodes for paediatric participants; it was uncertain whether acute rejection rates differed between the intervention and control group (1.69 versus 1.06 events/100 patient‐months). </p> </section> <section id="CD012854-sec-0070"> <h6 class="title">Graft loss</h6> <p>Seven studies (<a href="./references#CD012854-bbs2-0002" title="BessaA , MedinaJ , TedescoH , FelipeC . A prospective, randomised, controlled study to assess the effect of pharmaceutical intervention on compliance and knowledge of immunosuppression in kidney transplant recipients [abstract no: DI-090]. European Journal of Hospital Pharmacy2015;22(Suppl 1):A109-10. [EMBASE: 614322295]BessaAB , FelipeCR , HannunP , SayuriP , FelixMJ , RuppelP , et al. Prospective randomized trial investigating the influence of pharmaceutical care on the intra-individual variability of tacrolimus concentrations early after kidney transplant. Therapeutic Drug Monitoring2016;38(4):447-55. [MEDLINE: 27414973]">Bessa 2016</a>; <a href="./references#CD012854-bbs2-0003" title="Breu-DejeanN , DriotD , DupouyJ , Lapeyre-MestreM , RostaingL . Efficacy of psychoeducational intervention on allograft function in kidney transplant patients: 10-year results of a prospective randomized study. Experimental &amp; Clinical Transplantation2016;14(1):38-44. [MEDLINE: 26862823]Breu-DejeanN . Education program to reduce non-compliance after renal transplantation [doctorate thesis] [Effet d'une intervention psycho-éducationnelle sur l'observance thérapeutique chez les transplantés rénaux]. University of Toulouse2016. [CENTRAL: CN-01658149] Breu-DejeanNB , RontaingL , Lapeyre-MestreM , RogeB , DurandD . Educational program to reduce noncompliance after renal transplantation [abstract no: MO06]. In: 41st Congress. European Renal Association. European Dialysis and Transplantation Association; 2004 May 15-18; Lisbon, Portugal. 2004:214-5. [CENTRAL: CN-00636140] ">Breu‐Dejean 2016</a>; <a href="./references#CD012854-bbs2-0010" title="GarciaMF , BravinAM , GarciaPD , ConttiMM , NgaHS , TakaseHM , et al. Behavioral measures to reduce non-adherence in renal transplant recipients: a prospective randomized controlled trial. International Urology &amp; Nephrology2015;47(11):1899-905. [MEDLINE: 26377496]">Garcia 2015</a>; <a href="./references#CD012854-bbs2-0013" title="HenrikssonJ , TydenG , HoijerJ , WadstromJ . A prospective randomized trial on the effect of using an electronic monitoring drug dispensing device to improve adherence and compliance. Transplantation2016;100(1):203-9. [MEDLINE: 26588006]HenrikssonJ , WadstromJ , HoijerJ , TydenG . A prospective randomized trial on the effect of using an electronic monitoring drug dispensary device to improve adherence and non-compliance [abstract no: BO220]. Transplant International2015;28(Suppl 4):204. [EMBASE: 72111815]">Henriksson 2016</a>; <a href="./references#CD012854-bbs2-0017" title="JungHY , JeonY , SeongSJ , SeoJJ , ChoiJY , ChoJH , et al. ICT-based adherence monitoring in kidney transplant recipients: a randomized controlled trial. BMC Medical Informatics &amp; Decision Making2020;20(1):105. [MEDLINE: 32522263]JungHY , JeonY , SeongSJ , SeoJJ , ChoiJY , ChoJH , et al. Information and communication technology-based centralized monitoring system to increase adherence to immunosuppressive medication in kidney transplant recipients: a randomized controlled trial [abstract no: P1734]. Nephrology Dialysis Transplantation2020;35(Suppl 3):iii252. [EMBASE: 633422975]JungHY , SeongSJ , ChoiJY , ChoJH , ParkSH , KimCD , et al. The efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trial. Trials [Electronic Resource]2017;18(1):480. [MEDLINE: 29037222]">Jung 2017</a>; <a href="./references#CD012854-bbs2-0036" title="TaberDJ , PosadasMA , RaoV , McGillicuddyJ , RohanV , NadigSN , et al. The potential for improved medication adherence with a complete once daily immunosuppression regimen in kidney transplant: results of a randomized controlled study [abstract no: FR-PO1177]. Journal of the American Society of Nephrology2019;30(Abstract Suppl):750-1. [EMBASE: 633769114]TaberDJ , Posadas-SalasA , SuZ , RaoV , RohanV , NadigS , et al. Preliminary assessment of safety and adherence to a once-daily immunosuppression regimen in kidney transplantation: results of a randomized controlled pilot study. Clinical Transplantation2020;34(4):e13844. [MEDLINE: 32092187]">Taber 2020</a>; <a href="./references#CD012854-bbs2-0038" title="BignallO , PaiA , AmaralS , FurthS , BergmanN , GoebelJ , et al. Differences in reported barriers to immunosuppression adherence among a cohort of pediatric renal transplant recipients from the United States and Canada [abstract no: D161]. American Journal of Transplantation2016;16(Suppl 3):751. [EMBASE: 611700425]BoucquemontJ , FosterB , TAKE-IT Investigators. Sex and age differences in medication adherence in adolescent and young adult kidney transplant recipients [abstract no: SA-PO404]. Journal of the American Society of Nephrology2016;27(Abstracts):721A. [CENTRAL: CN-01657535] BoucquemontJ , FosterB . Adherence patterns in adolescent and young adult kidney transplant recipients [abstract no: 229]. American Journal of Transplantation2016;16(Suppl 3):284. [EMBASE: 611700136]BoucquemontJ , PaiAL , DharnidharkaVR , HebertD , FurthSL , FosterBJ . Gender differences in medication adherence among adolescent and young adult kidney transplant recipients. Transplantation2019;103(4):798-806. [MEDLINE: 29994983]BoucquemontJ , PaiAL , DharnidharkaVR , HebertD , ZelikovskyN , AmaralS , et al. Association between day of the week and medication adherence among adolescent and young adult kidney transplant recipients. American Journal of Transplantation2020;20(1):274-81. [MEDLINE: 31507087]FosterB , PaiA , FurthS . The TAKE-IT intervention improves medication adherence in adolescent kidney transplant recipients [abstract no: 359]. American Journal of Transplantation2017;17(Suppl 3):332-3. [EMBASE: 615704529]FosterB , ZhaoH , PaiA , ZelikovskyN , HollyCD , SmithJM , et al. Medication adherence barrier burden predicts subsequent taking adherence in adolescent kidney transplant recipients in the TAKE-IT trial [abstract no: SA-PO1027]. Journal of the American Society of Nephrology2015;26(Abstracts):870A. [CENTRAL: CN-01657534] FosterBJ , PaiA , ZhaoH , FurthS , TAKE-IT Study Group. The TAKE-IT study: aims, design, and methods. BMC Nephrology2014;15:139. [MEDLINE: 25176317]FosterBJ , PaiAL , ZelikovskyN , AmaralS , BellL , DharnidharkaVR , et al. A randomized trial of a multicomponent intervention to promote medication adherence: the teen adherence in kidney transplant effectiveness of intervention trial (TAKE-IT) [Erratum in: Am J Kidney Dis. 2019 Apr;73(4):578]. American Journal of Kidney Diseases2018;72(1):30-41. [MEDLINE: 29602631]FosterBJ , ZhaoH , PaiA , ZelikovskyN , HollyCD , SmithJM , et al. Medication adherence barrier burden predicts subsequent adherence to dosing time schedule in adolescent kidney transplant recipients in the TAKE-IT Trial [abstract no: SA-PO1031]. Journal of the American Society of Nephrology2015;26(Abstracts):871A. [CENTRAL: CN-01657537] LadnerDP , WolfMS . Transplant regimen adherence for kidney recipients by engaging information technologies: the TAKE-IT trial [abstract no: D302]. American Journal of Transplantation2019;19(Suppl 3):1145. [EMBASE: 628453783]">TAKE‐IT 2014</a>) reported graft loss, and five were included in the meta‐analysis. It is uncertain whether an intervention to increase adherence to immunosuppressant adherence prevents graft loss (<a href="./references#CD012854-fig-0012" title="">Analysis 4.2</a> (5 studies, 467 participants): RR 1.24, 95% CI 0.29 to 5.40; I² = 44%; low certainty evidence). <a href="./references#CD012854-bbs2-0017" title="JungHY , JeonY , SeongSJ , SeoJJ , ChoiJY , ChoJH , et al. ICT-based adherence monitoring in kidney transplant recipients: a randomized controlled trial. BMC Medical Informatics &amp; Decision Making2020;20(1):105. [MEDLINE: 32522263]JungHY , JeonY , SeongSJ , SeoJJ , ChoiJY , ChoJH , et al. Information and communication technology-based centralized monitoring system to increase adherence to immunosuppressive medication in kidney transplant recipients: a randomized controlled trial [abstract no: P1734]. Nephrology Dialysis Transplantation2020;35(Suppl 3):iii252. [EMBASE: 633422975]JungHY , SeongSJ , ChoiJY , ChoJH , ParkSH , KimCD , et al. The efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trial. Trials [Electronic Resource]2017;18(1):480. [MEDLINE: 29037222]">Jung 2017</a> reported no graft loss events in intervention and control groups. <a href="./references#CD012854-bbs2-0038" title="BignallO , PaiA , AmaralS , FurthS , BergmanN , GoebelJ , et al. Differences in reported barriers to immunosuppression adherence among a cohort of pediatric renal transplant recipients from the United States and Canada [abstract no: D161]. American Journal of Transplantation2016;16(Suppl 3):751. [EMBASE: 611700425]BoucquemontJ , FosterB , TAKE-IT Investigators. Sex and age differences in medication adherence in adolescent and young adult kidney transplant recipients [abstract no: SA-PO404]. Journal of the American Society of Nephrology2016;27(Abstracts):721A. [CENTRAL: CN-01657535] BoucquemontJ , FosterB . Adherence patterns in adolescent and young adult kidney transplant recipients [abstract no: 229]. American Journal of Transplantation2016;16(Suppl 3):284. [EMBASE: 611700136]BoucquemontJ , PaiAL , DharnidharkaVR , HebertD , FurthSL , FosterBJ . Gender differences in medication adherence among adolescent and young adult kidney transplant recipients. Transplantation2019;103(4):798-806. [MEDLINE: 29994983]BoucquemontJ , PaiAL , DharnidharkaVR , HebertD , ZelikovskyN , AmaralS , et al. Association between day of the week and medication adherence among adolescent and young adult kidney transplant recipients. American Journal of Transplantation2020;20(1):274-81. [MEDLINE: 31507087]FosterB , PaiA , FurthS . The TAKE-IT intervention improves medication adherence in adolescent kidney transplant recipients [abstract no: 359]. American Journal of Transplantation2017;17(Suppl 3):332-3. [EMBASE: 615704529]FosterB , ZhaoH , PaiA , ZelikovskyN , HollyCD , SmithJM , et al. Medication adherence barrier burden predicts subsequent taking adherence in adolescent kidney transplant recipients in the TAKE-IT trial [abstract no: SA-PO1027]. Journal of the American Society of Nephrology2015;26(Abstracts):870A. [CENTRAL: CN-01657534] FosterBJ , PaiA , ZhaoH , FurthS , TAKE-IT Study Group. The TAKE-IT study: aims, design, and methods. BMC Nephrology2014;15:139. [MEDLINE: 25176317]FosterBJ , PaiAL , ZelikovskyN , AmaralS , BellL , DharnidharkaVR , et al. A randomized trial of a multicomponent intervention to promote medication adherence: the teen adherence in kidney transplant effectiveness of intervention trial (TAKE-IT) [Erratum in: Am J Kidney Dis. 2019 Apr;73(4):578]. American Journal of Kidney Diseases2018;72(1):30-41. [MEDLINE: 29602631]FosterBJ , ZhaoH , PaiA , ZelikovskyN , HollyCD , SmithJM , et al. Medication adherence barrier burden predicts subsequent adherence to dosing time schedule in adolescent kidney transplant recipients in the TAKE-IT Trial [abstract no: SA-PO1031]. Journal of the American Society of Nephrology2015;26(Abstracts):871A. [CENTRAL: CN-01657537] LadnerDP , WolfMS . Transplant regimen adherence for kidney recipients by engaging information technologies: the TAKE-IT trial [abstract no: D302]. American Journal of Transplantation2019;19(Suppl 3):1145. [EMBASE: 628453783]">TAKE‐IT 2014</a> was not included in the meta‐analysis as it included graft loss data for paediatric participants. It reported no graft losses during the study period. </p> </section> <section id="CD012854-sec-0071"> <h6 class="title">Death</h6> <p>Six studies (<a href="./references#CD012854-bbs2-0002" title="BessaA , MedinaJ , TedescoH , FelipeC . A prospective, randomised, controlled study to assess the effect of pharmaceutical intervention on compliance and knowledge of immunosuppression in kidney transplant recipients [abstract no: DI-090]. European Journal of Hospital Pharmacy2015;22(Suppl 1):A109-10. [EMBASE: 614322295]BessaAB , FelipeCR , HannunP , SayuriP , FelixMJ , RuppelP , et al. Prospective randomized trial investigating the influence of pharmaceutical care on the intra-individual variability of tacrolimus concentrations early after kidney transplant. Therapeutic Drug Monitoring2016;38(4):447-55. [MEDLINE: 27414973]">Bessa 2016</a>; <a href="./references#CD012854-bbs2-0003" title="Breu-DejeanN , DriotD , DupouyJ , Lapeyre-MestreM , RostaingL . Efficacy of psychoeducational intervention on allograft function in kidney transplant patients: 10-year results of a prospective randomized study. Experimental &amp; Clinical Transplantation2016;14(1):38-44. [MEDLINE: 26862823]Breu-DejeanN . Education program to reduce non-compliance after renal transplantation [doctorate thesis] [Effet d'une intervention psycho-éducationnelle sur l'observance thérapeutique chez les transplantés rénaux]. University of Toulouse2016. [CENTRAL: CN-01658149] Breu-DejeanNB , RontaingL , Lapeyre-MestreM , RogeB , DurandD . Educational program to reduce noncompliance after renal transplantation [abstract no: MO06]. In: 41st Congress. European Renal Association. European Dialysis and Transplantation Association; 2004 May 15-18; Lisbon, Portugal. 2004:214-5. [CENTRAL: CN-00636140] ">Breu‐Dejean 2016</a>; <a href="./references#CD012854-bbs2-0009" title="DeVito DabbsA , DewM , MyersBA , SongM , LiR , ZomakR , et al. Randomized controlled trial (RCT) of pocket path, an mhealth intervention to promote self-management after lung transplantation [abstract no: A5361]. American Journal of Respiratory &amp; Critical Care Medicine2014;189:A5361. [EMBASE: 72047364]DeVito DabbsA , SongMK , MyersBA , LiR , HawkinsRP , PilewskiJM , et al. A randomized controlled trial of a mobile health intervention to promote self-management after lung transplantation. American Journal of Transplantation2016;16(7):2172-80. [MEDLINE: 26729617]GeramitaEM , DeVito DabbsAJ , DiMartiniAF , PilewskiJM , SwitzerGE , PoslusznyDM , et al. Impact of a mobile health intervention on long-term nonadherence after lung transplantation: follow-up after a randomized controlled trial. Transplantation2020;104(3):640-51. [MEDLINE: 31335759]HuL , DeVito DabbsA , DewMA , SereikaSM , LinglerJH . Patterns and correlates of adherence to self-monitoring in lung transplant recipients during the first 12 months after discharge from transplant. Clinical Transplantation2017;31(8):e13014. [MEDLINE: 28517112]RosenbergerEM , Devito DabbsAJ , DiMartiniAF , LandsittelDP , PilewskiJM , DewMA . Long-term follow-up of a randomized controlled trial evaluating a mobile health intervention for self-management in lung transplant recipients. American Journal of Transplantation2017;17(5):1286-93. [MEDLINE: 27664940]">DeVito Dabbs 2016</a>; <a href="./references#CD012854-bbs2-0010" title="GarciaMF , BravinAM , GarciaPD , ConttiMM , NgaHS , TakaseHM , et al. Behavioral measures to reduce non-adherence in renal transplant recipients: a prospective randomized controlled trial. International Urology &amp; Nephrology2015;47(11):1899-905. [MEDLINE: 26377496]">Garcia 2015</a>; <a href="./references#CD012854-bbs2-0035" title="SuhlingH , RademacherJ , ZinowskyI , FugeJ , GreerM , WarneckeG , et al. Conventional vs. tablet computer-based patient education following lung transplantation--a randomized controlled trial. PLoS ONE [Electronic Resource]2014;9(6):e90828. [MEDLINE: 24608864]SuhlingH , RademacherJ , ZinowskyI , FugeJ , GreerM , WarneckeG . Patient education via tablet-pc vs. conventional to improve compliance with immunosuppressive drug regimen after lung transplantation - a randomized controlled trial [abstract no: 2844]. European Respiratory Journal2013;42(Suppl 57):565S. [EMBASE: 71843332]">Suhling 2014</a>; <a href="./references#CD012854-bbs2-0036" title="TaberDJ , PosadasMA , RaoV , McGillicuddyJ , RohanV , NadigSN , et al. The potential for improved medication adherence with a complete once daily immunosuppression regimen in kidney transplant: results of a randomized controlled study [abstract no: FR-PO1177]. Journal of the American Society of Nephrology2019;30(Abstract Suppl):750-1. [EMBASE: 633769114]TaberDJ , Posadas-SalasA , SuZ , RaoV , RohanV , NadigS , et al. Preliminary assessment of safety and adherence to a once-daily immunosuppression regimen in kidney transplantation: results of a randomized controlled pilot study. Clinical Transplantation2020;34(4):e13844. [MEDLINE: 32092187]">Taber 2020</a>) reported death during the study follow‐up period. It is uncertain whether an intervention to increase adherence to immunosuppressant adherence prevents death (<a href="./references#CD012854-fig-0013" title="">Analysis 4.3</a> (6 studies, 652 participants): RR 1.04, 95% CI 0.77 to 1.40; I² = 0%; low certainty evidence). </p> </section> <section id="CD012854-sec-0072"> <h6 class="title">Hospital admission</h6> <p>Seven studies (<a href="./references#CD012854-bbs2-0002" title="BessaA , MedinaJ , TedescoH , FelipeC . A prospective, randomised, controlled study to assess the effect of pharmaceutical intervention on compliance and knowledge of immunosuppression in kidney transplant recipients [abstract no: DI-090]. European Journal of Hospital Pharmacy2015;22(Suppl 1):A109-10. [EMBASE: 614322295]BessaAB , FelipeCR , HannunP , SayuriP , FelixMJ , RuppelP , et al. Prospective randomized trial investigating the influence of pharmaceutical care on the intra-individual variability of tacrolimus concentrations early after kidney transplant. Therapeutic Drug Monitoring2016;38(4):447-55. [MEDLINE: 27414973]">Bessa 2016</a>; <a href="./references#CD012854-bbs2-0005" title="Chisholm-BurnsM , SpiveyC , Graff ZivinJ , LeeJ , SredzinskiE . Results of a behavioral contract intervention to improve adherence and healthcare outcomes among renal transplant recipients [abstract no: D1727]. American Journal of Transplantation2013;13(Suppl S5):540. [CENTRAL: CN-01007771] Chisholm-BurnsMA , EricksonS , SpiveyCA . Employment and health-related quality of life among renal transplant recipients [abstract no: 1140]. American Journal of Transplantation2011;11(Suppl 2):365. [EMBASE: 70406190]Chisholm-BurnsMA , SpiveyCA , GraffZJ , LeeJK , SredzinskiE , TolleyEA . Improving outcomes of renal transplant recipients with behavioral adherence contracts: a randomized controlled trial. American Journal of Transplantation2013;13(9):2364-73. [MEDLINE: 23819827]Chisholm-BurnsMA , SpiveyCA , SredzinskiE , ButlerS . Preliminary results of a behavioral contract intervention to improve adherence and quality of life among renal transplant recipients [abstract no: 1139]. American Journal of Transplantation2011;11(Suppl 2):365. [EMBASE: 70406189]Chisholm-BurnsMA , SpiveyCA , SredzinskiE , ButlerSL . Intervention toolbox to promote immunosuppressant therapy adherence in adult renal transplant recipients. Journal of the American Pharmacists Association: JAPhA2012;52(6):816-22. [MEDLINE: 23229970]">Chisholm‐Burns 2013</a>; <a href="./references#CD012854-bbs2-0009" title="DeVito DabbsA , DewM , MyersBA , SongM , LiR , ZomakR , et al. Randomized controlled trial (RCT) of pocket path, an mhealth intervention to promote self-management after lung transplantation [abstract no: A5361]. American Journal of Respiratory &amp; Critical Care Medicine2014;189:A5361. [EMBASE: 72047364]DeVito DabbsA , SongMK , MyersBA , LiR , HawkinsRP , PilewskiJM , et al. A randomized controlled trial of a mobile health intervention to promote self-management after lung transplantation. American Journal of Transplantation2016;16(7):2172-80. [MEDLINE: 26729617]GeramitaEM , DeVito DabbsAJ , DiMartiniAF , PilewskiJM , SwitzerGE , PoslusznyDM , et al. Impact of a mobile health intervention on long-term nonadherence after lung transplantation: follow-up after a randomized controlled trial. Transplantation2020;104(3):640-51. [MEDLINE: 31335759]HuL , DeVito DabbsA , DewMA , SereikaSM , LinglerJH . Patterns and correlates of adherence to self-monitoring in lung transplant recipients during the first 12 months after discharge from transplant. Clinical Transplantation2017;31(8):e13014. [MEDLINE: 28517112]RosenbergerEM , Devito DabbsAJ , DiMartiniAF , LandsittelDP , PilewskiJM , DewMA . Long-term follow-up of a randomized controlled trial evaluating a mobile health intervention for self-management in lung transplant recipients. American Journal of Transplantation2017;17(5):1286-93. [MEDLINE: 27664940]">DeVito Dabbs 2016</a>; <a href="./references#CD012854-bbs2-0013" title="HenrikssonJ , TydenG , HoijerJ , WadstromJ . A prospective randomized trial on the effect of using an electronic monitoring drug dispensing device to improve adherence and compliance. Transplantation2016;100(1):203-9. [MEDLINE: 26588006]HenrikssonJ , WadstromJ , HoijerJ , TydenG . A prospective randomized trial on the effect of using an electronic monitoring drug dispensary device to improve adherence and non-compliance [abstract no: BO220]. Transplant International2015;28(Suppl 4):204. [EMBASE: 72111815]">Henriksson 2016</a>; <a href="./references#CD012854-bbs2-0035" title="SuhlingH , RademacherJ , ZinowskyI , FugeJ , GreerM , WarneckeG , et al. Conventional vs. tablet computer-based patient education following lung transplantation--a randomized controlled trial. PLoS ONE [Electronic Resource]2014;9(6):e90828. [MEDLINE: 24608864]SuhlingH , RademacherJ , ZinowskyI , FugeJ , GreerM , WarneckeG . Patient education via tablet-pc vs. conventional to improve compliance with immunosuppressive drug regimen after lung transplantation - a randomized controlled trial [abstract no: 2844]. European Respiratory Journal2013;42(Suppl 57):565S. [EMBASE: 71843332]">Suhling 2014</a>; <a href="./references#CD012854-bbs2-0036" title="TaberDJ , PosadasMA , RaoV , McGillicuddyJ , RohanV , NadigSN , et al. The potential for improved medication adherence with a complete once daily immunosuppression regimen in kidney transplant: results of a randomized controlled study [abstract no: FR-PO1177]. Journal of the American Society of Nephrology2019;30(Abstract Suppl):750-1. [EMBASE: 633769114]TaberDJ , Posadas-SalasA , SuZ , RaoV , RohanV , NadigS , et al. Preliminary assessment of safety and adherence to a once-daily immunosuppression regimen in kidney transplantation: results of a randomized controlled pilot study. Clinical Transplantation2020;34(4):e13844. [MEDLINE: 32092187]">Taber 2020</a>; <a href="./references#CD012854-bbs2-0039" title="FlemingJN , GebregziabherM , PosadasA , SuZ , McGillicuddyJW , TaberDJ . Impact of a pharmacist-led, mHealth-based intervention on tacrolimus trough variability in kidney transplant recipients: a report from the TRANSAFE Rx randomized controlled trial. American Journal of Health-System Pharmacy2021;78(14):1287-93. [MEDLINE: 33821958]FlemingJN , TreiberF , McGillicuddyJ , GebregziabherM , TaberDJ . Improving transplant medication safety through a pharmacist-empowered, patient-centered, mhealth-based intervention: TRANSAFE Rx study protocol. JMIR Research Protocols2018;7(3):e59. [MEDLINE: 29500161]GonzalesHM , FlemingJN , GebregziabherM , Posadas-SalasMA , SuZ , McGillicuddyJW , et al. Pharmacist-led mobile health intervention and transplant medication safety: a randomized controlled clinical trial. Clinical Journal of the American Society of Nephrology: CJASN2021;16(5):776-84. [MEDLINE: 33931415]TaberDJ , FlemingJN , SuZ , MauldinP , McGillicuddyJW , PosadasA , et al. Significant hospitalization cost savings to the payer with a pharmacist-led mobile health intervention to improve medication safety in kidney transplant recipients. American Journal of Transplantation2021;21(10):3428-35. [MEDLINE: 34197699]TaberDJ , PilchNA , McGillicuddyJW , MardisC , TreiberF , FlemingJN . Using informatics and mobile health to improve medication safety monitoring in kidney transplant recipients. American Journal of Health-System Pharmacy2019;76(15):1143-9. [MEDLINE: 31361870]">TRANSAFE‐Rx 2018</a>) reported hospital admissions. It is uncertain whether an intervention to increase adherence to immunosuppressant adherence prevents hospital readmission. (<a href="./references#CD012854-fig-0014" title="">Analysis 4.4</a> (5 studies, 460 participants): RR 0.67, 95% CI 0.44 to 1.02; I² = 64%; low certainty evidence). <a href="./references#CD012854-bbs2-0009" title="DeVito DabbsA , DewM , MyersBA , SongM , LiR , ZomakR , et al. Randomized controlled trial (RCT) of pocket path, an mhealth intervention to promote self-management after lung transplantation [abstract no: A5361]. American Journal of Respiratory &amp; Critical Care Medicine2014;189:A5361. [EMBASE: 72047364]DeVito DabbsA , SongMK , MyersBA , LiR , HawkinsRP , PilewskiJM , et al. A randomized controlled trial of a mobile health intervention to promote self-management after lung transplantation. American Journal of Transplantation2016;16(7):2172-80. [MEDLINE: 26729617]GeramitaEM , DeVito DabbsAJ , DiMartiniAF , PilewskiJM , SwitzerGE , PoslusznyDM , et al. Impact of a mobile health intervention on long-term nonadherence after lung transplantation: follow-up after a randomized controlled trial. Transplantation2020;104(3):640-51. [MEDLINE: 31335759]HuL , DeVito DabbsA , DewMA , SereikaSM , LinglerJH . Patterns and correlates of adherence to self-monitoring in lung transplant recipients during the first 12 months after discharge from transplant. Clinical Transplantation2017;31(8):e13014. [MEDLINE: 28517112]RosenbergerEM , Devito DabbsAJ , DiMartiniAF , LandsittelDP , PilewskiJM , DewMA . Long-term follow-up of a randomized controlled trial evaluating a mobile health intervention for self-management in lung transplant recipients. American Journal of Transplantation2017;17(5):1286-93. [MEDLINE: 27664940]">DeVito Dabbs 2016</a> reported hospital readmissions as the median number of hospitalised days and found no evidence of a difference in the percentage of lung transplant recipients who had at least one hospital readmission or cumulative rehospitalisation days during the follow‐up period. <a href="./references#CD012854-bbs2-0039" title="FlemingJN , GebregziabherM , PosadasA , SuZ , McGillicuddyJW , TaberDJ . Impact of a pharmacist-led, mHealth-based intervention on tacrolimus trough variability in kidney transplant recipients: a report from the TRANSAFE Rx randomized controlled trial. American Journal of Health-System Pharmacy2021;78(14):1287-93. [MEDLINE: 33821958]FlemingJN , TreiberF , McGillicuddyJ , GebregziabherM , TaberDJ . Improving transplant medication safety through a pharmacist-empowered, patient-centered, mhealth-based intervention: TRANSAFE Rx study protocol. JMIR Research Protocols2018;7(3):e59. [MEDLINE: 29500161]GonzalesHM , FlemingJN , GebregziabherM , Posadas-SalasMA , SuZ , McGillicuddyJW , et al. Pharmacist-led mobile health intervention and transplant medication safety: a randomized controlled clinical trial. Clinical Journal of the American Society of Nephrology: CJASN2021;16(5):776-84. [MEDLINE: 33931415]TaberDJ , FlemingJN , SuZ , MauldinP , McGillicuddyJW , PosadasA , et al. Significant hospitalization cost savings to the payer with a pharmacist-led mobile health intervention to improve medication safety in kidney transplant recipients. American Journal of Transplantation2021;21(10):3428-35. [MEDLINE: 34197699]TaberDJ , PilchNA , McGillicuddyJW , MardisC , TreiberF , FlemingJN . Using informatics and mobile health to improve medication safety monitoring in kidney transplant recipients. American Journal of Health-System Pharmacy2019;76(15):1143-9. [MEDLINE: 31361870]">TRANSAFE‐Rx 2018</a> reported evidence for lower rates of hospitalisation in the intervention group (0.65 versus 1.08 hospitalisations/person‐years; P = 0.007). </p> </section> <section id="CD012854-sec-0073"> <h6 class="title">Health‐related quality of life</h6> <p>Six studies reported HRQoL, with heterogeneity across types of measures.</p> <p> <ul id="CD012854-list-0014"> <li> <p><a href="./references#CD012854-bbs2-0008" title="DeVito DabbsA , DewMA , MyersB , BegeyA , HawkinsR , RenD , et al. Evaluation of a hand-held, computer-based intervention to promote early self-care behaviors after lung transplant. Clinical Transplantation2009;23(4):537-45. [MEDLINE: 19473201]">DeVito Dabbs 2009</a> reported a difference in SF‐36 physical function scores between the intervention and control groups (F(1,27) = 7.6, P &lt; 0.0125, r = 0.46, t‐scores not reported). There was no evidence of a difference in SF‐36 mental function scores between the intervention and control groups. </p> </li> <li> <p><a href="./references#CD012854-bbs2-0016" title="JoostR , DorjeF , SchwitullaJ , EckardtKU , HugoC . Intensified pharmaceutical care is improving immunosuppressive medication adherence in kidney transplant recipients during the first post-transplant year: a quasi-experimental study. Nephrology Dialysis Transplantation2014;29(8):1597-607. [MEDLINE: 24914089]">Joost 2014</a> reported no difference in SF‐36 scores between the intervention and control groups (data not presented by group). </p> </li> <li> <p><a href="./references#CD012854-bbs2-0022" title="LiuJ . Effect of WeChat-based peer education on medication compliance and quality of life in patients with liver transplantation: a pilot study [abstract no: P-576]. Transplantation2019;103(8 Suppl 1):380. [EMBASE: 629265854]">Liu 2019c</a> reported no improvement at any measurement interval following the intervention; however, the method of measurement of QoL was not reported. </p> </li> <li> <p><a href="./references#CD012854-bbs2-0033" title="HilsS , SchmidA , BogatyrevaL , HauschkeD , Kramer-ZuckerA , PisarskiP . Telemedical supported aftercare after living kidney transplantation-a single center experience [abstract no: O179]. Transplant International2015;28(Suppl 4):69. [EMBASE: 72111423]HilsS , SchmidA , BogatyrevaL , HauschkeD , PisarskiP . Telemedical supported aftercare as an innovative project-study improves the quality of life after living kidney transplantation-a single center experience [abstract no: D2730]. Transplantation2014;98(Suppl 1):843. [EMBASE: 71546416]KaierK , HilsS , FetzerS , HehnP , SchmidA , HauschkeD , et al. Results of a randomized controlled trial analyzing telemedically supported case management in the first year after living donor kidney transplantation - a budget impact analysis from the healthcare perspective. Health Economics Review2017;7(1):1. [MEDLINE: 28092012]PisarskiP , HilsS , SchmidA , Kramer-ZuckerA , JanigenB . Telemedicin as an innovative project-study in adherence improvement after living kidney transplantation at the Transplantation Center Freiburg [abstract no: O162]. Transplant International2013;26(Suppl 2):73. [EMBASE: 71359226]SchmidA , HilsS , Kramer-ZuckerA , BogatyrevaL , HauschkeD , De GeestS , et al. Telemedically-supported case management of living-donor renal transplant recipients to optimize routine evidence-based aftercare: a single-center randomized controlled trial. American Journal of Transplantation2017;17(6):1594-605. [MEDLINE: 27873477]SchmidA , PisarskiP , HilsS , HauschkeD , BogatyrevaL . Telemedical supported after care in living kidney recipients-an innovative project-study at the Transplantation Center Freiburg interim results of a prospective ongoing study of 50 patients [abstract no: P84]. Transplant International2013;26(Suppl 1):43. [EMBASE: 71356349]">Schmid 2017</a> reported that psychological distress measured by the Brief Symptom Inventory 18 decreased in both groups, and HRQoL measured by the Fragebogen Alltagleben scale increased over the first year post‐transplant, with no scores or statistical analysis results provided. On the End‐Stage Renal Disease Symptom Checklist Transplantation Module, the intervention group reported less symptoms at 12 months in two subscales, cardiac and renal dysfunction, and side effects of corticosteroids (median = 0, IQR = 0.2 versus median = 0.4, IQR = 0.6; U = 133, P = 0.004, r = 0.42). </p> </li> <li> <p><a href="./references#CD012854-bbs2-0040" title="UrstadKH , OyenO , AndersenMH , MoumT , WahlAK . The effect of an educational intervention for renal recipients: a randomized controlled trial. Clinical Transplantation2012;26(3):E246-53. [MEDLINE: 22686948]">Urstad 2012</a> reported a difference in SF‐12 mental function scores between the intervention and control groups (effect size = 0.53, units not reported, P <i>=</i> 0.001). </p> </li> <li> <p><a href="./references#CD012854-bbs2-0028" title="AmaralS , FosterN , DashefskyH , KimJ , FurthS . Peers4path: challenges in measuring medication adherence in adolescent transplant recipients [abstract no: A485]. American Journal of Transplantation2014;14(Suppl 3):238. [EMBASE: 71544246]AmaralS , FosterN , DashefskyH , PaternoC , FurthS . Peers4Path: feasibility of medication adherence measures in adolescent transplant recipients [abstract no: FR-PO403]. Journal of the American Society of Nephrology2014;25(Abstracts):463A. [CENTRAL: CN-01657532] AmaralS , FosterN , YangA , ShultsJ , FurthS . Peers4Path: testing peer support as a mechanism to improve transplant outcomes among adolescents with solid organ transplants [abstract no: TH-PO1083]. Journal of the American Society of Nephrology2013;24(Abstracts):345-6A. [CENTRAL: CN-01657533] AmaralS , RogersR , PaternoC , FosterN , ShultsJ . Peers4path (promoting adolescent transplant health): a pilot study to test peer mentoring as an adherence intervention in adolescent transplant recipients [abstract no: 401.1]. Pediatric Transplantation2017;21(Suppl 1):33. [EMBASE: 616208171]StrachanC , PatonM , ReasonJ , AmaralS . Stakeholder perspectives in peer mentoring program for pediatric solid organ transplant recipients [abstract no: D323]. American Journal of Transplantation2019;19(Suppl 3):1153. [EMBASE: 628454820]">Peers4path 2014</a> reported improved QoL related to medication taking in the intervention group in adolescent patients (data not provided). </p> </li> </ul> </p> <p>No harms were reported in relation to intervention participation</p> </section> </section> <section id="CD012854-sec-0074"> <h5 class="title">Subgroup and sensitivity analysis </h5> <p>Overall, the planned subgroup and sensitivity analyses to explore sources of heterogeneity were not possible due to the lack of data observations and heterogeneity in the measurement of outcomes. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD012854-sec-0075" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD012854-sec-0075"></div> <section id="CD012854-sec-0076"> <h3 class="title" id="CD012854-sec-0076">Summary of main results</h3> <p>In this review, we have summarised 40 studies (103 reports) involving 3896 randomised participants (3718 adults, 178 adolescents) reporting the effects of a range of types of interventions to increase adherence to immunosuppressant therapy and related outcomes following a solid organ transplant. Nearly all studies focused on adult transplant recipients, with only two studies including adolescents. The majority of studies included kidney transplant recipients (80%). There was considerable heterogeneity in intervention duration, ranging from two to 12 months, and length of follow‐up, ranging from three to 120 months. Twenty‐seven out of 40 interventions were multi‐component interventions, with more than one behaviour change technique included. Risks of bias in the included studies were often unclear, particularly as five of the included studies were conference abstracts and information required to judge the risk of bias wasn't presented fully. </p> <p>There was low certainty evidence that interventions may increase dosing adherence to immunosuppressant medication, suggesting adherence interventions may support clinically important increases in the correct implementation of the immunosuppressant medication regimen. Based on a meta‐analysis of low‐certainty evidence, it is uncertain whether adherence interventions increased taking and timing adherence and reduction of drug holidays. A meta‐analysis of low certainty evidence showed limited evidence that an intervention to increase immunosuppressant adherence had an effect on secondary outcomes that represent surrogate clinical markers of immunosuppressant non‐adherence, including self‐reported adherence, drug trough concentration levels, acute graft rejection, graft loss and death, however it may reduce hospitalisations. Interpretation of effects of trough concentration levels of immunosuppressant medication was complicated by variability in target trough concentration levels across studies, in addition to consideration of dosing strategies and pharmacokinetics for once‐daily versus twice‐daily immunosuppressant medication formulations. It is important to note that clinical events such as death and graft loss are rare in short‐term follow‐up after an organ transplant (<a href="./references#CD012854-bbs2-0089" title="ForoutanF , FriesenEL , ClarkKE , MotaghiS , ZylaR , LeeY , et al. Risk factors for 1-year graft loss after kidney transplantation: systematic review and meta-analysis. Clinical Journal of The American Society of Nephrology: CJASN2019;14(11):1642-50. [MEDLINE: 31540931]">Foroutan 2019</a>) therefore, the studies included in this review were underpowered to examine the potential effects for these outcomes, and the current absence of evidence for these outcomes is insufficient to guide clinical practice at present. There was limited effect on patient‐reported health outcomes such as HRQoL. Due to the heterogeneity of intervention types and small sample sizes, we didn't have enough information to assess intervention efficacy by type of intervention. </p> <p>Overall, the currently available data in this review may provide some provisional evidence that interventions to increase adherence to immunosuppressant therapy may be of benefit clinically when attempting to increase dosing adherence post‐transplant. Interventions to increase adherence are difficult to study, given the variability in intervention content. Due to heterogeneity in the measurement and definition of adherence and outcomes and limitations in studies based on the reporting of methods, the confidence in the evidence was downgraded from high confidence to low confidence. None of the included studies included an economic evaluation of intervention cost‐effectiveness. Given the use of technology in several of the interventions, combined with health care professional time in delivering education, feedback and behavioural interventions (<a href="./references#CD012854-bbs2-0106" title="OberjéEJ , deKinderenRJ , EversSM , vanWoerkumCM , deBruinM . Cost effectiveness of medication adherence-enhancing interventions: a systematic review of trial-based economic evaluations. Pharmacoeconomics2013;31(12):1155-68. [MEDLINE: 24222477]">Oberjé 2013</a>), it is unknown if the interventions summarised here were cost‐effective and could be pragmatically integrated into routine clinical care </p> </section> <section id="CD012854-sec-0077"> <h3 class="title" id="CD012854-sec-0077">Overall completeness and applicability of evidence</h3> <p>We aimed to provide a comprehensive analysis of the benefits and harms of interventions to increase adherence to immunosuppressant therapy following a solid organ transplant. Whilst some evidence in support of adherence interventions was reported, we could not robustly assess the effect of these adherence interventions, as there was considerable heterogeneity in intervention type, sample size and measurement of the primary and secondary outcomes. This limited the potential to reasonably combine study results for meta‐analysis, which potentially limits the internal validity of the results of the review. The limited number of studies identified for inclusion prevented examination of possible sources of heterogeneity in subgroup analysis, including the impact of age, type of organ transplant, first versus subsequent transplant, objective versus subjective adherence and intervention type. Notably, there was no evidence of harm from participation in the intervention, indicating a low risk of adverse events in the considered interventions </p> </section> <section id="CD012854-sec-0078"> <h3 class="title" id="CD012854-sec-0078">Quality of the evidence</h3> <p>We assessed the quality of evidence using standard risks of bias domains specified by the Cochrane Risk of Bias tool and GRADE methodology. Five studies had data extracted from conference abstracts, which limited the comprehensive risk of bias assessment. The majority of studies were judged to be at high risk of bias for performance bias, as participants were unblinded in all studies. It must be noted that blinding participants to the intervention is difficult in this setting, given the required active participation in multi‐component interventions. Most studies were also judged to be at high risk of detection bias. Again, this is perhaps unrealistic to achieve in this setting, given the required engagement with technology and/or healthcare staff for medication management. Selection bias and reporting bias were judged to be at low risk across the majority of the studies. Using GRADE, the certainty of the evidence was assessed as low for all reported outcomes due to uncertain or high risk of bias, substantial inconsistency in intervention type and outcome measurement, and small, heterogeneous study populations. Further consideration is needed when assessing the risk of bias in complex, multi‐component behavioural interventions, as these methodologies may be susceptible to poorly understood forms of bias arising from participation (<a href="./references#CD012854-bbs2-0099" title="McCambridgeJ , KypriK , ElbourneD . In randomization we trust? There are overlooked problems in experimenting with people in behavioral intervention trials. Journal of Clinical Epidemiology2014;67(3):247-53. [MEDLINE: 24314401]">McCambridge 2014</a>). </p> <p>We identified inconsistencies in defining and measuring immunosuppressant medication adherence and surrogate markers of immunosuppressant medication adherence across the included interventions. The ESPACOMP Medication Adherence Reporting Guideline (EMERGE) group have called for transparency and consistency in measuring adherence and reporting medication adherence enhancing trials (<a href="./references#CD012854-bbs2-0081" title="De GeestS , ZulligLL , Dunbar-JacobJ , HelmyR , HughesDA , WilsonIB , et al. ESPACOMP Medication Adherence Reporting Guideline (EMERGE). Annals of Internal Medicine2018;169(1):30-5. [MEDLINE: 29946690]">De Geest 2018</a>). The ABC Taxonomy for describing and measuring adherence is considered state‐of‐the‐art when studying adherence in clinical populations (<a href="./references#CD012854-bbs2-0117" title="VrijensB , DimaAL , Van GanseE , vanBovenJF , EakinMN , FosterJM , et al. What we mean when we talk about adherence in respiratory mMedicine. Journal of Allergy &amp; Clinical Immunology in Practice2016;4(5):802-12. [MEDLINE: 27587314]">Vrijens 2016</a>) and was applied in this review to clearly delineate between the separate phases of adhering to an immunosuppressant medication regimen and reduce the heterogeneity of outcome measurement across intervention types. </p> </section> <section id="CD012854-sec-0079"> <h3 class="title" id="CD012854-sec-0079">Potential biases in the review process</h3> <p>A strength of this review includes its conduct according to a pre‐specified protocol. The main potential bias relates to the heterogeneity in the definition and measurement of the primary outcome. This resulted in pooled data for meta‐analyses which may have yielded unreliable effect estimates and precluded meta‐analysis for some outcomes. Another potential bias must be acknowledged in relation to our search strategy. Whilst the Cochrane Kidney and Transplant Specialised Register was systematically searched for this review, it is possible that some potentially eligible studies were missed due to publication after our last search date or missed conference proceedings. </p> </section> <section id="CD012854-sec-0080"> <h3 class="title" id="CD012854-sec-0080">Agreements and disagreements with other studies or reviews</h3> <p>Our findings are more comprehensive than previously published systematic reviews in this area and, overall, contain findings that are more cautious. A systematic review of 12 intervention studies in heart, kidney and liver transplant recipients (<a href="./references#CD012854-bbs2-0080" title="De BleserL , MattesonM , DobbelsF , RussellC , De GeestS . Interventions to improve medication adherence after transplantation: a systematic review. Transplant International2009;22(8):780-97. [MEDLINE: 19386076]">De Bleser 2009</a>) reported that combination interventions as part of a team approach in post‐transplant care may be effective in increasing adherence. Similarly, in a systematic review of 12 studies in kidney transplant patients, <a href="./references#CD012854-bbs2-0097" title="LowJK , WilliamsA , ManiasE , CrawfordK . Interventions to improve medication adherence in adult kidney transplant recipients: a systematic review. Nephrology Dialysis Transplantation2014;30(5):752-61. [MEDLINE: 24950938]">Low 2015</a> reported that multi‐dimensional interventions targeting behavioural risk factors may be most effective for enhancing medication adherence. This review was unable to form any conclusions on the effectiveness of different intervention types because of the limited number of studies of each type identified here. Similar to this review, both <a href="./references#CD012854-bbs2-0080" title="De BleserL , MattesonM , DobbelsF , RussellC , De GeestS . Interventions to improve medication adherence after transplantation: a systematic review. Transplant International2009;22(8):780-97. [MEDLINE: 19386076]">De Bleser 2009</a> and <a href="./references#CD012854-bbs2-0097" title="LowJK , WilliamsA , ManiasE , CrawfordK . Interventions to improve medication adherence in adult kidney transplant recipients: a systematic review. Nephrology Dialysis Transplantation2014;30(5):752-61. [MEDLINE: 24950938]">Low 2015</a> highlight limitations and differences in operational definitions of adherence and poor reporting of intervention and usual care content. Our findings also concur with those of <a href="./references#CD012854-bbs2-0104" title="NieuwlaatR , WilczynskiN , NavarroT , HobsonN , JefferyR , KeepanasserilA , et al. Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews2014, Issue 11. Art. No: CD000011. [DOI: 10.1002/14651858.CD000011.pub4]">Nieuwlaat 2014</a>, who examined interventions to enhance medication adherence in chronic health conditions in a Cochrane review and reported that significant heterogeneity in intervention types and outcome measurement, and a high risk of bias, resulted in inconsistent effects across studies. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD012854-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/urn:x-wiley:14651858:media:CD012854:CD012854-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD012854-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_n/nCD012854-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_t/tCD012854-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/full#CD012854-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_n/nCD012854-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012854-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/urn:x-wiley:14651858:media:CD012854:CD012854-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD012854-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_n/nCD012854-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_t/tCD012854-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/full#CD012854-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_n/nCD012854-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012854-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/urn:x-wiley:14651858:media:CD012854:CD012854-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012854-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_n/nCD012854-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_t/tCD012854-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/full#CD012854-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_n/nCD012854-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012854-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/urn:x-wiley:14651858:media:CD012854:CD012854-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Implementation of medication adherence, Outcome 1: Taking adherence" data-id="CD012854-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_n/nCD012854-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_t/tCD012854-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Implementation of medication adherence, Outcome 1: Taking adherence</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/references#CD012854-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_n/nCD012854-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012854-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/urn:x-wiley:14651858:media:CD012854:CD012854-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Implementation of medication adherence, Outcome 2: Dosing adherence" data-id="CD012854-fig-0005" src="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_n/nCD012854-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_t/tCD012854-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Implementation of medication adherence, Outcome 2: Dosing adherence</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/references#CD012854-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_n/nCD012854-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012854-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/urn:x-wiley:14651858:media:CD012854:CD012854-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Implementation of medication adherence, Outcome 3: Timing adherence" data-id="CD012854-fig-0006" src="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_n/nCD012854-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_t/tCD012854-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Implementation of medication adherence, Outcome 3: Timing adherence</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/references#CD012854-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_n/nCD012854-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012854-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/urn:x-wiley:14651858:media:CD012854:CD012854-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Implementation of medication adherence, Outcome 4: Drug holidays" data-id="CD012854-fig-0007" src="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_n/nCD012854-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_t/tCD012854-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Implementation of medication adherence, Outcome 4: Drug holidays</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/references#CD012854-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_n/nCD012854-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012854-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/urn:x-wiley:14651858:media:CD012854:CD012854-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Subjective adherence, Outcome 1: Self‐reported adherence (proportion)" data-id="CD012854-fig-0008" src="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_n/nCD012854-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_t/tCD012854-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Subjective adherence, Outcome 1: Self‐reported adherence (proportion)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/references#CD012854-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_n/nCD012854-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012854-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/urn:x-wiley:14651858:media:CD012854:CD012854-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Subjective adherence, Outcome 2: Self‐reported adherence (mean)" data-id="CD012854-fig-0009" src="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_n/nCD012854-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_t/tCD012854-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Subjective adherence, Outcome 2: Self‐reported adherence (mean)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/references#CD012854-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_n/nCD012854-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012854-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/urn:x-wiley:14651858:media:CD012854:CD012854-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Objective adherence, Outcome 1: Proportion of immunosuppressant trough concentration levels at target" data-id="CD012854-fig-0010" src="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_n/nCD012854-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_t/tCD012854-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: Objective adherence, Outcome 1: Proportion of immunosuppressant trough concentration levels at target </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/references#CD012854-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_n/nCD012854-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012854-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/urn:x-wiley:14651858:media:CD012854:CD012854-CMP-004.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Secondary outcomes, Outcome 1: Acute graft rejection" data-id="CD012854-fig-0011" src="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_n/nCD012854-CMP-004.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_t/tCD012854-CMP-004.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4: Secondary outcomes, Outcome 1: Acute graft rejection</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/references#CD012854-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_n/nCD012854-CMP-004.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012854-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/urn:x-wiley:14651858:media:CD012854:CD012854-CMP-004.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Secondary outcomes, Outcome 2: Graft loss" data-id="CD012854-fig-0012" src="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_n/nCD012854-CMP-004.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_t/tCD012854-CMP-004.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4: Secondary outcomes, Outcome 2: Graft loss</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/references#CD012854-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_n/nCD012854-CMP-004.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012854-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/urn:x-wiley:14651858:media:CD012854:CD012854-CMP-004.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Secondary outcomes, Outcome 3: Death" data-id="CD012854-fig-0013" src="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_n/nCD012854-CMP-004.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_t/tCD012854-CMP-004.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4: Secondary outcomes, Outcome 3: Death</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/references#CD012854-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_n/nCD012854-CMP-004.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012854-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/urn:x-wiley:14651858:media:CD012854:CD012854-CMP-004.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Secondary outcomes, Outcome 4: Hospital readmission" data-id="CD012854-fig-0014" src="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_n/nCD012854-CMP-004.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_t/tCD012854-CMP-004.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4: Secondary outcomes, Outcome 4: Hospital readmission</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/references#CD012854-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/media/CDSR/CD012854/image_n/nCD012854-CMP-004.04.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD012854-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Interventions for increasing immunosuppressant medication adherence versus standard care in solid organ transplant recipients</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Interventions for increasing immunosuppressant medication adherence versus standard care in solid organ transplant recipients</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> solid organ transplant recipients<br/><b>Setting:</b> transplant units and outpatient clinics </p> <p><b>Intervention:</b> interventions for increasing immunosuppressant medication adherence<br/><b>Comparison:</b> standard care </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b> </b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with standard care</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with interventions</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Taking adherence</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p> 819 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>893 per 1000</p> <p>(778 to 1000)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> RR 1.09<br/>(0.95 to 1.27) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> 445 (4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2 3 4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interventions were heterogeneous single and multi‐component interventions. Outcome was measured by electronic monitoring devices </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dosing adherence</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>778 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>887 per 1000</p> <p>(801 to 980)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 1.14<br/>(1.03 to 1.26) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>713 (8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/>LOW <sup>1 2 3 4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interventions were heterogeneous single and multi‐component interventions. Outcome was measured via electronic monitoring devices and pharmacy reconciliation </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Timing adherence</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>805 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>885 per 1000</p> <p>(789 to 990)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 1.10<br/>(0.98 to 1.23) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>632 (6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/>LOW <sup>1 2 3 4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interventions were heterogeneous single and multi‐component interventions. Outcome was measured by electronic monitoring devices </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drug holidays</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>676 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>757 per 1000</p> <p>(520 to 1000)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 1.12<br/>(0.77 to 1.62) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>445 (4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/>LOW <sup>1 2 3 4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interventions were heterogeneous single and multi‐component interventions. Outcome was measured by electronic monitoring devices </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Self‐reported adherence (proportion)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>586 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>709 per 1000</p> <p>(580 to 873)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.21<br/>(0.99 to 1.49) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>755 (9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2 3 4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions were heterogeneous single and multi‐component interventions.</p> <p>Self‐report measures included:</p> <p>Basel Assessment of Adherence to Immunosuppressant Medication Scale</p> <p>Immunosuppressant Therapy Adherence Scale</p> <p>MMAS</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Self‐reported adherence (mean)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p> ‐‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SMD was 0.65 higher with the intervention compared to the control<br/>(0.31 lower to 1.60 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>471 (5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2 3 4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions were heterogeneous single and multi‐component interventions.</p> <p>Self‐report measures were heterogenous, and tools included:</p> <p> <ul id="CD012854-list-0001"> <li> <p>Immunosuppressant Therapy Adherence Scale</p> </li> <li> <p>Transplant Effects Questionnaire, Adherence Subscale</p> </li> <li> <p>MMAS</p> </li> <li> <p>Medical Adherence Measure Medication Module</p> </li> </ul> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of immunosuppressant trough concentration levels at target</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>367 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>360 per 1000</p> <p>(249 to 514)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.98<br/>(0.68 to 1.40) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>348 (4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2 3 4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interventions were heterogeneous single and multi‐component interventions.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>SMD:</b> standardised mean difference </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded one level for inconsistency in intervention type </p> <p><sup>2</sup> Downgraded for inconsistency in outcome measurement </p> <p><sup>3</sup> Downgraded one level for uncertain or high risk of bias </p> <p><sup>4</sup> Downgraded one level for imprecision (small sample size or small number of events, confidence intervals overlap) </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Interventions for increasing immunosuppressant medication adherence versus standard care in solid organ transplant recipients</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/full#CD012854-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012854-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Implementation of medication adherence</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Taking adherence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>445</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.95, 1.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Dosing adherence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>713</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [1.03, 1.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Timing adherence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>632</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.98, 1.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Drug holidays <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>445</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.77, 1.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Implementation of medication adherence</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/references#CD012854-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012854-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Subjective adherence</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Self‐reported adherence (proportion) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>755</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.21 [0.99, 1.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Self‐reported adherence (mean) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>471</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [‐0.31, 1.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Subjective adherence</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/references#CD012854-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012854-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Objective adherence</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Proportion of immunosuppressant trough concentration levels at target <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>348</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.68, 1.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Objective adherence</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/references#CD012854-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012854-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Secondary outcomes</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.1 Acute graft rejection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>820</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.33, 1.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.2 Graft loss <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>467</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [0.29, 5.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.3 Death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>652</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.77, 1.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.4 Hospital readmission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>460</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.44, 1.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Secondary outcomes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012854.pub2/references#CD012854-tbl-0005">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD012854.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD012854-note-0006">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD012854-note-0014">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD012854-note-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD012854-note-0013">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD012854-note-0011">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD012854-note-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pt#CD012854-note-0009">Português</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD012854-note-0007">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD012854-note-0008">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012854\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012854\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012854\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012854\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012854\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012854\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012854\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012854\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012854\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012854\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012854\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012854\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012854\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012854\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012854\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012854\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012854\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012854\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=zCmos3jT&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012854.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012854.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD012854.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD012854.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012854.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740725498168"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012854.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740725498171"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012854.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e7caead69f4b8',t:'MTc0MDcyNTUwMC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 